GENE,ORGAN_SYSTEM,CONDITION,AGE_GROUP
AAAS,,Achalasia-addisonianism-alacrimia syndrome,Pediatric
AARS1,Neurologic,Charcot-Marie-Tooth disease; axonal; type 2N; Epileptic encephalopathy; early infantile; 29,N/A
AARS2,Neurologic,Leukoencephalopathy; progressive; with ovarian failure,Pediatric
ABAT,Neurologic,GABA-transaminase deficiency,Pediatric
ABCA1,Neurologic,Hypoalphalipoproteinemia; primary; 1; Tangier disease,Pediatric
ABCB7,Neurologic,Anemia; sideroblastic; and spinocerebellar ataxia,N/A
ABCD1,Neurologic,Adrenoleukodystrophy,Pediatric
ABCD3,Neurologic,Bile acid synthesis defect; congenital; 5,Pediatric
ABCD4,Neurologic,Methylmalonic aciduria and homocystinuria; cblJ type,Pediatric
ABHD12,Neurologic,Polyneuropathy; hearing loss; ataxia; retinitis pigmentosa; and cataract,N/A
ACAD8,Neurologic,Isobutyryl-CoA dehydrogenase deficiency,Pediatric
ACAD9,Neurologic,Mitochondrial complex I deficiency; nuclear type 20,Pediatric
ACADM,Neurologic,Acyl-CoA dehydrogenase; medium chain; deficiency of,Pediatric
ACADS,Neurologic,Acyl-CoA dehydrogenase; short-chain; deficiency of,Pediatric
ACADVL,Neurologic,Acyl-CoA dehydrogenase; very long chain; deficiency of,Pediatric
ACAT1,Neurologic,Alpha-methylacetoacetic aciduria,Pediatric
ACD,Neurologic,Dyskeratosis congenita; autosomal dominant 6; Dyskeratosis congenita; autosomal recessive 7,Pediatric
ACER3,Neurologic,Leukodystrophy; progressive; early childhood-onset (PLDECO),N/A
ACO2,Neurologic,Infantile cerebellar-retinal degeneration; Optic atrophy 9,N/A
ACOX1,Neurologic,Peroxisomal acyl-CoA oxidase deficiency,N/A
ACP5,Neurologic,Spondyloenchondrodysplasia with immune dysregulation,Pediatric
ACSF3,Neurologic,Combined malonic and methylmalonic aciduria,Pediatric
ACSL4,Neurologic,Mental retardation; X-linked 63,N/A
ACTA1,Neurologic,Myopathy; congenital; with fiber-type disproportion 1; Nemaline myopathy 3; Myopathy; nemaline; with stiffness and hypertonia; Myopathy; scapuloperoneal,N/A
ACTA2,Neurologic,Moyamoya disease 5; Multisystemic smooth muscle dysfunction syndrome; Aortic aneurysm; familial thoracic 6,Pediatric
ACTB,Neurologic,Baraitser-Winter syndrome 1,Pediatric
ACTG1,Neurologic,Deafness; autosomal dominant 20; Baraitser-Winter syndrome 2,Pediatric
ACTG2,Neurologic,Megacystis-microcolon-intestinal hypoperistalsis syndrome; Visceral myopathy,Pediatric
ACTL6B,Neurologic,Intellectual developmental disorder with severe speech and ambulation defects; Epileptic encephalopathy; early infantile; 76,N/A
ACY1,Neurologic,Aminoacylase 1 deficiency,N/A
ADAM22,Neurologic,Epileptic encephalopathy; early infantile; 61,N/A
ADAMTS10,Neurologic,Weill-Marchesani syndrome 1,Pediatric
ADAMTS13,Neurologic,Thrombotic thrombocytopenic purpura; familial (Schulman-Upshaw syndrome),Pediatric
ADAMTS18,Neurologic,Knobloch syndrome 2; Microcornea; myopic chorioretinal atrophy; and telecanthus; Retinal dystrophy; early onset; autosomal recessive,N/A
ADAR,Neurologic,Dyschromatosis symmetrica hereditaria; Aicardi-Goutieres syndrome 6,N/A
ADAT3,Neurologic,Mental retardation; autosomal recessive 36,N/A
ADCY5,Neurologic,Dyskinesia; familial; with facial myokymia,Adult
ADCY6,Neurologic,Lethal congenital contracture syndrome 8,N/A
ADD3,Neurologic,Cerebral palsy; spastic quadriplegic; 3,N/A
ADGRG1,Neurologic,Polymicrogyria; bilateral frontoparietal; Polymicrogyria; bilateral perisylvian,N/A
ADGRG6,Neurologic,Lethal congenital contracture syndrome 9,N/A
ADGRV1,Neurologic,Usher syndrome; type IIC,Pediatric
ADK,Neurologic,Hypermethioninemia due to adenosine kinase deficiency,N/A
ADNP,Neurologic,Helsmoortel-van der Aa syndrome (Mental retardation; autosomal dominant 28),N/A
ADPRHL2,Neurologic,Neurodegeneration; childhoo-onset; stress-induced; with variable ataxia and seizures,N/A
ADRA2B,Neurologic,Epilepsy; myoclonic; familial adult; 2,N/A
ADRB1,Neurologic,Beta-blocker response; association with,Pediatric
ADSL,Neurologic,Adenylosuccinase deficiency,N/A
AFF2,Neurologic,Premature ovarian failure,Pediatric
AFF4,Neurologic,Cognitive impairment; coarse facies; Heart defects; Obesity; Pulmonary involvement; Short stature; and skeletal dysplasia (CHOPS syndrome),N/A
AFG3L2,Neurologic,Spinocerebellar ataxia 28; Spastic ataxia 5; autosomal recessive,N/A
AGA,Neurologic,Aspartylglucosaminuria,N/A
AGK,Neurologic,Sengers syndrome,Pediatric
AGL,Neurologic,Glycogen storage disease III,Pediatric
AGPS,Neurologic,Rhizomelic chondrodysplasia punctata; type 3,N/A
AGRN,Neurologic,Myasthenic syndrome; congenital 8,Pediatric
AGTPBP1,Neurologic,Childhood-onset neurodegeneration with cerebellar atrophy,N/A
AGTR2,Neurologic,Mental retardation; X-linked 88,N/A
AHCY,Neurologic,Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency,Pediatric
AHDC1,Neurologic,Mental retardation; autosomal dominant 25 (Xia-Gibbs syndrome),N/A
AHI1,Neurologic,Joubert syndrome 3,N/A
AIFM1,Neurologic,Deafness; X-linked 5,Pediatric
AIMP1,Neurologic,Leukodystrophy; hypomyelinating; 3,N/A
AIMP2,Neurologic,Leukodystrophy; hypomyelinating; 17,N/A
AK1,Neurologic,Adenylate kinase deficiency; hemolytic anemia due to,Pediatric
AKT1,Neurologic,Cowden syndrome 6; Proteus syndrome ,Pediatric
AKT3,Neurologic,Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,N/A
ALAD,Neurologic,Porphyria; acute hepatic,Pediatric
ALDH18A1,Neurologic,Cutis laxa; autosomal dominant 3; Spastic paraplegia 9A; autosomal dominant; Cutis laxa; autosomal recessive; type IIIA; Spastic paraplegia 9B; autosomal recessive,N/A
ALDH1A3,Neurologic,Microphthalmia; isolated 8,N/A
ALDH3A2,Neurologic,Sjogren-Larsson syndrome,N/A
ALDH4A1,Neurologic,Hyperprolinemia; type II ,N/A
ALDH5A1,Neurologic,Succinic semialdehyde dehydrogenase deficiency,N/A
ALDH7A1,Neurologic,Epilepsy; pyridoxine-dependent,Pediatric
ALDOA,Neurologic,Glycogen storage disease XII,Pediatric
ALDOB,Neurologic,Fructose intolerance; hereditary,Pediatric
ALG1,Neurologic,Congenital disorder of glycosylation; type Ik,Pediatric
ALG11,Neurologic,Congenital disorder of glycosylation; type Ip,Pediatric
ALG12,Neurologic,Congenital disorder of glycosylation; type Ig,Pediatric
ALG13,Neurologic,Epileptic encephalopathy; early infantile; 36,N/A
ALG14,Neurologic,Myasthenic syndrome; congenital 15,Pediatric
ALG2,Neurologic,Congenital disorder of glycosylation; type Ii; Myasthenic syndrome; congenital 14,Pediatric
ALG3,Neurologic,Congenital disorder of glycosylation; type Id,Pediatric
ALG6,Neurologic,Congenital disorder of glycosylation; type Ic,Pediatric
ALG8,Neurologic,Congenital disorder of glycosylation; type Ih,Pediatric
ALG9,Neurologic,Congenital disorder of glycosylation; type Il,Pediatric
ALKBH8,Neurologic,Intellectual developmental disorder; autosomal recessive 71,N/A
ALPL,Neurologic,Hypophosphatasia; infantile; Odontohypophosphatasia,Pediatric
ALS2,Neurologic,Spastic paralysis; infantile onset ascending; Primary lateral sclerosis; juvenile; Amyotrophic lateral sclerosis 2,N/A
ALS2CL,Neurologic,Schizophrenia,N/A
ALX1,Neurologic,Frontonasal dysplasia 3,N/A
ALX3,Neurologic,Frontonasal dysplasia 1,N/A
ALX4,Neurologic,Parietal foramina 2; Frontonasal dysplasia 2,N/A
AMACR,Neurologic,Bile acid synthesis defect; congenital; 4; Alpha-methylacyl-CoA racemase deficiency,Pediatric
AMCN,Neurologic,Arthrogryposis multiplex congenita; neurogenic,N/A
AMER1,Neurologic,Osteopathia striata with cranial sclerosis,N/A
AMPD2,Neurologic,Pontocerebellar hypoplasia type 9; Spastic paraplegia 63,N/A
AMT,Neurologic,Glycine encephalopathy,Pediatric
ANG,Neurologic,Amyotrophic lateral sclerosis 9,N/A
ANKLE2,Neurologic,Microcephaly; primary autosomal recessive; 16,N/A
ANKRD11,Neurologic,KBG syndrome,N/A
ANO10,Neurologic,Spinocerebellar ataxia; autosomal recessive 10,N/A
ANO3,Neurologic,Dystonia 24,N/A
ANOS1,Neurologic,Kallmann syndrome 1,Pediatric
ANXA11,Neurologic,Amytrophic lateral sclerosis 23,N/A
AP1S1,Neurologic,MEDNIK syndrome,Pediatric
AP1S2,Neurologic,Mental retardation; X-linked syndromic; Fried type (Pettigrew syndrome),N/A
AP2M1,Neurologic,Intellectual developmental disorder 60 with seizures,N/A
AP3B1,Neurologic,Hermansky-Pudlak syndrome 2,Pediatric
AP3B2,Neurologic,Epileptic encephalopathy; early infantile; 48,N/A
AP3D1,Neurologic,Hermansky-Pudlak syndrome 10,Pediatric
AP4B1,Neurologic,Spastic paraplegia 47; autosomal recessive,N/A
AP4E1,Neurologic,Stuttering; familial persistent; 1; Spastic paraplegia 51; autosomal recessive,N/A
AP4M1,Neurologic,Spastic paraplegia 50; autosomal recessive,N/A
AP4S1,Neurologic,Spastic paraplegia 52; autosomal recessive,N/A
AP5Z1,Neurologic,Spastic paraplegia 48; autosomal recessive,N/A
APC2,Neurologic,Sotos syndrome 3,N/A
APOB,Neurologic,Hypercholesterolemia; familial; 2; Hypobetalipoproteinemia; familial 1,Pediatric
APOC2,Neurologic,Apolipoprotein C-II deficiency (Hyperlipoproteinemia; type Ib),Pediatric
APP,Neurologic,Alzheimer disease; familial; Cerebral amyloid angiopathy,N/A
APTX,Neurologic,Ataxia; early-onset; with oculomotor apraxia and hypoalbuminemia,N/A
AR,Neurologic,Androgen insensitivity; Androgen insensitivity; partial,Pediatric
ARCN1,Neurologic,Rhizomelic short stature with microcephaly; micrognathia; and developmental delay (SRMMD),N/A
ARF1,Neurologic,Periventricular nodular heterotopia 8,N/A
ARFGEF2,Neurologic,Heterotopia; periventricular; autosomal recessive,N/A
ARG1,Neurologic,Hyperargininemia,Pediatric
ARHGEF10,Neurologic,Slowed nerve conduction velocity; autosomal dominant (Hereditary motor and sensory neuropathy),N/A
ARHGEF2,Neurologic,Neurodevelopmental disorder with midbrain and hindbrain malformations (NEDMHM),N/A
ARHGEF6,Neurologic,Mental retardation; X-linked 46,N/A
ARHGEF9,Neurologic,Epileptic encephalopathy; early infantile; 8,N/A
ARID1A,Neurologic,Mental retardation; autosomal dominant 14; Coffin-Siris syndrome 2,N/A
ARID1B,Neurologic,Coffin-Siris syndrome 1,N/A
ARID2,Neurologic,Coffin-Siris syndrome 6,N/A
ARL13B,Neurologic,Joubert syndrome 8,N/A
ARL3,Neurologic,Joubert syndrome 35; Retinitis pigmentosa 83,N/A
ARL6,Neurologic,Retinitis pigmentosa 55; Bardet Biedl syndrome 3,N/A
ARL6IP1,Neurologic,Spastic paraplegia 61,N/A
ARMC9,Neurologic,Joubert syndrome 30,Pediatric
ARNT2,Neurologic,Webb-Datani syndrome,Pediatric
ARSA,Neurologic,Metachromatic leukodystrophy,N/A
ARSL,Neurologic,Chondrodysplasia punctata 1; X-linked recessive ,N/A
ARV1,Neurologic,Epileptic encephalopathy; early infantile; 38,N/A
ARX,Neurologic,Partington X-linked mental retardation syndrome; Epileptic encephalopathy; early infantile; 1; Lissencephaly; X-linked 2; Hydranencephaly with abnormal genitalia; Mental retardation; X-linked 29/32/33/38/43/54/76/87; Proud syndrome; Corpus callosum; agenesis of; with abnormal genitalia,N/A
ASAH1,Neurologic,Farber lipogranulomatosis; Spinal muscular atrophy with progressive myoclonic epilepsy,N/A
ASCC1,Neurologic,Barrett esophagus/Esophageal adenocarcinoma,Adult
ASCL1,Neurologic,Central hypoventilation syndrome; congenital (Haddad syndrome),Pediatric
ASH1L,Neurologic,Mental retardation; autosomal dominant; 50,N/A
ASL,Neurologic,Argininosuccinic aciduria,Pediatric
ASNS,Neurologic,Asparagine synthetase deficiency,Pediatric
ASPA,Neurologic,Aspartoacylase deficiency (Canavan disease),N/A
ASPM,Neurologic,Microcephaly; primary autosomal recessive; 5,N/A
ASS1,Neurologic,Citrullinemia ,Pediatric
ASXL1,Neurologic,Bohring-Opitz syndrome,N/A
ASXL2,Neurologic,Shashi-Pena syndrome,N/A
ASXL3,Neurologic,Bainbridge-Ropers syndrome,N/A
ATAD1,Neurologic,Hyperekplexia 4,Pediatric
ATAD3A,Neurologic,Harel-Yoon syndrome,N/A
ATCAY,Neurologic,Ataxia; cerebellar; Cayman type,N/A
ATIC,Neurologic,AICAR transformylase/IMP cyclohydrolase deficiency,N/A
ATL1,Neurologic,Neuropathy; hereditary sensory; type 1D; Spastic paraplegia 3; autosomal dominant,N/A
ATL3,Neurologic,Neuropathy; hereditary sensory; type IF,N/A
ATM,Neurologic,Breast cancer; susceptibility to; Ataxia-Telangiectasia,Pediatric (Ataxia-Telangiectasia); Adult (Breast cancer; susceptibility to)
ATN1,Neurologic,Congenital hypotonia; epilepsy; developmental delay; and digital anomalies; Dentatorubro-pallidoluysian atrophy,N/A
ATP13A2,Neurologic,Kufor-Rakeb syndrome (Parkinson disease 9); Ceroid lipofuscinosis; neuronal; 12; Spastic paraplegia; autosomal recessive; 78,N/A
ATP1A1,Neurologic,Hypomagnesemia; seizures; and mental retardation 2,Pediatric
ATP1A2,Neurologic,Alternating hemiplegia of childhood 1; Migraine; familial hemiplegic 2,Pediatric
ATP1A3,Neurologic,Alternating hemiplegia of childhood 2,Pediatric
ATP2B3,Neurologic,Spinocerebellar ataxia; X-linked 1,N/A
ATP5F1A,Neurologic,Combined oxidative phosphorylation deficiency 22; Mitochondrial complex V (ATP synthase) deficiency; nuclear type 4,N/A
ATP5F1E,Neurologic,Mitochondrial complex V (ATP synthase) deficiency; nuclear type 3,N/A
ATP6AP1,Neurologic,Immunodeficiency 47,Pediatric
ATP6AP2,Neurologic,Mental retardation; X-linked; syndromic; Hedera type; Parkinsonism with spasticity; X-linked,N/A
ATP6V0A2,Neurologic,Cutis laxa; autosomal recessive; type IIA; Wrinkly skin syndrome,N/A
ATP6V1A,Neurologic,Cutis laxa; autosomal recessive; type IID,Pediatric
ATP6V1B2,Neurologic,Deafness; congenital; with onychodystrophy; autosomal dominant; Zimmermann-Laband syndrome 2,Pediatric
ATP7A,Neurologic,Menkes disease,Pediatric
ATP7B,Neurologic,Wilson disease,Pediatric
ATP8A2,Neurologic,Cerebellar ataxia; mental retardation; and dysequilibrium syndrome 4,N/A
ATPAF2,Neurologic,Mitochondrial complex V (ATP synthase) deficiency; nuclear type 1,N/A
ATR,Neurologic,Cutaneous telangiectasia and cancer syndrome; familial; Seckel syndrome 1,Pediatric
ATRX,Neurologic,Alpha-thalassemia/mental retardation syndrome; Mental retardation-hypotonic facies syndrome; X-linked,N/A
ATXN1,Neurologic,Spinocerebellar ataxia 1,N/A
ATXN10,Neurologic,Spinocerebellar ataxia 10,N/A
ATXN2,Neurologic,Spinocerebellar ataxia 2,N/A
ATXN3,Neurologic,Spinocerebellar ataxia 3 (Machado-Joseph disease),N/A
ATXN7,Neurologic,Spinocerebellar ataxia 7,N/A
ATXN8,Neurologic,Spinocerebellar ataxia 8,N/A
ATXN8OS,Neurologic,Spinocerebellar ataxia 8,N/A
AUH,Neurologic,3-methylglutaconic aciduria; type I,N/A
AUTS2,Neurologic,Mental retardation; autosomal dominant 26,N/A
B2M,Neurologic,Immunodeficiency 43,Pediatric
B3GALNT1,Neurologic,Blood group; P system,Pediatric
B3GALNT2,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 11,N/A
B3GLCT,Neurologic,Peters-plus syndrome,Pediatric
B4GALNT1,Neurologic,Spastic paraplegia 26; autosomal recessive,N/A
B4GALT1,Neurologic,Congenital disorder of glycosylation; type IId,Pediatric
B4GALT7,Neurologic,Ehlers-Danlos syndrome; spondylodysplastic type; 1,N/A
B4GAT1,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 13,N/A
B9D1,Neurologic,Joubert syndrome 27; Meckel syndrome 9,N/A
B9D2,Neurologic,Meckel syndrome 10,N/A
BAG3,Neurologic,Cardiomyopathy; dilated; 1HH; Myopathy; myofibrillar 6,Adult
BBIP1,Neurologic,Bardet-Biedl syndrome 18,N/A
BBS1,Neurologic,Bardet-Biedl syndrome 1,N/A
BBS10,Neurologic,Bardet-Biedl syndrome 10,N/A
BBS12,Neurologic,Bardet-Biedl syndrome 12,N/A
BBS2,Neurologic,Bardet-Biedl syndrome 2; Retinitis pigmentosa 74,N/A
BBS4,Neurologic,Bardet-Biedl syndrome 4,N/A
BBS5,Neurologic,Bardet-Biedl syndrome 5,N/A
BBS7,Neurologic,Bardet-Biedl syndrome 7,N/A
BBS9,Neurologic,Bardet-Biedl syndrome 9,N/A
BCAP31,Neurologic,Deafness; dystonia; and cerebral hypomyelination,N/A
BCKDHA,Neurologic,Maple syrup urine disease; type Ia,Pediatric
BCKDHB,Neurologic,Maple syrup urine disease; type Ib,Pediatric
BCKDK,Neurologic,Branched-chain ketoacid dehydrogenase kinase deficiency,Pediatric
BCL11A,Neurologic,Dias-Logan syndrome,N/A
BCL11B,Neurologic,Immunodeficiency 49; Intellectual developmental disorder with speech delay; dysmorphic facies; and T-cell abnormalities,Pediatric
BCORL1,Neurologic,Shukla-Vernon syndrome,N/A
BCS1L,Neurologic,Bjornstad syndrome,Pediatric
BDNF,Neurologic,Central hypoventilation syndrome; congenital,Pediatric
BEAN1,Neurologic,Spinocerebellar ataxia 31,N/A
BGN,Neurologic,Meester-Loeys syndrome,Pediatric
BHLHE41,Neurologic,Short sleeper; familial natural; 1,N/A
BICD2,Neurologic,Spinal muscular atrophy; lower extremity-predominant; 2A; childhood onset; autosomal dominant; Spinal muscular atrophy; lower extremity-predominant; 2B; prenatal onset; autosomal dominant,N/A
BLM,Neurologic,Bloom syndrome,Pediatric
BMP4,Neurologic,Microphthalmia; syndromic 6; Orofacial cleft 11,N/A
BOLA3,Neurologic,Multiple mitochondrial dysfunctions syndrome 2,N/A
BPTF,Neurologic,Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies (NEDDFL),N/A
BRAF,Neurologic,Noonan syndrome; Cardiofaciocutaneous syndrome 1; LEOPARD syndrome 3,Pediatric
BRAT1,Neurologic,Rigidity and multifocal seizure syndrome; lethal neonatal,N/A
BRCA1,Neurologic,Breast-ovarian cancer; familial; susceptibility to; 1; Pancreatic cancer; susceptibility to; 4; Fanconi anemia; complementation group S,Pediatric (Fanconi anemia; complementation group S); (Adult (Breast-ovarian cancer; familial; susceptibility to; 1; Pancreatic cancer; susceptibility to; 4)
BRCA2,Neurologic,Breast-ovarian cancer; familial; susceptibility to; Pancreatic cancer; susceptibility to; 2; Glioma susceptibility 3; Fanconi anemia; complementation group D1; Wilms tumor; Medulloblastoma,Pediatric (Fanconi anemia; complementation group D1); Adult (Breast-ovarian cancer; familial; susceptibility to; Pancreatic cancer; susceptibility to; 2; Glioma susceptibility 3; Wilms tumor; Medulloblastoma)
BRF1,Neurologic,Cerebellofaciodental syndrome,N/A
BRIP1,Neurologic,Breast cancer; Fanconi anemia; complementation group J,Pediatric (Fanconi anemia; complementation group J); Adult (Breast  cancer)
BRPF1,Neurologic,Intellectual disability disorder with dysmorphic facies and ptosis (IDDDFP),N/A
BRWD3,Neurologic,Mental retardation; X-linked 93,N/A
BSCL2,Neurologic,Lipodystrophy; congenital generalized; type 2; Encephalopathy; progressive; with or without lipodystrophy,Pediatric
BTD,Neurologic,Biotinidase deficiency,Pediatric
BUB1B,Neurologic,Mosaic variegated aneuploidy syndrome; Premature chromatid separation trait,Pediatric
C12ORF4,Neurologic,Mental retardation; autosomal recessive 66,N/A
C12ORF57,Neurologic,Corpus callosum hypoplasia; recessive; Temtamy syndrome,N/A
C12ORF65,Neurologic,Combined oxidative phosphorylation deficiency 7; Spastic paraplegia 55; autosomal recessive ,N/A
C19ORF12,Neurologic,Neurodegeneration with brain iron accumulation 4; Spastic paraplegia 43,N/A
C1QBP,Neurologic,Combined oxidative phosphorylation deficiency 33,Pediatric
C2CD3,Neurologic,Orofaciodigital syndrome XIV,N/A
C5,Neurologic, Eculizumab; poor response to; Complement component 5 deficiency,Pediatric
C8ORF37,Neurologic,Bardet-Biedl syndrome 21; Cone-rod dystrophy 16; Retinitis pigmentosa 64,N/A
C9ORF72,Neurologic,Frontotemporal dementia and/or amyotrophic lateral sclerosis 1,N/A
CA2,Neurologic,Osteopetrosis; autosomal recessive 3; with renal tubular acidosis,Pediatric
CA8,Neurologic,Cerebellar ataxia; mental retardation; and dysequilibrium syndrome 3,N/A
CACNA1A,Neurologic,Episodic ataxia; type 2; Migraine; familial hemiplegic 1,Pediatric
CACNA1B,Neurologic,Dystonia 23,Pediatric
CACNA1C,Neurologic,Brugada syndrome 3; Timothy syndrome,Pediatric
CACNA1D,Neurologic,Primary aldosteronism; seizures; and neurologic abnormalities; Sinoatrial node dysfunction and deafness,Pediatric
CACNA1E,Neurologic,Epileptic encephalopathy; early infantile; 69,Pediatric
CACNA1G,Neurologic,Spinocerebellar ataxia 42; Spinocerebellar ataxia 42; early-onset; severe; with neurodevelopmental deficits,N/A
CACNA1H,Neurologic,Hyperaldosteronism; familial; type IV,Pediatric
CACNA2D2,Neurologic,Cerebellar atrophy with seizures and variable developmental delay; Early infantile epileptic encephalopathy; High voltage gated calcium channelopathy-related; autosomal recessive,N/A
CACNB4,Neurologic,Episodic ataxia; type 5,Pediatric
CACNG2,Neurologic,Mental retardation; autosomal dominant 10,N/A
CAD,Neurologic,Epileptic encephalopathy; early infantile; 50 (Congenital disorder of glycosylation; type Iz),Pediatric
CALM1,Neurologic,Long QT syndrome 14; Recurrent cardiac arrest; infantile; Ventricular tachycardia; catecholaminergic polymorphic; 4,Pediatric
CALM2,Neurologic,Long QT syndrome 15,Pediatric
CAMK2A,Neurologic,Mental retardation; autosomal dominant; 53; Mental retardation; autosomal recessive; 63,N/A
CAMK2B,Neurologic,Mental retardation; autosomal dominant; 54,N/A
CAMK2G,Neurologic,Intellectual developmental disorder 59,N/A
CAMTA1,Neurologic,Cerebellar ataxia; nonprogressive; with mental retardation,N/A
CANT1,Neurologic,Desbuquois dysplasia 1; Epiphyseal dysplasia; multiple; 7,N/A
CAPN1,Neurologic,Spastic paraplegia 76; autosomal recessive,N/A
CARS2,Neurologic,Combined oxidative phosphorylation deficiency 27,N/A
CASK,Neurologic,Mental retardation and microcephaly with pontine and cerebellar hypoplasia; FG syndrome 4; Mental retardation; with or without nystagmus,Pediatric
CASR,Neurologic,Hyperparathyroidism; neonatal; Hypocalcemia; autosomal dominant 1; Hypocalciuric hypercalcemia; type I; Hyperparathyroidism; neonatal severe primary; Hypoparathyroidism; familial isolated; Hyperparathyroidism; familial primary,Pediatric
CAV1,Neurologic,Pulmonary hypertension; primary 3; Lipodystrophy; familial partial; type 7; Lipodystrophy; congenital generalized; type 3,Pediatric
CBL,Neurologic,Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia; Juvenile myelomonocytic leukemia; familial,Pediatric
CBS,Neurologic,Homocystinuria due to cystathionine beta-synthase deficiency,Pediatric
CC2D1A,Neurologic,Mental retardation; autosomal recessive 3,N/A
CC2D2A,Neurologic,Joubert syndrome 9; Meckel syndrome 6; COACH syndrome,N/A
CCBE1,Neurologic,Hennekam lymphangiectasia-lymphedema syndrome,Pediatric
CCDC115,Neurologic,Congenital disorder of glycosylation; type IIo,Pediatric
CCDC137,Neurologic,Schizophrenia,N/A
CCDC174,Neurologic,Hypotonia; infantile; with psychomotor retardation,N/A
CCDC22,Neurologic,Ritscher-Schinzel syndrome 2,N/A
CCDC47,Neurologic,Trichohepatoneurodevelopmental syndrome,Pediatric
CCDC88A,Neurologic,PEHO-like syndrome,N/A
CCDC88C,Neurologic,Spinocerebellar ataxia 40; Hydrocephalus; congenital; 1,N/A
CCM2,Neurologic,Cerebral cavernous malformations 2,Pediatric
CCND2,Neurologic,Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome,N/A
CCNK,Neurologic,Intellectual developmental disorder with hypertelorism and distinctive facies,N/A
CCT5,Neurologic,Neuropathy; hereditary sensory; with spastic paraplegia,N/A
CD59,Neurologic,Hemolytic anemia; CD59-mediated; with or without immune-mediated polyneuropathy,Pediatric
CD96,Neurologic,C syndrome (Opitz trigonocephaly syndrome),N/A
CDC42,Neurologic,Takenouchi-Kosaki syndrome,N/A
CDC45,Neurologic,Meier-Gorlin syndrome 7,N/A
CDC6,Neurologic,Meier-Gorlin syndrome 5,N/A
CDCA7,Neurologic,Immunodeficiency-centromeric instability-facial anomalies syndrome 3,Pediatric
CDH11,Neurologic,Elsahy-Waters syndrome,N/A
CDH15,Neurologic,Mental retardation; autosomal dominant 3,N/A
CDK10,Neurologic,Al Kaissi syndrome,N/A
CDK13,Neurologic,Congenital heart defects; dysmorphic facial features; and intellectual developmental disorder,N/A
CDK5,Neurologic,Lissencephaly 7 with cerebellar hypoplasia,N/A
CDK5RAP2,Neurologic,Microcephaly; primary autosomal recessive; 3,Pediatric
CDK6,Neurologic,Microcephaly 12; primary; autosomal recessive,N/A
CDKL5,Neurologic,Epileptic encephalopathy; early infantile; 2; Rett syndrome; atypical; Angelman-like syndrome,N/A
CDKN1C,Neurologic,IMAGE syndrome; Beckwith-Wiedemann syndrome,Pediatric
CDON,Neurologic,Holoprosencephaly 11,N/A
CDT1,Neurologic,Meier-Gorlin syndrome 4,N/A
CENPE,Neurologic,Microcephaly 13; primary; autosomal recessive,N/A
CENPF,Neurologic,Stromme syndrome,N/A
CENPJ,Neurologic,Seckel syndrome 4; Microcephaly; primary autosomal recessive; 6,N/A
CEP120,Neurologic,Joubert syndrome 31; Short-rib thoracic dysplasia 13 with or without polydactyly,N/A
CEP135,Neurologic,Microcephaly 8; primary; autosomal recessive,N/A
CEP152,Neurologic,Seckel syndrome 5; Microcephaly 9; primary; autosomal recessive,N/A
CEP164,Neurologic,Nephronophthisis 15,N/A
CEP290,Neurologic,Leber congenital amaurosis 10; Meckel syndrome 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14,N/A
CEP41,Neurologic,Joubert syndrome 15,N/A
CEP55,Neurologic,Multinucleated neurons; anhydramnios; renal dysplasia; cerebellar hypoplasia and hydranencephaly (MARCH),N/A
CEP57,Neurologic,Mosaic variegated aneuploidy syndrome 2,Pediatric
CEP63,Neurologic,Seckel syndrome 6,N/A
CEP83,Neurologic,Nephronophthisis 18,N/A
CERS1,Neurologic,Epilepsy; progressive myoclonic 8,N/A
CERT1,Neurologic,Mental retardation; autosomal dominant 34,N/A
CHAMP1,Neurologic,Mental retardation; autosomal dominant 40,N/A
CHAT,Neurologic,Myasthenic syndrome; congenital 6; presynaptic,Pediatric
CHCHD10,Neurologic,Myopathy; isolated mitochondrial; autosomal dominant,Pediatric
CHCHD2,Neurologic,Parkinson disease 22; autosomal dominant,N/A
CHD1,Neurologic,Pilarowski-Bjornsson syndrome,N/A
CHD2,Neurologic,Epileptic encephalopathy; childhood-onset,N/A
CHD3,Neurologic,Snijders Blok-Campeau syndrome,N/A
CHD4,Neurologic,Sifrim-Hitz-Weiss syndrome,Pediatric
CHD7,Neurologic,CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia,Pediatric
CHD8,Neurologic,Autism; susceptibility to 18,N/A
CHKB,Neurologic,Muscular dystrophy; congenital; megaconial type,Pediatric
CHMP1A,Neurologic,Pontocerebellar hypoplasia; type 8,N/A
CHMP2B,Neurologic,Amyotrophic lateral sclerosis; CHMP2B-related; Dementia; familial; nonspecific; Frontotemporal dementia; chromosome 3-linked ,N/A
CHN1,Neurologic,Duane retraction syndrome 2,N/A
CHP1,Neurologic,Spastic ataxia 9; autosomal recessive,N/A
CHRNA1,Neurologic,Myasthenic syndrome; congenital; 1A; slow-channel; Myasthenic syndrome; congenital; 1B; fast-channel,Pediatric
CHRNA2,Neurologic,Epilepsy; nocturnal frontal lobe; type 4,N/A
CHRNA4,Neurologic,Epilepsy; nocturnal frontal lobe; type 1,N/A
CHRNA7,Neurologic,Neurocognitive dysfunction with distinctive craniofacial features,N/A
CHRNB1,Neurologic,Myasthenic syndrome; congenital; 2A; slow-channel; Myasthenic syndrome; congenital; 2C; associated with acetylcholine receptor deficiency,Pediatric
CHRNB2,Neurologic,Epilepsy; nocturnal frontal lobe; type 3,N/A
CHRND,Neurologic,Myasthenic syndrome; congenital; 3A; slow-channel; Myasthenic syndrome; congenital; 3B; fast-channel; Myasthenic syndrome; congenital; 3C; associated with acetylcholine receptor deficiency,Pediatric
CHRNE,Neurologic,Myasthenic syndrome; congenital; associated with acetylcholine receptor deficiency;  Myasthenic syndrome; congenital; 4B; fast-channel; Myasthenic syndrome; congenital; 4C; associated with acetylcholine receptor deficiency,Pediatric
CHSY1,Neurologic,Temtamy preaxial brachydactyly syndrome,Pediatric
CHUK,Neurologic,Cocoon syndrome,N/A
CIC,Neurologic,Mental retardation; autosomal dominant 45,N/A
CILK1,Neurologic,Epilepsy; juvenile myoclonic; susceptibility to; 10; Endocrine-cerebroosteodysplasia,N/A
CIT,Neurologic,Microcephaly 17; primary; autosomal recessive,N/A
CIZ1,Neurologic,Primary cervical dystonia; adult-onset,N/A
CKAP2L,Neurologic,Filippi syndrome,N/A
CLAM,Neurologic,Pontocerebellar hypoplasia; type 3,N/A
CLCF1,Neurologic,Crisponi/Cold-induced sweating syndrome 2,Pediatric
CLCN2,Neurologic,Hyperaldosteronism; familial; type II,Pediatric
CLCN4,Neurologic,Raynaud-Claes syndrome,N/A
CLCN7,Neurologic,Osteopetrosis; autosomal dominant 2; Osteopetrosis; autosomal recessive 4,Pediatric
CLIC2,Neurologic,Mental retardation; X-linked; syndromic 32,Adult
CLN3,Neurologic,Ceroid lipofuscinosis; neuronal; 3,N/A
CLN5,Neurologic,Ceroid lipofuscinosis; neuronal; 5,N/A
CLN6,Neurologic,Ceroid lipofuscinosis; neuronal; 6; Ceroid lipofuscinosis; neuronal; 4A; autosomal recessive,N/A
CLN8,Neurologic,Ceroid lipofuscinosis; neuronal; 8; Ceroid lipofuscinosis; neuronal; 8; Northern epilepsy variant,N/A
CLP1,Neurologic,Pontocerebellar hypoplasia type 10,N/A
CLPB,Neurologic,3-methylglutaconic aciduria with cataracts; neurologic involvement; and neutropenia (MEGCANN),Pediatric
CLPP,Neurologic,Perrault syndrome 3,Pediatric
CLTC,Neurologic,Mental retardation; autosomal dominant; 56,N/A
CNBP,Neurologic,Myotonic dystrophy 2,Pediatric
CNKSR2,Neurologic,Mental retardation; X-linked; syndromic; Houge type,N/A
CNNM2,Neurologic,Hypomagnesemia 6; renal,Pediatric
CNOT1,Neurologic,Holoprosencephaly 12; with or without pancreatic agenesis,Pediatric
CNOT2,Neurologic,Intellectual developmental disorder with nasal speech; dysmorphic facies; and variable skeletal anomalies,N/A
CNPY3,Neurologic,Epileptic encephalopathy; early infantile; 60,N/A
CNTN2,Neurologic,Epilepsy; familial adult myoclonic 5,N/A
CNTNAP1,Neurologic,Lethal congenital contracture syndrome 7; Neuropathy; congenital hypomyelinating; 3,N/A
CNTNAP2,Neurologic,Cortical dysplasia-focal epilepsy syndrome; Pitt-Hopkins like syndrome 1,N/A
COA3,Neurologic,Mitochondrial complex IV deficiency,N/A
COA6,Neurologic,Cardioencephalomyopathy; fatal infantile; due to cytochrome c oxidase deficiency 4,N/A
COA7,Neurologic,Spinocerebellar ataxia; autosomal recessive; with axonal neuropathy 3,N/A
COA8,Neurologic,Mitochondrial complex IV deficiency,N/A
COASY,Neurologic,Neurodegeneration with brain iron accumulation 6; Pontocerebellar hypoplasia; type 12,N/A
COG1,Neurologic,Congenital disorder of glycosylation; type IIg,Pediatric
COG2,Neurologic,Congenital disorder of glycosylation; type IIq,Pediatric
COG4,Neurologic,Congenital disorder of glycosylation; type IIj,Pediatric
COG5,Neurologic,Congenital disorder of glycosylation; type IIi,Pediatric
COG6,Neurologic,Congenital disorder of glycosylation; type IIl,Pediatric
COG7,Neurologic,Congenital disorder of glycosylation; type IIe,Pediatric
COG8,Neurologic,Congenital disorder of glycosylation; type IIh,Pediatric
COL13A1,Neurologic,Myasthenic syndrome; congenital; 19,Pediatric
COL18A1,Neurologic,Knobloch syndrome 1,N/A
COL3A1,Neurologic,Ehlers-Danlos syndrome; vascular type; Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome,Pediatric
COL4A1,Neurologic,Angiopathy; hereditary; with nephropathy; aneurysms; and muscle cramps; Brain small vessel disease 1 with or without ocular anomalies; Anterior segment dysgenesis with cerebral involvement; Porencephaly 1; Retinal artery tortuosity; Schizencephaly,Adult
COL6A2,Neurologic,Ullrich congenital muscular dystrophy 1 ; Myosclerosis; congenital; Bethlem myopathy 1; Epilepsy; progressive myoclonic; autosomal recessive,N/A
COLEC10,Neurologic,3MC syndrome 3,N/A
COLEC11,Neurologic,3MC syndrome 2,Pediatric
COLGALT1,Neurologic,Brain small vessel disease 3,N/A
COLQ,Neurologic,Myasthenic syndrome; congenital; 5,Pediatric
COPB2,Neurologic,Microcephaly 19; primary; autosomal recessive,N/A
COQ2,Neurologic,Coenzyme Q10 deficiency 1,Pediatric
COQ4,Neurologic,Coenzyme Q10 deficiency 7,Pediatric
COQ6,Neurologic,Coenzyme Q10 deficiency; primary 6,Pediatric
COQ7,Neurologic,Coenzyme Q10 deficiency; primary 8,Pediatric
COQ8A,Neurologic,Coenzyme Q10 deficiency; primary 4; Progressive cerebellar ataxia and atrophy,Pediatric
COQ9,Neurologic,Coenzyme Q10 deficiency 5,Pediatric
COX10,Neurologic,Mitochondrial complex IV deficiency; Leigh syndrome,N/A
COX14,Neurologic,Mitochondrial complex IV deficiency,N/A
COX15,Neurologic,Leigh syndrome; Cardioencephalomyopathy; fatal infantile; due to cytochrome c oxidase deficiency 2,N/A
COX20,Neurologic,Mitochondrial complex IV deficiency,N/A
COX4I2,Neurologic,Exocrine pancreatic insufficiency; dyserythropoietic anemia; and calvarial hyperostosis,Pediatric
COX6A1,Neurologic,Charcot-Marie-Tooth disease; recessive intermediate D,N/A
COX6B1,Neurologic,Mitochondrial complex IV deficiency,N/A
COX7B,Neurologic,Linear skin defects with multiple congenital anomalies 2,N/A
COX8A,Neurologic,Mitochondrial complex IV deficiency,N/A
CP,Neurologic,Aceruloplasminemia; Hypoceruloplasminemia,Pediatric
CPA6,Neurologic,Febrile seizures; familial; 11; Epilepsy; familial temporal lobe; 5,N/A
CPLANE1,Neurologic,Joubert syndrome 17; Orofaciodigital syndrome VI,N/A
CPLX1,Neurologic,Epileptic encephalopathy; early infantile 63,N/A
CPOX,Neurologic,Coproporphyria; Harderoporphyria,Pediatric
CPS1,Neurologic,Carbamoylphosphate synthetase I deficiency,Pediatric
CPT1A,Neurologic,Carnitine palmitoyltransferase deficiency I,Pediatric
CPT1C,Neurologic,Spastic paraplegia 73; autosomal dominant,N/A
CPT2,Neurologic,Carnitine palmitoyltransferase II deficiency,Pediatric
CRADD,Neurologic,Mental retardation; autosomal recessive 34; with variant lissencephaly,N/A
CRAT,Neurologic,Neurodegeneration with brain iron accumulation 8,N/A
CRB2,Neurologic,Focal segmental glomerulosclerosis 9; Ventriculomegaly with cystic kidney disease,N/A
CRBN,Neurologic,Mental retardation; autosomal recessive 2,N/A
CREBBP,Neurologic,Rubinstein-Taybi syndrome; Menke-Hennekam syndrome 1,Pediatric
CRIPT,Neurologic,Short stature with microcephaly and distinctive facies,N/A
CRLF1,Neurologic,Crisponi/Cold-induced sweating syndrome; type 1,Pediatric
CRPPA,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital; with brain and eye anomalies); type A; 7; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 7,N/A
CRY1,Neurologic,Delayed sleep phase syndrome; susceptibility to,N/A
CSF1R,Neurologic,Leukoencephalopathy; diffuse hereditary; with spheroids; Brain abnormalities; neurodegeneration; and dysosteosclerosis,N/A
CSNK1D,Neurologic,Advanced sleep phase syndrome; familial; 2,N/A
CSNK2A1,Neurologic,Okur-Chung neurodevelopmental syndrome,Pediatric
CSPP1,Neurologic,Jeune asphyxiating thoracic dystrophy; Joubert syndrome 21,N/A
CST3,Neurologic,Cerebral amyloid angiopathy,N/A
CSTB,Neurologic,Myoclonic epilepsy of Unverricht and Lundborg,N/A
CTBP1,Neurologic,Hypotonia; ataxia; developmental delay; and tooth enamel defect syndrome,N/A
CTC1,Neurologic,Cerebroretinal microangiopathy with calcifications and cysts 1,N/A
CTCF,Neurologic,Mental retardation; autosomal dominant; 21,N/A
CTDP1,Neurologic,Congenital cataracts; facial dysmorphism; and neuropathy,Pediatric
CTNNA2,Neurologic,Cortical dysplasia; complex; with other brain malformations; 9,N/A
CTNNB1,Neurologic,Exudative vitreoretinopathy 7; Neurodevelopmental disorder with spastic diplegia and visual defect (Mental retardation; autosomal dominant 19),N/A
CTSA,Neurologic,Galactosialidosis,Pediatric
CTSD,Neurologic,Ceroid lipofuscinosis; neuronal; 10,N/A
CTSF,Neurologic,Neuronal ceroid lipofuscinosis 13,N/A
CTU2,Neurologic,Microcephaly; facial dysmorphism; renal agenesis; and ambiguous genitalia syndrome,N/A
CUL4B,Neurologic,Mental retardation; X-linked; syndromic 15 (Cabezas type),N/A
CUX1,Neurologic,Global developmental delay with or without impaired intellectual development,N/A
CUX2,Neurologic,Epileptic encephalopathy; early infantile 67,N/A
CWC27,Neurologic,Retinitis pigmentosa with or without skeletal anomalies (RPSKA),N/A
CWF19L1,Neurologic,Spinocerebellar ataxia; autosomal recessive 17,N/A
CXORF56,Neurologic,Mental retardation; X-linked; 107,N/A
CYB5R3,Neurologic,Methemoglobinemia due to methemoglobin reductase deficiency,Pediatric
CYFIP2,Neurologic,Epileptic encephalopathy; early infantile; 65,N/A
CYP27A1,Neurologic,Cerebrotendinous xanthomatosis,Pediatric
CYP2U1,Neurologic,Spastic paraplegia 56; autosomal recessive,N/A
CYP7B1,Neurologic,Bile acid synthesis defect; congenital; 3,Pediatric
CYTB,Neurologic,Myoglobinuria; recurrent; Leber hereditary optic neuropathy; Cardiomyopathy; infantile histiocytoid,N/A
D2HGDH,Neurologic,D-2-hydroxyglutaric aciduria 1,N/A
DAB1,Neurologic,Spinocerebellar ataxia 37,N/A
DAG1,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 9; Muscular dystrophy-dystroglycanopathy; type C; 9,N/A
DARS1,Neurologic,Hypomyelination with brainstem and spinal cord involvement and leg spasticity,N/A
DARS2,Neurologic,Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation,N/A
DBH,Neurologic,Dopamine beta-hydroxylase deficiency,Pediatric
DBT,Neurologic,Maple syrup urine disease; type II,Pediatric
DCAF17,Neurologic,Woodhouse-Sakati syndrome,Pediatric
DCAF8,Neurologic,Giant axonal neuropathy 2; autosomal dominant,Adult
DCC,Neurologic,Mirror movements 1; Gaze palsy; familial horizontal; with progressive scoliosis 2,N/A
DCHS1,Neurologic,Mitral valve prolapse 2; Van Maldegrem syndrome 1,Pediatric
DCPS,Neurologic,Al-Raqad syndrome,N/A
DCTN1,Neurologic,Neuropathy; distal hereditary motor; type VIIB; Perry syndrome,N/A
DCX,Neurologic,Lissencephaly; X-linked; 1,N/A
DDC,Neurologic,Aromatic l-amino acid decarboxylase deficiency,Pediatric
DDHD1,Neurologic,Spastic paraplegia 28; autosomal recessive,N/A
DDHD2,Neurologic,Spastic paraplegia 54,N/A
DDOST,Neurologic,Congenital disorder of glycosylation; type Ir,Pediatric
DDX11,Neurologic,Warsaw breakage syndrome,N/A
DDX3X,Neurologic,Mental retardation; X-linked 102,N/A
DDX59,Neurologic,Orofaciodigital syndrome V,N/A
DEAF1,Neurologic,Mental retardation; autosomal dominant 24; Dyskinesia; seizures; and intellectual development disorder,N/A
DECR1,Neurologic,2;4-dienoyl-CoA reductase deficiency,N/A
DEGS1,Neurologic,Leukodystrophy; hypomyelinating; 18,N/A
DENND5A,Neurologic,Epileptic encephalopathy; early infantile; 49,N/A
DEPDC5,Neurologic,Epilepsy; familial focal; with variable foci 1,N/A
DES,Neurologic,Myopathy; myofibrillar 1; Cardiomyopathy; dilated; 1I; Muscular dystrophy; limb-girdle; type 2R,Pediatric
DGCR2,Neurologic,Schizophrenia,N/A
DGUOK,Neurologic,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type),Pediatric
DHCR24,Neurologic,Desmosterolosis,N/A
DHCR7,Neurologic,Smith-Lemli-Opitz syndrome,Pediatric
DHDDS,Neurologic,Developmental delay and seizures with or without movement abnormalities (DEDSM); Retinitis pigmentosa 59,N/A
DHFR,Neurologic,Megaloblastic anemia due to dihydrofolate reductase deficiency,Pediatric
DHH,Neurologic,46;XY partial gonadal dysgenesis; with minifascicular neuropathy; 46;XY sex reversal 7,Pediatric
DHPS,Neurologic,Neurodevelopmental disorder with seizures and speech and walking impairment,N/A
DHTKD1,Neurologic,Charcot-Marie-Tooth disease; axonal; type 2Q; 2-aminoadipic and 2-oxoadipic aciduria,N/A
DHX30,Neurologic,Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL),N/A
DIAPH1,Neurologic,Deafness; autosomal dominant 1,Pediatric
DIP2B,Neurologic,Mental retardation; FRA12A type,N/A
DIS3L2,Neurologic,Perlman syndrome,Pediatric
DKC1,Neurologic,Dyskeratosis congenita; X-linked; Hoyeraal-Hreidarsson syndrome,Pediatric
DLAT,Neurologic,Pyruvate dehydrogenase E2 deficiency,Pediatric
DLD,Neurologic,Dihydrolipoyl dehydrogenase deficiency,Pediatric
DLG3,Neurologic,Mental retardation; X-linked 90,N/A
DLL1,Neurologic,Holoprosencephaly,N/A
DMD,Neurologic,Duchenne muscular dystrophy; Becker muscular dystrophy; Cardiomyopathy; dilated; 3B,Pediatric
DMPK,Neurologic,Myotonic dystrophy 1,Pediatric
DMXL2,Neurologic,Polyendocrine-polyneuropathy syndrome,Pediatric
DNA2,Neurologic,Progressive external ophthalmoplegia with mitochondrial deletions; autosomal dominant; 6; Seckel syndrome 8,N/A
DNAJB2,Neurologic,Spinal muscular atrophy; distal; autosomal recessive; 5; Charcot-Marie-Tooth disease; axonal; type 2T,N/A
DNAJC13,Neurologic,Parkinson disease 21,N/A
DNAJC19,Neurologic,3-methylglutaconic aciduria; type V,Pediatric
DNAJC21,Neurologic,Bone marrow failure syndrome 3,Pediatric
DNAJC3,Neurologic,Ataxia; combined cerebellar and peripheral; with hearing loss and diabetes mellitus,N/A
DNAJC5,Neurologic,Ceroid lipofuscinosis; neuronal 4B; autosomal dominant,N/A
DNAJC6,Neurologic,Parkinson disease 19A; juvenile-onset,N/A
DNAL4,Neurologic,Mirror movements 3,N/A
DNM1,Neurologic,Epileptic encephalopathy; early infantile 31,N/A
DNM1L,Neurologic,Encephalopathy due to defective mitochondrial and peroxisomal fission 1; Optic atrophy 5,N/A
DNM2,Neurologic,Charcot-Marie-Tooth disease; dominant intermediate B; Charcot-Marie-Tooth disease; axonal; type 2M; Myopathy; centronuclear; 1; Lethal congenital contracture syndrome 5,N/A
DNMT1,Neurologic,Neuropathy; hereditary sensory; type IE; Cerebellar ataxia; deafness; and narcolepsy; autosomal dominant,N/A
DNMT3A,Neurologic,Tatton-Brown-Rahman syndrome,N/A
DNMT3B,Neurologic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,Pediatric
DOCK3,Neurologic,Neurodevelopmental disorder with impaired intellectual development; hypotonia; and ataxia,N/A
DOCK6,Neurologic,Adams-Oliver syndrome 2,N/A
DOCK7,Neurologic,Epilepitic encephalopathy; early infantile; 23,N/A
DOCK8,Neurologic,Hyper-IgE recurrent infection syndrome 2; autosomal recessive,Pediatric
DOK7,Neurologic,Myasthenic syndrome; congenital; 10,Pediatric
DOLK,Neurologic,Congenital disorder of glycosylation; type Im,Pediatric
DONSON,Neurologic,Microcephaly; short stature; and limb abnormalities (MISSLA); Microcephaly-Micromelia syndrome,N/A
DPAGT1,Neurologic,Myasthenic syndrome; congenital; 13; Congenital disorder of glycosylation; type Ij,Pediatric
DPF2,Neurologic,Coffin-Siris syndrome 7,N/A
DPH1,Neurologic,Developmental delay with short stature; dysmorphic features; and sparse hair,N/A
DPM1,Neurologic,Congenital disorder of glycosylation; type Ie,Pediatric
DPM2,Neurologic,Congenital disorder of glycosylation; type Iu,Pediatric
DPM3,Neurologic,Muscular dystrophy-dystroglycanopathy; type C; 15 (Congenital disorder of glycosylation; type Io),Pediatric
DPP6,Neurologic,Ventricular fibrillation; paroxysmal familial; 2,Pediatric
DPYS,Neurologic,Dihydropyriminidase deficiency,Pediatric
DSE,Neurologic,Ehlers-Danlos syndrome; musculocontractural type 2,Pediatric
DSG1,Neurologic,Severe dermatitis; multiple allergies; and metabolic wasting syndrome (SAM syndrome),Pediatric
DST,Neurologic,Epidermolysis bullosa simplex; autosomal recessive 2; Neuropathy; hereditary sensory and autonomic; type VI,N/A
DSTYK,Neurologic,Congenital anomalies of the kidney and urinary tract; 1,Pediatric
DUSP6,Neurologic,Hypogonadotropic hypogonadism 19; with or without anosmia,Pediatric
DYNC1H1,Neurologic,Charcot-Marie-Tooth disease; axonal; type 2O; Mental retardation; autosomal dominant 13; Spinal muscular atrophy; lower extremity-predominant 1; autosomal dominant,N/A
DYNC2H1,Neurologic,Short-rib thoracic dysplasia 3 with or without polydactyly,N/A
DYRK1A,Neurologic,Mental retardation; autosomal dominant 7,N/A
EARS2,Neurologic,Combined oxidative phosphorylation deficiency 12,N/A
EBF3,Neurologic,Hypotonia; ataxia; and delayed development syndrome (HADDS),N/A
EBP,Neurologic,Chondrodysplasia punctata 2; X-linked dominant; Male EBP disorder with neurologic defects (MEND),N/A
ECE1,Neurologic,Hirschsprung disease; cardiac defects; and autonomic dysfunction,N/A
ECHS1,Neurologic,Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency,N/A
ECM1,Neurologic,Lipoid proteinosis,N/A
EDC3,Neurologic,Mental retardation; autosomal recessive 50,N/A
EDN3,Neurologic,Waardenburg syndrome; type 4B; Central hypoventilation syndrome; congenital; Hirschsprung disease; susceptibility to; 4,Pediatric
EED,Neurologic,Cohen-Gibson syndrome,N/A
EEF1A2,Neurologic,Epileptic encephalopathy; early infantile; 33; Mental retardation; autosomal dominant 28,N/A
EEF2,Neurologic,Spinocerebellar ataxia 26,N/A
EFHC1,Neurologic,Epilepsy; myoclonic juvenile; Epilepsy; juvenile absence; susceptibility to; 1; Epilepsy; severe intractable,N/A
EFL1,Neurologic,Shwachman-Diamond syndrome 2,Pediatric
EFTUD2,Neurologic,Mandibulofacial dysostosis; Guion-Almeida type; Esophageal atresia; syndromic,Pediatric
EGR2,Neurologic,Charcot-Marie-Tooth disease; demyelinating; type 1D; Neuropathy; congenital hypomyelinating; 1; autosomal recessive; Dejerine-Sottas disease,N/A
EHMT1,Neurologic,Kleefstra syndrome 1,N/A
EIF2AK3,Neurologic,Epiphyseal dysplasia; multiple; with early-onset diabetes mellitus (Wolcott-Rallison syndrome),Pediatric
EIF2B1,Neurologic,Leukoencephalopathy with vanishing white matter; Ovarioleukodystrophy,Pediatric
EIF2B2,Neurologic,Leukoencephalopathy with vanishing white matter; Ovarioleukodystrophy,Pediatric
EIF2B3,Neurologic,Leukoencephalopathy with vanishing white matter; Ovarioleukodystrophy,Pediatric
EIF2B4,Neurologic,Leukoencephalopathy with vanishing white matter; Ovarioleukodystrophy,Pediatric
EIF2B5,Neurologic,Leukoencephalopathy with vanishing white matter; Ovarioleukodystrophy,Pediatric
EIF2S3,Neurologic,MEHMO syndrome,Pediatric
EIF3F,Neurologic,Intellectual developmental disorder 67,N/A
EIF4E,Neurologic,Autism; susceptibility to; 19,N/A
EIF4G1,Neurologic,Parkinson disease 18; Macular dystrophy with central cone involvement,N/A
ELAC2,Neurologic,Combined oxidative phosphorylation deficiency 17,Pediatric
ELOVL1,Neurologic,Ichthyotic keratoderma; spasticity; hypomyelination; and dysmorphic facies,N/A
ELOVL4,Neurologic,Icthyosis; spastic quadriplegia; and mental retardation; Spinocerebellar ataxia 34; Startgardt disease 3,N/A
ELOVL5,Neurologic,Spinocerebellar ataxia 39,N/A
ELP1,Neurologic,Neuropathy; hereditary sensory and autonomic; type III,N/A
ELP2,Neurologic,Mental retardation; autosomal recessive 58,N/A
EMC1,Neurologic,Cerebellar atrophy; visual impairment; and psychomotor retardation,N/A
EMG1,Neurologic,Bowen-Conradi syndrome,N/A
EML1,Neurologic,Band heterotopia,N/A
EMX2,Neurologic,Schizencephaly,N/A
ENTPD1,Neurologic,Spastic paraplegia 64,N/A
EP300,Neurologic,Rubinstein-Taybi syndrome 2; Menke-Hennekam syndrome 2,Pediatric
EPB41L1,Neurologic,Mental retardation; autosomal dominant 11,N/A
EPG5,Neurologic,Vici syndrome,Pediatric
EPM2A,Neurologic,Epilepsy; progressive myoclonic 2A (Lafora),N/A
EPRS1,Neurologic,Leukodystrophy; hypomyelinating; 15,N/A
ERBB3,Neurologic,Erythroleukemia; familial; susceptibility to (AD),N/A
ERBB4,Neurologic,Amyotrophic lateral sclerosis 19,N/A
ERCC1,Neurologic,Cerebrooculofacioskeletal syndrome 4,N/A
ERCC2,Neurologic,Trichothiodystrophy 1; photosensitive; Xeroderma pigmentosum; group D,Pediatric
ERCC3,Neurologic,Xeroderma pigmentosum; complementation group B; Trichothiodystrophy 2; photosensitive,Pediatric
ERCC4,Neurologic,Fanconi anemia; complementation group Q; Xeroderma pigmentosum; group F,Pediatric
ERCC5,Neurologic,Xeroderma pigmentosum; complementation group G; Xeroderma pigmentosum; complementation group G/Cockayne syndrome,Pediatric
ERCC6,Neurologic,Premature ovarian failure 11; Xeroderma Pigmentosum-Cockayne Syndrome; De Sanctis-Cacchione syndrome,Pediatric
ERCC6L2,Neurologic,Bone marrow failure syndrome 2,Pediatric
ERCC8,Neurologic,UV-sensitive syndrome 2; Cockayne syndrome A,N/A
ERF,Neurologic,Chitayat syndrome,Pediatric
ERGIC1,Neurologic,Arthrogryposis multiplex congenita; neurogenic type,N/A
ERLIN1,Neurologic,Spastic paraplegia 62; autosomal recessive,N/A
ERLIN2,Neurologic,Spastic paraplegia 18; autosomal recessive,N/A
ERMARD,Neurologic,Periventricular nodular heterotopia 6,N/A
ESAM,Neurologic,Schizophrenia,N/A
ESCO2,Neurologic,SC phocomelia syndrome; Roberts syndrome,N/A
ETFA,Neurologic,Multiple acyl-CoA dehydrogenase deficiency; Glutaric aciduria II,Pediatric
ETFB,Neurologic,Multiple acyl-CoA dehydrogenase deficiency; Glutaric aciduria II,Pediatric
ETFDH,Neurologic,Multiple acyl-CoA dehydrogenase deficiency; Glutaric aciduria II,Pediatric
ETHE1,Neurologic,Ethylmalonic encephalopathy,Pediatric
EXOSC2,Neurologic,Short stature; hearing loss; retinitis pigmentosa; and distinctive facies (SHRF),Pediatric
EXOSC3,Neurologic,Pontocerebellar hypoplasia type 1B,N/A
EXOSC8,Neurologic,Pontocerebellar hypoplasia; type 1C,N/A
EXT2,Neurologic,Exostoses; multiple; type 2,Pediatric
EXTL3,Neurologic,Immunoskeletal dysplasia with neurodevelopmental abnormalities (ISDNA),Pediatric
EZH2,Neurologic,Weaver syndrome,N/A
FA2H,Neurologic,Spastic paraplegia 35; autosomal recessive,N/A
FAAHP1,Neurologic,Pain sensitivity quantitative trait locus 1,N/A
FADD,Neurologic,Infections; recurrent; with encephalopathy; hepatic dysfunction; and cardiovascular malformations,Pediatric
FAM126A,Neurologic,Leukodystrophy; hypomyelinating; 5,N/A
FAM20C,Neurologic,Hypophosphatemia; hyperphosphaturia; dental anomalies; intracerebral calcifications and osteosclerosis (Raine syndrome),Pediatric
FANCA,Neurologic,Fanconi anemia; complementation group A,Pediatric
FANCB,Neurologic,Fanconi anemia;complementation group B,Pediatric
FANCC,Neurologic,Fanconi anemia; complementation group C,Pediatric
FANCD2,Neurologic,Fanconi anemia; complementation group D2,Pediatric
FANCE,Neurologic,Fanconi anemia; complementation group E,Pediatric
FANCF,Neurologic,Fanconia anemia; complementation group F,Pediatric
FANCG,Neurologic,Fanconi anemia type G,Pediatric
FANCI,Neurologic,Fanconi anemia; complementation group I,Pediatric
FANCL,Neurologic,Fanconi anemia; complementation group L,Pediatric
FANCM,Neurologic,Fanconi anemia type M; Premature ovarian failure 15,Pediatric
FAR1,Neurologic,Peroxisomal fatty acyl-CoA reductase 1 disorder,N/A
FARS2,Neurologic,Combined oxidative phosphorylation deficiency 14; Spastic paraplegia 77; autosomal recessive,N/A
FARSB,Neurologic,Rajab interstitial lung disease with brain calcifications,Pediatric
FASTKD2,Neurologic,Mitochondrial complex IV deficiency,N/A
FAT2,Neurologic,Spinocerebellar ataxia 45,N/A
FAT4,Neurologic,Hennekam lymphangiectasia-lymphedema syndrome 2,Pediatric
FBLN5,Neurologic,Neuropathy; hereditary; with or witout age-related macular degeneration; Macular degeneration; age-related; 3; Cutis laxa; autosomal dominant 2; Cutis laxa; autosomal recessive; type IA,N/A
FBN1,Neurologic,Marfan syndrome; MASS syndrome; Shprintzen-Goldberg syndrome; Marfanoid-progeroid-lipodystrophy syndrome; Ectopia lentis 1; isolated; autosomal dominant,Pediatric
FBXL3,Neurologic,Intellectual developmental disorder with short stature; facial anomalies; and speech defects,N/A
FBXL4,Neurologic,Mitochondrial DNA depletion syndrome 13,N/A
FBXO11,Neurologic,Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,N/A
FBXO31,Neurologic,Mental retardation 45; autosomal recessive,N/A
FBXO38,Neurologic,Neuronopathy; distal hereditary motor; type IID,N/A
FBXO7,Neurologic,Parkinson disease 15; autosomal recessive,N/A
FCMTE2,Neurologic,Epilepsy; myoclonic; adult familial; 2,N/A
FCSK,Neurologic,Congenital disorder of glycosylation with defective fucosylation 2,N/A
FDFT1,Neurologic,Squalene synthase deficiency,N/A
FDX2,Neurologic,Mitochondrial myopathy; episodic; with or without optic atrophy and reversible leukoencephalopathy,Pediatric
FEZF1,Neurologic,Hypogonadotropic hypogonadism 22 with or without anosmia,Pediatric
FGD1,Neurologic,Aarskog-Scott syndrome; Mental retardation; X-linked syndromic 16,N/A
FGD4,Neurologic,Charcot-Marie-Tooth disease; type 4H,N/A
FGF12,Neurologic,Epileptic encephalopathy; early infantile; 47,N/A
FGF14,Neurologic,Spinocerebellar ataxia 27,N/A
FGF17,Neurologic,Hypogonadotropic hypogonadism 20; with or without anosmia,Pediatric
FGF8,Neurologic,Hypogonadotropic hypogonadism 6; with or without anosmia,Pediatric
FGFR1,Neurologic,Hypogonadotropic hypogonadism 2 with or without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome,Pediatric
FGFR2,Neurologic,Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Sraniofacial-skeletal-dermatological dysplasia; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome,Pediatric
FGFR3,Neurologic,Camptodactyly; tall stature; and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Lacrimoauriculodentodigital syndrome; Muenke syndrome,Pediatric
FH,Neurologic,Hereditary leiomyomatosis and renal cell cancer,Pediatric
FIBP,Neurologic,Thauvin-Robinet-Faivre syndrome,Pediatric
FIG4,Neurologic,Amyotrophic lateral sclerosis 11; Charcot-Marie Tooth disease; autosomal recessive; type 4J; Polymicrogyria; bilateral temporooccipital; Yunis-Varon syndrome,N/A
FITM2,Neurologic,Siddiqi syndrome,Pediatric
FKBP14,Neurologic,Ehlers-Danlos syndrome; kyphoscoliotic type; 2,Pediatric
FKRP,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 5; Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation); type B; 5; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 5,Pediatric
FKTN,Neurologic,Cardiomyopathy; dilated; 1X; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 4; Muscular dystrophy-dystroglycanopathy (congenital without mental retardation); type B; 4; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 4,Pediatric
FLAD1,Neurologic,Lipid storage myopathy due to FLAD1 deficiency (LSMFLAD),Pediatric
FLNA,Neurologic,Cardiac valvular dysplasia; X-linked; Heterotopia; periventricular; Ehlers-Danlos variant;  Intestinal pseudoobstruction; neuronal; X-linked/Congenital short bowel syndrome,Pediatric
FLRT3,Neurologic,Hypogonadotropic hypogonadism 21; with or without anosmia,Pediatric
FLVCR1,Neurologic,Ataxia; posterior column; with retinitis pigmentosa,N/A
FLVCR2,Neurologic,Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome,N/A
FMN2,Neurologic,Mental retardation; autosomal recessive; 47,N/A
FMR1,Neurologic,Premature ovarian failure 1,Pediatric
FOLR1,Neurologic,Neurodegeneration due to cerebral folate deficiency,Pediatric
FOXG1,Neurologic,Rett syndrome; congenital variant,N/A
FOXH1,Neurologic,Holoprosencephaly; Congenital heart malformations,N/A
FOXP1,Neurologic,Mental retardation with language impairment and autistic features,N/A
FOXP2,Neurologic,Speech-language disorder 1,N/A
FOXRED1,Neurologic,Mitochondrial complex I deficiency; nuclear type 19; Leigh syndrome,N/A
FRAS1,Neurologic,Fraser syndrome 1,N/A
FREM2,Neurologic,Fraser syndrome 2; Cryptophthalmos; unilateral or bilateral; isolated,N/A
FRMD4A,Neurologic,Corpus callosum; agenesis of; with facial anomalies and cerebellar ataxia (Fine-Flusser syndrome),N/A
FRMD7,Neurologic,Nystagmus; infantile periodic alternating; X-linked,N/A
FRMPD4,Neurologic,Mental retardation; X-linked 104,N/A
FRRS1L,Neurologic,Epileptic encephalopathy; early infantile; 37,N/A
FTL,Neurologic,L-ferritin deficiency; Neurodegeneration with brain iron accumulation 3; Hyperferritinemia with or without cataract,N/A
FTO,Neurologic,Growth retardation; developmental delay; and facial dysmorphism,N/A
FTSJ1,Neurologic,Mental retardation; X-linked 9,N/A
FUCA1,Neurologic,Fucosidosis,N/A
FUS,Neurologic,Amyotrophic lateral sclerosis 6; with or without frontotemporal dementia; Tremor; hereditary essential; 4,N/A
FUT8,Neurologic,Congenital disorder of glycosylation with defective fucosylation 1,N/A
FXN,Neurologic,Friedreich ataxia 1,Pediatric
G6PC3,Neurologic,Neutropenia; severe congenital; 4; autosomal recessive; Dursun syndrome,Pediatric
GAA,Neurologic,Glycogen storage disease II,Pediatric
GABBR2,Neurologic,Epileptic encephalopathy; early infantile; 59; Neurodevelopmental disorder with poor language and loss of hand skills (AD),N/A
GABRA1,Neurologic,Epilepsy; idiopathic; generalized; susceptibility to; 13; Epilepsy; childhood absence; susceptibility to; 4; Epileptic encephalopathy; early infantile 19,N/A
GABRA2,Neurologic,Epileptic encephalopathy; early infantile; 78,N/A
GABRA5,Neurologic,Epileptic encephalopathy; early infantile; 79,N/A
GABRB1,Neurologic,Epileptic encephalopathy; early infantile; 45,N/A
GABRB2,Neurologic,Epileptic encephalopathy; infantile or early childhood; 2,N/A
GABRB3,Neurologic,Epilepsy; childhood absence; susceptibility to; 5; Epileptic encephalopathy; early infantile; 43,N/A
GABRG2,Neurologic,Dravet syndrome; Generalized epilepsy with febrile seizures plus; type 3; Familial febrile seizures 8; Epilepsy; childhood absence; susceptibility to; 2; Epileptic encephalopathy; early infantile; 74,N/A
GAD1,Neurologic,Cerebral palsy; spastic quadriplegic; 1,N/A
GAL,Neurologic,Epilepsy; familial temporal lobe; 8,N/A
GALC,Neurologic,Krabbe disease,Pediatric
GALE,Neurologic,Galactose epimerase deficiency,Pediatric
GALK1,Neurologic,Galactokinase deficiency,Pediatric
GALT,Neurologic,Galactosemia,Pediatric
GAMT,Neurologic,Guanidinoacetate methyltransferase deficiency,Pediatric
GAN,Neurologic,Giant axonal neuropathy 1; autosomal recessive,N/A
GARS1,Neurologic,Charcot-Marie-Tooth disease; type 2D; Neuropathy; distal hereditary motor; type VA,N/A
GAS1,Neurologic,Holoprosencephaly 4,N/A
GATA6,Neurologic,Heart defects; congenital; and other congenital anomalies,Pediatric
GATAD2B,Neurologic,Mental retardation; autosomal dominant; 18,N/A
GATM,Neurologic,Cerebral creatine deficiency syndrome 3,Pediatric
GBA,Neurologic,Gaucher disease,Pediatric
GBA2,Neurologic,Spastic paraplegia 46; autosomal recessive,N/A
GBE1,Neurologic,Glycogen storage disease IV,Pediatric
GCDH,Neurologic,Glutaric aciduria; type I,Pediatric
GCH1,Neurologic,Hyperphenylalaninemia; BH4-deficient; B; Autosomal Recessive Dopa-Responsive Dystonia with or without Hyperphenylalaninemia; GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia,Pediatric
GCSH,Neurologic,Glycine encephalopathy,Pediatric
GDAP1,Neurologic,Charcot-Marie-Tooth disease; recessive intermediate; A; Charcot-Marie-Tooth disease; axonal; with vocal cord paresis; Charcot-Marie-Tooth disease; axonal; type 2K; Charcot-Marie-Tooth disease; type 4A,N/A
GDAP2,Neurologic,Spinocerebellar ataxia; autosomal recessive 27,N/A
GDI1,Neurologic,Mental retardation; X-linked 41,N/A
GDNF,Neurologic,Central hypoventilation syndrome; Hirschsprung disease; susceptibility to; 3,Pediatric
GEMIN4,Neurologic,Neurodevelopmental disorder with microcephaly; cataracts; and renal abnormalities,Pediatric
GFAP,Neurologic,Alexander disease,N/A
GFER,Neurologic,Myopathy; mitochondrial progressive; with congenital cataract; hearing loss; and developmental delay ,N/A
GFM1,Neurologic,Combined oxidative phosphorylation deficiency 1,N/A
GFM2,Neurologic,Combined oxidative phosphorylation deficiency 39,N/A
GFPT1,Neurologic,Myasthenic syndrome; congenital 12,Pediatric
GGT1,Neurologic,Glutathionuria,N/A
GIGYF2,Neurologic,Parkinson disease; autosomal dominant; 11,N/A
GJB1,Neurologic,Charcot-Marie-Tooth neuropathy; X-linked dominant; 1 ,N/A
GJB3,Neurologic,Deafness; autosomal recessive; Deafness; autosomal dominant; with peripheral neuropathy; Deafness digenic,Pediatric
GJC2,Neurologic,Lymphedema malformation 3; Spastic paraplegia 44; autosomal recessive; Leukodystrophy; hypomyelinating; 2,N/A
GK,Neurologic,Glycerol kinase deficiency,Pediatric
GLA,Neurologic,Fabry disease; Fabry disease; cardiac variant ,Pediatric
GLB1,Neurologic,Mucopolysaccharidosis type IVB (Morquio syndrome B); GM1-gangliosidosis; type I; GM1-gangliosidosis; type II; GM1-gangliosidosis; type III,N/A
GLDC,Neurologic,Glycine encephalopathy,Pediatric
GLDN,Neurologic,Lethal congenital contracture syndrome 11,N/A
GLE1,Neurologic,Congenital arthrogryposis with anterior horn cell disease; Lethal congenital contracture syndrome 1,N/A
GLI2,Neurologic,Culler-Jones syndrome,Pediatric
GLI3,Neurologic,Acrocallosal syndrome; Pallister-Hall syndrome; Grieg cephalopolysndactyly syndrome; Polydactyly; postaxial; type A1; Polydactyly; preaxial; type IV; Polydactyly; postaxial; types A1 and B,N/A
GLIS3,Neurologic,Diabetes mellitus; neonatal; with congenital hypothyroidism,Pediatric
GLRA1,Neurologic,Hyperekplexia 1,Pediatric
GLRB,Neurologic,Hyperekplexia 2,Pediatric
GLRX5,Neurologic,Anemia; sideroblastic 3; pyridoxine-refractory,Pediatric
GLS,Neurologic,Infantile cataract; skin abnormalities; glutamate excess; and impaired intellectual development; Epileptic encephalopathy; early infantile; 71; Global developmental delay; progressive ataxia; and elevated glutamine,N/A
GLUL,Neurologic,Glutamine deficiency; congenital,Pediatric
GLYCTK,Neurologic,D-glyceric aciduria,N/A
GM2A,Neurologic,GM2-gangliosidosis; AB variant,N/A
GMNN,Neurologic,Meier-Gorlin syndrome 6,N/A
GMPPA,Neurologic,Alacrima; achalasia; and mental retardation syndrome,N/A
GMPPB,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 14; Limb-girdle muscular dystrophy-dystroglycanopathy; type B; 14; Limb-girdle muscular dystrophy-dystroglycanopathy; type C; 14,Pediatric
GNAL,Neurologic,Dystonia 25,N/A
GNAO1,Neurologic,Neurodevelopmental disorder with involuntary movements (NEDIM),Pediatric
GNB1,Neurologic,Mental retardation; autosomal dominant 42,N/A
GNB4,Neurologic,Charcot-Marie-Tooth disease; dominant intermediate F,N/A
GNB5,Neurologic,Intellectual developmental disorder with cardiac arrhythmia (IDDCA); Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia (LADCI),Pediatric
GNE,Neurologic,Sialuria; French type ; Nonaka myopathy; Inclusion body myopathy; autosomal recessive,N/A
GNPAT,Neurologic,Rhizomelic chondrodysplasia punctata; rhizomelic; type 2,N/A
GNPTAB,Neurologic,Mucolipidosis III alpha/beta (Pseudo-Hurler polydstrophy); Mucolipidosis II alpha/beta (I-cell disease),N/A
GNRH1,Neurologic,Hypogonadotropic hypogonadism 12 with or without anosmia,Pediatric
GNS,Neurologic,Mucopolysaccharidosis IIID (Sanfilippo syndrome D),N/A
GOSR2,Neurologic,Epilepsy; progessive myoclonic 6,N/A
GPAA1,Neurologic,Glycosylphosphatidylinositol biosynthesis defect 15,N/A
GPC3,Neurologic,Simpson-Golabi-Behmel syndrome; type 1,Pediatric
GPC6,Neurologic,Omodysplasia 1,N/A
GPHN,Neurologic,Hyperekplexia; autosomal dominant; Molybdenum cofactor deficiency; type C,N/A
GPR88,Neurologic,Chorea; childhood-onset; with psychomotor retardation,N/A
GPSM2,Neurologic,Chudley-McCullough syndrome,Pediatric
GPT2,Neurologic,Mental retardation; autosomal recessive 49,N/A
GPX4,Neurologic,Sedaghatian-type spondylometaphyseal dysplasia,N/A
GRIA3,Neurologic,Mental retardation; X-linked 94,N/A
GRIA4,Neurologic,Neurodevelopmental disorder with or without seizures and gait abnormalities,N/A
GRID2,Neurologic,Spinocerebellar ataxia; autosomal recessive 18,N/A
GRIK2,Neurologic,Mental retardation; autosomal recessive 6,N/A
GRIN1,Neurologic,Neurodevelopmental disorder with or without hyperkinetic movements and seizures; autosomal dominant; Neurodevelopmental disorder with or without hyperkinetic movements and seizures; autosomal recessive,N/A
GRIN2A,Neurologic,Epilepsy; focal; with speech disorder and with or without mental retardation,Pediatric
GRIN2B,Neurologic,Mental retardation; autosomal dominant 6; with or without seizures; Epileptic encephalopathy; early infantile 27,N/A
GRIN2D,Neurologic,Epileptic encephalopathy; early infantile; 46,Pediatric
GRIP1,Neurologic,Fraser syndrome 3,N/A
GRM1,Neurologic,Spinocerebellar ataxia 44; Spinocerebellar ataxia; autosomal recessive 13,N/A
GRN,Neurologic,Frontotemporal lobar degeneration with TDP43 inclusions; GRN-related; Neuronal ceroid lipofuscinosis 11,N/A
GSN,Neurologic,Amyloidosis; Finnish type,Adult
GSS,Neurologic,Glutathione synthetase deficiency,Pediatric
GTF2E2,Neurologic,Trichothiodystrophy 6; nonphotosensitive,N/A
GTF2H5,Neurologic,Trichothiodystrophy 3; photosensitive,N/A
GTPBP2,Neurologic,Jaberi-Elahi syndrome,N/A
GUF1,Neurologic,Epileptic encephalopathy; early infantile 40,N/A
GUSB,Neurologic,Mucopolysaccharidosis type VII,N/A
GYS1,Neurologic,Glycogen storage disease; type 0; muscle,Pediatric
GYS2,Neurologic,Glycogen storage disease; type 0; liver,Pediatric
H1-4,Neurologic,Rahman syndrome,N/A
H19,Neurologic,Wilms tumor 2; Beckwith-Wiedemann syndrome,Pediatric
HACE1,Neurologic,Spastic paraplegia and psychomotor retardation with or without seizures,N/A
HADHA,Neurologic,Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency; Trifunctional protein deficiency,Pediatric
HADHB,Neurologic,Trifunctional protein deficiency,Pediatric
HARS1,Neurologic,Usher syndrome; type 3B,Pediatric
HAX1,Neurologic,Neutropenia; severe congenital; 3,Pediatric
HBB,Neurologic,Beta-thalassemia; Heinz body anemias; Erythrocytosis; familial 6; Sickle cell disease; Thalassemia-beta; dominant inclusion body; Other Thalassemias/Hemoglobinopathies,Pediatric
HCCS,Neurologic,Linear skin defects with multiple congenital anomalies 1 (MIDAS syndrome),Pediatric
HCFC1,Neurologic,Combined methylmalonic acidemia and hyperhomocysteinemia,Pediatric
HCN1,Neurologic,Epileptic encephalopathy; early infantile; 24; Generalized epilepsy with febrile seizures plus; type 10,N/A
HCRT,Neurologic,Narcolepsy 1,N/A
HDAC4,Neurologic,Brachydacytly-mental retardation syndrome,N/A
HDAC6,Neurologic,Chondrodysplasia with platyspondyly; distinctive brachydactyly; hydrocephaly; and microphthalmia,N/A
HDAC8,Neurologic,Cornelia de Lange syndrome 5,N/A
HDC,Neurologic,Tourette's syndrome,N/A
HECW2,Neurologic,Neurodevelopmental disorder with hypotonia; seizures; and absent language,N/A
HELLS,Neurologic,Immunodeficiency-centromeric instability-facial anomalies syndrome 4,Pediatric
HEPACAM,Neurologic,Megalencephalic leukoencephalopathy with subcortical cysts 2B; remitting; with or without mental retardation; Megalencephalic leukoencephalopathy with subcortical cysts 2A,N/A
HEPHL1,Neurologic,Abnormal hair; joint laxity; and developmental delay,N/A
HERC1,Neurologic,Macrocephaly; dysmorphic facies; and psychomotor retardation,N/A
HERC2,Neurologic,Skin/hair/eye pigmentation 1; Mental retardation; autosomal recessive 38,N/A
HES7,Neurologic,Spondylocostal dysostosis 4; autosomal recessive,N/A
HESX1,Neurologic,Pituitary hormone deficiency; combined; Septooptic dysplasia,Pediatric
HEXA,Neurologic,Tay-Sachs disease; GM2-gangliosidosis; Hexosaminidase A deficiency,N/A
HEXB,Neurologic,Sandhoff disease,N/A
HGSNAT,Neurologic,Mucopolysaccharidosis type IIIC (Sanfilippo syndrome C); Retinitis pigmentosa 73,N/A
HIBCH,Neurologic,3-hydroxyisobutryl-CoA hydrolase deficiency,Pediatric
HIKESHI,Neurologic,Leukodystrophy; hypomyelinating; 13,N/A
HIVEP2,Neurologic,Mental retardation; autosomal dominant 43,N/A
HK1,Neurologic,Hemolytic anemia; nonspherocytic; due to hexokinase deficiency,Pediatric
HLCS,Neurologic,Holocarboxylase synthetase deficiency,Pediatric
HMBS,Neurologic,Hydroxymethylbilane synthase deficiency; Porphyria; acute intermittent,Pediatric
HMGB3,Neurologic,Microphthalmia; syndromic 13,N/A
HMGCL,Neurologic,3-hydroxy-3-methylglutaryl-CoA lyase deficiency,Pediatric
HMGCS2,Neurologic,3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency,Pediatric
HMOX1,Neurologic,Heme oxygenase 1 deficiency,N/A
HNMT,Neurologic,Mental retardation; autosomal recessive 51,N/A
HNRNPA1,Neurologic,Amyotrophic lateral sclerosis 20; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3,N/A
HNRNPA2B1,Neurologic,Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2,N/A
HNRNPH2,Neurologic,Mental retardation; X-linked; syndromic; Bain type,N/A
HNRNPK,Neurologic,Au-Kline syndrome,N/A
HNRNPU,Neurologic,Epileptic encephalopathy; early infantile; 54,N/A
HOXA1,Neurologic,Athabaskan brainstem dysgenesis syndrome; Bosley-Salih-Alorainy syndrome,Pediatric
HOXB1,Neurologic,Facial paresis; hereditary congenital; 3,Pediatric
HPCA,Neurologic,Dystonia 2; torsion; autosomal recessive,N/A
HPD,Neurologic,Tyrosinemia; type III; Hawksinuria,Pediatric
HPRT1,Neurologic,Kelley-Seegmiller syndrome; Lesch-Nyhan syndrome,Pediatric
HPSE2,Neurologic,Ochoa syndrome; Urofacial syndrome 1,Pediatric
HRAS,Neurologic,Costello syndrome; Congenital myopathy with excess of muscle spindles,Pediatric
HS6ST1,Neurologic,Hypogonadotropic hypogonadism 15; with or without anosmia,Pediatric
HS6ST2,Neurologic,Mental retardation; X-linked; syndromic; Paganini-Miozzo type,N/A
HSD17B10,Neurologic,HSD10 mitochondrial disease; Mental retardation; X-linked syndromic 10,N/A
HSD17B4,Neurologic,Perrault syndrome 1,Pediatric
HSPB1,Neurologic,Neuropathy; distal hereditary motor; type IIB; Charcot-Marie-Tooth disease; axonal; type 2F ,N/A
HSPB3,Neurologic,Neuronopathy; distal hereditary motor; type IIC,N/A
HSPB8,Neurologic,Charcot-Marie-Tooth disease; axonal; type 2L; Neuronopahty; distal hereditary motor; type IIA,N/A
HSPD1,Neurologic,Spastic paraplegia 13; autosomal dominant; Leukodystrophy; hypomyelinating; 4,N/A
HTRA1,Neurologic,Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy type 2 (CADASIL2); Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL),N/A
HTRA2,Neurologic,3-methylglutaconic aciduria type VIII,N/A
HTT,Neurologic,Huntington disease; Lopes-Maciel-Rodan syndrome (LOMARS),N/A
HUWE1,Neurologic,Mental retardation; X-linked syndromic; Turner type; Xp11.22 microduplication syndrome,N/A
HYLS1,Neurologic,Hydrolethalus syndrome,N/A
IARS1,Neurologic,Growth retardation; intellectual developmental disorder; hypotonia; and hepatopathy,Pediatric
IARS2,Neurologic,Cataracts; growth hormone deficiency; sensory neuropathy; sensorineural hearing loss; and skeletal dysplasia (CAGSSS),Pediatric
IBA57,Neurologic,Multiple mitochondrial dysfunctions syndrome 3; Spastic paraplegia 74; autosomal recessive,N/A
IDH2,Neurologic,D-2-hydroxyglutaric aciduria 2,N/A
IDUA,Neurologic,Mucopolysaccharidosis type I,Pediatric
IER3IP1,Neurologic,Microcephaly; epilepsy; and diabetes syndrome,N/A
IFIH1,Neurologic,Aicardi-Goutieres syndrome 7; Singleton-Merten syndrome 1,Pediatric
IFT140,Neurologic,Short-rib thoracic dysplasia 9 with or without polydactyly,N/A
IFT172,Neurologic,Retinitis pigmentosa 71; Short rib thoracic dysplasia 10 with or without polydactyly,N/A
IFT27,Neurologic,Bardet Biedl syndrome 19,N/A
IFT43,Neurologic,Cranioectodermal dysplasia 3; Retinitis pigmentosa 81; Short-rib thoracic dysplasia 18 with polydactyly,N/A
IFT52,Neurologic,Short-rib thoracic dysplasia 16 with or without polydactyly,N/A
IFT74,Neurologic,Bardet Biedl syndrome 20,N/A
IFT88,Neurologic,Ciliopathy; IFT88-related,N/A
IGBP1,Neurologic,Corpus callosum; agenesis of; with mental retardation; ocular coloboma and micrognathia,N/A
IGF1,Neurologic,Insulin-like growth factor I deficiency,Pediatric
IGF2,Neurologic,Growth restriction; severe; with distinctive facies,Pediatric
IGHMBP2,Neurologic,Spinal muscular atrophy; distal; autosomal recessive; 1; Charcot-Marie-Tooth disease; axonal; type 2S,N/A
IGSF1,Neurologic,Central hypothyroidism and testicular enlargement,Pediatric
IKBKG,Neurologic,Immunodeficiency 33; Ectodermal; dysplasia; anhidrotic; lymphedema and immunodeficiency; Immunodeficiency; isolated; Incontinentia pigmenti; Invasive pneumococcal disease; recurrent; isolated; 2; Ectodermal dysplasia and immune deficiency 1,Pediatric
IL17RD,Neurologic,Hypogonadotropic hypogonadism 18; with or without anosmia,Pediatric
IL1RAPL1,Neurologic,Mental retardation; X-linked 21,N/A
IL6ST,Neurologic,Hyper-IgE recurrent infection syndrome 4; autosomal recessive,Pediatric
IMPA1,Neurologic,Mental retardation; autosomal recessive 59,N/A
INF2,Neurologic,Focal segmental glomerulosclerosis 5 ; Charcot-Marie-Tooth disease; dominant intermediate E,N/A
INPP5E,Neurologic,Joubert syndrome 1; Mental retardation; truncal obesity; retinal dystrophy; and micropenis (MORM syndrome),N/A
INPP5K,Neurologic,Muscular dystrophy; congenital; with cataracts and intellectual disability (MDCCAID),N/A
INVS,Neurologic,Nephronophthisis 2,N/A
IQSEC2,Neurologic,Mental retardation; X-linked 1,N/A
IREB2,Neurologic,Neurodegeneration; early-onset; with choreoathetoid movements and microcytic anemia,N/A
IRF2BPL,Neurologic,Neurodevelopmental disorder with regression; abnormal movements; loss of speech; and seizures,N/A
ISCA1,Neurologic,Multiple mitochondrial dysfunctions syndrome 5,N/A
ISCA2,Neurologic,Multiple mitochondrial dysfunctions syndrome 4,N/A
ISG15,Neurologic,Immunodeficiency 38; with basal ganglia calcification,Pediatric
ITCH,Neurologic,Autoimmune disease; syndromic multisystem,Pediatric
ITGA7,Neurologic,Muscular dystrophy; congenital; due to integrin alpha-7 deficiency,N/A
ITM2B,Neurologic,Cerebral amyloid angiopathy; Dementia; familial Danish; Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities,N/A
ITPA,Neurologic,Inosine triphosphatase deficiency,Pediatric
ITPR1,Neurologic,Gillespie syndrome; Spinocerebellar ataxia 15; Spinocerebellar ataxia 29,N/A
IVD,Neurologic,Isovaleric acidemia,Pediatric
JAG1,Neurologic,Alagille syndrome; Deafness; congenital heart defects; and posterior embryotoxon,Pediatric
JAM3,Neurologic,Hemorrhagic destruction of the brain; subependymal calcification; and cataracts,N/A
JPH3,Neurologic,Huntington disease-like 2,N/A
KANK1,Neurologic,Cerebral palsy; spastic quadriplegic; 2,N/A
KANSL1,Neurologic,Koolen-de Vries syndrome,N/A
KARS1,Neurologic,Deafness; autosomal recessive 89,Pediatric
KAT6A,Neurologic,Mental retardation; autosomal dominant 32,N/A
KAT6B,Neurologic,Ohdo syndrome; SBBYS variant; Genitopatellar syndrome,Pediatric
KATNB1,Neurologic,Lissencephaly 6; with microcephaly,N/A
KCNA1,Neurologic,Episodic ataxia; type 1/myokymia syndrome,Pediatric
KCNA2,Neurologic,Epileptic encephalopathy; early infantile 32,N/A
KCNA4,Neurologic,Microcephaly; cataracts; impaired intellectual development; and dystonia with abnormal striatum,N/A
KCNC1,Neurologic,Epilepsy; progressive myoclonic 7,N/A
KCNC3,Neurologic,Spinocerebellar ataxia 13,N/A
KCND3,Neurologic,Brugada syndrome 9,Pediatric
KCNH1,Neurologic,Temple-Baraitser syndrome; Zimmermann-Laband syndrome 1,N/A
KCNJ10,Neurologic,Deafness; autosomal recessive 4; with enlarged vestibular aqueduct; Pendred syndrome; digenic; Seizures; sensorineural deafness; ataxia; mental retardation; and electrolyte imbalance (SESAME syndrome),Pediatric
KCNJ11,Neurologic,Hyperinsulinemic hypoglycemia; familial; 2; Diabetes mellitus; transient neonatal; 3; Diabetes; permanent neonatal; Diabetes; permanent neonatal; with Neurologic features,Pediatric
KCNJ6,Neurologic,Keppen-Lubinsky syndrome,N/A
KCNK18,Neurologic,Migraine; with or without aura; susceptibility to; 13,N/A
KCNK4,Neurologic,Facial dysmorphism; hypertrichosis; epilepsy; intellectual disability/developmental delay; and gingival overgrowth syndrome,N/A
KCNK9,Neurologic,Birk-Barel mental retardation dysmorphism syndrome,N/A
KCNMA1,Neurologic,Epilepsy; idiopathic generalized; susceptibility to; 16; Paroxysmal nonkinesigenic dyskinesia 3 with or without generalized epilepsy; Cerebellar atrophy; developmental delay; and seizures,N/A
KCNQ1OT1,Neurologic,Beckwith-Wiedemann syndrome,Pediatric
KCNQ2,Neurologic,Epileptic encephalopathy; early infantile; 7,Pediatric
KCNQ3,Neurologic,Seizures; benign familial neonatal; 2,N/A
KCNQ5,Neurologic,Mental retardation; autosomal dominant 46,N/A
KCNT1,Neurologic,Epilepsy; nocturnal frontal lobe; 5; Early infantile epileptic encephalopathy 14,Pediatric
KCNT2,Neurologic,Epileptic encephalopathy; early infantile; 57,N/A
KCTD17,Neurologic,Dystonia 26; myoclonic,N/A
KCTD7,Neurologic,Epilepsy; progressive myoclonic 3; with or without intracellular inclusions,N/A
KDM1A,Neurologic,Cleft palate; psychomotor retardation; and distinctive facial features,N/A
KDM5B,Neurologic,Mental retardation; autosomal recessive 65,N/A
KDM5C,Neurologic,Mental retardation; X-linked; syndromic; Claes-Jensen type,N/A
KDM6A,Neurologic,Kabuki syndrome 2,N/A
KDM6B,Neurologic,Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities,N/A
KIAA0556,Neurologic,Joubert syndrome 26,Pediatric
KIAA0586,Neurologic,Joubert syndrome 23; Short rib thoracic dysplasia 14 with polydactyly,N/A
KIAA0753,Neurologic,Orofaciodigital syndrome XV,N/A
KIDINS220,Neurologic,Spastic paraplegia; intellectual disability; nystagmus; and obesity (SINO),N/A
KIF11,Neurologic,Microcephaly with or without chorioretinopathy; lymphedema; or mental retardation,N/A
KIF14,Neurologic,Meckel syndrome 12; Microcephaly 20; primary; autosomal recessive,N/A
KIF1A,Neurologic,Mental retardation; autosomal dominant 9; Neuropathy; hereditary sensory; type IIC; Spastic paraplegia 30; autosomal recessive,N/A
KIF1B,Neurologic,Neuroblastoma; susceptibility to; Pheochromocytoma,Pediatric
KIF1C,Neurologic,Spastic ataxia 2; autosomal recessive,N/A
KIF2A,Neurologic,Cortical dysplasia; complex; with other brain malformations 3,N/A
KIF4A,Neurologic,Mental retardation; X-linked 100,N/A
KIF5A,Neurologic,Neonatal intractable myoclonus (NEIMY); Spastic paraplegia 10; autosomal dominant; Amyotrophic lateral sclerosis; susceptibility to; 25,N/A
KIF5C,Neurologic,Cortical dysplasia; complex; with other brain malformations 2,N/A
KIF7,Neurologic,Hydrolethalus syndrome 2; Acrocallosal syndrome; Joubert syndrome 12; Al-Gazali-Bakalinova syndrome,N/A
KIFBP,Neurologic,Goldberg-Shprintzen megacolon syndrome,N/A
KIRREL3,Neurologic,Mental retardation; autosomal dominant 4,N/A
KISS1,Neurologic,Hypogonadotropic hypogonadism 13 with or without anosmia,Pediatric
KISS1R,Neurologic,Hypogonadotropic hypogonadism 8 with or without anosmia,Pediatric
KLC2,Neurologic,Spastic paraplegia; optic atrophy; and neuropathy,N/A
KLHL15,Neurologic,Mental retardation; X-linked 103,N/A
KLHL7,Neurologic,Crisponi/Cold-induced sweating syndrome 3,Pediatric
KMT2A,Neurologic,Wiedemann-Steiner syndrome,N/A
KMT2B,Neurologic,Dystonia  28; childhood-onset,N/A
KMT2C,Neurologic,Kleefstra syndrome 2,N/A
KMT2D,Neurologic,Kabuki syndrome 1,Pediatric
KMT2E,Neurologic,O'Donnell-Luria-Rodan syndrome,N/A
KMT5B,Neurologic,Mental retardation; autosomal dominant; 51,N/A
KNL1,Neurologic,Microcephaly 4; primary; autosomal recessive,N/A
KPTN,Neurologic,Mental retardation; autosomal recessive 41,N/A
KRAS,Neurologic,Noonan syndrome; Cardiofaciocutaneous syndrome,Pediatric
KRIT1,Neurologic,Cerebral cavernous malformations 1,Pediatric
L1CAM,Neurologic,Hydrocephalus due to congenital stenosis of aqueduct of Sylvius; Mental retardation; aphasia; shuffling gait; and adducted thumbs (MASA) syndrome; CRASH syndrome; Corpus callosum; partial agenesis of; Spastic paraplegia-1,N/A
L2HGDH,Neurologic,L-2-hydroxyglutaric aciduria,Pediatric
LAGE3,Neurologic,Galloway-Mowat syndrome 2; X-linked,N/A
LAMA1,Neurologic,Poretti-Boltshauser syndrome,N/A
LAMA2,Neurologic,Schizophrenia; Muscular dystrophy; congenital merosin-deficient; 1A; Muscular dystrophy; limb-girdle; autosomal recessive 23,N/A
LAMB1,Neurologic,Lissencephaly 5,N/A
LAMB2,Neurologic,Pierson syndrome; Nephrotic syndrome; type 5; with or without ocular abnormalities,N/A
LAMC3,Neurologic,Cortical malformations; occipital,N/A
LAMP2,Neurologic,Danon disease,Pediatric
LARGE1,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 6; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation); type B; 6 ,N/A
LARP7,Neurologic,Alazami syndrome,N/A
LARS1,Neurologic,Infantile liver failure syndrome 1,N/A
LAS1L,Neurologic,Wilson-Turner X-linked mental retardation syndrome,N/A
LDHD,Neurologic,D-lactic aciduria,N/A
LGI1,Neurologic,Epilepsy; familial temporal lobe; 1,N/A
LGI4,Neurologic,Arthrogryposis multiplex congenita; neurogenic; with myelin defect,N/A
LHX3,Neurologic,Pituitary hormone deficiency; combined; 3,Pediatric
LHX4,Neurologic,Pituitary hormone deficiency; combined; 4,Pediatric
LIAS,Neurologic,Pyruvate dehydrogensae lipoic acid synthetase deficiency,N/A
LIFR,Neurologic,Stuve-Wiedemann syndrome,N/A
LIG4,Neurologic,LIG4 syndrome; Severe combined immunodeficiency with sensitivity to ionizing radiation,Pediatric
LINGO1,Neurologic,Mental retardation; autosomal recessive 64,N/A
LINS1,Neurologic,Mental retardation; autosomal recessive 27,N/A
LIPT1,Neurologic,Lipoyltransferase 1 deficiency,N/A
LIPT2,Neurologic,Encephalopathy; neonatal severe; with lactic acidosis and brain abnormalities,N/A
LITAF,Neurologic,Charcot-Marie-Tooth disease; type 1C,N/A
LMAN2L,Neurologic,Mental retardation; autosomal recessive; 52,N/A
LMBRD1,Neurologic,Methylmalonic aciduria and homocystinuria; cblF type,Pediatric
LMNA,Neurologic,Cardiomyopathy; dilated; 1A; Heart-hand syndrome; Slovenian type; Emery-Dreiffus muscular dystrophy 2; autosomal dominant; Emery-Dreiffus muscular dystrophy 3; autosomal recessive; Muscular dystrophy; congenital; LMNA-related; Muscular dystrophy; limb-girdle; type 1B; Cardiomyopathy; dilated; with hypergonadotropic hypogonadism (Malouf syndrome); Lipodystrophy; familial partial; 2 (Dunnigan type),Pediatric
LMNB1,Neurologic,Leukodystrophy; demyelinating; adult-onset; autosomal dominant,N/A
LMNB2,Neurologic,Liopdystrophy; partial; acquired; Epilepsy; progressive myoclonic; 9,N/A
LNPK,Neurologic,Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum,N/A
LONP1,Neurologic,Cerebral; Ocular; Dental; Auricular; and Skeletal anomalies (CODAS) syndrome,N/A
LRP1,Neurologic,Schizophrenia; Keratosis pilaris atrophicans,N/A
LRP4,Neurologic,Cenani-Lenz syndactyly syndrome; Myasthenic syndrome; congenital 17; Sclerosteosis 2,N/A
LRPPRC,Neurologic,Leigh syndrome; French-Canadian type,N/A
LRRK2,Neurologic,Parkinson disease 8; autosomal dominant; Dementia; Lewy body,N/A
LRSAM1,Neurologic,Charcot-Marie-Tooth disease; axonal; type 2P,N/A
LYRM4,Neurologic,Combined oxidative phosphorylation deficiency 19,N/A
LYRM7,Neurologic,Mitochondrial complex III deficiency; nuclear type 8,N/A
LYST,Neurologic,Chediak-Higashi syndrome,Pediatric
LZTFL1,Neurologic,Bardet-Biedl syndrome 17,N/A
LZTR1,Neurologic,Schwannomatosis 2; Noonan syndrome 10; Noonan syndrome 2,Pediatric (Noonan syndrome 10; Noonan syndrome 2); Adult (Schwannomatosis 2)
MAB21L1,Neurologic,Cerebellar; ocular; craniofacial; and genital syndrome,N/A
MAB21L2,Neurologic,Microphthalmia/coloboma and skeletal dysplasia syndrome,N/A
MACF1,Neurologic,Lissencephaly 9 with complex brainstem malformation,N/A
MAD2L2,Neurologic,Fanconi anemia; complementation group V,Pediatric
MAF,Neurologic,Ayme-Gripp syndrome,Pediatric
MAFB,Neurologic,Duane retraction syndrome-3 (DURS3) with or without deafness,Pediatric
MAG,Neurologic,Spastic paraplegia; autosomal recessive 75,N/A
MAGEL2,Neurologic,Schaaf-Yang syndrome (Prader-Willi-like syndrome),Pediatric
MAGT1,Neurologic,Immunodeficiency; X-linked; with magnesium defect; Epstein-Barr virus infection and neoplasia,Pediatric
MAN1B1,Neurologic,Mental retardation; autosomal recessive 15,N/A
MAN2B1,Neurologic,Mannosidosis; alpha B; lysosomal,Pediatric
MANBA,Neurologic,Mannosidosis; beta A; lysosomal,N/A
MAOA,Neurologic,Brunner syndrome,N/A
MAP11,Neurologic,Microcephaly 25; primary; autosomal recessive,N/A
MAP2K1,Neurologic,Cardiofaciocutaneous syndrome 3,Pediatric
MAP2K2,Neurologic,Cardiofaciocutaneous syndrome 4,Pediatric
MAPK10,Neurologic,Epileptic encephalopathy; Lennox-Gastaut type,N/A
MAPK8IP3,Neurologic,Neurodevelopmental disorder with or without variable brain abnormalities,N/A
MAPRE2,Neurologic,Congenital symmetric circumferential skin creases 2,N/A
MAPT,Neurologic,Supranuclear palsy; progressive; 1; Frontotemporal dementia; Parkinson-dementia syndrome; Pick disease,N/A
MARS1,Neurologic,Interstitial lung and liver disease,Pediatric
MARS2,Neurologic,Combined oxidative phosphorylation deficiency 25; Spastic ataxia 3; autosomal recessive,N/A
MASP1,Neurologic,3MC syndrome 1,Pediatric
MAST1,Neurologic,Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations,N/A
MAT1A,Neurologic,Methionine adenosyltransferase I/III deficiency,Pediatric
MBD5,Neurologic,Mental retardation; autosomal dominant 1,N/A
MBOAT7,Neurologic,Mental retardation; autosomal recessive 57,N/A
MBTPS2,Neurologic,Keratosis follicularis spinulosa decalvans; X-linked; IFAP syndrome with or without BRESHECK syndrome; Palmoplantar keratoderma; mutilating; with periorificial keratotic plaques; X-linked; Osteogenesis imperfecta; type XIX,N/A
MCCC1,Neurologic,3-Methylcrotonyl-CoA carboxylase 1 deficiency,Pediatric
MCCC2,Neurologic,3-Methylcrotonyl-CoA carboxylase 2 deficiency,Pediatric
MCEE,Neurologic,Methylmalonyl-CoA epimerase deficiency,N/A
MCM3AP,Neurologic,Peripheral neuropathy; autosomal recessive; with or without impaired intellectual development,N/A
MCOLN1,Neurologic,Mucolipidosis IV,N/A
MCPH1,Neurologic,Microcephaly; primary autosomal recessive; 1,N/A
MDH2,Neurologic,Epileptic encephalopathy; early infantile; 51,N/A
MECP2,Neurologic,Rett syndrome; Encephalopathy; neonatal severe; due to MECP2 mutations; Autism; X-linked 3; Mental retardation; X-linked syndromic 13; Angelman-like syndrome; Mental retardation; X-linked 79; Mental retardation; X-linked syndromic; Lubs type,N/A
MECR,Neurologic,Dystonia; childhood-onset; with optic atrophy and basal ganglia abnormalities (DYTOABG),N/A
MED12,Neurologic,Lujan-Fryns syndrome; Opitz-Kaveggia syndrome; Mental retardation; X-linked; with Marfanoid habitus; FG syndrome; Ohdo syndrome; X-linked,N/A
MED13L,Neurologic,Transposition of the great arteries; dextro-looped 1; Mental retardation and distinctive facial features with or without cardiac defects; Congenital heart defects and intellectual disability; Intellectual disability; autosomal recessive,N/A
MED17,Neurologic,Microcephaly; postnatal progressive; with seizures and brain atrophy,N/A
MED23,Neurologic,Mental retardation; autosomal recessive 18,N/A
MED25,Neurologic,Basel-Vanagait-Smirin-Yosef syndrome; Charcot-Marie-Tooth disease; axonal; tybe 2B2,N/A
MEF2C,Neurologic,Mental retardation; autosomal dominant 20,N/A
MEIS2,Neurologic,Cleft palate; cardiac defects; and mental retardation (CPCMR),N/A
METTL23,Neurologic,Mental retardation; autosomal recessive 44,N/A
MFF,Neurologic,Encephalopathy due to defective mitochondrial and peroxisomal fission 2,N/A
MFN2,Neurologic,Charcot-Marie-Tooth disease; type 2A2A; Charcot-Marie-Tooth disease; type 2A2B; Hereditary motor and sensory neuropathy; type VIA,N/A
MFSD2A,Neurologic,Microcephaly 15; primary; autosomal recessive,N/A
MFSD8,Neurologic,Ceroid lipofuscinosis; neuronal; 7,N/A
MGAT2,Neurologic,Congenital disorder of glycosylation; type IIa,Pediatric
MGME1,Neurologic,Mitochondrial DNA depletion syndrome 11,Pediatric
MGP,Neurologic,Keutel syndrome,N/A
MICOS13,Neurologic,Combined oxidative phosphorylation deficiency 37,N/A
MICU1,Neurologic,Myopathy with extrapyramidal signs,N/A
MID1,Neurologic,Opitz GBBB syndrome; type I,N/A
MID2,Neurologic,Mental retardation; X-linked 101,N/A
MIPEP,Neurologic,Combined oxidative phosphorylation deficiency 31,Pediatric
MIR17HG,Neurologic,Feingold syndrome 2,N/A
MKKS,Neurologic,McKusick-Kaufman syndrome; Bardet-Biedl syndrome 6,N/A
MKS1,Neurologic,Joubert syndrome 28; Meckel syndrome 1; Bardet-Biedl syndrome 13,N/A
MLC1,Neurologic,Megalencephalic leukoencephalopathy with subcortical cysts 1,N/A
MLYCD,Neurologic,Malonyl-CoA decarboxylase deficiency,Pediatric
MMAA,Neurologic,Methylmalonic acidemia; cblA type,Pediatric
MMAB,Neurologic,Methylmalonic acidemia; cblB type,Pediatric
MMACHC,Neurologic,Methylmalonic aciduria and homocystinuria; cblC type,Pediatric
MMADHC,Neurologic,Methylmalonic aciduria and homocystinuria; cblD type,Pediatric
MME,Neurologic,Spinocerebellar ataxia 43; Charcot-Marie-Tooth disease; axonal; type 2T,N/A
MMUT,Neurologic,Methylmalonic acidemia due to methylmalonyl-CoA mutase deficiency,Pediatric
MOCS1,Neurologic,Molybdenum cofactor deficiency; type A,Pediatric
MOCS2,Neurologic,Molybdenum cofactor deficiency; type B,N/A
MOG,Neurologic,Narcolepsy 7,N/A
MOGS,Neurologic,Congenital disorder of glycosylation; type IIb,Pediatric
MORC2,Neurologic,Charcot-Marie-Tooth disease type; axonal; type 2Z,N/A
MPC1,Neurologic,Mitochondrial pyruvate carrier deficiency,N/A
MPDU1,Neurologic,Congenital disorder of glycosylation; type If,Pediatric
MPDZ,Neurologic,Hydrocephalus; nonsyndromic; autosomal recessive 2,N/A
MPLKIP,Neurologic,Trichothiodystrophy 4; nonphotosensitive,N/A
MPV17,Neurologic,Mitochondrial DNA depletion syndrome 6 (hepatocerebral type),Pediatric
MPZ,Neurologic,Charcot-Marie-Tooth disease; dominant intermediate 3; Charcot-Marie-Tooth disease; axonal; type 2J; Charcot-Marie-Tooth disease; axonal; type 2I; Neuropathy; congenital hypomyelinating 1; Roussy-Levy syndrome; Dejerine-Sottas disease; Charcot-Marie-Tooth disease; type 1B; Hypomyelinating neuropathy; congenital; 2,N/A
MR1,Neurologic,Paroxysmal nonkinesigenic dyskinesia 1,N/A
MRAS,Neurologic,Noonan syndrome 11,Pediatric
MRE11,Neurologic,Breast cancer; susceptibility to,Adult
MRM2,Neurologic,Mitochondrial DAN depletion syndrome 17,N/A
MRPL3,Neurologic,Combined oxidative phosphorylation deficiency 9,N/A
MRPS14,Neurologic,Combined oxidative phosphorylation deficiency 38,Pediatric
MRPS16,Neurologic,Combined oxidative phosphorylation deficiency 2,N/A
MRPS2,Neurologic,Combined oxidative phosphorylation deficiency 36,N/A
MRPS22,Neurologic,Combined oxidative phosphorylation deficiency 5; Ovarian dysgenesis 7,N/A
MRPS34,Neurologic,Combined oxidative phosphorylation deficiency 32,N/A
MRPS7,Neurologic,Combined oxidative phosphorylation deficiency 34,Pediatric
MSMO1,Neurologic,Microcephaly; congenital cataract; and psoriasiform dermatitis,Pediatric
MSTO1,Neurologic,Myopathy; mitochondrial; and ataxia,N/A
MT-ATP6,Neurologic,Myopathy; lactic acidosis; and sideroblastic anemia 3,N/A
MT-ATP8,Neurologic,Brain pseudoatrophy; reversible; valproate-induced; susceptibility to,Pediatric
MT-CO1,Neurologic,Deafness; mitochondrial,Pediatric
MT-CO2,Neurologic,Cytochrome c oxidase deficiency,N/A
MT-CO3,Neurologic,Myoglobinuria; recurrent,N/A
MT-ND1,Neurologic,Deafness; mitochondrial,Pediatric
MT-ND2,Neurologic,Leber hereditary optic neuropathy; Mitochondrial complex I deficiency,N/A
MT-ND3,Neurologic,Leber optic atrophy and dystonia; Mitochondrial complex I deficiency; mitochondrial type 1,N/A
MT-ND4,Neurologic,Leber hereditary optic neuropathy; Leber optic atrophy and dystonia; Mitochondrial complex I deficiency,N/A
MT-ND5,Neurologic,Myoclonic epilepsy with ragged red fibers; Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes; Leber hereditary optic neuropathy; Mitochondrial complex I deficiency,N/A
MT-ND6,Neurologic,Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes; Oncocytoma; Leber hereditary optic neuropathy; Leber optic atrophy and dystonia; Mitochondrial complex I deficiency,N/A
MT-TC,Neurologic,Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes,N/A
MT-TE,Neurologic,Diabetes-deafness syndrome; Mitochondrial myopathy; infantile; transient; Mitochondrial myopathy with diabetes,N/A
MT-TF,Neurologic,Myoclonic epilepsy with ragged red fibers; Nephropathy; tubulointerstitial; Encephalopathy; mitochondrial; Epilepsy; mitochondrial; Myopathy; mitochondrial; Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes,N/A
MT-TL1,Neurologic,Brain pseudoatrophy; reversible; valproate-induced; susceptibility to,Pediatric
MT-TS1,Neurologic,Deafness,Pediatric
MTFMT,Neurologic,Combined oxidative phosphorylation deficiency 15,Pediatric
MTHFD1,Neurologic,Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia (CIMAH),Pediatric
MTHFR,Neurologic,Homocystinuria due to MTHFR deficiency,Pediatric
MTHFS,Neurologic,Neurodevelopmental disorder with microcephaly; epilepsy; and hypomyelination,Pediatric
MTMR2,Neurologic,Charcot-Marie-Tooth disease; type 4B1,N/A
MTO1,Neurologic,Combined oxidative phosphorylation deficiency 10,Pediatric
MTOR,Neurologic,Smith-Kingsmore syndrome,N/A
MTPAP,Neurologic,Spastic ataxia 4; autosomal recessive,N/A
MTR,Neurologic,Homocystinuria-megaloblastic anemia; cblG complementation type,Pediatric
MTRR,Neurologic,Homocystinuria-megaloblastic anemia; cobalamin E complementation type,Pediatric
MTTP,Neurologic,Abetalipoproteinemia,Pediatric
MUSK,Neurologic,Myasthenic syndrome; congenital; 9; associated with acetylcholine receptor deficiency,Pediatric
MYCN,Neurologic,Feingold syndrome 1,N/A
MYH14,Neurologic,Deafness; autosomal dominant 4; Deafness; autosomal dominant 4B; Peripheral neuropathy; myopathy; hoarseness; and hearing loss,N/A
MYO18B,Neurologic,Klippel-Feil syndrome 4; autosomal recessive; with myopathy and facial dysmorphism,N/A
MYO5A,Neurologic,Griscelli syndrome; type 1,N/A
MYO9A,Neurologic,Myasthenic syndrome; congenital; 24; presynaptic,Pediatric
MYORG,Neurologic,Basal ganglia calcification; idiopathic; 7; autosomal recessive,N/A
MYOT,Neurologic,Myopathy; myofibrillar; 3,Pediatric
MYPN,Neurologic,Cardiomyopathy; dilated; 1KK; Cardiomyopathy; familial hypertrophic; 22; Cardiomyopathy; familial restrictive; 4,Pediatric
MYRF,Neurologic,Encephalitis/encephalopathy; mild; with reversible myelin vacuolization,Pediatric
MYT1L,Neurologic,Mental retardation; autosomal dominant 39,N/A
NAA10,Neurologic,N-terminal acetyltransferase deficiency (Ogden syndrome),Pediatric
NAA15,Neurologic,Mental retardation; autosomal dominant; 50,N/A
NACC1,Neurologic,Neurodevelopmental disorder with epilepsy; cataracts; feeding difficulties; and delayed brain myelination (NECFM),N/A
NADK2,Neurologic,2;4-dienoyl-CoA reductase deficiency,N/A
NAGA,Neurologic,Kanzaki disease; Alpha-n-acetylgalactosaminidase deficiency; Schindler disease type I; Schindler disease type III,N/A
NAGLU,Neurologic,Mucopolysaccharidosis type IIIB (Sanfilippo syndrome B),N/A
NAGS,Neurologic,N-acetylglutamate synthase deficiency,Pediatric
NALCN,Neurologic,Congenital contractures of the limbs and face; hypotonia; and developmental delay; Hypotonia; infantile; with psychomotor retardation and characteristic facies 1,N/A
NANS,Neurologic,Spondyloepimetaphyseal dysplasiam Genevieve type,N/A
NARS2,Neurologic,Deafness; autosomal recessive 94,Pediatric
NAT8L,Neurologic,N-acetylaspartate deficiency,N/A
NAXD,Neurologic,Encephalopathy; progressive; early-onset; with brain edema and/or leukoencephalopathy; 2,Pediatric
NAXE,Neurologic,Early-onset progressive encephalopathy with brain edema and/or leukoencephalopathy (PEBEL),N/A
NBN,Neurologic,Breast cancer; susceptibility to; Nijmegen breakage syndrome,Pediatric (Nijmegen breakage syndrome); Adult (Breast cancer; susceptibility to)
NCAPD2,Neurologic,Microcephaly 21; primary; autosomal recessive,N/A
NCAPD3,Neurologic,Microcephaly 22; primary; autosomal recessive,N/A
NCAPG2,Neurologic,Kahn-Kahn-Katsanis syndrome,N/A
NCAPH,Neurologic,Microcephaly 23; primary; autosomal recessive,N/A
NDE1,Neurologic,Lissencephaly 4; Microhydranencephaly,N/A
NDRG1,Neurologic,Charcot-Marie-Tooth disease; type 4D,N/A
NDST1,Neurologic,Mental retardation; autosomal recessive 46,N/A
NDUFA1,Neurologic,Mitochondrial complex I deficiency; nuclear type 12,N/A
NDUFA10,Neurologic,Mitochondrial complex I deficiency; nuclear type 22; Leigh syndrome,N/A
NDUFA11,Neurologic,Mitochondrial complex I deficiency; nuclear type 14,N/A
NDUFA12,Neurologic,Mitochondrial complex I deficiency; nuclear type 23; Leigh syndrome,N/A
NDUFA13,Neurologic,Thyroid carcinoma; Hurthle cell,Adult
NDUFA2,Neurologic,Mitochondrial complex I deficiency; nuclear type 13; Leigh syndrome,N/A
NDUFA6,Neurologic,Mitochondrial complex I deficiency; nuclear type 33,N/A
NDUFA9,Neurologic,Mitochondrial complex I deficiency; nuclear type 26; Leigh syndrome,N/A
NDUFAF1,Neurologic,Mitochondrial complex I deficiency; nuclear type 11,N/A
NDUFAF2,Neurologic,Mitochondrial complex I deficiency; nuclear type 10; Leigh syndrome,N/A
NDUFAF3,Neurologic,Mitochondrial complex I deficiency; nuclear type 18,N/A
NDUFAF4,Neurologic,Mitochondrial complex I deficiency; nuclear type 15,N/A
NDUFAF5,Neurologic,Mitochondrial complex I deficiency; nuclear type 16,N/A
NDUFAF6,Neurologic,Mitochondrial complex I deficiency; nuclear type 17; Leigh syndrome,N/A
NDUFB11,Neurologic,Linear skin defects with multiple congenital anomalies 3,Pediatric
NDUFB3,Neurologic,Mitochondrial complex I deficiency; nuclear type 25,N/A
NDUFB8,Neurologic,Mitochondrial complex I deficiency; nuclear type 32,N/A
NDUFB9,Neurologic,Mitochondrial complex I deficiency; nuclear type 24,N/A
NDUFS1,Neurologic,Mitochondrial complex I deficiency; nuclear type 5,N/A
NDUFS2,Neurologic,Mitochondrial complex I deficiency; nuclear type 6,N/A
NDUFS3,Neurologic,Mitochondrial complex I deficiency; nuclear type 8; Leigh syndrome,N/A
NDUFS4,Neurologic,Mitochondrial complex I deficiency; nuclear type 1; Leigh syndrome,N/A
NDUFS6,Neurologic,Mitochondrial complex I deficiency; nuclear type 9,N/A
NDUFS7,Neurologic,Mitochondrial complex I deficiency; nuclear type 3; Leigh syndrome,N/A
NDUFS8,Neurologic,Mitochondrial complex I deficiency; nuclear type 2; Leigh syndrome,N/A
NDUFV1,Neurologic,Mitochondrial complex I deficiency; nuclear type 4,N/A
NDUFV2,Neurologic,Mitochondrial complex I deficiency; nuclear type 7,N/A
NECAP1,Neurologic,Epileptic encephalopathy; early infantile 21,N/A
NECTIN1,Neurologic,Cleft lip/palate-ectodermal dysplasia syndrome,N/A
NEDD4L,Neurologic,Periventricular nodular heterotopia 7,N/A
NEFH,Neurologic,Charcot-Marie-Tooth disease; axonal; type 2CC,N/A
NEFL,Neurologic,Charcot-Marie-Tooth disease; axonal; type 2E; Charcot-Marie-Tooth disease; dominant intermediate G; Charcot-Marie-Tooth disease; type 1F,N/A
NEK1,Neurologic,Short-rib thoracic dysplasia 6 with or without polydactyly,N/A
NEK9,Neurologic,Arthrogryposis; Perthes disease; and upward gaze palsy; Lethal congenital contracture syndrome 10,N/A
NEU1,Neurologic,Sialidosis; type I; Sialidosis; type II,N/A
NEUROD2,Neurologic,Epileptic encephalopathy; early infantile; 72,Pediatric
NEXMIF,Neurologic,Mental retardation; X-linked 98,N/A
NF1,Neurologic,Neurofibromatosis type 1; Neurofibromatosis-Noonan syndrome; Watson syndrome,Pediatric
NFASC,Neurologic,Neurodevelopmental disorder with central and peripheral motor dysfunction,N/A
NFE2L2,Neurologic,Immunodeficiency; developmental delay; and hypohomocysteinemia (IMDDHH),Pediatric
NFIA,Neurologic,Brain malformations with or without urinary tract defects,Pediatric
NFIB,Neurologic,Macrocephaly; acquired; with impaired intellectual development,N/A
NFIX,Neurologic,Marshall-Smith syndrome; Sotos syndrome 2,N/A
NFU1,Neurologic,Multiple mitochondrial dysfunctions syndrome 1,N/A
NGF,Neurologic,Neuropathy; hereditary sensory and autonomic; type V,N/A
NGLY1,Neurologic,Congenital disorder of deglycosylation,Pediatric
NHEJ1,Neurologic,Severe combined immunodeficiency with microcephaly; growth retardation; and sensitivity to ionizing radiation,Pediatric
NHLRC1,Neurologic,Epilepsy; progressive myoclonic 2B (Lafora),N/A
NHLRC2,Neurologic,Fibrosis; neurodegeneration; and cerebral angiomatosis,N/A
NHP2,Neurologic,Dyskeratosis congenita; autosomal recessive 2,Pediatric
NIN,Neurologic,Seckel syndrome 7,N/A
NIPA1,Neurologic,Spastic paraplegia 6; autosomal dominant,N/A
NIPBL,Neurologic,Cornelia de Lange syndrome 1,N/A
NKX2-1,Neurologic,Choreoathetosis; hypothyroidism; and neonatal respiratory distress; Thyroid cancer; nonmedullary 1,Pediatric/Adult
NKX6-2,Neurologic,Spastic ataxia 8; autosomal recessive; with hypomyelinating leukodystrophy,N/A
NLGN3,Neurologic,Asperger syndrome; X-linked 1; Autism; X-linked 1,N/A
NLGN4X,Neurologic,Asperger syndrome; X-linked 2; Autism; X-linked 2; Mental retardation; X-linked,N/A
NOL3,Neurologic,Myoclonus; familial;1 ,N/A
NONO,Neurologic,Mental retardation; X-linked; syndrome 34,N/A
NOP10,Neurologic,Dyskeratosis congenita; autosomal recessive 1,Pediatric
NOP56,Neurologic,Spinocerebellar ataxia 36,N/A
NOTCH2,Neurologic,Alagille syndrome 2,Pediatric
NOTCH2NLC,Neurologic,Neuronal intranuclear inclusion disease,N/A
NOTCH3,Neurologic,Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1 (CADASIL1); Myofibromatosis; infantile 2,Pediatric
NPC1,Neurologic,Niemann-Pick disease; type C1; Niemann-Pick disease; type D ,N/A
NPC2,Neurologic,Niemann-pick disease; type C2,N/A
NPHP1,Neurologic,Joubert syndrome 4; Nephronophthisis 1; Senior-Loken syndrome 1,N/A
NPRL2,Neurologic,Epilepsy; familial focal; with variable foci 2,N/A
NPRL3,Neurologic,Epilepsy; familial focal; with variable foci 3,N/A
NR2F1,Neurologic,Bosch-Boonstra optic atrophy syndrome,N/A
NRAS,Neurologic,Autoimmune lymphoproliferative syndrome type IV; Noonan syndrome 6,Pediatric
NRIP1,Neurologic,Congenital anomalies of the kidney and urinary tract 3,Pediatric
NRXN1,Neurologic,Schizophrenia 17; Pitt-Hopkins-like syndrome 2,N/A
NSD1,Neurologic,Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome,Pediatric
NSMF,Neurologic,Hypogonadotropic hypogonadism 9 with or without anosmia,Pediatric
NT5C2,Neurologic,Spastic paraplegia 45,N/A
NTN1,Neurologic,Mirror movements 4,N/A
NTRK1,Neurologic,Insensitivity to pain; congenital; with anhidrosis,Pediatric
NTRK2,Neurologic,Obesity; hyperphagia; and developmental delay,N/A
NUBPL,Neurologic,Mitochondrial complex I deficiency; nuclear type 21,N/A
NUP107,Neurologic,Nephrotic syndrome; type 11; Ovarian dysgenesis 6; Galloway-Mowat syndrome 7,N/A
NUP133,Neurologic,Nephrotic syndrome; type 18; Galloway-Mowat syndrome 8,N/A
NUP214,Neurologic,Encephalopathy; acute; infection-induced; suseptibility to; 9,N/A
NUP37,Neurologic,Microcephaly 24; primary; autosomal recessive,N/A
NUP62,Neurologic,Striatonigral degeneration; infantile,N/A
NUP88,Neurologic,Fetal akinesia deformation sequence 4,N/A
NUS1,Neurologic,Mental retardation; autosomal dominant; 55; with seizures; Congenital disorder of glycosylation; type 1aa,N/A
NUTM2B-AS1,Neurologic,Oculopharyngeal myopathy with leukoencephalopathy 1,N/A
NXF5,Neurologic,Familial heart block and focal segmental glomerulosclerosis,Pediatric
OAT,Neurologic,Gyrate atrophy of choroid and retina,Pediatric
OCLN,Neurologic,Pseudo-TORCH syndrome 1 (Band-like calcification with simplified gyration and polymicrogyria),N/A
OCRL,Neurologic,Dent disease 2; Lowe syndrome,Pediatric
OFD1,Neurologic,Orofaciodigital syndrome 1; Simpson-Golabi-Behmel syndrome type 2; Joubert syndrome 10; Retinitis pigmentosa 23,N/A
OGT,Neurologic,Mental retardation; X-linked 106,N/A
OPA1,Neurologic,Glaucoma; normal tension; susceptibility to,Adult
OPA3,Neurologic,3-methylglutaconic aciduria; type III; Optic atrophy 3; autosomal dominant,N/A
OPHN1,Neurologic,Mental retardation; X-linked; with cerebellar hypoplasia and distinctive facial appearance,N/A
OPTN,Neurologic,Glaucoma; normal tension; susceptibility to; Glaucoma 1; open angle; E ,Adult
ORAI1,Neurologic,Immunodeficiency 9,Pediatric
OSGEP,Neurologic,Galloway-Mowat syndrome 3,N/A
OSTM1,Neurologic,Osteopetrosis; autosomal recessive 5,N/A
OTC,Neurologic,Ornithine transcarbamylase deficiency,Pediatric
OTUD6B,Neurologic,Intellectual developmental disorder with dysmorphic facies; seizures; and distal limb anomalies (IDDFSDA),N/A
OTX2,Neurologic,Pituitary hormone deficiency; combined 6; Microphthalmia; syndromic 5; Retinal dystrophy; early-onset; and pituitary dysfunction,Pediatric
P4HB,Neurologic,Cole Carpenter syndrome 1,N/A
P4HTM,Neurologic,Hypotonia; hyperventilation; impaired intellectual development; dysautonomia; epilepsy; and eye abnormalities,Pediatric
PACS1,Neurologic,Schuss-Hoeijmakers syndrome (Mental retardation; autosomal dominant 17),N/A
PACS2,Neurologic,Epileptic encephalopathy; early infantile; 66,N/A
PAFAH1B1,Neurologic,Lissencephaly 1,N/A
PAH,Neurologic,Phenylketonuria; Hyperphenylalaninemia; non-PKU mild,Pediatric
PAK1,Neurologic,Intellectual developmental disorder with macrocephaly; seizures; and speech delay,N/A
PAK3,Neurologic,Mental retardation; X-linked 30,N/A
PALB2,Neurologic,Breast cancer; Pancreatic cancer; susceptibility to 3; Fanconi anemia; complementation group N,Pediatric (Fanconi anemia; complementation group N); Adult (Breast cancer; Pancreatic cancer; susceptibility to 3)
PAM16,Neurologic,Spondylometaphyseal dysplasia; Megarbane-Dagher-Melki type,N/A
PANK2,Neurologic,Hypoprebetalipoproteinemia; acanthocytosis; retinitis pigmentosa; and pallidal degeneration; Neurodegeneration with brain iron accumulation 1  ,N/A
PARK7,Neurologic,Parkinson disease 7; autosomal recessive early-onset,N/A
PARN,Neurologic,Pulmonary fibrosis and/or bone marrow failure; telomere-related 4; Dyskeratosis congenita; autosomal recessive 6,Pediatric
PARS2,Neurologic,Epileptic encephalopathy; early infantile; 75,N/A
PAX1,Neurologic,Otofaciocervical syndrome 2,Pediatric
PAX6,Neurologic,Anterior segment dysgenesis 5; Cataract with late-onset corneal dystrophy; Aniridia; Aniridia; cerebellar ataxia; and mental retardation (Gillespie syndrome); Optic nerve hypoplasia; Keratitis; Foveal hypoplasia 1; Coloboma; ocular; autosomal dominant; Morning glory disc anomaly,Pediatric
PBX1,Neurologic,Congenital anomalies of the kidney and urinary tract syndrome with or without hearing loss; abnormal ears; or developmental delay (CAKUTHED),Pediatric
PC,Neurologic,Pyruvate carboxylase deficiency,Pediatric
PCCA,Neurologic,Propionic acidemia,Pediatric
PCCB,Neurologic,Propionic acidemia,Pediatric
PCDH12,Neurologic,Microcephaly; seizures; spasticity; and brain calcifications (MISSBC),N/A
PCDH19,Neurologic,Epileptic encephalopathy; early infantile; 9,N/A
PCGF2,Neurologic,Turnpenny-Fry syndrome,N/A
PCNA,Neurologic,Ataxia-telangiectasia-like disorder 2,Pediatric
PCNT,Neurologic,Microcephalic osteodysplastic primordial dwarfism; type II,N/A
PDCD10,Neurologic,Cerebral cavernous malformations 3,Pediatric
PDE10A,Neurologic,Striatal degeneration; autosomal dominant 2; Infantile-onset dyskinesia,N/A
PDE4D,Neurologic,Acrodysostosis 2; with or without hormone resistance,Pediatric
PDE6D,Neurologic,Joubert syndrome 22,N/A
PDE8B,Neurologic,Pigmented nodular adrenocortical disease; primary; 3,Pediatric
PDGFB,Neurologic,Basal ganglia calcification; idiopathic; 5,N/A
PDGFRB,Neurologic,Basal ganglia calcification; idiopathic; 4; Kosaki overgrowth syndrome; Myofibromatosis; infantile 1; Premature aging syndrome; Penttinen type,Pediatric
PDHA1,Neurologic,Pyruvate dehydrogenase E1-alpha deficiency; Leigh syndrome; X-linked,Pediatric
PDHB,Neurologic,Pyruvate dehydrogensae E1-beta deficiency,N/A
PDHX,Neurologic,Pyruvate dehydrogenase E3-binding protein deficiency,Pediatric
PDK3,Neurologic,Charcot-Marie-Tooth disease; X-linked; dominant;6,N/A
PDP1,Neurologic,Pyruvate dehydrogenase phosphatase deficiency,N/A
PDSS1,Neurologic,Coenzyme Q10 deficiency 2,Pediatric
PDSS2,Neurologic,Coenzyme Q10 deficiency 3,Pediatric
PDX1,Neurologic,Pancreatic agenesis 1; Neonatal diabetes mellitus,Pediatric
PDXK,Neurologic,Hereditary motor and sensory neuropathy; type VIC; with optic atrophy (Charcot-Marie-Tooth disease; type 6C),N/A
PDYN,Neurologic,Spinocerebellar ataxia 23,N/A
PEPD,Neurologic,Prolidase deficiency,Pediatric
PER2,Neurologic,Advanced sleep phase syndrome; familial;1,N/A
PER3,Neurologic,Advanced sleep phase syndrome; familial; 3,N/A
PET100,Neurologic,Mitochondrial complex IV deficiency,N/A
PEX1,Neurologic,Heimler syndrome 1,Pediatric
PEX10,Neurologic,Peroxisome biogenesis disorder 6A (Zellweger syndrome); Peroxisome biogenesis disorder 6B,N/A
PEX11B,Neurologic,Peroxisome biogenesis factor disorder 14B,N/A
PEX12,Neurologic,Peroxisome biogenesis disorder 3A; Peroxisome biogenesis factor disorder 3B,N/A
PEX13,Neurologic,Peroxisome biogenesis disorder 11A (Zellweger syndrome); Peroxisome biogenesis disorder 11B,N/A
PEX14,Neurologic,Peroxisome biogenesis factor disorder 14; Zellweger syndrome,N/A
PEX16,Neurologic,Peroxisome biogenesis factor disorder 8A (Zellweger syndrome); Peroxisome biogenesis disorder 8B,N/A
PEX19,Neurologic,Peroxisome biogenesis disorder; 19; Zellweger syndrome,N/A
PEX2,Neurologic,Peroxisome biogenesis disorder 5A; Peroxisome biogenesis disorder 5B,N/A
PEX26,Neurologic,Peroxisome biogenesis disorder 7A; Peroxisome biogenesis disorder 7B; Adrenoleukodystrophy; neonatal; Refsum disease; infantile,N/A
PEX3,Neurologic,Peroxisome biogenesis factor disorder 3; Peroxisome biogenesis disorder 10A (Zellweger); Peroxisome biogenesis disorder 10B,N/A
PEX5,Neurologic,Peroxisome biogenesis disorder 2A (Zellweger syndrome); Peroxisome biogenesis disorder 2B; Rhizomelic chondrodysplasia punctata; type 5,N/A
PEX6,Neurologic,Heimler syndrome 2 (Peroxisome biogenesis disorder 4C),Pediatric
PEX7,Neurologic,Refsum disease,Pediatric
PFN1,Neurologic,Amyotrophic lateral sclerosis 18,N/A
PGAP1,Neurologic,Mental retardation; autosomal recessive 42,N/A
PGAP2,Neurologic,Hyperphosphatasia with mental retardation syndrome 3,N/A
PGAP3,Neurologic,Hyperphosphatasia with mental retardation syndrome 4,N/A
PGK1,Neurologic,Phosphoglycerate kinase 1 deficiency,Pediatric
PGM1,Neurologic,Congenital disorder of glycosylation; type It,Pediatric
PGM3,Neurologic,Immunodeficiency 23,Pediatric
PHACTR1,Neurologic,Epileptic encephalopathy; early infantile; 70,N/A
PHC1,Neurologic,Microcephaly 11; primary; autosomal recessive,N/A
PHEX,Neurologic,Hypophosphatemic rickets; X-linked dominant,Pediatric
PHF6,Neurologic,Borjeson-Forssman-Lehmann syndrome,N/A
PHF8,Neurologic,Mental retardation syndrome; X-linked; Siderius type,N/A
PHGDH,Neurologic,Phosphoglycerate dehydrogenase deficiency,Pediatric
PHIP,Neurologic,Developmental delay; intellectual disability; obesity; and dysmorphic features,N/A
PHKA2,Neurologic,Glycogen storage disease; type IXa1/Glycogen storage disease; type IXa2 (Phosphorylase kinase deficiency),Pediatric
PHKG2,Neurologic,Glycogen storage disease IXc,Pediatric
PHOX2B,Neurologic,Central hypoventilation syndrome; congenital; Neuroblastoma with Hirschsprung disease; Neuroblastoma; susceptiblity to; 2,Pediatric
PHYH,Neurologic,Refsum disease,Pediatric
PI4KA,Neurologic,Perisylvian polymicrogyria; cerebellar hypoplasia; and arthrogryposis,N/A
PIBF1,Neurologic,Joubert syndrome 33,N/A
PIEZO2,Neurologic,Arthrogryposis; distal; type 3; Arthrogryposis; distal; type 5; Marden-Walker syndrome; Arthrogryposis; distal; with impaired proprioception and touch,N/A
PIGA,Neurologic,Multiple congenital anomalies-hypotonia-seizures syndrome 2,N/A
PIGB,Neurologic,Epileptic encephalopathy; early infantile; 80,N/A
PIGC,Neurologic,Glycosylphosphatidylinositol biosynthesis defect 16,N/A
PIGG,Neurologic,Mental retardation; autosomal recessive 53,N/A
PIGH,Neurologic,Glycosylphosphatidylinositol biosynthesis defect 17,N/A
PIGL,Neurologic,CHIME syndrome,N/A
PIGM,Neurologic,Glycosylphosphatidylinositol deficiency,Pediatric
PIGN,Neurologic,Multiple congenital anomalies-hypotonia-seizures syndrome 1,N/A
PIGO,Neurologic,Hyperphosphatasia with mental retardation syndrome 2,N/A
PIGP,Neurologic,Epileptic encephalopathy; early infantile; 55,N/A
PIGQ,Neurologic,Epileptic encephalopathy; early infantile; 77,N/A
PIGT,Neurologic,Multiple congenital anomalies-hypotonia-seizures syndrome 3,N/A
PIGU,Neurologic,Glycosylphosphatidylinositol biosynthesis defect 21,N/A
PIGV,Neurologic,Hyperphosphatasia with mental retardation syndrome 1,N/A
PIGW,Neurologic,Glycosylphosphatidylinositol biosynthesis defect 11,N/A
PIGY,Neurologic,Hyperphosphatasia with mental retardation syndrome 6,N/A
PIK3C2A,Neurologic,Oculoskeletodental syndrome,Pediatric
PIK3R2,Neurologic,Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1,N/A
PIK3R5,Neurologic,Ataxia-oculomotor apraxia 3,N/A
PINK1,Neurologic,Parkinson disease 6; autosomal recessive; early onset,N/A
PLA2G6,Neurologic,Parkinson disease 14; autosomal recessive; Neurodegeneration with brain iron accumulation 2A; Neurodegeneration with brain iron accumulation 2B,N/A
PLAA,Neurologic,Neurodevelopmental disorder with progressive microcephaly; spasticity; and brain anomalies (NDMSBA),N/A
PLCB1,Neurologic,Epileptic encephalopathy; early infantile; 12,Pediatric
PLD3,Neurologic,Spinocerebellar ataxia 46,N/A
PLEKHG2,Neurologic,Leukodystrophy and acquired microcephaly with or without dystonia,N/A
PLEKHG5,Neurologic,Charcot-Marie-Tooth disease; recessive intermediate C; Spinal muscular atrophy; distal; autosomal recessive; 4,N/A
PLG,Neurologic,Plasminogen deficiency; type I,Pediatric
PLK4,Neurologic,Microcephaly and chorioretinopathy; autosomal recessive 2,N/A
PLP1,Neurologic,Spastic paraplegia-2; Pelizaeus-Merzbacher disease,N/A
PLPBP,Neurologic,Epilepsy; early-onset; vitamin B6-dependent,Pediatric
PMM2,Neurologic,Congenital disorder of glycosylation; type Ia,Pediatric
PMP2,Neurologic,Charcot-Marie-Tooth disease; demyelinating; type 1G,N/A
PMP22,Neurologic,Roussy-Levy syndrome; Charcot-Marie-Tooth syndrome; type 1A; Charcot-Marie-Tooth syndrome with deafness (type 1E); Neuropathy; hereditary; with liability to pressurve palsies; Dejerine-Sottas disease; Neuropathy; inflammatory demyelinating ,N/A
PMPCA,Neurologic,Spinocerebellar ataxia; autosomal recessive 2,N/A
PNKP,Neurologic,Ataxia-oculomotor apraxia 4; Microcephaly; seizures; and developmental delay,N/A
PNP,Neurologic,Purine nucleoside phosphorylase deficiency,Pediatric
PNPLA6,Neurologic,Boucher-Neuhauser syndrome; Laurence-Moon syndrome; Oliver-McFarlane syndrome,Pediatric
PNPLA8,Neurologic,Mitochondrial myopathy with lactic acidosis,N/A
PNPO,Neurologic,Pyridoxamine 5'-phosphate oxidase deficiency,Pediatric
PNPT1,Neurologic,Deafness; autosomal recessive 70,Pediatric
POC1A,Neurologic,Short stature; onychodysplasia; facial dysmorphism; and hypotrichosis (SOFT syndrome),N/A
POGZ,Neurologic,Mental retardation; autosomal dominant 37 (White-Sutton syndrome),N/A
POLA1,Neurologic,Pigmentary disorder; reticulate; with systemic manifestations; X-linked; Van Esch-O'Driscoll syndrome,Pediatric
POLG,Neurologic,Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal dominant 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive 1; Mitochondrial DNA depletion syndrome 4B; Sensory ataxia; dysarthria; and ophthalmoparesis; Mitochondrial DNA depletion syndrome 4A (Alpers type); Alpers syndrome;  POLG-related ataxia neuropathy spectrum disorders,N/A
POLG2,Neurologic,Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal dominant 4; Mitochondrial DNA depletion syndrome 16,N/A
POLR1C,Neurologic,Treacher Collins syndrome 3,Pediatric
POLR3A,Neurologic,Leukodystrophy; hypomyelinating; 7; with or without oligodontia and/or hypogonadotropic hypogonadism; Wiedemann-Rautenstrauch syndrome,N/A
POLR3B,Neurologic,Leukodystrophy; hypomyelinating; 8; with or without oligodontia and/or hypogonadotropic hypogonadism,N/A
POMGNT1,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 3; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation); type B; 3; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 3; Retinitis pigmentosa 76,N/A
POMGNT2,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 8; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 8,N/A
POMK,Neurologic,Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies; type A; 12; Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies; type C; 12; Muscle-eye brain disease; Walker-Warburg syndrome,N/A
POMT1,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 1; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation); type B; 1; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 1 ,Pediatric
POMT2,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 2 ; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation); type B; 2; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C 2,Pediatric
POP1,Neurologic,Anauxetic dysplasia 2,N/A
POR,Neurologic,Antley-Bixler syndrome; Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency,Pediatric
PORCN,Neurologic,Focal dermal hypoplasia,N/A
POU3F3,Neurologic,Snijders Block-Fisher syndrome,N/A
PPA2,Neurologic,Sudden cardiac failure; alcohol induced,Pediatric
PPM1D,Neurologic,Intellectual developmental disorder with gastrointestinal difficulties and high pain threhold (Jansen-De Vries syndrome),N/A
PPOX,Neurologic,Porphyria variegata,Pediatric
PPP1CB,Neurologic,Noonan syndrome-like disorder with loose anagen hair 2,Pediatric
PPP1R15B,Neurologic,Microcephaly; short stature; and impaired glucose metabolism 2,Pediatric
PPP2CA,Neurologic,Neurodevelopmental disorder and language delay with or without structural brain abnormalities,N/A
PPP2R1A,Neurologic,Mental retardation; autosomal dominant 36,N/A
PPP2R2B,Neurologic,Spinocerebellar ataxia 12,N/A
PPP2R3C,Neurologic,Spermatogenic failure 36; Gonadal dysgenesis; dysmorphic facies; retinal dystrophy; and myopathy,N/A
PPP2R5D,Neurologic,Mental retardation; autosomal dominant 35,N/A
PPP3CA,Neurologic,Epileptic encephalopathy; infantile or early childhood; 1; Arthrogryposis; cleft palate; craniosynostosis; and impaired intellectual development,N/A
PPT1,Neurologic,Ceroid lipofuscinosis; neuronal; 1,N/A
PQBP1,Neurologic,Renpenning syndrome 1,N/A
PRDM12,Neurologic,Neuropathy; hereditary sensory and autonomic; type VIII,N/A
PRDM8,Neurologic,Epilepsy; progressive myoclonic; 10,N/A
PRDX1,Neurologic,Methylmalonic aciduria and homocystinuria; cblC type; digenic,Pediatric
PREPL,Neurologic,Myasthenic syndrome; congenital 22,Pediatric
PRICKLE1,Neurologic,Epilepsy; progressive myoclonic; 1B,N/A
PRICKLE2,Neurologic,Epilepsy; progessive myoclonic 5,N/A
PRKAR1A,Neurologic,Pigmented nodular adrenocortical disease; primary; 1; Carney complex; type 1; Myxoma; intracardiac; Acrodysostosis 1; with or without hormone resistance,Pediatric
PRKCG,Neurologic,Spinocerebellar ataxia 14,N/A
PRKD1,Neurologic,Congenital heart defects and ectodermal dysplasia,N/A
PRKDC,Neurologic,Immunodeficiency 26 with or without neurologic abnormalities,Pediatric
PRKN,Neurologic,Parkinson disease 2; autosomal recessive juvenile,N/A
PRKRA,Neurologic,Dystonia 16,N/A
PRMT7,Neurologic,Short stature; brachydactyly; intellectual developmental disability; and seizures (SBIDDS),N/A
PRNP,Neurologic,Spongiform encephalopathy with neuropsychiatric features; Huntington disease-like 1; Gerstmann-Straussler disease; Creutzfeldt-Jakob disease; Insomnia; fatal familial; Dementia; Lewy body,N/A
PRODH,Neurologic,Hyperprolinemia; type I,N/A
PROK2,Neurologic,Hypogonadotropic hypogonadism 4 with or without anosmia,Pediatric
PROKR2,Neurologic,Hypogonadotropic hypogonadism 3 with or without anosmia,Pediatric
PRPS1,Neurologic,Arts syndrome; Deafness; X-linked 1; Phosphoribosylpyrophosphate synthetase I superactivity ,Pediatric
PRRT2,Neurologic,Episodic kinesigenic dyskinesia 1,Pediatric
PRSS12,Neurologic,Mental retardation; autosomal recessive 1,N/A
PRUNE1,Neurologic,Neurodevelopmental disorder with microcephaly; hypotonia; and variable brain anomalies (NMIHBA),N/A
PRX,Neurologic,Dejerine-Sottas disease; Charcot-Marie-Tooth disease; type 4F ,N/A
PSAP,Neurologic,Krabbe disease; atypical; Combined saposin deficiency; Gaucher disease; atypical; due to saposin C deficiency; Metachromatic leukodystrophy due to saposin-b deficiency,N/A
PSAT1,Neurologic,Phosphoserine aminotransferase deficiency,Pediatric
PSEN1,Neurologic,Cardiomyopathy; dilated 1U,Pediatric
PSEN2,Neurologic,Cardiomyopathy; dilated; 1V; Peripartum/pregnancy-associated cardiomyopathy ,Pediatric
PSMA3,Neurologic,Proteasome-associated autoinflammatory syndrome 2,Pediatric
PSMB4,Neurologic,Proteasome-associated autoinflammatory syndrome 3,Pediatric
PSMB8,Neurologic,Proteasome-associated autoinflammatory syndrome 1,Pediatric
PSMD12,Neurologic,Stankiewicz-Isidor syndrome,N/A
PSPH,Neurologic,Phosphoserine phosphatase deficiency,Pediatric
PTCH1,Neurologic,Basal cell nevus syndrome,Pediatric
PTCHD1,Neurologic,Autism susceptibility; X-linked 4,N/A
PTDSS1,Neurologic,Lenz-Majewski hyperostotic dwarfism,N/A
PTEN,Neurologic,PTEN hamartoma tumor syndrome; Cowden syndrome 1; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma; familial; Endometrial cancer,Pediatric
PTF1A,Neurologic,Pancreatic and cerebellar agenesis; Pancreatic agenesis 2,Pediatric
PTPN11,Neurologic,Noonan syndrome 1; LEOPARD syndrome 1,Pediatric
PTRH2,Neurologic,Infantile-onset multisystem neurologic; endocrine; and pancreatic disease (IMNEPD),Pediatric
PTS,Neurologic,Hyperphenylalaninemia; BH4-deficient; A,Pediatric
PUM1,Neurologic,Spinocerebellar ataxia 47,N/A
PURA,Neurologic,Mental retardation; autosomal dominant 31,N/A
PUS1,Neurologic,Myopathy; lactic acidosis; and sideroblastic anemia 1,Pediatric
PUS3,Neurologic,Mental retardation; autosomal recessive 55,N/A
PUS7,Neurologic,Intellectual developmental disorder with abnormal behavior; microcephaly; and short stature,N/A
PYCR1,Neurologic,Cutis laxa; autosomal recessive; type IIB; Cutis laxa; autosomal recessive type IIIB,N/A
PYCR2,Neurologic,Leukodystrophy; hypomyelinating 10,N/A
QARS1,Neurologic,Microcephaly; progressive; seizures; and cerebral and cerebellar atrophy,N/A
QDPR,Neurologic,Hyperphenylalaninemia; BH4-deficient; C,Pediatric
QRICH1,Neurologic,Ververi-Brady syndrome,N/A
RAB11B,Neurologic,Neurodevelopmental disorder with ataxic gait; absent speech; and decreased cortical white matter,N/A
RAB18,Neurologic,Warburg micro syndrome 3,N/A
RAB23,Neurologic,Carpenter syndrome 1,N/A
RAB27A,Neurologic,Griscelli syndrome; type 2; Elejalde syndrome,Pediatric
RAB33B,Neurologic,Dyggve-Melchior-Clausen syndrome; Smith-McCort dysplasia 2,N/A
RAB39B,Neurologic,Mental retardation; X-linked 72; Waisman syndrome,N/A
RAB3GAP1,Neurologic,Warburg micro syndrome 1,Pediatric
RAB3GAP2,Neurologic,Warburg micro syndrome 2; Martsolf syndrome ,Pediatric
RAB7A,Neurologic,Charcot-Marie-Tooth disease; axonal; type 2B,N/A
RAC1,Neurologic,Neurologic,N/A
RAC3,Neurologic,Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies,N/A
RAD21,Neurologic,Cornelia de Lange syndrome 4; Mungan syndrome,N/A
RAD50,Neurologic,Breast cancer; susceptibility to,Adult
RAD51,Neurologic,Mirror movements 2; Fanconi anemia; complementation group R,N/A
RAD51C,Neurologic,Breast-ovarian cancer; familial; susceptibility to; Fanconi anemia goup O,Pediatric (Fanconi anemia goup O); Adult (Breast-ovarian cancer; familial; susceptibility to)
RAF1,Neurologic,Cardiomyopathy; dilated; 1NN; LEOPARD syndrome 2; Noonan syndrome 5,Pediatric
RAI1,Neurologic,Smith-Magenis syndrome,N/A
RANBP2,Neurologic,Encephalopathy; acute; infection-induced; 3; susceptibility to ,Pediatric
RAPGEF2,Neurologic,Epilepsy; familial adult myoclonic; 7,N/A
RAPSN,Neurologic,Myasthenic syndrome; congenital 11; associated with acetylcholine receptor deficiency,Pediatric
RARB,Neurologic,Microphthalmia; syndromic 12,N/A
RARS1,Neurologic,Leukodystrophy; hypomyelinating 9,N/A
RARS2,Neurologic,Pontocerebellar hypoplasia; type 6,N/A
RB1CC1,Neurologic,Schizophrenia,N/A
RBBP8,Neurologic,Seckel syndrome 2; Jawad syndrome,N/A
RBCK1,Neurologic,Polyglucosan body myopathy 1,Pediatric
RBM12,Neurologic,Schizophrenia 19,N/A
RBM28,Neurologic,Alopecia; neurologic defects; and endocrinopathy syndrome,Pediatric
RBMX,Neurologic,Mental retardation; X-linked; syndromic 11; Shashi type,N/A
RBPJ,Neurologic,Adams-Oliver syndrome 3,N/A
RDH11,Neurologic,Microphthalmia; isolated; with coloboma 10; Retinal dystrophy; juvenile cataracts; and short stature syndrome,N/A
REEP1,Neurologic,Spastic paraplegia 31; Distal hereditary motor neuronopathy VB ,N/A
REEP2,Neurologic,Spastic paraplegia 72; autosomal dominant; Spastic paraplegia 72; autosomal recessive,N/A
RELN,Neurologic,Epilepsy; familial temporal lobe; 7; Lissencephaly 2,N/A
REPS1,Neurologic,Neurodegeneration with brain iron accumulation 7,N/A
RERE,Neurologic,Neurodevelopmental disorder with or without anomalies of the brain; eye; or heart (NEDBEH),N/A
RET,Neurologic,Central hypoventilation syndrome; congenital; Multiple endocrine neoplasia; type IIA; Multiple endocrine neoplasia; type IIB; Medullary thyroid carcinoma; familial; Pheochromocytoma; Hirschsprung disease; susceptibility to 1,Pediatric
RETREG1,Neurologic,Neuropathy; hereditary sensory and autonomic; type IIB,N/A
RFC1,Neurologic,Cerebellar ataxia; neuropathy; and vestibular areflexia syndrome,N/A
RFT1,Neurologic,Congenital disorder of glycosylation; type In,Pediatric
RFWD3,Neurologic,Fanconi anemia; complementation group W,Pediatric
RHOBTB2,Neurologic,Epileptic encephalopathy; early infantile; 64,N/A
RIN2,Neurologic,Macrocephaly; alopecia; cutis laxa; and scoliosis,N/A
RIT1,Neurologic,Noonan syndrome 8,Pediatric
RLIM,Neurologic,Tonne-Kalscheuer syndrome ,N/A
RMND1,Neurologic,Combined oxidative phosphorylation deficiency 11,N/A
RMRP,Neurologic,Anauxetic dysplasia 1; Cartilage-hair hypoplasia; Metaphyseal dysplasia without hypotrichosis,Pediatric
RNASEH1,Neurologic,Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive; 2,N/A
RNASEH2A,Neurologic,Aicardi-Goutieres syndrome 4,N/A
RNASEH2B,Neurologic,Aicardi-Goutieres syndrome 2,N/A
RNASEH2C,Neurologic,Aicardi-Goutieres syndrome 3,N/A
RNASET2,Neurologic,Leukoencephalopathy; cystic; without megalencephaly,Pediatric
RNF113A,Neurologic,Trichothiodystrophy 5; nonphotosensitive,Pediatric
RNF125,Neurologic,Tenorio syndrome,N/A
RNF13,Neurologic,Epileptic encephalopathy; early infantile; 73,N/A
RNF135,Neurologic,Macrocephaly; macrosomia; facial dysmorphism syndrome,N/A
RNF168,Neurologic,RIDDLE syndrome,Pediatric
RNF216,Neurologic,Cerebellar ataxia and hypogonadotropic hypogonadism (Gordon Holmes syndrome),Pediatric
RNU4ATAC,Neurologic,Roifman syndrome,Pediatric
ROBO3,Neurologic,Gaze palsy; familial horizontal; with progressive scoliosis 1,N/A
ROGDI,Neurologic,Kohlschutter-Tonz syndrome,N/A
RORA,Neurologic,Intellectual developmental disorder with or without epilepsy or cerebellar ataxia,N/A
RORB,Neurologic,Epilepsy; idiopathic generalized; susceptibilty to; 15,N/A
RPGRIP1L,Neurologic,Meckel syndrome 5; Joubert syndrome 7; COACH syndrome,N/A
RPIA,Neurologic,Ribose 5-phosphate isomerase deficiency,N/A
RPL10,Neurologic,Mental retardation; X-linked; syndromic; 35,N/A
RPL15,Neurologic,Diamond-Blackfan anemia 12,Pediatric
RPS19,Neurologic,Diamond-Blackfan anemia 1,Pediatric
RPS23,Neurologic,Brachycephaly; trichomegaly; and developmental delay,N/A
RPS6KA3,Neurologic,Coffin-Lowry syndrome; Mental retardation; X-linked 19,Pediatric
RRAS2,Neurologic,Noonan syndrome 12,Pediatric
RRM2B,Neurologic,Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal dominant; 5; Mitochondrial DNA depletion syndrome 8A; Mitochondrial DNA depletion syndrome 8B,N/A
RSPRY1,Neurologic,Spondyloepimetaphyseal dysplasia; Faden-Alkuraya type,N/A
RSRC1,Neurologic,Intellectual development disorder; autosomal recessive 70,N/A
RTEL1,Neurologic,Pulmonary fibrosis and/or bone marrow failure; telomere-related 3; Dyskeratosis congenita; autosomal dominant 4; Dyskeratosis congenita; autosomal recessive 5,Pediatric
RTN2,Neurologic,Spastic paraplegia 12; autosomal dominant,N/A
RTN4IP1,Neurologic,Optic atrophy 10 with or without ataxia; mental retardation; and seizures,N/A
RTTN,Neurologic,Microcephaly; short stature; and polymicrogyria with or without seizures,N/A
RUBCN,Neurologic,Spinocerebellar ataxia; autosomal recessive 15,N/A
RUSC2,Neurologic,Mental retardation; autosomal recessive; 61,N/A
RXYLT1,Neurologic,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 10,N/A
SACS,Neurologic,Spastic ataxia; Charlevoix-Saguenay type,N/A
SAMD12,Neurologic,Epilepsy; familial adult myoclonic; 1,N/A
SAMD9,Neurologic,Mirage syndrome; Tumoral calcinosis; normophosphatemic,Pediatric
SAMD9L,Neurologic,Ataxia-pancytopenia syndrome,Pediatric
SAMHD1,Neurologic,Aicardi-Goutieres syndrome 5,Pediatric
SAR1B,Neurologic,Chylomicron retention disease (Anderson disease),Pediatric
SARS1,Neurologic,Neurodevelopmental disorder with microcephaly; ataxia; and seizures,N/A
SARS2,Neurologic,Hyperuricemia; pulmonary hypertension; renal failure; and alkalosis,N/A
SASS6,Neurologic,Microcephaly 14; primary; autosomal recessive,N/A
SATB2,Neurologic,Glass syndrome,N/A
SBF1,Neurologic,Charcot-Marie-Tooth disease; type 4B3,N/A
SBF2,Neurologic,Charcot-Marie-Tooth disease; type 4B2 with early-onset glaucoma,Pediatric
SC5D,Neurologic,Lathosterolosis,N/A
SCAPER,Neurologic,Intellectual developmental disorder and retinitis pigmentosa,N/A
SCARB2,Neurologic,Epilepsy; progressive myoclonic 4; with or without renal failure,N/A
SCN10A,Neurologic,Episodic pain syndrome; familial; 2,N/A
SCN11A,Neurologic,Episodic pain syndrome; familial; 3; Neuropathy; hereditary sensory and autonomic; type VII,N/A
SCN1A,Neurologic,Migraine; familial hemiplegic 3; Early infantile epileptic encephalopathy 6 (AD); Generalized epilepsy with febrile seizures plus; type 2 (AD),Pediatric
SCN1B,Neurologic,Atrial fibrillation; familial 13; Brugada syndrome 5,Pediatric
SCN2A,Neurologic,Epileptic encephalopathy; early infantile; 11; Seizures; benign familial infantile; 3,Pediatric
SCN3A,Neurologic,Epilepsy; familial focal; with variable foci 4; Epileptic encephalopathy; early infantile; 62,N/A
SCN4A,Neurologic,Paramyotonia congenita; Hyperkalemic periodic paralysis; type 2; Hypokalemic periodic paralysis; type 2; Normokalemic potassium-sensitive periodic paralysis; Malignant hyperthermia; susceptibility to; Myasthenic syndrome; congenital; 16; Myotonia; potassium-aggravated,Pediatric
SCN8A,Neurologic,Epileptic encephalopathy; early infantile; 13; Seizures; benign familial infantile; 5,Pediatric
SCN9A,Neurologic,Paroxysmal extreme pain disorder,Pediatric
SCO1,Neurologic,Mitochondrial complex IV deficiency,N/A
SCO2,Neurologic,Myopia 6; Leigh syndrome; Cardioencephalomyopathy; fatal infantile; due to cytochrome c oxidase deficiency 1; Hypertrophic cardiomyopathy,N/A
SCP2,Neurologic,Leukoencephalopathy with dystonia and motor neuropathy,N/A
SCYL1,Neurologic,Spinocerebellar ataxia; autosomal recessive 21,Pediatric
SDCCAG8,Neurologic,Bardet-Biedl syndrome 16; Senior-Loken syndrome 7,N/A
SDHA,Neurologic,Paragangliomas 5; Gastrointestinal stromal tumors; Cardiomyopathy; dilated; 1GG; Leigh syndrome/Mitochondrial respiratory chain complex II deficiency,Adult (Paragangliomas 5; Gastrointestinal stromal tumors); Pediatric (Cardiomyopathy; dilated; 1GG; Leigh syndrome/Mitochondrial respiratory chain complex II deficiency)
SDHAF1,Neurologic,Mitochondrial complex II deficiency,Pediatric
SDHD,Neurologic,Cowden syndrome 3; Paraganglioma and gastric stromal sarcoma; Pheochromocytoma; Paragangliomas 1; Carcinoid tumors; intestinal,Pediatric
SECISBP2,Neurologic,Selenoprotein deficiency; Thyroid hormone metabolism; abnormal,N/A
SEMA3A,Neurologic,Hypogonadotropic hypogonadism 16 with or without anosmia,Pediatric
SEMA3E,Neurologic,CHARGE syndrome,N/A
SEPSECS,Neurologic,Pontocerebellar hypoplasia; type 2D,N/A
SEPTIN9,Neurologic,Amyotrophy; hereditary neuralgic,N/A
SERAC1,Neurologic,3-methylglutaconic aciduria with deafness; encephalopathy; and Leigh-like syndrome ,N/A
SERPINI1,Neurologic,Encephalopathy; familial; with neuroserpin inclusion bodies,N/A
SET,Neurologic,Mental retardation; autosomal dominant; 58,N/A
SETBP1,Neurologic,Mental retardation; autosomal dominant 29; Schinzel-Giedion midface retraction syndrome,N/A
SETD2,Neurologic,Luscan-Lumish syndrome,N/A
SETD5,Neurologic,Mental retardation; autosomal dominant 23,N/A
SETX,Neurologic,Spinocerebellar ataxia; autosomal recessive 1; Amyotrophic lateral sclerosis 4; juvenile; Ataxia with oculomotor apraxia; type 2,N/A
SFXN4,Neurologic,Combined oxidative phosphorylation deficiency 18,N/A
SGPL1,Neurologic,Nephrotic syndrome 14,Pediatric
SGSH,Neurologic,Mucopolysaccharidosis type IIIA (Sanfilippo syndrome A),N/A
SH3KBP1,Neurologic,Immunodeficiency 61,Pediatric
SH3PXD2B,Neurologic,Frank-ter Haar syndrome,Pediatric
SH3TC2,Neurologic,Charcot-Marie-Tooth disease; type 4C; Mononeuropathy of the median nerve; mild,N/A
SHANK2,Neurologic,Autism; susceptibility to 17,N/A
SHANK3,Neurologic,Phelan-McDermid syndrome; Schizophrenia 15,N/A
SHH,Neurologic,Holoprosencephaly 3; Microphthalmia with coloboma 5 ,N/A
SHOC2,Neurologic,Noonan-like syndrome with loose anagen hair 1,Pediatric
SHROOM4,Neurologic,Stocco dos Santos X-linked mental retardation syndrome,N/A
SIGMAR1,Neurologic,Amyotrophic lateral sclerosis 16; juvenile; Frontotemporal lobar degeneration-motor neuron disease; Spinal muscular atrophy; distal; autosomal recessive; 2,N/A
SIK1,Neurologic,Epileptic encephalopathy; early infantile 30,N/A
SIK3,Neurologic,Spondyloepimetaphyseal dysplasia; Krakow type,Pediatric
SIL1,Neurologic,Marinesco-Sjogren syndrome,N/A
SIN3A,Neurologic,Witteveen-Kolk syndrome,N/A
SIX3,Neurologic,Holoprosencephaly 2,N/A
SKI,Neurologic,Shprintzen-Goldberg syndrome,Pediatric
SLC10A7,Neurologic,Short stature; amelogenesis imperfecta; and skeletal dysplasia with scoliosis,N/A
SLC12A5,Neurologic,Epileptic encephalopathy; early infantile; 34,N/A
SLC12A6,Neurologic,Agenesis of the corpus callosum with peripheral neuropathy (Andermann syndrome),N/A
SLC13A3,Neurologic,Leukoencephalopathy; acute reversible; with increased urinary alpha-ketoglutarate,N/A
SLC13A5,Neurologic,Epileptic encephalopathy; early infantile 25; with ameliogenesis imperfecta,N/A
SLC16A1,Neurologic,Hyperinsulinemic hypoglycemia; familial; 7; Erythrocyte lactate transporter defect; Monocarboxylate transporter 1 deficiency,Pediatric (Erythrocyte lactate transporter defect; Monocarboxylate transporter 1 deficiency ); Adult (Hyperinsulinemic hypoglycemia; familial; 7)
SLC16A2,Neurologic,Allan-Herndon-Dudley syndrome,Pediatric
SLC17A5,Neurologic,Infantile sialic acid storage disorder; Sialuria; Finnish type (Salla disease),N/A
SLC18A2,Neurologic,Parkinsonism-dystonia; infantile; 2,Pediatric
SLC19A3,Neurologic,Thiamine metabolism dysfunction syndrome 2 (biotin or thiamine responsive),Pediatric
SLC1A1,Neurologic,Dicarboxylic aminoaciduria,Adult
SLC1A2,Neurologic,Epileptic encephalopathy; early infantile; 41,N/A
SLC1A3,Neurologic,Episodic ataxia; type 6,Pediatric
SLC1A4,Neurologic,Spastic tetraplegia; thin corpus callosum; and progressive microcephaly,N/A
SLC20A2,Neurologic,Basal ganglia calcification; idiopathic; 1,N/A
SLC22A5,Neurologic,Carnitine deficiency; systemic primary,Pediatric
SLC25A1,Neurologic,Myasthenic syndrome; congenital; 23; presynaptic,Pediatric
SLC25A12,Neurologic,Epileptic encephalopathy; early infantile; 39,N/A
SLC25A13,Neurologic,Citrin deficiency,Pediatric
SLC25A15,Neurologic,Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,Pediatric
SLC25A19,Neurologic,Thiamine metabolism dysfunction syndrome 4; Microcephaly; Amish type,N/A
SLC25A20,Neurologic,Carnitine-acylcarnitine translocase deficiency,Pediatric
SLC25A22,Neurologic,Epileptic encephalopathy; early infantile; 3,N/A
SLC25A26,Neurologic,Combined oxidative phosphorylation deficiency 28,N/A
SLC25A3,Neurologic,Micochondrial phosphate carrier deficiency,N/A
SLC25A4,Neurologic,Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type); Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal dominant; 2; Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type),Pediatric
SLC25A42,Neurologic,Metabolic crises; recurrent; with variable encephalomyopathic features and neurologic regression,N/A
SLC25A46,Neurologic,Neuropathy; hereditary motor and sensory; type VIB,N/A
SLC2A1,Neurologic,GLUT1 deficiency syndrome 1; GLUT1 deficiency syndrome 2; Dystonia 9; Epilepsy; idiopathic generalized; susceptibility to; 12; Stomatin-deficient cryohydrocytosis with neurologic defects,Pediatric
SLC30A10,Neurologic,Hypermanganesemia with dystonia; polycythemia; and cirrhosis,Pediatric
SLC30A9,Neurologic,Birk-Landau-Perez syndrome,Pediatric
SLC33A1,Neurologic,Congenital cataracts; hearing loss; and neurodegeneration,Pediatric
SLC35A1,Neurologic,Congenital disorder of glycosylation; type IIf,Pediatric
SLC35A2,Neurologic,Congenital disorder of glycosylation; type IIm,Pediatric
SLC35A3,Neurologic,Arthrogryposis; mental retardation; and seizures,N/A
SLC35C1,Neurologic,Congenital disorder of glycosylation; type IIc; Leukocyte adhesion deficiency; type II,Pediatric
SLC39A14,Neurologic,Hyperostosis cranialis interna; Hypermanganesemia with dystonia 2,Pediatric
SLC39A8,Neurologic,Congenital disorder of glycosylation; type IIn,Pediatric
SLC45A1,Neurologic,Intellectual developmental disorder with neuropsychiatric features (IDDNPF),N/A
SLC46A1,Neurologic,Folate malabsorption; hereditary,Pediatric
SLC4A4,Neurologic,Renal tubular acidosis; proximal; with ocular abnormalities and/or migraine,Pediatric
SLC52A1,Neurologic,Riboflavin deficiency,Pediatric
SLC52A2,Neurologic,Brown-Vialetto-Van Laere syndrome 2,Pediatric
SLC52A3,Neurologic,Brown-Vialetto-Van Laere syndrome 1; Fazio-Londe disease,Pediatric
SLC5A7,Neurologic,Myasthenic syndrome; congenital; 20; presynaptic,Pediatric
SLC6A17,Neurologic,Mental retardation; autosomal recessive 48,N/A
SLC6A19,Neurologic,Hartnup disease,Pediatric
SLC6A2,Neurologic,Orthostatic intolerance,N/A
SLC6A3,Neurologic,Parkinsonism-dystonia; infantile 1,N/A
SLC6A5,Neurologic,Hyperekplexia 3,Pediatric
SLC6A8,Neurologic,Creatine deficiency syndrome 1,Pediatric
SLC6A9,Neurologic,Glycine encephalopathy with normal serum glycine,N/A
SLC7A7,Neurologic,Lysinuric protein intolerance,Pediatric
SLC9A1,Neurologic,Spinocerebellar ataxia; autosomal recessive 19 (Lichtenstein-Knorr syndrome),N/A
SLC9A6,Neurologic,Mental retardation; X-linked syndromic; Christianson type,N/A
SLC9A7,Neurologic,Intellectual developmental disorder; X-linked 108,N/A
SLC9A9,Neurologic,Autism susceptibility 16,N/A
SLITRK1,Neurologic,Trichotillomania; Tourette syndrome,N/A
SLX4,Neurologic,Fanconi anemia; complementation group P,Pediatric
SMAD6,Neurologic,Aortic valve disease 2,Pediatric
SMARCA2,Neurologic,Nicolaides-Baraitser syndrome,N/A
SMARCA4,Neurologic,Rhabdoid tumor predisposition syndrome 2,Pediatric
SMARCAL1,Neurologic,Schimke immunoosseous dysplasia,Pediatric
SMARCB1,Neurologic,Schwannomatosis; Rhabdoid tumor predisposition syndrome 1,Pediatric
SMARCC2,Neurologic,Coffin-Siris syndrome 8,N/A
SMARCD2,Neurologic,Specific granule defiency 2,Pediatric
SMARCE1,Neurologic,Meningioma; familial; susceptibility to,Pediatric
SMC1A,Neurologic,Cornelia de Lange syndrome 2,N/A
SMC3,Neurologic,Cornelia de Lange syndrome 3,N/A
SMG9,Neurologic,Heart and brain malformation syndrome,N/A
SMN1,Neurologic,Spinal muscular atrophy; type I; Spinal muscular atrophy; type II; Spinal muscular atrophy; type III; Spinal muscular atrophy; type IV,N/A
SMN2,Neurologic,Spinal muscular atrophy; modifier of,N/A
SMPD1,Neurologic,Niemann-Pick disease; type A; Niemann-Pick disease; type B,N/A
SMPD4,Neurologic,Neurodevelopmental disorder with microcephaly; arthrogryposis; and structural brain anomalies,Pediatric
SMS,Neurologic,Mental retardation; X-linked; Snyder-Robinson type,N/A
SNAP25,Neurologic,Myasthenic syndrome; congenital 18; with intellectual disability and ataxia,N/A
SNAP29,Neurologic,Cerebral dysgenesis; neuropathy; ichthyosis; and palmoplantar keratoderma syndrome (CEDNIK syndrome),N/A
SNCA,Neurologic,Parkinson disease 1; Parkinson disease 4; Dementia with Lewy bodies,N/A
SNCAIP,Neurologic,Parkinson disease,N/A
SNCB,Neurologic,Dementia with Lewy bodies,N/A
SNIP1,Neurologic,Psychomotor retardation; epilepsy; and craniofacial dysmorphism,N/A
SNORD118,Neurologic,Leukoencephalopathy; brain calcifications; and cysts (Labrune syndrome),N/A
SNRPB,Neurologic,Cerebrocostomandibular syndrome,N/A
SNX14,Neurologic,Spinocerebellar ataxia; autosomal recessive 20,N/A
SOBP,Neurologic,Mental retardation; anterior maxillary protrusion; and strabismus,N/A
SOD1,Neurologic,Amyotrophic lateral sclerosis; Keratoconus; Spastic tetraplegia and axial hypotonia; progressive,N/A
SON,Neurologic,ZTTK syndrome,N/A
SOS1,Neurologic,Noonan syndrome 4,Pediatric
SOS2,Neurologic,Noonan syndrome 9,Pediatric
SOX10,Neurologic,Waardenburg syndrome; type 4C; Waardenburg syndrome; type 2E; Peripheral demyelinating neuropathy; central dysmyelination; Waardenburg syndrome; and Hirschsprung disease; Hirschsprung disease; susceptibility to; 10,Pediatric
SOX11,Neurologic,Coffin-Siris syndrome 9 (Mental retardation; autosomal dominant 27),N/A
SOX18,Neurologic,Hypotrichosis-lymphedema-telangiectasia syndrome; Hypotrichosis-lymphedema-telangiectasia-renal defect  syndrome,N/A
SOX2,Neurologic,Microphthalmia; syndromic 3,Pediatric
SOX3,Neurologic,Panhypopituitarism; X-linked,Pediatric
SOX4,Neurologic,Coffin-Siris syndrome 10,N/A
SOX5,Neurologic,Lamb-Shaffer syndrome,N/A
SOX9,Neurologic,46; XY sex reversal 10; Campomelic dysplasia,Pediatric
SP110,Neurologic,Hepatic venoocclusive disease with immunodeficiency,Pediatric
SPART,Neurologic,Spastic paraplegia 20; autosomal recessive (Troyer syndrome),N/A
SPAST,Neurologic,Spastic paraplegia 4; autosomal dominant,N/A
SPATA5,Neurologic,Epilepsy; hearing loss; and mental retardation syndrome (EHLMRS),Pediatric
SPECC1L,Neurologic,Facial clefting; oblique; 1; Opitz GBBB syndrome; type II; Hypertelorism; Teebi type,N/A
SPEG,Neurologic,Centronuclear myopathy 5,Pediatric
SPG11,Neurologic,Amyotrophic lateral sclerosis 5; juvenile recessive; Charcot-Marie-Tooth disease; axonal; type 2X; Spastic paraplegia 11,N/A
SPG21,Neurologic,Spastic paraplegia 21 (Mast syndrome),N/A
SPG7,Neurologic,Spastic paraplegia 7; autosomal recessive,N/A
SPR,Neurologic,Dystonia; Dopa-responsive; due to sepiapterin reductase deficiency,Pediatric
SPRED1,Neurologic,Legius syndrome,N/A
SPRY4,Neurologic,Hypogonadotropic hypogonadism 17; with or without anosmia,Pediatric
SPTAN1,Neurologic,Epileptic encephalopathy; early infantile; 5,N/A
SPTBN2,Neurologic,Spinocerebellar ataxia 5; autosomal dominant; Spinocerebellar ataxia 14; autosomal recessive,N/A
SPTBN4,Neurologic,Spherocytosis; type 3; Pyropoikilocytosis; hereditary; Ellipsocytosis 2,N/A
SPTLC1,Neurologic,Neuropathy; hereditary sensory and autonomic; type IA; Neuropathy; hereditary sensory and autonomic; type IC,N/A
SQSTM1,Neurologic,Paget disease of bone 3,Pediatric
SRCAP,Neurologic,Floating-Harbor syndrome,N/A
SRD5A3,Neurologic,Kahrizi syndrome; Congenital disorder of glycosylation; type Iq,Pediatric
SRPX2,Neurologic,Rolandic epilepsy; mental retardation; and speech dyspraxia,N/A
SSR4,Neurologic,Congenital disorder of glycosylation; type Iy,N/A
ST3GAL3,Neurologic,Mental retardation; autosomal recessive 12; Epileptic encephalopathy; early infantile; 15,N/A
ST3GAL5,Neurologic,Salt and pepper developmental regression syndrome (Ganglioside GM3 synthase deficiency),N/A
STAG1,Neurologic,Mental retardation; autosomal dominant 47,N/A
STAG2,Neurologic,Mullegama-Klein-Martinez syndrome (Neurodevelopmental disorder; X-linked; with craniofacial abnormalities),N/A
STAMBP,Neurologic,Microcephaly-capillary malformation syndrome,N/A
STIL,Neurologic,Microcephaly; primary autosomal recessive; 7,N/A
STIM1,Neurologic,Stormorken syndrome; Immunodeficiency 10,Pediatric
STN1,Neurologic,Cerebroretinal microangiopathy with calcifications and cysts 2,Pediatric
STRA6,Neurologic,Microphthalmia; syndromic 9,N/A
STRADA,Neurologic,Polyhydramnios; megalencephaly; and symptomatic epilepsy,N/A
STT3A,Neurologic,Congenital disorder of glycosylation; type Iw,N/A
STT3B,Neurologic,Congenital disorder of glycosylation; type Ix,N/A
STUB1,Neurologic,Spinocerebellar ataxia 48; Spinocerebellar ataxia; autosomal recessive 16,N/A
STX11,Neurologic,Hemophagocytic lymphohistiocytosis; familial; 4,Pediatric
STX1B,Neurologic,Generalized epilepsy with febrile seizures plus; type 9,N/A
STXBP1,Neurologic,Epileptic encephalopathy; early infantile 4,N/A
STXBP2,Neurologic,Hemophagocytic lymphohistiocytosis; familial 5,Pediatric
SUCLA2,Neurologic,Mitochondrial DNA depletion syndrome 5,Pediatric
SUCLG1,Neurologic,Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria),N/A
SUFU,Neurologic,Medulloblastoma; Basal cell nevus syndrome,Pediatric
SUMF1,Neurologic,Multiple sulfatase deficiency,N/A
SUOX,Neurologic,Sulfite oxidase deficiency,Pediatric
SURF1,Neurologic,Charcot-Marie-Tooth disease type 4K; Leigh syndrome,N/A
SVBP,Neurologic,Neurodevelopmental disorder with ataxia; hypotonia; and microcephaly,N/A
SYN1,Neurologic,Epilepsy; X-linked; with variable learning disabilities and behavior disorders,N/A
SYNE1,Neurologic,Emery-Dreifuss muscular dystrophy 4; autosomal dominant,Pediatric
SYNGAP1,Neurologic,Mental retardation; autosomal dominant 5,N/A
SYNJ1,Neurologic,Epileptic encephalopathy; early infantile; 53; Parkinson disease 20; early-onset,N/A
SYP,Neurologic,Mental retardation; X-linked 96,N/A
SYT1,Neurologic,Baker-Gordon syndrome,N/A
SYT14,Neurologic,Spinocerebellar ataxia; autosomal recessive 11,N/A
SYT2,Neurologic,Myasthenic syndrome; congenital 7; presynaptic,N/A
SZT2,Neurologic,Epileptic encephalopathy; early infantile; 18,N/A
TACO1,Neurologic,Mitochondrial complex IV deficiency,N/A
TAF1,Neurologic,Dystonia 3; torsion; X-linked; Mental retardation; X-linked; syndromic 33,N/A
TAF13,Neurologic,Mental retardation; autosomal recessive 60,N/A
TAF2,Neurologic,Mental retardation; autosomal recessive 40,N/A
TAF6,Neurologic,Alazami-Yuan syndrome,N/A
TANGO2,Neurologic,Metabolic encephalomyopathic crises; recurrent; with rhabdomyolysis; cardiac arrhythmias; and neurodegeneration (MECRCN),Pediatric
TARDBP,Neurologic,Amyotrophic lateral sclerosis 10; with or without frontotemporal dementia,N/A
TARS1,Neurologic,Trichothiodystrophy 7; nonphotosensitive,Pediatric
TARS2,Neurologic,Combined oxidative phosphorylation deficiency 21,N/A
TAS2R16,Neurologic,Beta-glucopyranoside tasting,N/A
TAS2R38,Neurologic,Thiourea tasting; Phenylthiocarbamide tasting,N/A
TAT,Neurologic,Tyrosinemia; type II,Pediatric
TAZ,Neurologic,Barth syndrome (3-Methylglutaconic aciduria; type II),Pediatric
TBC1D20,Neurologic,Warburg micro syndrome 4,N/A
TBC1D23,Neurologic,Pontocerebellar hypoplasia; type 11,N/A
TBC1D24,Neurologic,Deafness; onychodystrophy; osteodystrophy; mental retardation; and seizures (DOORS) syndrome; Deafness; autosomal recessive 86,Pediatric
TBC1D7,Neurologic,Macrocephaly/megalencephaly syndrome; autosomal recessive,N/A
TBCD,Neurologic,Early-onset progressive encephalopathy with brain atrophy and thin corpus callosum (PEBAT),N/A
TBCE,Neurologic,Kenny-Caffey syndrome; type 1; Hypoparathyroidism-retardation-dysmorphism syndrome,Pediatric
TBCK,Neurologic,Hypotonia; infantile; with psychomotor retardation and characteristic facies 3,N/A
TBK1,Neurologic,Encephalopathy; acute; infection-induceed (herpes-specific); susceptibility to; 8,Pediatric
TBL1XR1,Neurologic,Mental retardation; autosomal dominant 41; Pierpont syndrome,N/A
TBP,Neurologic,Spinocerebellar ataxia 17,N/A
TBR1,Neurologic,Intellectual developmental disorder with autism and speech delay,N/A
TBX1,Neurologic,Conotruncal anomaly face syndrome; Tetralogy of Fallot,N/A
TBX2,Neurologic,Vertebral anomalies and variable endocrine and T-cell dysfunction,Pediatric
TBX4,Neurologic,Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension,Pediatric
TBXAS1,Neurologic,Ghosal hematodiaphyseal syndrome,Pediatric
TCF12,Neurologic,Craniosynostosis 3,N/A
TCF20,Neurologic,Developmental delay with variable intellectual impairment and behavioral abnormalities,N/A
TCF4,Neurologic,Corneal dystrophy; Fuchs endothelial; 3; Pitt-Hopkins syndrome,N/A
TCIRG1,Neurologic,Osteopetrosis; autosomal recessive 1,Pediatric
TCN2,Neurologic,Transcobalamin II deficiency,Pediatric
TCTN1,Neurologic,Joubert syndrome 13,N/A
TCTN2,Neurologic,Joubert syndrome 24; Meckel syndrome 8,N/A
TCTN3,Neurologic,Joubert syndrome 18; Orofaciodigital syndrome IV (Mohr-Majewski syndrome),N/A
TDGF1,Neurologic,Forebrain anomalies; Congenital cardiac malformations,N/A
TDP1,Neurologic,Spinocerebellar ataxia; autosomal recessive; with axonal neuropathy 1,N/A
TDP2,Neurologic,Spinocerebellar ataxia; autosomal recessive 23,N/A
TECPR2,Neurologic,Spastic paraplegia 49; autosomal recessive,N/A
TECR,Neurologic,Mental retardation; autosomal recessive 14,N/A
TELO2,Neurologic,You-Hoover-Fong syndrome,N/A
TENM3,Neurologic,Microphthalmia; isolated; with coloboma 9,N/A
TENM4,Neurologic,Tremor; hereditary essential; 5,N/A
TERC,Neurologic,Dyskeratosis congenita; autosomal dominant 1; Aplastic anemia; Pulmonary fibrosis and/or bone marrow failure; telomere-related 2,Pediatric
TERT,Neurologic,Aplastic anemia; Dyskeratosis congenita; autosomal dominant; Dyskeratosis congenita; autosomal recessive; Pulmonary fibrosis and/or bone marrow failure; telomere-related 1,Pediatric
TFAM,Neurologic,Mitochondrial DNA depletion syndrome 15 (hepatocerebral type),N/A
TFAP2A,Neurologic,Branchiooculofacial sydrome,Pediatric
TFG,Neurologic,Neuropathy; hereditary motor and sensory; Okinawa type; Spastic paraplegia 57,N/A
TGFB1,Neurologic,Camurati-Engelmann disease; Inflammatory bowel disease; immunodeficiency; and encephalopathy,Pediatric
TGIF1,Neurologic,Holoprosencephaly 4,N/A
TGM6,Neurologic,Spinocerebellar ataxia 35,N/A
TH,Neurologic,Segawa syndrome; autosomal recessive,Pediatric
THAP1,Neurologic,Dystonia 6; torsion,N/A
THOC2,Neurologic,Mental retardation; X-linked 12,N/A
TIMM50,Neurologic,3-methylglutaconic aciduria; type IX,N/A
TIMM8A,Neurologic,Opticoacoustic nerve atrophy with dementia; Jensen syndrome; Mohr-Tranebjaerg syndrome ,Pediatric
TIMMDC1,Neurologic,Mitochondrial complex I deficiency; nuclear type 31,N/A
TINF2,Neurologic,Dyskeratosis congenita; autosomal dominant 3; Revesz syndrome,Pediatric
TKT,Neurologic,Short stature; developmental delay; and congenital heart defects,N/A
TLK2,Neurologic,Mental retardation; autosomal dominant 57,N/A
TMCO1,Neurologic,Craniofacial dysmorphism; skeletal anomalies; and mental retardation syndrome,Pediatric
TMEM106B,Neurologic,Leukodystrophy; hypomyelinating 16,N/A
TMEM107,Neurologic,Joubert syndrome 29; Meckel syndrome 13; Orofaciodigital syndrome XVI,N/A
TMEM126A,Neurologic,Optic atrophy 7 with or without auditory neuropathy,N/A
TMEM126B,Neurologic,Mitochondrial complex I deficiency; nuclear type 29,Pediatric
TMEM138,Neurologic,Joubert syndrome 16,N/A
TMEM165,Neurologic,Congenital disorder of glycosylation; type IIk,N/A
TMEM199,Neurologic,Congenital disorder of glycosylation; type IIp,Pediatric
TMEM216,Neurologic,Joubert syndrome 2; Meckel syndrome 2,N/A
TMEM231,Neurologic,Joubert syndrome 20; Meckel syndrome 11,N/A
TMEM237,Neurologic,Joubert syndrome 14,N/A
TMEM240,Neurologic,Spinocerebellar ataxia 21,N/A
TMEM260,Neurologic,Structural heart defects and renal anomalies syndrome (SHDRA),N/A
TMEM67,Neurologic,Nephronophthisis 11; Meckel syndrome 3; Joubert syndrome 6; COACH syndrome; RHYNS syndrome,N/A
TMEM70,Neurologic,Mitochondrial complex V (ATP synthase) deficiency; nuclear type 2,N/A
TMEM94,Neurologic,Intellectual developmental disorder with cardiac defects and dysmorphic facies,N/A
TMLHE,Neurologic,Epsilon-trimethyllysine hydroxylase deficiency,Pediatric
TMTC3,Neurologic,Lissencephaly 8,N/A
TNFRSF1A,Neurologic,Periodic fever; familial; autosomal dominant (TNF receptor-associated periodic syndrome),Pediatric
TNFSF11,Neurologic,Osteopetrosis; autosomal recessive 2,Pediatric
TNIK,Neurologic,Mental retardation; autosomal recessive 54,N/A
TNRC6A,Neurologic,Epilepsy; familial adult myoclonic; 6,N/A
TOE1,Neurologic,Pontocerebellar hypoplasia type 7,N/A
TOP3A,Neurologic,Microcephaly; growth restriction; and increased sister chromatid exchange 2; Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive 5,Pediatric (Microcephaly; growth restriction; and increased sister chromatid exchange 2); Adult (Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive 5)
TOR1A,Neurologic,Dystonia 1; torsion,N/A
TOR1AIP1,Neurologic,Muscular dystrophy; autosomal recessive; with rigid spine and distal joint contractures,Pediatric
TP53,Neurologic,Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma; intracranial; Osteogenic sarcoma; Breast cancer; familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer; Bone marrow failure syndrome 5,Pediatric
TP53RK,Neurologic,Galloway-Mowat syndrome 4,N/A
TPI1,Neurologic,Triosephosphate isomerase deficiency,Pediatric
TPK1,Neurologic,Thiamine metabolism dysfunction syndrome 5,Pediatric
TPP1,Neurologic,Ceroid lipofuscinosis; neuronal; 2; Spinocerebellar ataxia; autosomal recessive 7,N/A
TPRKB,Neurologic,Galloway-Mowat syndrome 5,N/A
TPSAB1,Neurologic,Irritable bowel syndrome; cutaneous complaints; connective tissue abnormalities; and dysautonomia,N/A
TRAF3IP1,Neurologic,Senior-Loken syndrome 9,N/A
TRAIP,Neurologic,Seckel syndrome 9,N/A
TRAK1,Neurologic,Epileptic encephalopathy; early infantile; 68,N/A
TRAPPC11,Neurologic,Muscular dystrophy; limb-girdle; autosomal recessive; 18,N/A
TRAPPC12,Neurologic,Encephalopathy; progressive; early-onset; with brain atrophy and spasticity (PEBAS),N/A
TRAPPC2L,Neurologic,Encephalopathy; progressive; early-onset; with episodic rhabdomyolysis,N/A
TRAPPC6B,Neurologic,Neurodevelopmental disorder with microcephaly; epilepsy; and brain atrophy,N/A
TRAPPC9,Neurologic,Mental retardation; autosomal recessive 13,N/A
TRDN,Neurologic,Ventricular tachycardia; catecholaminergic polymorphic; 5; with or without muscle weakness,Pediatric
TREM2,Neurologic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 (Nasu-Hakola disease); Early-onset dementia without bone cysts,N/A
TREX1,Neurologic,Aicardi-Goutieres syndrome 1,Pediatric
TRIM2,Neurologic,Charcot-Marie-Tooth disease; axonal; type 2R,N/A
TRIM32,Neurologic,Muscular dystrophy; limb-girdle; ; autosomal recessive; 8; Bardet-Biedl syndrome 11,N/A
TRIM36,Neurologic,Anencephaly,N/A
TRIM37,Neurologic,Mulibrey nanism,Pediatric
TRIO,Neurologic,Mental retardation; autosomal dominant 44,N/A
TRIP12,Neurologic,Mental retardation; autosomal dominant 49,N/A
TRIP13,Neurologic,Mosaic variegated aneuploidy syndrome 3,Pediatric
TRIP4,Neurologic,Spinal muscular atrophy with congenital bone fractures 1; Muscular dystrophy; congenital; Davignon-Chauveau type,N/A
TRIT1,Neurologic,Combined oxidative phosphorylation deficiency 35,N/A
TRMT1,Neurologic,Intellectual developmental disorder; autosomal recessive 68,N/A
TRMT10A,Neurologic,Microcephaly; short stature; and impaired glucose metabolism 1,Pediatric
TRMT10C,Neurologic,Combined oxidative phosphorylation deficiency 30,N/A
TRMT5,Neurologic,Combined oxidative phosphorylation deficiency 26,N/A
TRNH,Neurologic,Deafness; nonsyndromic; sensorineural,Pediatric
TRNI,Neurologic,Deafness; mitochondrial; Hypertension; hypercholesterolemia; and hypomagnesemia  (Maternal),Pediatric
TRNK,Neurologic,Parkinson disease; mitochondrial; Myoclonic epilepsy with ragged red fibers; Diabetes-deafness syndrome; Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes,N/A
TRNP,Neurologic,Myoclonic epilepsy with ragged red fibers,N/A
TRNQ,Neurologic,Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes,N/A
TRNS2,Neurologic,Myoclonic epilepsy with ragged red fibers; Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes; Retinitis pigmentosa-deafness syndrome,N/A
TRNT,Neurologic,Mitochondrial myopathy; lethal,N/A
TRNT1,Neurologic,Sideroblastic anemia with B-cell immunodeficiency; periodic fevers; and developmental delay,Pediatric
TRPA1,Neurologic,Episodic pain syndrome; familial; 1,N/A
TRPC3,Neurologic,Spinocerebellar ataxia 41,N/A
TRPS1,Neurologic,Trichorhinophalangeal syndrome; type I; Trichorhinophalangeal syndrome; type III,N/A
TRPV4,Neurologic,Avascular necrosis of femoral head; primary 2,N/A
TRRAP,Neurologic,Developmental delay with or without dysmorphic facies and autism; Schizophrenia,N/A
TSC1,Neurologic,Tuberous sclerosis; Lymphangioleiomyomatosis,Pediatric
TSC2,Neurologic,Tuberous sclerosis 2; Lymphangioleiomyomatosis ,Pediatric
TSEN15,Neurologic,Pontocerebellar hypoplasia type 2F,N/A
TSEN2,Neurologic,Pontocerebellar hypoplasia type 2B,N/A
TSEN34,Neurologic,Pontocerebellar hypoplasia; type 2C,N/A
TSEN54,Neurologic,Pontocerebellar hypoplasia; type 2A; Pontocerebellar hypoplasia type 4; Pontocerebellar hypoplasia type 5,N/A
TSFM,Neurologic,Combined oxidative phosphorylation deficiency 3,N/A
TSPAN7,Neurologic,Mental retardation; X-linked 58,N/A
TSPYL1,Neurologic,Sudden infant death with dysgenesis of the testes syndrome; 46; XY disorder of sex development,N/A
TTBK2,Neurologic,Spinocerebellar ataxia 11,N/A
TTC19,Neurologic,Mitochondrial complex III deficiency; nuclear type 2,N/A
TTC21B,Neurologic,Nephronophthisis 12; Short-rib thoracic dysplasia 4 with or without polydactyly,N/A
TTC8,Neurologic,Bardet-Biedl syndrome 8; Retinitis pigmentosa 51,N/A
TTI2,Neurologic,Mental retardation; autosomal recessive 39,N/A
TTPA,Neurologic,Ataxia with isolated vitamin E deficiency,Pediatric
TTR,Neurologic,Amyloidosis; hereditary; transthyretin-related; Dystransthyretinemic hyperthyroxinemia,Pediatric
TUBA1A,Neurologic,Lissencephaly 3,N/A
TUBA4A,Neurologic,Amyotrophic lateral sclerosis 22,N/A
TUBA8,Neurologic,Polymicrogyria with optic nerve hypoplasia,N/A
TUBB,Neurologic,Congenital symmetric circumferential skin creases 1; Cortical dysplasia; complex; with other brain malformations 6,N/A
TUBB2A,Neurologic,Cortical dysplasia; complex; with other brain malformations 5,N/A
TUBB2B,Neurologic,Cortical dysplasia; complex; with other brain malformations 7,N/A
TUBB3,Neurologic,Cortical dysplasia; complex; with other brain malformations 1; Fibrosis of extraocular muscles; congenital; 3A,N/A
TUBB4A,Neurologic,Dystonia 4; torsion; autosomal dominant; Leukodystrophy; hypomyelinating; 6,N/A
TUBB6,Neurologic,Facial palsy; congenital; with ptosis and velopharyngeal dysfunction (FPVEPD),N/A
TUBG1,Neurologic,Cortical dysplasia; complex; with other brain malformations 4,N/A
TUBGCP4,Neurologic,Microcephaly and chorioretinopathy; autosomal recessive 3,N/A
TUBGCP6,Neurologic,Microcephaly and chorioretinopathy; autosomal recessive 1,N/A
TUFM,Neurologic,Combined oxidative phosphorylation deficiency 4,N/A
TUSC3,Neurologic,Mental retardation; autosomal recessive 7,N/A
TWNK,Neurologic,Mitochondrial DNA depletion syndrome 7 (hepatocerebral type); Perrault syndrome 5,Pediatric
TXN2,Neurologic,Combined oxidative phosphorylation deficiency 29,Pediatric
TYMP,Neurologic,Mitochondrial DNA depletion syndrome 1 (MNGIE type),N/A
TYROBP,Neurologic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 (Nasu-Hakola disease),N/A
UBA1,Neurologic,Spinal muscular atrophy; X-linked 2; infantile,N/A
UBA5,Neurologic,Epileptic encephalopathy; early infantile; 44; Spinocerebellar ataxia; autosomal recessive 24,N/A
UBAP1,Neurologic,Spastic paraplegia 80; autosomal dominant,N/A
UBE2A,Neurologic,Mental retardation; X-linked; syndromic; Nascimento-type,N/A
UBE2T,Neurologic,Fanconi anemia; complementation group T,Pediatric
UBE3A,Neurologic,Angelman syndrome,N/A
UBE3B,Neurologic,Kaufman oculocerebrofacial syndrome (Blepharophimosis-ptosis-intellectual disability syndrome),N/A
UBQLN2,Neurologic,Amyotrophic lateral sclerosis 15; with or without frontotemporal dementia,N/A
UBR1,Neurologic,Johanson-Blizzard syndrome,Pediatric
UBTF,Neurologic,Neurodegeneration; childhood-onset; with brain atrophy,N/A
UCHL1,Neurologic,Parkinson disease 5; autosomal dominant; Spastic paraplegia 79; autosomal recessive,N/A
UFC1,Neurologic,Neurodevelopmental disorder with spasticity and poor growth,N/A
UFM1,Neurologic,Leukodystrophy; hypomyelinating; 14,N/A
UMPS,Neurologic,Orotic aciduria,Pediatric
UNC80,Neurologic,Hypotonia; infantile; with psychomotor retardation and characteristic facies 2,N/A
UPB1,Neurologic,Beta-ureidopropionase deficiency,N/A
UPF3B,Neurologic,Mental retardation; X-linked; syndromic 14,N/A
UQCC2,Neurologic,Mitochondrial complex III deficiency; nuclear type 7,N/A
UQCC3,Neurologic,Mitochondrial complex III deficiency; nuclear type 9,N/A
UQCRC2,Neurologic,Mitochondrial complex III deficiency; nuclear type 5,N/A
UQCRQ,Neurologic,Mitochondrial complex III deficiency; nuclear type 4,N/A
UROC1,Neurologic,Urocanase deficiency,N/A
USP18,Neurologic,Pseudo-TORCH syndrome 2,N/A
USP27X,Neurologic,Mental retardation; X-linked 105,N/A
USP9X,Neurologic,Mental retardation; X-linked 99; Mental retardation; X-linked 99; syndromic; female restricted,N/A
VAC14,Neurologic,Striatonigral degeneration; childhood-onset,N/A
VAMP1,Neurologic,Myasthenic syndrome; congenital; 25; presynaptic,Pediatric
VANGL1,Neurologic,Caudal regression syndrome; Neural tube defects,N/A
VAPB,Neurologic,Amyotrophic lateral sclerosis 8; Spinal muscular atrophy; late-onset; Finkel type,N/A
VARS1,Neurologic,Neurodevelopmental disorder with microcephaly; seizures; and cortical atrophy,N/A
VARS2,Neurologic,Combined oxidative phosphorylation deficiency 20,N/A
VAX1,Neurologic,Microphthalmia; syndromic 11,N/A
VCP,Neurologic,Amyotrophic lateral sclerosis 14; with or without frontotemporal dementia; Charcot-Marie-Tooth disease type; axonal type; 2Y; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1,N/A
VLDLR,Neurologic,Cerebellar ataxia; mental retardation; and dysequilibrium syndrome 1,N/A
VPS11,Neurologic,Leukodystrophy; hypomyelinating 12,N/A
VPS13A,Neurologic,Choreoacanthocytosis,N/A
VPS13B,Neurologic,Cohen syndrome,Pediatric
VPS13C,Neurologic,Parkinson disease 23; autosomal recessive; early onset,N/A
VPS13D,Neurologic,Spinocerebellar ataxia; autosomal recessive 4,N/A
VPS33A,Neurologic,Mucopolysaccharidosis-plus syndrome,N/A
VPS35,Neurologic,Parkinson disease 17,N/A
VPS37A,Neurologic,Spastic paraplegia 53; autosomal recessive,N/A
VPS39,Neurologic,Schizophrenia,N/A
VPS51,Neurologic,Pontocerebellar hypoplasia; type 13,N/A
VPS53,Neurologic,Pontocerebellar hypoplasia; type 2E,N/A
VRK1,Neurologic,Pontocerebellar hypoplasia type 1A,N/A
VWA3B,Neurologic,Spinocerebellar ataxia; autosomal recessive 22,N/A
WAC,Neurologic,DeSanto-Shinawi syndrome,N/A
WARS1,Neurologic,Neuronopathy; distal hereditary motor; type IX,N/A
WARS2,Neurologic,Neurodevelopmental disorder; mitochondrial with abnormal movements and lactic acidosis and with or without seizures (NEMMLAS),N/A
WASHC4,Neurologic,Mental retardation; autosomal recessive 43,N/A
WASHC5,Neurologic,Spastic paraplegia 8; Ritscher-Schinzel syndrome 1 (3C syndrome),N/A
WDFY3,Neurologic,Microcephaly; 18; primary; autosomal dominant,N/A
WDPCP,Neurologic,Bardet-Biedl syndrome 15; Congenital heart defects; hamartomas of tongue; and polysyndactyly; Meckel-Gruber syndrome type 6; modifier of,N/A
WDR11,Neurologic,Hypogonadotropic hypogonadism 14 with or without anosmia,Pediatric
WDR19,Neurologic,Short-rib thoracic dysplasia 5 with or without polydactyly; Cranioectodermal dysplasia 4; Nephronophthisis 13; Retinitis pigmentosa; Senior-Loken syndrome 8,N/A
WDR26,Neurologic,Skraban-Deardorff syndrome,N/A
WDR4,Neurologic,Galloway-Mowat syndrome 6,Pediatric
WDR45,Neurologic,Neurodegeneration with brain iron accumulation 5,N/A
WDR45B,Neurologic,Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures,N/A
WDR62,Neurologic,Microcephaly 2; primary; autosomal recessive; with or without cortical malformations,N/A
WDR73,Neurologic,Galloway-Mowat syndrome,N/A
WDR81,Neurologic,Cerebellar ataxia; mental retardation; and dysequilibrium syndrome 2; Hydrocephalus; nonsyndromic; autosomal recessive 3,N/A
WFS1,Neurologic,Wolfram syndrome 1,Pediatric
WIPI2,Neurologic,Intellectual developmental disorder with short stature and variable skeletal anomalies,N/A
WNK1,Neurologic,Pseudohypoaldosteronism; type IIC; Neuropathy; hereditary sensory and autonomic; type IIA,Pediatric
WWOX,Neurologic,Epileptic encephalopathy; early infantile; 28; Spinocerebellar ataxia; autosomal recessive 12,N/A
XK,Neurologic,McLeod syndrome,Pediatric
XPA,Neurologic,Xeroderma pigmentosum; group A,Pediatric
XPC,Neurologic,Xeroderma pigmentosum; group C,Pediatric
XPNPEP3,Neurologic,Nephronophthisis-like nephropathy 1,N/A
XPR1,Neurologic,Basal ganglia calcification; idiopathic; 6,N/A
XRCC1,Neurologic,Spinocerebellar ataxia; autosomal recessive; 26,N/A
XRCC2,Neurologic,Fanconi anemia; complementation group U,N/A
XRCC4,Neurologic,Short stature; microcephaly; and endocrine dysfunction,Pediatric
XYLT1,Neurologic,Desbuquois dysplasia 2,N/A
YAP1,Neurologic,Ocular coloboma with or without hearing impairment; cleft lip/palate; and/or mental retardation,Pediatric
YARS1,Neurologic,Charcot-Marie-Tooth disease; dominant intermediate C,N/A
YME1L1,Neurologic,Optic atrophy 11,N/A
YWHAG,Neurologic,Epileptic encephalopathy; early infantile; 56,N/A
YWHAZ,Neurologic,Popov-Chang syndrome,N/A
YY1,Neurologic,Gabriele-de Vries syndrome (GADEVS),N/A
YY1AP1,Neurologic,Grange syndrome,Pediatric
ZBTB11,Neurologic,Intellectual development disorder; autosomal recessive; 69,N/A
ZBTB16,Neurologic,Skeletal defects; genital hypoplasia; and mental retardation,N/A
ZBTB18,Neurologic,Mental retardation; autosomal dominant 22,N/A
ZBTB20,Neurologic,Primrose syndrome,N/A
ZBTB24,Neurologic,Immunodeficiency-Centromeric Instability-Facial Anomalies 2,Pediatric
ZC3H14,Neurologic,Mental retardation; autosomal recessive 56,N/A
ZC4H2,Neurologic,Wieacker-Wolff syndrome,N/A
ZDHHC15,Neurologic,Mental retardation; X-linked 91,N/A
ZDHHC9,Neurologic,Mental retardation; X-linked syndromic; Raymond type,N/A
ZEB2,Neurologic,Mowat-Wilson syndrome,N/A
ZFHX2,Neurologic,Marsili syndrome,N/A
ZFPM2,Neurologic,46;XY sex reversal 9,Pediatric
ZFYVE26,Neurologic,Spastic paraplegia 15,N/A
ZFYVE27,Neurologic,Spastic paraplegia 33; autosomal dominant,N/A
ZIC1,Neurologic,Craniosynostosis 6,N/A
ZIC2,Neurologic,Holoprosencephaly 5,N/A
ZIC3,Neurologic,Congenital heart defects; nonsyndromic; 1; X-linked; Heterotaxy; visceral; 1; X-linked; VACTERL association; X-linked; with or without hydrocephalus,N/A
ZIM2,Neurologic,Schizophrenia,N/A
ZMPSTE24,Neurologic,Mandibuloacral dysplasia with type B lipodystrophy; Restrictive dermopathy; lethal,N/A
ZMYND11,Neurologic,Mental retardation; autosomal domianant; 30,N/A
ZNF142,Neurologic,Neurodevelopmental disorder with impaired speech and hyperkinetic movements,N/A
ZNF148,Neurologic,Global developmental delay; absent or hypoplastic corpus callosum; and dysmorphic facies (GDACCF),N/A
ZNF335,Neurologic,Microcephaly 10; primary; autosomal recessive,N/A
ZNF341,Neurologic,Hyper-IgE recurrent infection syndrome 3; autosomal recessive,Pediatric
ZNF41,Neurologic,Mental retardation; X-linked 89,N/A
ZNF423,Neurologic,Joubert syndrome 19; Nephronophthisis 14,N/A
ZNF462,Neurologic,Weiss-Kruszka syndrome,N/A
ZNF480,Neurologic,Schizophrenia,N/A
ZNF565,Neurologic,Schizophrenia,N/A
ZNF592,Neurologic,Spinocerebellar ataxia; autosomal recessive 5,N/A
ZNF674,Neurologic,Mental retardation; X-linked 92,N/A
ZNF711,Neurologic,Mental retardation; X-linked 97,N/A
ZNF81,Neurologic,Mental retardation; X-linked 45,N/A
ZNHIT3,Neurologic,PEHO syndrome,N/A
ZSWIM6,Neurologic,Acromelic frontonasal dysostosis; Neurodevelopmental disorder with movement abnormalities; abnormal gait; and autistic features,N/A
ABCB11,Oncologic,Cholestasis; progressive familial intrahepatic 2,Pediatric
ACD,Oncologic,Dyskeratosis congenita; autosomal dominant 6; Dyskeratosis congenita; autosomal recessive 7,Pediatric
ADA,Oncologic,Severe combined immunodeficiency due to adenosine deaminase deficiency,Pediatric
AIP,Oncologic,Pituitary adenoma 1; multiple types,Pediatric
AKR1C2,Oncologic,46;XY sex reversal 8,Pediatric
AKT1,Oncologic,Cowden syndrome 6; Proteus syndrome ,Pediatric
ALK,Oncologic,Neuroblastoma; susceptibility to; 3,Pediatric
AMH,Oncologic,Persistent Mullerian duct syndrome; type I,Pediatric
AMHR2,Oncologic,Persistent Mullerian duct syndrome; type II,Pediatric
APC,Oncologic,Familial adenomatous polyposis; Gardner syndrome; Desmoid disease; hereditary,Pediatric
AR,Oncologic,Androgen insensitivity; Androgen insensitivity; partial,Pediatric
ARHGEF1,Oncologic,Immunodeficiency 62,Pediatric
ARMC5,Oncologic,ACTH-independent macronodular adrenal hyperplasia 2,Adult
ASCC1,Oncologic,Barrett esophagus/Esophageal adenocarcinoma,Adult
ATM,Oncologic,Breast cancer; susceptibility to; Ataxia-Telangiectasia,Pediatric (Ataxia-Telangiectasia); Adult (Breast cancer; susceptibility to)
ATR,Oncologic,Cutaneous telangiectasia and cancer syndrome; familial; Seckel syndrome 1,Pediatric
AXIN2,Oncologic,Oligodontia-colorectal cancer syndrome,Adult
BAP1,Oncologic,Tumor predisposition syndrome,Pediatric
BARD1,Oncologic,Breast cancer; susceptibility to,Adult
BLM,Oncologic,Bloom syndrome,Pediatric
BMPR1A,Oncologic,Polyposis syndrome; hereditary mixed; 2; Polyposis; juvenile intestinal,Adult
BRAF,Oncologic,Noonan syndrome; Cardiofaciocutaneous syndrome 1; LEOPARD syndrome 3,Pediatric
BRCA1,Oncologic,Breast-ovarian cancer; familial; susceptibility to; 1; Pancreatic cancer; susceptibility to; 4; Fanconi anemia; complementation group S,Pediatric (Fanconi anemia; complementation group S); (Adult (Breast-ovarian cancer; familial; susceptibility to; 1; Pancreatic cancer; susceptibility to; 4)
BRCA2,Oncologic,Breast-ovarian cancer; familial; susceptibility to; Pancreatic cancer; susceptibility to; 2; Glioma susceptibility 3; Fanconi anemia; complementation group D1; Wilms tumor; Medulloblastoma,Pediatric (Fanconi anemia; complementation group D1); Adult (Breast-ovarian cancer; familial; susceptibility to; Pancreatic cancer; susceptibility to; 2; Glioma susceptibility 3; Wilms tumor; Medulloblastoma)
BRIP1,Oncologic,Breast cancer; Fanconi anemia; complementation group J,Pediatric (Fanconi anemia; complementation group J); Adult (Breast  cancer)
BUB1B,Oncologic,Mosaic variegated aneuploidy syndrome; Premature chromatid separation trait,Pediatric
C11ORF80,Oncologic,Hydatidiform mole; recurrent; 4,Pediatric
C1S,Oncologic,Ehlers-Danlos syndrome; periodontal type 2; Complement component C1s deficiency,Pediatric
CARD11,Oncologic,B-cell expansion with NFKB and T-cell anergy; Immunodeficiency 11,Pediatric
CARMIL2,Oncologic,Immunodeficiency 58,Pediatric
CASP10,Oncologic,Autoimmune lymphoproliferative syndrome; type IIA,Pediatric
CBL,Oncologic,Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia; Juvenile myelomonocytic leukemia; familial,Pediatric
CD27,Oncologic,Lymphoproliferative syndrome 2,Pediatric
CD40LG,Oncologic,Immunodeficiency; with hyper-IgM; type 1,Pediatric
CD70,Oncologic,Lymphoproliferative syndrome 3,Pediatric
CDC73,Oncologic,Hyperparathyroidism 1; Hyperparathyroidism-jaw tumor syndrome; Carcinoma; parathyroid,Pediatric
CDH1,Oncologic,CDH1-related cancer,Adult
CDH23,Oncologic,Pituitary adenoma 5; multiple types; Deafness; autosomal recessive 12; Usher syndrome; type 1D; Usher syndrome; type 1D /F digenic,Pediatric (Deafness; autosomal recessive 12; Usher syndrome; type 1D; Usher syndrome; type 1D /F digenic)/Adult (Pituitary adenoma; multiple types)
CDK4,Oncologic,Melanoma; cutaneous malignant; susceptibility to; 3,Adult
CDKN1B,Oncologic,Multiple endocrine neoplasia; type IV,Pediatric
CDKN1C,Oncologic,IMAGE syndrome; Beckwith-Wiedemann syndrome,Pediatric
CDKN2A,Oncologic,Melanoma and neural system tumor syndrome; Melanoma; familial; Melanoma-pancreatic cancer syndrome,Pediatric
CEBPA,Oncologic,Acute myeloid leukemia; familial,Pediatric
CHEK2,Oncologic,Li-Fraumeni syndrome 2,Adult
CIB1,Oncologic,Epidermodysplasia verruciformis; susceptibility to; 3,Pediatric
CLPB,Oncologic,3-methylglutaconic aciduria with cataracts; neurologic involvement; and neutropenia (MEGCANN),Pediatric
CORO1A,Oncologic,Immunodeficiency 8,Pediatric
CREBBP,Oncologic,Rubinstein-Taybi syndrome; Menke-Hennekam syndrome 1,Pediatric
CTHRC1,Oncologic,Barrett esophagus/Esophageal adenocarcinoma,Adult
CTLA4,Oncologic,Autoimmune lymphoproliferative syndrome; type V,Pediatric
CTNNA1,Oncologic,Hereditary diffuse gastric cancer; familial,Adult
CTPS1,Oncologic,Immunodeficiency 24,Pediatric
CYB5A,Oncologic,46; XY disorder of sex development; Methemoglobinemia and ambiguous genitalia,Pediatric
CYLD,Oncologic,Spiegler-Brooke syndrome; Trichoepithelioma; multiple familial; 1; Cylindromatosis; familial,Pediatric
CYP11A1,Oncologic,Adrenal insufficiency; congenital; with 46;XY sex reversal; partial or complete,Pediatric
CYP11B1,Oncologic,Adrenal hyperplasia; congenital; due to 11-beta-hydroxylase deficiency; Hyperaldosteronism; familial; type I,Pediatric
CYP11B2,Oncologic,Corticosterone methyloxidase type I deficiency; Corticosterone methyloxidase type II deficiency;  Glucocorticoid-remediable aldosteronism,Pediatric
CYP17A1,Oncologic,Adrenal hyperplasia; congenital; due to 17-alpha-hydroxylase deficiency,Pediatric
CYP21A2,Oncologic,Adrenal hyperplasia; congenital; due to 21-hydroxylase deficiency; Hyperandrogenism; nonclassic type; due to 21-hydroxylase deficiency,Pediatric
DDB2,Oncologic,Xeroderma pigmentosum; group E,Pediatric
DDX41,Oncologic,Familial myeloproliferative/lymphoproliferative neoplasms; multiple types; susceptibility to,Adult
DHH,Oncologic,46;XY partial gonadal dysgenesis; with minifascicular neuropathy; 46;XY sex reversal 7,Pediatric
DICER1,Oncologic,DICER1 syndrome,Pediatric
DIS3L2,Oncologic,Perlman syndrome,Pediatric
DKC1,Oncologic,Dyskeratosis congenita; X-linked; Hoyeraal-Hreidarsson syndrome,Pediatric
DLST,Oncologic,Paragangliomas 7,Adult
DNAJC21,Oncologic,Bone marrow failure syndrome 3,Pediatric
DOCK8,Oncologic,Hyper-IgE recurrent infection syndrome 2; autosomal recessive,Pediatric
EGFR,Oncologic,Acute myeloid leukemia; familial; Lung cancer; familial; susceptibilty to; Inflammatory skin and bowel disease; neonatal; 2,Pediatric
EGLN1,Oncologic,Erythrocytosis; familial; 3,Pediatric
ELANE,Oncologic,Neutropenia; severe congenital 1; autosomal dominant; Neutropenia; cyclic,Pediatric
ENG,Oncologic,Hereditary hemorrhagic telangiectasia; type 1; Juvenile polyposis syndrome,Pediatric
EPAS1,Oncologic,Erthyrocytosis; familial 4,Pediatric
EPCAM,Oncologic,Colorectal cancer; hereditary nonpolyposis; type 8; Diarrhea 5; with tufting enteropathy; congenital,Pediatric
ERBB3,Oncologic,Erythroleukemia; familial; susceptibility to (AD),N/A
ERCC2,Oncologic,Trichothiodystrophy 1; photosensitive; Xeroderma pigmentosum; group D,Pediatric
ERCC3,Oncologic,Xeroderma pigmentosum; complementation group B; Trichothiodystrophy 2; photosensitive,Pediatric
ERCC4,Oncologic,Fanconi anemia; complementation group Q; Xeroderma pigmentosum; group F,Pediatric
ERCC5,Oncologic,Xeroderma pigmentosum; complementation group G; Xeroderma pigmentosum; complementation group G/Cockayne syndrome,Pediatric
ERCC6,Oncologic,Premature ovarian failure 11; Xeroderma Pigmentosum-Cockayne Syndrome; De Sanctis-Cacchione syndrome,Pediatric
ETV6,Oncologic,Thrombocytopenia 5,Pediatric
EXT1,Oncologic,Exostoses; multiple; type 1,Pediatric
EXT2,Oncologic,Exostoses; multiple; type 2,Pediatric
FAH,Oncologic,Tyrosinemia; type I,Pediatric
FANCA,Oncologic,Fanconi anemia; complementation group A,Pediatric
FANCB,Oncologic,Fanconi anemia;complementation group B,Pediatric
FANCC,Oncologic,Fanconi anemia; complementation group C,Pediatric
FANCD2,Oncologic,Fanconi anemia; complementation group D2,Pediatric
FANCE,Oncologic,Fanconi anemia; complementation group E,Pediatric
FANCF,Oncologic,Fanconia anemia; complementation group F,Pediatric
FANCG,Oncologic,Fanconi anemia type G,Pediatric
FANCI,Oncologic,Fanconi anemia; complementation group I,Pediatric
FANCL,Oncologic,Fanconi anemia; complementation group L,Pediatric
FANCM,Oncologic,Fanconi anemia type M; Premature ovarian failure 15,Pediatric
FAS,Oncologic,Autoimmune lymphoproliferative syndrome; type IA,Pediatric
FASLG,Oncologic,Autoimmune lymphoproliferative syndrome; type IB,Pediatric
FERMT1,Oncologic,Kindler syndrome,Adult
FH,Oncologic,Hereditary leiomyomatosis and renal cell cancer,Pediatric
FLCN,Oncologic,Birt-Hogg-Dube syndrome; Pneumothorax; primary spontaneous ,Adult
FOXE1,Oncologic,Thyroid cancer; nonmedullary 4; Hypothyroidism; thyroidal; with spiky hair and cleft palate (Bamforth-Lazarus syndrome); Congenital hypothyroidism,Pediatric/Adult
G6PC,Oncologic,Glycogen storage disease Ia,Pediatric
GALNT12,Oncologic,Colorectal cancer; susceptibility to; 1,Adult
GATA2,Oncologic,Immunodeficiency 21; Emberger syndrome; Myelodysplastic syndrome; Acute myeloid leukemia; familial; Chronic neutropenia associated with monocytopenia; evolving to myelodysplasia and acute myeloid leukemia,Pediatric
GCM2,Oncologic,Hypoparathyroidism; familial isolated; Hyperparathyroidism 4,Pediatric
GFI1,Oncologic,Neutropenia; severe congenital; 2 autosomal dominant; Neutropenia; nonimmune chronic idiopathic; of adults ,Pediatric
GJB2,Oncologic,Deafness; autosomal recessive 1A; Deafness; digenic; Hystrix-like ichthyosis with deafness; Deafness; autosomal dominant 3A; Bart-Pumphrey syndrome; Keratoderma; palmoplantar; with deafness; Vohwinkel syndrome; Keratitis-icthyosis-deafness syndrome,Pediatric
GNAS,Oncologic,Pseudohypoparathyroidism; type IA; Pseudohypoparathyroidism; type IB; Pseudohypoparathyroidism; type IC; Progressive osseous heteroplasia; McCune-Albright syndrome,Pediatric
GPC3,Oncologic,Simpson-Golabi-Behmel syndrome; type 1,Pediatric
GREM1,Oncologic,Polyposis syndrome; mixed hereditary 1,Pediatric
H19,Oncologic,Wilms tumor 2; Beckwith-Wiedemann syndrome,Pediatric
HABP2,Oncologic,Thyroid cancer; nonmedullary 5,Pediatric
HAVCR2,Oncologic,T-cell lymphoma; subcutaneous panniculitis-like,Pediatric
HAX1,Oncologic,Neutropenia; severe congenital; 3,Pediatric
HMBS,Oncologic,Hydroxymethylbilane synthase deficiency; Porphyria; acute intermittent,Pediatric
HNF1A,Oncologic,Renal cell carcinoma; nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young; type III,Pediatric
HNF1B,Oncologic,Renal cell carcinoma; nonpapillary chromophobe,Adult
HRAS,Oncologic,Costello syndrome; Congenital myopathy with excess of muscle spindles,Pediatric
IKZF1,Oncologic,Immunodeficiency; common variable; 13,Pediatric
IL7,Oncologic,Epidermodysplasia verruciformis; susceptibility to; 5,Pediatric
INSR,Oncologic,Hyperinsulinemic hypoglycemia; familial; 5; Rabson-Mendenhall syndrome; Donohoe syndrome,Pediatric
IPMK,Oncologic,Small intestinal carcinoid; hereditary,Pediatric
ITK,Oncologic,Lymphoproliferative syndrome 1,Pediatric
KCNQ1OT1,Oncologic,Beckwith-Wiedemann syndrome,Pediatric
KHDC3L,Oncologic,Hydatidiform mole; recurrent; 2,Pediatric
KIF1B,Oncologic,Neuroblastoma; susceptibility to; Pheochromocytoma,Pediatric
KIT,Oncologic,Gastrointestinal stromal tumor; Mastocytosis; cutaneous,Adult
KLHDC8B,Oncologic,Hodgkin lymphoma,Pediatric
KLLN,Oncologic,Cowden syndrome 4 ,Adult
KRAS,Oncologic,Noonan syndrome; Cardiofaciocutaneous syndrome,Pediatric
L2HGDH,Oncologic,L-2-hydroxyglutaric aciduria,Pediatric
LHCGR,Oncologic,Leydig cell hypoplasia type I; Leydig cell hypoplasia type II; Luteinizing hormone resistance; female; Precocious puberty; male,Pediatric
LIG4,Oncologic,LIG4 syndrome; Severe combined immunodeficiency with sensitivity to ionizing radiation,Pediatric
LYST,Oncologic,Chediak-Higashi syndrome,Pediatric
LZTR1,Oncologic,Schwannomatosis 2; Noonan syndrome 10; Noonan syndrome 2,Pediatric (Noonan syndrome 10; Noonan syndrome 2); Adult (Schwannomatosis 2)
MAD2L2,Oncologic,Fanconi anemia; complementation group V,Pediatric
MAFA,Oncologic,Insulinomatosis and diabetes mellitus syndrome,Pediatric
MAP2K1,Oncologic,Cardiofaciocutaneous syndrome 3,Pediatric
MAP2K2,Oncologic,Cardiofaciocutaneous syndrome 4,Pediatric
MAP3K1,Oncologic,46;XY sex reversal 6,Pediatric
MAP3K6,Oncologic,Familial gastric cancer,Adult
MAX,Oncologic,Pheochromocytoma,Pediatric
MCM4,Oncologic,Immunodeficiency 54,Pediatric
MEI1,Oncologic,Hydatidiform mole; recurrent; 3,Pediatric
MEN1,Oncologic,Multiple endocrine neoplasia type I; Hyperparathyroidism; familial primary,Adult
MET,Oncologic,Renal cell carcinoma; papillary; Deafness; autosomal recessive 97,Pediatric (Deafness; autosomal recessive 97); Adult (Renal cell carcinoma; papillary)
MITF,Oncologic,Waardenburg syndrome; type 2A; Tietz albinism-deafness syndrome; Coloboma; osteopetrosis; microphthalmia; macrocephaly; albinism; and deafness (COMMAD); Melanoma; cutaneous malignant; susceptibility to; 8; Renal cell carcinoma with or without malignant melanoma,Pediatric (Waardenburg syndrome; type 2A; Tietz albinism-deafness syndrome; Coloboma; osteopetrosis; microphthalmia; macrocephaly; albinism; and deafness (COMMAD)); Adult (Melanoma; cutaneous malignant; susceptibility to; 8; Renal cell carcinoma with or without malignant melanoma)
MLH1,Oncologic,Colorectal cancer; hereditary nonpolyposis; type 2; Mismatch repair cancer syndrome; Endometrial cancer; Muir-Torre syndrome,Adult (Colorectal cancer; hereditary nonpolyposis; type 2; Endometrial cancer; Muir-Torre syndrome)/Pediatric (Mismatch repair cancer syndrome)
MLH3,Oncologic,Colorectal cancer; hereditary nonpolyposis type 7; Endometrial carcinoma,Adult
MN1,Oncologic,Meningioma; familial,Pediatric
MNX1,Oncologic,Currarino syndrome,Pediatric
MPIG6B,Oncologic,Thrombocytopenia; anemia; and myelofibrosis,Pediatric
MPL,Oncologic,Thrombocythemia 2; Amegakaryocytic thrombocytopenia,Pediatric
MPV17,Oncologic,Mitochondrial DNA depletion syndrome 6 (hepatocerebral type),Pediatric
MRE11,Oncologic,Breast cancer; susceptibility to,Adult
MSH2,Oncologic,Colorectal cancer; hereditary nonpolyposis; type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome,Adult (Colorectal cancer; hereditary nonpolyposis; type 1; Endometrial cancer; Muir-Torre syndrome)/Pediatric (Mismatch repair cancer syndrome)
MSH3,Oncologic,Endometrial carcinoma,Adult
MSH6,Oncologic,Colorectal cancer; hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer,Adult (Colorectal cancer; hereditary nonpolyposis type 5; Endometrial cancer)/Pediatric (Mismatch repair cancer syndrome)
MSR1,Oncologic,Barrett esophagus/esophageal adenocarcinoma; Prostate cancer,Adult
MTAP,Oncologic,Diaphyseal medullary stenosis with malignant fibrous histiocytoma,Pediatric
MUTYH,Oncologic,Familial adenomatous polyposis; 2; Colorectal adenomatous polyposis; autosomal recessive; with pilomatricomas ,Adult
NBN,Oncologic,Breast cancer; susceptibility to; Nijmegen breakage syndrome,Pediatric (Nijmegen breakage syndrome); Adult (Breast cancer; susceptibility to)
NDUFA13,Oncologic,Thyroid carcinoma; Hurthle cell,Adult
NF1,Oncologic,Neurofibromatosis type 1; Neurofibromatosis-Noonan syndrome; Watson syndrome,Pediatric
NF2,Oncologic,Neurofibromatosis type II; Schwannomatosis 2,Pediatric
NHP2,Oncologic,Dyskeratosis congenita; autosomal recessive 2,Pediatric
NKX2-1,Oncologic,Choreoathetosis; hypothyroidism; and neonatal respiratory distress; Thyroid cancer; nonmedullary 1,Pediatric/Adult
NLRP1,Oncologic,Palmoplantar carcinoma; multiple self-healing; Autoinflammation with arthritis and dyskeratosis,Pediatric
NLRP7,Oncologic,Hydatidiform mole; recurrent; 1,Pediatric
NOP10,Oncologic,Dyskeratosis congenita; autosomal recessive 1,Pediatric
NOTCH3,Oncologic,Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1 (CADASIL1); Myofibromatosis; infantile 2,Pediatric
NPAT,Oncologic,Nodular lymphocyte predominant Hodgkin lymphoma; familial,Adult
NR0B1,Oncologic,Adrenal hypoplasia; congenital; 46;XY sex reversal 2 ,Pediatric
NR5A1,Oncologic,Adrenocortical insufficiency; 46;XX sex reversal 4; 46; XY sex reversal 3; Premature ovarian failure 7,Pediatric
NRAS,Oncologic,Autoimmune lymphoproliferative syndrome type IV; Noonan syndrome 6,Pediatric
NSD1,Oncologic,Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome,Pediatric
NTHL1,Oncologic,Familial adenomatous polyposis 3,Adult
PALB2,Oncologic,Breast cancer; Pancreatic cancer; susceptibility to 3; Fanconi anemia; complementation group N,Pediatric (Fanconi anemia; complementation group N); Adult (Breast cancer; Pancreatic cancer; susceptibility to 3)
PARN,Oncologic,Pulmonary fibrosis and/or bone marrow failure; telomere-related 4; Dyskeratosis congenita; autosomal recessive 6,Pediatric
PAX5,Oncologic,Leukemia; acute lymphoblastic; susceptibility to; 3,Pediatric
PBRM1,Oncologic,Clear cell renal cell carcinoma,Adult
PCNA,Oncologic,Ataxia-telangiectasia-like disorder 2,Pediatric
PDGFRA,Oncologic,Gastrointestinal stromal tumor; GIST-plus syndrome,Adult
PGM3,Oncologic,Immunodeficiency 23,Pediatric
PHOX2B,Oncologic,Central hypoventilation syndrome; congenital; Neuroblastoma with Hirschsprung disease; Neuroblastoma; susceptiblity to; 2,Pediatric
PIK3CA,Oncologic,Cowden syndrome 5,Adult
PIK3CD,Oncologic,Immunodeficiency 14,Pediatric
PMS2,Oncologic,Colorectal cancer; hereditary nonpolyposis type 4; Mismatch repair cancer syndrome ,Adult (Colorectal cancer; hereditary nonpolyposis type 4)/Pediatric (Mismatch repair cancer syndrome)
PNP,Oncologic,Purine nucleoside phosphorylase deficiency,Pediatric
POLD1,Oncologic,Colorectal cancer; susceptibility to; 10,Pediatric
POLE,Oncologic,Colorectal cancer; susceptibility to; 12; Facial dysmorphism; immunodeficiency; livedo; and short stature syndrome (FILS syndrome); Intrauterine growth retardation; metaphyseal dysplasia; adrenal hypoplasia congenita; genital anomalies; and immunodeficiency (IMAGEI),Pediatric
POLH,Oncologic,Xeroderma pigmentosum; variant type,Pediatric
POT1,Oncologic,Glioma susceptibility 9; Melanoma; cutaneous malignant; susceptibility to 10,Pediatric
POU6F2,Oncologic,Wilms tumor 5,Pediatric
PRF1,Oncologic,Hemophagocytic lymphohistiocytosis; familial; 2; Lymphoma; non-Hodgkin; Aplastic anemia; adult-onset ,Pediatric
PRKAR1A,Oncologic,Pigmented nodular adrenocortical disease; primary; 1; Carney complex; type 1; Myxoma; intracardiac; Acrodysostosis 1; with or without hormone resistance,Pediatric
PRLR,Oncologic,Hyperprolactinemia; Multiple fibroadenomas of the breast,Pediatric
PRSS1,Oncologic,Pancreatitis; hereditary,Pediatric
PTCH1,Oncologic,Basal cell nevus syndrome,Pediatric
PTCH2,Oncologic,Basal cell nevus syndrome,Pediatric
PTEN,Oncologic,PTEN hamartoma tumor syndrome; Cowden syndrome 1; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma; familial; Endometrial cancer,Pediatric
PTPN11,Oncologic,Noonan syndrome 1; LEOPARD syndrome 1,Pediatric
RAB27A,Oncologic,Griscelli syndrome; type 2; Elejalde syndrome,Pediatric
RAD50,Oncologic,Breast cancer; susceptibility to,Adult
RAD51C,Oncologic,Breast-ovarian cancer; familial; susceptibility to; Fanconi anemia goup O,Pediatric (Fanconi anemia goup O); Adult (Breast-ovarian cancer; familial; susceptibility to)
RAD51D,Oncologic,Ovarian cancer; familial; susceptibility to,Adult
RASGRP1,Oncologic,Immunodeficiency 64,Pediatric
RB1,Oncologic,Retinoblastoma,Pediatric
RECQL4,Oncologic,Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome,Pediatric
REST,Oncologic,Wilms tumor 6; susceptibility to,Pediatric
RET,Oncologic,Central hypoventilation syndrome; congenital; Multiple endocrine neoplasia; type IIA; Multiple endocrine neoplasia; type IIB; Medullary thyroid carcinoma; familial; Pheochromocytoma; Hirschsprung disease; susceptibility to 1,Pediatric
RFWD3,Oncologic,Fanconi anemia; complementation group W,Pediatric
RHBDF2,Oncologic,Tylosis with esophageal cancer,Adult
RHOH,Oncologic,Epidermodysplasia verruciformis; susceptibility to; 4,Pediatric
RIT1,Oncologic,Noonan syndrome 8,Pediatric
RMRP,Oncologic,Anauxetic dysplasia 1; Cartilage-hair hypoplasia; Metaphyseal dysplasia without hypotrichosis,Pediatric
RNASEL,Oncologic,Prostate cancer; hereditary; 1,Adult
RNF139,Oncologic,Renal cell carcinoma; clear cell,Pediatric
RNF168,Oncologic,RIDDLE syndrome,Pediatric
RNF43,Oncologic,Sessile serrated polyposis cancer syndrome,Adult
RPL11,Oncologic,Diamond-Blackfan anemia 7,Pediatric
RPL15,Oncologic,Diamond-Blackfan anemia 12,Pediatric
RPL18,Oncologic,Diamond-Blackfan anemia 18,Pediatric
RPL26,Oncologic,Diamond-Blackfan anemia 11,Pediatric
RPL27,Oncologic,Diamond-Blackfan anemia 16,Pediatric
RPL35,Oncologic,Diamond-Blackfan anemia 19,Pediatric
RPL35A,Oncologic,Diamond-Blackfan anemia 5,Pediatric
RPL5,Oncologic,Diamond-Blackfan anemia 6,Pediatric
RPS10,Oncologic,Diamond-Blackfan anemia 9,Pediatric
RPS15A,Oncologic,Diamond-Blackfan anemia 20,Pediatric
RPS17,Oncologic,Diamond-Blackfan anemia 4,Pediatric
RPS19,Oncologic,Diamond-Blackfan anemia 1,Pediatric
RPS24,Oncologic,Diamond-Blackfan anemia 3,Pediatric
RPS26,Oncologic,Diamond-Blackfan anemia 10,Pediatric
RPS27,Oncologic,Diamond-Blackfan anemia 17,Pediatric
RPS28,Oncologic,Diamond-Blackfan anemia 15 with mandibulofacial dysostosis,Pediatric
RPS29,Oncologic,Diamond-Blackfan anemia 13,Pediatric
RPS7,Oncologic,Diamond-Blackfan anemia 8,Pediatric
RSPO1,Oncologic,Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and 46;XX sex reversal,Adult
RTEL1,Oncologic,Pulmonary fibrosis and/or bone marrow failure; telomere-related 3; Dyskeratosis congenita; autosomal dominant 4; Dyskeratosis congenita; autosomal recessive 5,Pediatric
RUNX1,Oncologic,Platelet disorder; familial; with associated myeloid malignancy,Pediatric
SAMD9L,Oncologic,Ataxia-pancytopenia syndrome,Pediatric
SASH1,Oncologic,Cancer; alopecia; pigment dyscrasia; onychodystrophy; and keratoderma,Adult
SBDS,Oncologic,Shwachman-Diamond syndrome; Aplastic anemia,Pediatric
SDHA,Oncologic,Paragangliomas 5; Gastrointestinal stromal tumors; Cardiomyopathy; dilated; 1GG; Leigh syndrome/Mitochondrial respiratory chain complex II deficiency,Adult (Paragangliomas 5; Gastrointestinal stromal tumors); Pediatric (Cardiomyopathy; dilated; 1GG; Leigh syndrome/Mitochondrial respiratory chain complex II deficiency)
SDHAF2,Oncologic,Paragangliomas 2,Pediatric
SDHB,Oncologic,Cowden syndrome 2; Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Pheochromocytoma; Paragangliomas 4,Pediatric
SDHC,Oncologic,Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Paragangliomas 3,Pediatric
SDHD,Oncologic,Cowden syndrome 3; Paraganglioma and gastric stromal sarcoma; Pheochromocytoma; Paragangliomas 1; Carcinoid tumors; intestinal,Pediatric
SEC23B,Oncologic,Cowden syndrome 7; Anemia; dyserythropoietic congenital; type II ,Pediatric (Anemia; dyserythropoietic congenital; type II); Adult (Cowden syndrome 7)
SETBP1,Oncologic,Mental retardation; autosomal dominant 29; Schinzel-Giedion midface retraction syndrome,N/A
SFTPA2,Oncologic,Pulmonary fibrosis; idiopathic,Pediatric
SH2D1A,Oncologic,Lymphoproliferative syndrome; X-linked; 1,Pediatric
SLC25A11,Oncologic,Paragangliomas 6,Adult
SLC25A13,Oncologic,Citrin deficiency,Pediatric
SLC37A4,Oncologic,Glycogen storage disease Ib; Glycogen storage disease Ic; Glycogen storage disease Id,Pediatric
SLC5A5,Oncologic,Thyroid dyshormonogenesis 1,Pediatric
SLX4,Oncologic,Fanconi anemia; complementation group P,Pediatric
SMAD4,Oncologic,Hereditary hemorrhagic telangiectasia; type 1; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome; Polyposis; juvenile intestinal; Myhre syndrome,Pediatric
SMARCA4,Oncologic,Rhabdoid tumor predisposition syndrome 2,Pediatric
SMARCAD1,Oncologic,Huriez syndrome,Adult
SMARCB1,Oncologic,Schwannomatosis; Rhabdoid tumor predisposition syndrome 1,Pediatric
SMARCE1,Oncologic,Meningioma; familial; susceptibility to,Pediatric
SOX9,Oncologic,46; XY sex reversal 10; Campomelic dysplasia,Pediatric
SPINK1,Oncologic,Pancreatitis; hereditary,Pediatric
SQSTM1,Oncologic,Paget disease of bone 3,Pediatric
SRD5A2,Oncologic,Steroid 5-alpha-reductase 2 deficiency,Pediatric
SRP72,Oncologic,Bone marrow failure syndrome 1,Pediatric
SRY,Oncologic,46;XY disorder of sex development; 46; XX disorder of sex development,Pediatric
STAR,Oncologic,Lipoid adrenal hyperplasia,Pediatric
STAT1,Oncologic,Immunodeficiency 31A; Immunodeficiency 31B; Immunodeficiency 31C,Pediatric
STAT3,Oncologic,Hyper-IgE recurrent infection syndrome 1; autosomal dominant; Autoimmune disease; multisystem; infantile onset 1,Pediatric
STK11,Oncologic,Peutz-Jeghers syndrome,Pediatric
STS,Oncologic,Steroid sulfatase deficiency,Pediatric
STX11,Oncologic,Hemophagocytic lymphohistiocytosis; familial; 4,Pediatric
SUFU,Oncologic,Medulloblastoma; Basal cell nevus syndrome,Pediatric
TBXT,Oncologic,Chordoma,Pediatric
TERC,Oncologic,Dyskeratosis congenita; autosomal dominant 1; Aplastic anemia; Pulmonary fibrosis and/or bone marrow failure; telomere-related 2,Pediatric
TERT,Oncologic,Aplastic anemia; Dyskeratosis congenita; autosomal dominant; Dyskeratosis congenita; autosomal recessive; Pulmonary fibrosis and/or bone marrow failure; telomere-related 1,Pediatric
TG,Oncologic,Thyroid dyshormonogenesis 3,Pediatric
THPO,Oncologic,Thrombocythemia 1,Pediatric
TINF2,Oncologic,Dyskeratosis congenita; autosomal dominant 3; Revesz syndrome,Pediatric
TJP2,Oncologic,Hypercholanemia; familial; Cholestasis; progressive familial intrahepatic 4,Pediatric
TMC6,Oncologic,Epidermodysplasia verruciformis; susceptibility to; 1,Pediatric
TMC8,Oncologic,Epidermodysplasia verruciformis; susceptibility to; 2,Pediatric
TMEM127,Oncologic,Pheochromocytoma,Adult
TNFRSF10B,Oncologic,Squamous cell carcinoma; head and neck,Pediatric
TNFRSF11A,Oncologic,Familial expansile osteolysis; Paget disease of bone 2; early-onset; Osteopetrosis; autosomal recessive 7,Pediatric (Polyostotic osteolytic dysplasia; hereditary expansile/Osteopetrosis; autosomal recessive 7); Adult (Paget disease of bone)
TP53,Oncologic,Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma; intracranial; Osteogenic sarcoma; Breast cancer; familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer; Bone marrow failure syndrome 5,Pediatric
TPO,Oncologic,Thyroid dyshormonogenesis 2A,Pediatric
TRIM37,Oncologic,Mulibrey nanism,Pediatric
TRIP13,Oncologic,Mosaic variegated aneuploidy syndrome 3,Pediatric
TSC1,Oncologic,Tuberous sclerosis; Lymphangioleiomyomatosis,Pediatric
TSC2,Oncologic,Tuberous sclerosis 2; Lymphangioleiomyomatosis ,Pediatric
TSR2,Oncologic,Diamond-Blackfan anemia 14 with mandibulofacial dysostosis,Pediatric
UBE2T,Oncologic,Fanconi anemia; complementation group T,Pediatric
UNC13D,Oncologic,Hemophagocytic lymphohistiocytosis; familial 3,Pediatric
VHL,Oncologic,Von Hippel Lindau; Erythrocytosis; familial; 2 (Chuvash polycythemia); Pheochromocytoma,Pediatric
WRAP53,Oncologic,Dyskeratosis congenita; autosomal recessive 3,Pediatric
WRN,Oncologic,Werner syndrome,Pediatric
WT1,Oncologic,Denys-Drash syndrome; Wilms tumor; type 1; Frasier syndrome,Pediatric
XIAP,Oncologic,Lymphoproliferative syndrome; X-linked; 2,Pediatric
XPA,Oncologic,Xeroderma pigmentosum; group A,Pediatric
XPC,Oncologic,Xeroderma pigmentosum; group C,Pediatric
XRCC4,Oncologic,Short stature; microcephaly; and endocrine dysfunction,Pediatric
ZNF687,Oncologic,Paget disease of bone 6,Adult
AARS2,Cardiovascular,Leukoencephalopathy; progressive; with ovarian failure,Pediatric
ABCA1,Cardiovascular,Hypoalphalipoproteinemia; primary; 1; Tangier disease,Pediatric
ABCC6,Cardiovascular,Pseudoxanthoma elasticum,Pediatric
ABCC9,Cardiovascular,Cardiomyopathy; dilated; 10; Atrial fibrillation; familial 12; Cantu syndrome,Pediatric
ABCD4,Cardiovascular,Methylmalonic aciduria and homocystinuria; cblJ type,Pediatric
ABCG5,Cardiovascular,Sitosterolemia,Pediatric
ABCG8,Cardiovascular,Sitosterolemia,Pediatric
ABL1,Cardiovascular,Congenital heart defects and skeletal malformations syndrome (CHDSKM),Adult
ACAD8,Cardiovascular,Isobutyryl-CoA dehydrogenase deficiency,Pediatric
ACAD9,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 20,Pediatric
ACADVL,Cardiovascular,Acyl-CoA dehydrogenase; very long chain; deficiency of,Pediatric
ACTA2,Cardiovascular,Moyamoya disease 5; Multisystemic smooth muscle dysfunction syndrome; Aortic aneurysm; familial thoracic 6,Pediatric
ACTB,Cardiovascular,Baraitser-Winter syndrome 1,Pediatric
ACTC1,Cardiovascular,Cardiomyopathy; dilated ; 1R; Cardiomyopathy; familial hypertrophic 11; Cardiomyopathy; restrictive; Left ventricular noncompaction; Atrial septal defect 5,Pediatric
ACTG1,Cardiovascular,Deafness; autosomal dominant 20; Baraitser-Winter syndrome 2,Pediatric
ACTN2,Cardiovascular,Cardiomyopathy; dilated; 1AA; with or without left ventricular noncompaction; Cardiomyopathy; hypertrophic 23; with or without left ventricular noncompaction,Pediatric
ACVR2B,Cardiovascular,Heterotaxy; visceral; 4; autosomal,N/A
ACVRL1,Cardiovascular,Telangiectasia; hereditary hemorrhagic; type 2,Pediatric
ADAM17,Cardiovascular,Inflammatory skin and bowel disease; neonatal 1,Pediatric
ADAMTS10,Cardiovascular,Weill-Marchesani syndrome 1,Pediatric
ADAMTSL2,Cardiovascular,Geleophysic dysplasia 1,Pediatric
ADCY5,Cardiovascular,Dyskinesia; familial; with facial myokymia,Adult
ADK,Cardiovascular,Hypermethioninemia due to adenosine kinase deficiency,N/A
ADNP,Cardiovascular,Helsmoortel-van der Aa syndrome (Mental retardation; autosomal dominant 28),N/A
AEBP1,Cardiovascular,Ehlers-Danlos syndrome; classic-like; 2,Pediatric
AFF4,Cardiovascular,Cognitive impairment; coarse facies; Heart defects; Obesity; Pulmonary involvement; Short stature; and skeletal dysplasia (CHOPS syndrome),N/A
AGA,Cardiovascular,Aspartylglucosaminuria,N/A
AGK,Cardiovascular,Sengers syndrome,Pediatric
AGL,Cardiovascular,Glycogen storage disease III,Pediatric
AGPAT2,Cardiovascular,Lipodystrophy; congenital generalized; type 1,Pediatric
AGXT,Cardiovascular,Hyperoxaluria; primary; type 1,Pediatric
AHCY,Cardiovascular,Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency,Pediatric
AKAP9,Cardiovascular,Long QT syndrome 11,Pediatric
AKT1,Cardiovascular,Cowden syndrome 6; Proteus syndrome ,Pediatric
ALDH18A1,Cardiovascular,Cutis laxa; autosomal dominant 3; Spastic paraplegia 9A; autosomal dominant; Cutis laxa; autosomal recessive; type IIIA; Spastic paraplegia 9B; autosomal recessive,N/A
ALG12,Cardiovascular,Congenital disorder of glycosylation; type Ig,Pediatric
ALG8,Cardiovascular,Congenital disorder of glycosylation; type Ih,Pediatric
ALG9,Cardiovascular,Congenital disorder of glycosylation; type Il,Pediatric
ALMS1,Cardiovascular,Alstrom syndrome,Pediatric
ALPK3,Cardiovascular,Cardiomyopathy; familial hypertrophic 27,Pediatric
AMER1,Cardiovascular,Osteopathia striata with cranial sclerosis,N/A
ANK2,Cardiovascular,Long QT syndrome; 4; Cardiac arrhythmia; ankyrin-B-related ,Pediatric
ANKLE2,Cardiovascular,Microcephaly; primary autosomal recessive; 16,N/A
ANKS6,Cardiovascular,Nephronophthisis 16,N/A
APOA1,Cardiovascular,Hypoalphalipoproteinemia; primary 2; Amyloidosis; systemic nonneuronopathic,Pediatric
APOA2,Cardiovascular,Apolipoprotein A-II deficiency,N/A
APOA5,Cardiovascular,Hyperlipoproteinemia; type V,Pediatric
APOB,Cardiovascular,Hypercholesterolemia; familial; 2; Hypobetalipoproteinemia; familial 1,Pediatric
APOC2,Cardiovascular,Apolipoprotein C-II deficiency (Hyperlipoproteinemia; type Ib),Pediatric
APOC3,Cardiovascular,Apolipoprotein C-III deficiency,N/A
APOE,Cardiovascular,Hyperlipoproteinemia; type III; Lipoprotein glomerulopathy; Sea-blue histiocyte disease,Pediatric
APP,Cardiovascular,Alzheimer disease; familial; Cerebral amyloid angiopathy,N/A
ARL2BP,Cardiovascular,Retinitis pigmentosa with or without situs inversus,N/A
ARL6,Cardiovascular,Retinitis pigmentosa 55; Bardet Biedl syndrome 3,N/A
ARMC4,Cardiovascular,Ciliary dyskinesia; primary; 23,Pediatric
ARSB,Cardiovascular,Mucopolysaccharidosis type VI (Maroteaux-Lamy),Pediatric
ASXL2,Cardiovascular,Shashi-Pena syndrome,N/A
ATN1,Cardiovascular,Congenital hypotonia; epilepsy; developmental delay; and digital anomalies; Dentatorubro-pallidoluysian atrophy,N/A
ATP5F1A,Cardiovascular,Combined oxidative phosphorylation deficiency 22; Mitochondrial complex V (ATP synthase) deficiency; nuclear type 4,N/A
ATP6V1A,Cardiovascular,Cutis laxa; autosomal recessive; type IID,Pediatric
ATP6V1E1,Cardiovascular,Cutis laxa; autosomal recessive; type IIC,Pediatric
ATP7A,Cardiovascular,Menkes disease,Pediatric
ATPAF2,Cardiovascular,Mitochondrial complex V (ATP synthase) deficiency; nuclear type 1,N/A
B2M,Cardiovascular,Immunodeficiency 43,Pediatric
B3GALNT2,Cardiovascular,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 11,N/A
B3GAT3,Cardiovascular,Multiple joint dislocations; short stature; craniofacial dysmorphism; and congenital heart defects,N/A
BAG3,Cardiovascular,Cardiomyopathy; dilated; 1HH; Myopathy; myofibrillar 6,Adult
BANF1,Cardiovascular,Nestor-Guillermo progeria syndrome,N/A
BBS1,Cardiovascular,Bardet-Biedl syndrome 1,N/A
BBS10,Cardiovascular,Bardet-Biedl syndrome 10,N/A
BBS12,Cardiovascular,Bardet-Biedl syndrome 12,N/A
BBS2,Cardiovascular,Bardet-Biedl syndrome 2; Retinitis pigmentosa 74,N/A
BBS4,Cardiovascular,Bardet-Biedl syndrome 4,N/A
BBS5,Cardiovascular,Bardet-Biedl syndrome 5,N/A
BBS7,Cardiovascular,Bardet-Biedl syndrome 7,N/A
BBS9,Cardiovascular,Bardet-Biedl syndrome 9,N/A
BCL11B,Cardiovascular,Immunodeficiency 49; Intellectual developmental disorder with speech delay; dysmorphic facies; and T-cell abnormalities,Pediatric
BCOR,Cardiovascular,Microphthalmia; syndromic 2; Oculofaciocardiodental syndrome,N/A
BGN,Cardiovascular,Meester-Loeys syndrome,Pediatric
BMP2,Cardiovascular,Short stature; facial dysmorphism; and skeletal anomalies with or without cardiac anomalies,Pediatric
BMPR2,Cardiovascular,Pulmonary hypertension; primary 1; Pulmonary venoocclusive disease 1,Pediatric
BOLA3,Cardiovascular,Multiple mitochondrial dysfunctions syndrome 2,N/A
BRAF,Cardiovascular,Noonan syndrome; Cardiofaciocutaneous syndrome 1; LEOPARD syndrome 3,Pediatric
BSCL2,Cardiovascular,Lipodystrophy; congenital generalized; type 2; Encephalopathy; progressive; with or without lipodystrophy,Pediatric
BVES,Cardiovascular,Muscular dystrophy; limb-girdle; autosomal recessive; 25,Pediatric
C1QBP,Cardiovascular,Combined oxidative phosphorylation deficiency 33,Pediatric
C1R,Cardiovascular,Ehlers-Danlos syndrome; periodontal type 1,Pediatric
C2CD3,Cardiovascular,Orofaciodigital syndrome XIV,N/A
CACNA1B,Cardiovascular,Dystonia 23,Pediatric
CACNA1C,Cardiovascular,Brugada syndrome 3; Timothy syndrome,Pediatric
CACNA1D,Cardiovascular,Primary aldosteronism; seizures; and neurologic abnormalities; Sinoatrial node dysfunction and deafness,Pediatric
CACNA1S,Cardiovascular,Malignant hyperthermia susceptibility 5; Thyrotoxic period paralysis; susceptibility 1; Hypokalemic periodic paralysis; type 1,Pediatric
CACNB2,Cardiovascular,Brugada syndrome 4,Pediatric
CALM1,Cardiovascular,Long QT syndrome 14; Recurrent cardiac arrest; infantile; Ventricular tachycardia; catecholaminergic polymorphic; 4,Pediatric
CALM2,Cardiovascular,Long QT syndrome 15,Pediatric
CALR3,Cardiovascular,Cardiomyopathy; familial hypertrophic; 19,Pediatric
CASQ2,Cardiovascular,Ventricular tachycardia; catecholaminergic; polymorphic; 2,Pediatric
CAV1,Cardiovascular,Pulmonary hypertension; primary 3; Lipodystrophy; familial partial; type 7; Lipodystrophy; congenital generalized; type 3,Pediatric
CAV3,Cardiovascular,Cardiomyopathy; familial hypertrophic; Long QT syndrome 9; Creatine phosphokinase; elevated serum,Pediatric
CAVIN1,Cardiovascular,Lipodystrophy; congenital generalized; type 4,N/A
CBL,Cardiovascular,Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia; Juvenile myelomonocytic leukemia; familial,Pediatric
CBS,Cardiovascular,Homocystinuria due to cystathionine beta-synthase deficiency,Pediatric
CCBE1,Cardiovascular,Hennekam lymphangiectasia-lymphedema syndrome,Pediatric
CCDC103,Cardiovascular,Ciliary dyskinesia; primary; 17,Pediatric
CCDC114,Cardiovascular,Ciliary dyskinesia; primary; 20,Pediatric
CCDC151,Cardiovascular,Ciliary dyskinesia; primary; 30,Pediatric
CCDC174,Cardiovascular,Hypotonia; infantile; with psychomotor retardation,N/A
CCDC22,Cardiovascular,Ritscher-Schinzel syndrome 2,N/A
CCDC39,Cardiovascular,Ciliary dyskinesia; primary; 14,Pediatric
CCDC40,Cardiovascular,Ciliary dyskinesia; primary; 15,Pediatric
CCM2,Cardiovascular,Cerebral cavernous malformations 2,Pediatric
CD96,Cardiovascular,C syndrome (Opitz trigonocephaly syndrome),N/A
CDAN1,Cardiovascular,Anemia; dyserythropoietic  congenital; type Ia,Pediatric
CDK13,Cardiovascular,Congenital heart defects; dysmorphic facial features; and intellectual developmental disorder,N/A
CELA2A,Cardiovascular,Abdominal obesity-metabolic syndrome 4,Pediatric
CEP290,Cardiovascular,Leber congenital amaurosis 10; Meckel syndrome 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14,N/A
CEP57,Cardiovascular,Mosaic variegated aneuploidy syndrome 2,Pediatric
CETP,Cardiovascular,Hyperalphalipoproteinemia 1,N/A
CFAP298,Cardiovascular,Ciliary dyskinesia; primary 26,Pediatric
CFAP53,Cardiovascular,Heterotaxy; visceral; 6; autosomal recessive,Pediatric
CFC1,Cardiovascular,Transposition of the great arteries; dextro-looped 2; Double-outlet right ventricle; Heterotaxy; visceral; 2; autosomal dominant,N/A
CHD4,Cardiovascular,Sifrim-Hitz-Weiss syndrome,Pediatric
CHD7,Cardiovascular,CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia,Pediatric
CHKB,Cardiovascular,Muscular dystrophy; congenital; megaconial type,Pediatric
CHST14,Cardiovascular,Ehlers-Danlos syndrome; musculocontractural type 1,Pediatric
CHST3,Cardiovascular,Spondyloepiphyseal dysplasia with congenital joint dislocations,N/A
CHUK,Cardiovascular,Cocoon syndrome,N/A
CIDEC,Cardiovascular,Lipodystrophy; familial partial; type 5,Pediatric
CITED2,Cardiovascular,Atrial septal defect 8; Ventricular septal defect 2,N/A
CLIC2,Cardiovascular,Mental retardation; X-linked; syndromic 32,Adult
CLPB,Cardiovascular,3-methylglutaconic aciduria with cataracts; neurologic involvement; and neutropenia (MEGCANN),Pediatric
CNBP,Cardiovascular,Myotonic dystrophy 2,Pediatric
COA5,Cardiovascular,Cardioencephalomyopathy; fatal infantile; due to cytochrome c oxidase deficiency 3,N/A
COA6,Cardiovascular,Cardioencephalomyopathy; fatal infantile; due to cytochrome c oxidase deficiency 4,N/A
COG1,Cardiovascular,Congenital disorder of glycosylation; type IIg,Pediatric
COG7,Cardiovascular,Congenital disorder of glycosylation; type IIe,Pediatric
COL1A1,Cardiovascular,Ehlers-Danlos syndrome; classic type; 1,Pediatric
COL1A2,Cardiovascular,Ehlers-Danlos syndrome; cardiac valvular form,Pediatric
COL3A1,Cardiovascular,Ehlers-Danlos syndrome; vascular type; Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome,Pediatric
COL4A1,Cardiovascular,Angiopathy; hereditary; with nephropathy; aneurysms; and muscle cramps; Brain small vessel disease 1 with or without ocular anomalies; Anterior segment dysgenesis with cerebral involvement; Porencephaly 1; Retinal artery tortuosity; Schizencephaly,Adult
COL4A2,Cardiovascular,Hemorrhage; intracerebral; susceptibility to,Adult
COL5A1,Cardiovascular,Ehlers-Danlos syndrome; classic type; 1,Pediatric
COL5A2,Cardiovascular,Ehlers-Danlos syndrome; classic type; 2,Pediatric
COQ4,Cardiovascular,Coenzyme Q10 deficiency 7,Pediatric
COQ7,Cardiovascular,Coenzyme Q10 deficiency; primary 8,Pediatric
COX10,Cardiovascular,Mitochondrial complex IV deficiency; Leigh syndrome,N/A
COX14,Cardiovascular,Mitochondrial complex IV deficiency,N/A
COX15,Cardiovascular,Leigh syndrome; Cardioencephalomyopathy; fatal infantile; due to cytochrome c oxidase deficiency 2,N/A
COX7B,Cardiovascular,Linear skin defects with multiple congenital anomalies 2,N/A
CPT1A,Cardiovascular,Carnitine palmitoyltransferase deficiency I,Pediatric
CPT2,Cardiovascular,Carnitine palmitoyltransferase II deficiency,Pediatric
CREBBP,Cardiovascular,Rubinstein-Taybi syndrome; Menke-Hennekam syndrome 1,Pediatric
CRELD1,Cardiovascular,Atrioventricular septal defect; partial; with or without heterotaxy,N/A
CRYAB,Cardiovascular,Myopathy; myofibrillar; 2; Cardiomyopathy; dilated; 1II ,Pediatric
CSRP3,Cardiovascular,Cardiomyopathy; familial hypertrophic 12; Cardiomyopathy; dilated; 1M,Pediatric
CST3,Cardiovascular,Cerebral amyloid angiopathy,N/A
CTC1,Cardiovascular,Cerebroretinal microangiopathy with calcifications and cysts 1,N/A
CTDP1,Cardiovascular,Congenital cataracts; facial dysmorphism; and neuropathy,Pediatric
CTNNA3,Cardiovascular,Arrhythmogenic right ventricular dysplasia; familial; 13,Pediatric
CTSA,Cardiovascular,Galactosialidosis,Pediatric
CTU2,Cardiovascular,Microcephaly; facial dysmorphism; renal agenesis; and ambiguous genitalia syndrome,N/A
CYP21A2,Cardiovascular,Adrenal hyperplasia; congenital; due to 21-hydroxylase deficiency; Hyperandrogenism; nonclassic type; due to 21-hydroxylase deficiency,Pediatric
CYP27A1,Cardiovascular,Cerebrotendinous xanthomatosis,Pediatric
CYTB,Cardiovascular,Myoglobinuria; recurrent; Leber hereditary optic neuropathy; Cardiomyopathy; infantile histiocytoid,N/A
D2HGDH,Cardiovascular,D-2-hydroxyglutaric aciduria 1,N/A
DCAF17,Cardiovascular,Woodhouse-Sakati syndrome,Pediatric
DCAF8,Cardiovascular,Giant axonal neuropathy 2; autosomal dominant,Adult
DCHS1,Cardiovascular,Mitral valve prolapse 2; Van Maldegrem syndrome 1,Pediatric
DDX11,Cardiovascular,Warsaw breakage syndrome,N/A
DDX58,Cardiovascular,Singleton-Merten syndrome 2,Pediatric
DDX59,Cardiovascular,Orofaciodigital syndrome V,N/A
DES,Cardiovascular,Myopathy; myofibrillar 1; Cardiomyopathy; dilated; 1I; Muscular dystrophy; limb-girdle; type 2R,Pediatric
DHCR7,Cardiovascular,Smith-Lemli-Opitz syndrome,Pediatric
DLL4,Cardiovascular,Adams-Oliver syndrome 6,N/A
DMD,Cardiovascular,Duchenne muscular dystrophy; Becker muscular dystrophy; Cardiomyopathy; dilated; 3B,Pediatric
DMPK,Cardiovascular,Myotonic dystrophy 1,Pediatric
DNAAF1,Cardiovascular,Ciliary dyskinesia; primary; 13,Pediatric
DNAAF2,Cardiovascular,Ciliary dyskinesia; primary; 10,Pediatric
DNAAF4,Cardiovascular,Ciliary dyskinesia; primary 25,Pediatric
DNAAF5,Cardiovascular,Ciliary dyskinesia; primary; 18,Pediatric
DNAH1,Cardiovascular,Ciliary dyskinesia; primary; 37,Pediatric
DNAH11,Cardiovascular,Ciliary dyskinesia; primary; 7,Pediatric
DNAH5,Cardiovascular,Ciliary dyskinesia; primary; 3,Pediatric
DNAH9,Cardiovascular,Ciliary dyskinesia; primary; 40,Pediatric
DNAI1,Cardiovascular,Ciliary dyskinesia; primary; 1,Pediatric
DNAI2,Cardiovascular,Ciliary dyskinesia; primary; 9,Pediatric
DNAJC19,Cardiovascular,3-methylglutaconic aciduria; type V,Pediatric
DNAL1,Cardiovascular,Ciliary dyskinesia; primary; 16,Pediatric
DNMT3A,Cardiovascular,Tatton-Brown-Rahman syndrome,N/A
DOCK6,Cardiovascular,Adams-Oliver syndrome 2,N/A
DOLK,Cardiovascular,Congenital disorder of glycosylation; type Im,Pediatric
DPF2,Cardiovascular,Coffin-Siris syndrome 7,N/A
DPH1,Cardiovascular,Developmental delay with short stature; dysmorphic features; and sparse hair,N/A
DPM3,Cardiovascular,Muscular dystrophy-dystroglycanopathy; type C; 15 (Congenital disorder of glycosylation; type Io),Pediatric
DPP6,Cardiovascular,Ventricular fibrillation; paroxysmal familial; 2,Pediatric
DSC2,Cardiovascular,Arrhythmogenic right ventricular dysplasia; familial; 11; Arrhythmogenic right ventricular dysplasia with  palmoplantar keratoderma and woolly hair,Pediatric (Arrhythmogenic right ventricular dysplasia with  palmoplantar keratoderma and woolly hair); Adult (Arrhythmogenic right ventricular dysplasia; familial; 11)
DSE,Cardiovascular,Ehlers-Danlos syndrome; musculocontractural type 2,Pediatric
DSG1,Cardiovascular,Severe dermatitis; multiple allergies; and metabolic wasting syndrome (SAM syndrome),Pediatric
DSG2,Cardiovascular,Cardiomyopathy; dilated; 1BB; Arrhythmogenic right ventricular dysplasia; familial; 10,Pediatric
DSP,Cardiovascular,Arrhythmogenic right ventricular dysplasia; familial 8; Cardiomyopathy; dilated; with wooly hair and keratoderma; Cardiomyopathy; dilated; with wooly hair; keratoderma; and tooth agenesis,Pediatric
DTNA,Cardiovascular,Left ventricular noncompaction 1,Pediatric
DYRK1B,Cardiovascular,Abdominal obesity-metabolic syndrome 3,Adult
DYSF,Cardiovascular,Miyoshi muscular dystrophy 1; Muscular dystrophy; limb-girdle; autosomal recessive; 2; Myopathy; distal; with anterior tibial onset,Pediatric
ECE1,Cardiovascular,Hirschsprung disease; cardiac defects; and autonomic dysfunction,N/A
EFEMP2,Cardiovascular,Cutis laxa; autosomal recessive type IB,Pediatric
EFTUD2,Cardiovascular,Mandibulofacial dysostosis; Guion-Almeida type; Esophageal atresia; syndromic,Pediatric
EGFR,Cardiovascular,Acute myeloid leukemia; familial; Lung cancer; familial; susceptibilty to; Inflammatory skin and bowel disease; neonatal; 2,Pediatric
EHMT1,Cardiovascular,Kleefstra syndrome 1,N/A
EIF2AK3,Cardiovascular,Epiphyseal dysplasia; multiple; with early-onset diabetes mellitus (Wolcott-Rallison syndrome),Pediatric
EIF2AK4,Cardiovascular,Pulmonary venoocclusive disease 2,Pediatric
ELAC2,Cardiovascular,Combined oxidative phosphorylation deficiency 17,Pediatric
ELMO2,Cardiovascular,Vascular malformation; primary intraosseus,Pediatric
ELN,Cardiovascular,Cutis laxa; autosomal dominant 1; Supravalvular aortic stenosis,Pediatric
EMD,Cardiovascular,Emery-Dreifuss muscular dystrophy 1; X-linked,Pediatric
ENG,Cardiovascular,Hereditary hemorrhagic telangiectasia; type 1; Juvenile polyposis syndrome,Pediatric
ENPP1,Cardiovascular,Hypophosphatemic rickets; autosomal recessive 2; Arterial calcification; generalized; of infancy; 1,Pediatric
EOGT,Cardiovascular,Adams-Oliver syndrome 4,N/A
EPG5,Cardiovascular,Vici syndrome,Pediatric
EPHB4,Cardiovascular,Capillary malformation-arteriovenous malformation 2,Pediatric
ERBB3,Cardiovascular,Erythroleukemia; familial; susceptibility to (AD),N/A
ERCC4,Cardiovascular,Fanconi anemia; complementation group Q; Xeroderma pigmentosum; group F,Pediatric
ESCO2,Cardiovascular,SC phocomelia syndrome; Roberts syndrome,N/A
ETHE1,Cardiovascular,Ethylmalonic encephalopathy,Pediatric
EVC,Cardiovascular,Ellis-van Creveld syndrome; Weyers acrofacial dysostosis,N/A
EVC2,Cardiovascular,Ellis-van Creveld syndrome; Weyers acrodental dysostosis,N/A
EYA4,Cardiovascular,Cardiomyopathy; dilated; 1J,Adult
FADD,Cardiovascular,Infections; recurrent; with encephalopathy; hepatic dysfunction; and cardiovascular malformations,Pediatric
FARSB,Cardiovascular,Rajab interstitial lung disease with brain calcifications,Pediatric
FBLN5,Cardiovascular,Neuropathy; hereditary; with or witout age-related macular degeneration; Macular degeneration; age-related; 3; Cutis laxa; autosomal dominant 2; Cutis laxa; autosomal recessive; type IA,N/A
FBN1,Cardiovascular,Marfan syndrome; MASS syndrome; Shprintzen-Goldberg syndrome; Marfanoid-progeroid-lipodystrophy syndrome; Ectopia lentis 1; isolated; autosomal dominant,Pediatric
FBN2,Cardiovascular,Congenital contractural arachnodactyly (Beals syndrome),Pediatric
FDFT1,Cardiovascular,Squalene synthase deficiency,N/A
FGA,Cardiovascular,Afibrinogenemia; congenital; Dysfibrinogenemia; congenital; Hypodysfibrinogenemia; congenital; Familial visceral amyloidosis,Pediatric
FHL1,Cardiovascular,Reducing bod myopathy; X-linked 1A; with infantile or early childhood onset; Reducing bod myopathy; X-linked 1B; with late childhood or adult onset; Emery-Dreifuss muscular dystrophy 6; X-linked; Myopathy; X-linked; with postural muscle atrophy; Uruguay faciocardiomusculoskeletal syndrome,Pediatric
FIBP,Cardiovascular,Thauvin-Robinet-Faivre syndrome,Pediatric
FKBP14,Cardiovascular,Ehlers-Danlos syndrome; kyphoscoliotic type; 2,Pediatric
FKRP,Cardiovascular,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 5; Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation); type B; 5; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 5,Pediatric
FKTN,Cardiovascular,Cardiomyopathy; dilated; 1X; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 4; Muscular dystrophy-dystroglycanopathy (congenital without mental retardation); type B; 4; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 4,Pediatric
FLAD1,Cardiovascular,Lipid storage myopathy due to FLAD1 deficiency (LSMFLAD),Pediatric
FLNA,Cardiovascular,Cardiac valvular dysplasia; X-linked; Heterotopia; periventricular; Ehlers-Danlos variant;  Intestinal pseudoobstruction; neuronal; X-linked/Congenital short bowel syndrome,Pediatric
FLNC,Cardiovascular,Cardiomyopathy; familial hypertrophic 26; Cardiomyopthy; familial restrictive 5; Myopathy; distal; 4; Myopathy; myofibrillar; 5,Adult
FLT4,Cardiovascular,Lymphatic malformation 1,Pediatric
FLVCR2,Cardiovascular,Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome,N/A
FOXC1,Cardiovascular,Peters anomaly; Axenfeld-Rieger syndrome; type 3; Anterior segment dysgenesis 3,Adult
FOXC2,Cardiovascular,Lymphedema-distichiasis syndrome,N/A
FOXE3,Cardiovascular,Aortic aneurysm; familial thoracic 11; susceptibility to; Anterior segment dysgenesis 2,Pediatric
FOXF1,Cardiovascular,Alveolar capillary dysplasia with misalignment of pulmonary veins,N/A
FOXH1,Cardiovascular,Holoprosencephaly; Congenital heart malformations,N/A
FOXRED1,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 19; Leigh syndrome,N/A
FSHMD1A,Cardiovascular,Facioscapulohumeral muscular dystrophy 1A,Pediatric
FTO,Cardiovascular,Growth retardation; developmental delay; and facial dysmorphism,N/A
FXN,Cardiovascular,Friedreich ataxia 1,Pediatric
G6PC,Cardiovascular,Glycogen storage disease Ia,Pediatric
G6PC3,Cardiovascular,Neutropenia; severe congenital; 4; autosomal recessive; Dursun syndrome,Pediatric
GAA,Cardiovascular,Glycogen storage disease II,Pediatric
GANAB,Cardiovascular,Polycystic kidney disease 3 with or without polycystic liver disease,Pediatric
GATA4,Cardiovascular,Atrioventricular septal defect 4; Ventricular septal defect 1; Atrial septal defect 2; Testicular anomalies with or without congenital heart disease; Tetralogy of Fallot,Pediatric
GATA5,Cardiovascular,Congenital heart defects; multiple types; 5,Pediatric
GATA6,Cardiovascular,Heart defects; congenital; and other congenital anomalies,Pediatric
GATAD1,Cardiovascular,Cardiomyopathy; dilated; 2B,Adult
GBA,Cardiovascular,Gaucher disease,Pediatric
GBE1,Cardiovascular,Glycogen storage disease IV,Pediatric
GCDH,Cardiovascular,Glutaric aciduria; type I,Pediatric
GDF1,Cardiovascular,Congenital heart defects; multiple types; 6,N/A
GDF2,Cardiovascular,Hereditary hemorrhagic telangiectasia; type 5,Pediatric
GFM1,Cardiovascular,Combined oxidative phosphorylation deficiency 1,N/A
GGCX,Cardiovascular,Vitamin K-dependent clotting factors; combined deficiency of; 1; Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency,Pediatric
GJA1,Cardiovascular,Oculodentodigital dysplasia,Pediatric
GJA5,Cardiovascular,Atrial fibrillation; familial 11; Progressive familial heart block; type I; Atrial standstill; digenic,Adult
GJC2,Cardiovascular,Lymphedema malformation 3; Spastic paraplegia 44; autosomal recessive; Leukodystrophy; hypomyelinating; 2,N/A
GLA,Cardiovascular,Fabry disease; Fabry disease; cardiac variant ,Pediatric
GLB1,Cardiovascular,Mucopolysaccharidosis type IVB (Morquio syndrome B); GM1-gangliosidosis; type I; GM1-gangliosidosis; type II; GM1-gangliosidosis; type III,N/A
GLMN,Cardiovascular,Glomuvenous malformations,N/A
GMPPB,Cardiovascular,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 14; Limb-girdle muscular dystrophy-dystroglycanopathy; type B; 14; Limb-girdle muscular dystrophy-dystroglycanopathy; type C; 14,Pediatric
GNB5,Cardiovascular,Intellectual developmental disorder with cardiac arrhythmia (IDDCA); Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia (LADCI),Pediatric
GNPTAB,Cardiovascular,Mucolipidosis III alpha/beta (Pseudo-Hurler polydstrophy); Mucolipidosis II alpha/beta (I-cell disease),N/A
GNPTG,Cardiovascular,Mucolipidosis III gamma,N/A
GPC3,Cardiovascular,Simpson-Golabi-Behmel syndrome; type 1,Pediatric
GPC6,Cardiovascular,Omodysplasia 1,N/A
GPD1L,Cardiovascular,Brugada syndrome 2,Pediatric
GPIHBP1,Cardiovascular,Hyperlipoproteinemia; type ID,Pediatric
GPX4,Cardiovascular,Sedaghatian-type spondylometaphyseal dysplasia,N/A
GSN,Cardiovascular,Amyloidosis; Finnish type,Adult
GTPBP3,Cardiovascular,Combined oxidative phosphorylation deficiency 23,Pediatric
GUCY1A1,Cardiovascular,Moyamoya disease 6 with or without achalasia,Pediatric
GUSB,Cardiovascular,Mucopolysaccharidosis type VII,N/A
GYG1,Cardiovascular,Glycogen storage disease XV,Pediatric
GYS1,Cardiovascular,Glycogen storage disease; type 0; muscle,Pediatric
HAAO,Cardiovascular,Vertebral; cardiac; renal; and limb defects syndrome 1,N/A
HADHA,Cardiovascular,Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency; Trifunctional protein deficiency,Pediatric
HADHB,Cardiovascular,Trifunctional protein deficiency,Pediatric
HAMP,Cardiovascular,Hemochromatosis; type 2B,Pediatric
HBB,Cardiovascular,Beta-thalassemia; Heinz body anemias; Erythrocytosis; familial 6; Sickle cell disease; Thalassemia-beta; dominant inclusion body; Other Thalassemias/Hemoglobinopathies,Pediatric
HCCS,Cardiovascular,Linear skin defects with multiple congenital anomalies 1 (MIDAS syndrome),Pediatric
HCN4,Cardiovascular,Brugada syndrome 8; Sick sinus syndrome 2,Pediatric
HFE,Cardiovascular,Hemochromatosis,Pediatric
HGD,Cardiovascular,Alkaptonuria,Pediatric
HIKESHI,Cardiovascular,Leukodystrophy; hypomyelinating; 13,N/A
HJV,Cardiovascular,Hemochromatosis; type 2A,Pediatric
HNRNPK,Cardiovascular,Au-Kline syndrome,N/A
HOXA1,Cardiovascular,Athabaskan brainstem dysgenesis syndrome; Bosley-Salih-Alorainy syndrome,Pediatric
HRAS,Cardiovascular,Costello syndrome; Congenital myopathy with excess of muscle spindles,Pediatric
HSPA9,Cardiovascular,Anemia; sideroblastic 4,Pediatric
HTRA1,Cardiovascular,Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy type 2 (CADASIL2); Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL),N/A
HYDIN,Cardiovascular,Ciliary dyskinesia; primary; 5,Pediatric
HYLS1,Cardiovascular,Hydrolethalus syndrome,N/A
IDH2,Cardiovascular,D-2-hydroxyglutaric aciduria 2,N/A
IDS,Cardiovascular,Mucopolysaccharidosis type II,Pediatric
IDUA,Cardiovascular,Mucopolysaccharidosis type I,Pediatric
IFIH1,Cardiovascular,Aicardi-Goutieres syndrome 7; Singleton-Merten syndrome 1,Pediatric
IGFBP7,Cardiovascular,Retinal arterial macroaneurysm with supravalvular pulmonic stenosis,N/A
INPPL1,Cardiovascular,Opsismodysplasia,Pediatric
INSR,Cardiovascular,Hyperinsulinemic hypoglycemia; familial; 5; Rabson-Mendenhall syndrome; Donohoe syndrome,Pediatric
INTU,Cardiovascular,Orofaciodigital syndrome XVII; Short-rib throacic dysplasia 20 with polydactyly,N/A
INVS,Cardiovascular,Nephronophthisis 2,N/A
ISCU,Cardiovascular,Myopathy with lactic acidosis; hereditary,Pediatric
IVD,Cardiovascular,Isovaleric acidemia,Pediatric
JAG1,Cardiovascular,Alagille syndrome; Deafness; congenital heart defects; and posterior embryotoxon,Pediatric
JAM3,Cardiovascular,Hemorrhagic destruction of the brain; subependymal calcification; and cataracts,N/A
JPH2,Cardiovascular,Cardiomyopathy; familial hypertrophic 17,Pediatric
JUP,Cardiovascular,Arrhythmogenic right ventricular dysplasia; familial; 12; Naxos disease,Adult
KANSL1,Cardiovascular,Koolen-de Vries syndrome,N/A
KAT6A,Cardiovascular,Mental retardation; autosomal dominant 32,N/A
KCNA5,Cardiovascular,Atrial fibrillation; familial; 7,Adult
KCND3,Cardiovascular,Brugada syndrome 9,Pediatric
KCNE1,Cardiovascular,Long QT syndrome 5; Jervell and Lange-Nielsen syndrome 2,Pediatric
KCNE2,Cardiovascular,Long QT syndrome 6; Atrial fibrillation; familial 4,Pediatric
KCNE3,Cardiovascular,Brugada syndrome 6,Pediatric
KCNH2,Cardiovascular,Long QT syndrome 2; Short QT syndrome 1,Pediatric
KCNJ2,Cardiovascular,Atrial fibrillation; familial 9; Short QT syndrome 3; Andersen syndrome; Long QT syndrome 7,Pediatric
KCNJ5,Cardiovascular,Long QT syndrome 13; Hyperaldosteronism; familial; type III,Pediatric
KCNK3,Cardiovascular,Pulmonary hypertension; primary; 4,Pediatric
KCNQ1,Cardiovascular,Long QT syndrome 1; Jervell and Lange-Nielsen syndrome 1; Short QT syndrome 2; Atrial fibrillation; familial 3,Pediatric
KDM6A,Cardiovascular,Kabuki syndrome 2,N/A
KIF11,Cardiovascular,Microcephaly with or without chorioretinopathy; lymphedema; or mental retardation,N/A
KMT2D,Cardiovascular,Kabuki syndrome 1,Pediatric
KMT2E,Cardiovascular,O'Donnell-Luria-Rodan syndrome,N/A
KRAS,Cardiovascular,Noonan syndrome; Cardiofaciocutaneous syndrome,Pediatric
KRIT1,Cardiovascular,Cerebral cavernous malformations 1,Pediatric
KYNU,Cardiovascular,Hydroxykynureninuria; Vertebral; cardiac; renal; and limb defects syndrome 2,N/A
LAMA4,Cardiovascular,Cardiomyopathy; dilated; 1JJ,Pediatric
LAMP2,Cardiovascular,Danon disease,Pediatric
LCAT,Cardiovascular,Lecithin:cholesterol acyltransferase deficiency (Norum disease); Fish-eye disease,Pediatric
LDB3,Cardiovascular,Cardiomyopathy; dilated 1C; with or without ventricular noncompaction; Myopathy; myofibrillar 4,Pediatric
LDLR,Cardiovascular,Hypercholesterolemia; familial,Pediatric
LDLRAP1,Cardiovascular,Hypercholesterolemia; familial; 4,Pediatric
LEFTY2,Cardiovascular,Left-right axis malformations,N/A
LIMS2,Cardiovascular,Muscular dystrophy; autosomal recessive; with cardiomyopathy and triangular tongue,Adult
LIPA,Cardiovascular,Cholesterol ester storage disease; Wolman disease,Pediatric
LIPC,Cardiovascular,Hepatic lipase deficiency,Pediatric
LIPE,Cardiovascular,Lipodystrophy; familial partial; type 6,Pediatric
LIPI,Cardiovascular,Hypertriglyceridemia; familial,Pediatric
LMBR1,Cardiovascular,Acheiropody; Syndactyly; type IV; Laurin-Sandrow syndrome; Triphalangeal thumb; type I; Polydactyly; preaxial type II; Triphalangeal thumb-polysyndactyly syndrome; Tibial aplasia/hypoplasia; Hypoplastic or aplastic tibia with polydactyly,N/A
LMBRD1,Cardiovascular,Methylmalonic aciduria and homocystinuria; cblF type,Pediatric
LMF1,Cardiovascular,Combined lipase deficiency,Pediatric
LMNA,Cardiovascular,Cardiomyopathy; dilated; 1A; Heart-hand syndrome; Slovenian type; Emery-Dreiffus muscular dystrophy 2; autosomal dominant; Emery-Dreiffus muscular dystrophy 3; autosomal recessive; Muscular dystrophy; congenital; LMNA-related; Muscular dystrophy; limb-girdle; type 1B; Cardiomyopathy; dilated; with hypergonadotropic hypogonadism (Malouf syndrome); Lipodystrophy; familial partial; 2 (Dunnigan type),Pediatric
LOX,Cardiovascular,Aortic aneurysm; familial thoracic 10,Pediatric
LPL,Cardiovascular,Hyperlipidemia; familial combined; 3; Lipoprotein lipase deficiency,Pediatric
LRBA,Cardiovascular,Common variable immunodeficiency 8; with autoimmunity,Pediatric
LRP6,Cardiovascular,Coronary artery disease; autosomal dominant 2,Pediatric
LRRC56,Cardiovascular,Ciliary dyskinesia; primary 39,Pediatric
LRRC6,Cardiovascular,Ciliary dyskinesia; primary 19,Pediatric
LTBP2,Cardiovascular,Glaucoma 3; primary congenital; D; Microspherophakia and/or megalocornea; with ectopia lentis and with or without secondary glaucoma; Weill-Marchesani syndrome 3,Pediatric
LTBP4,Cardiovascular,Cutis laxa with severe pulmonary; gastrointestinal; and urinary abnormalities,N/A
LZTFL1,Cardiovascular,Bardet-Biedl syndrome 17,N/A
LZTR1,Cardiovascular,Schwannomatosis 2; Noonan syndrome 10; Noonan syndrome 2,Pediatric (Noonan syndrome 10; Noonan syndrome 2); Adult (Schwannomatosis 2)
MAP2K1,Cardiovascular,Cardiofaciocutaneous syndrome 3,Pediatric
MAP2K2,Cardiovascular,Cardiofaciocutaneous syndrome 4,Pediatric
MAP3K7,Cardiovascular,Cardiospondylocarpofacial syndrome,Pediatric
MED13L,Cardiovascular,Transposition of the great arteries; dextro-looped 1; Mental retardation and distinctive facial features with or without cardiac defects; Congenital heart defects and intellectual disability; Intellectual disability; autosomal recessive,N/A
MED25,Cardiovascular,Basel-Vanagait-Smirin-Yosef syndrome; Charcot-Marie-Tooth disease; axonal; tybe 2B2,N/A
MEGF8,Cardiovascular,Carpenter syndrome 2,N/A
MEIS2,Cardiovascular,Cleft palate; cardiac defects; and mental retardation (CPCMR),N/A
MFAP5,Cardiovascular,Aortic aneurysm; familial thoracic 9,Pediatric
MGME1,Cardiovascular,Mitochondrial DNA depletion syndrome 11,Pediatric
MGP,Cardiovascular,Keutel syndrome,N/A
MIB1,Cardiovascular,Left ventricular noncompaction 7,Pediatric
MICOS13,Cardiovascular,Combined oxidative phosphorylation deficiency 37,N/A
MID1,Cardiovascular,Opitz GBBB syndrome; type I,N/A
MIPEP,Cardiovascular,Combined oxidative phosphorylation deficiency 31,Pediatric
MKKS,Cardiovascular,McKusick-Kaufman syndrome; Bardet-Biedl syndrome 6,N/A
MKS1,Cardiovascular,Joubert syndrome 28; Meckel syndrome 1; Bardet-Biedl syndrome 13,N/A
MLYCD,Cardiovascular,Malonyl-CoA decarboxylase deficiency,Pediatric
MMACHC,Cardiovascular,Methylmalonic aciduria and homocystinuria; cblC type,Pediatric
MMP21,Cardiovascular,Heterotaxy; visceral; 7,N/A
MMUT,Cardiovascular,Methylmalonic acidemia due to methylmalonyl-CoA mutase deficiency,Pediatric
MRAS,Cardiovascular,Noonan syndrome 11,Pediatric
MRPL3,Cardiovascular,Combined oxidative phosphorylation deficiency 9,N/A
MRPL44,Cardiovascular,Combined oxidative phosphorylation deficiency 16,Pediatric
MRPS14,Cardiovascular,Combined oxidative phosphorylation deficiency 38,Pediatric
MRPS22,Cardiovascular,Combined oxidative phosphorylation deficiency 5; Ovarian dysgenesis 7,N/A
MT-ATP6,Cardiovascular,Myopathy; lactic acidosis; and sideroblastic anemia 3,N/A
MT-ATP8,Cardiovascular,Brain pseudoatrophy; reversible; valproate-induced; susceptibility to,Pediatric
MT-RNR1,Cardiovascular,Deafness; mitochondrial,Pediatric
MT-TC,Cardiovascular,Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes,N/A
MT-TL1,Cardiovascular,Brain pseudoatrophy; reversible; valproate-induced; susceptibility to,Pediatric
MTFMT,Cardiovascular,Combined oxidative phosphorylation deficiency 15,Pediatric
MTHFR,Cardiovascular,Homocystinuria due to MTHFR deficiency,Pediatric
MTO1,Cardiovascular,Combined oxidative phosphorylation deficiency 10,Pediatric
MTR,Cardiovascular,Homocystinuria-megaloblastic anemia; cblG complementation type,Pediatric
MYBPC3,Cardiovascular,Cardiomyopathy; familial hypertrophic; 4; Cardiomyopathy; dilated; 1MM; Left ventricular noncompaction 10,Pediatric
MYCN,Cardiovascular,Feingold syndrome 1,N/A
MYH11,Cardiovascular,Aortic aneurysm; familial thoracic 4,Pediatric
MYH6,Cardiovascular,Cardiomyopathy; dilated; 1EE; Cardiomyopathy; familial hypertrophic 14,Pediatric
MYH7,Cardiovascular,Cardiomyopathy; dilated; 1S; Cardiomyopathy; familial hypertrophic 1; Myopathy; distal; Myopathy; myosin storage; autosomal recessive,Pediatric
MYL2,Cardiovascular,Cardiomyopathy; familial hypertrophic; 10,Pediatric
MYL3,Cardiovascular,Cardiomyopathy; familial hypertrophic; 8,Pediatric
MYL4,Cardiovascular,Atrial fibrillation; familial; 18,Pediatric
MYLK,Cardiovascular,Aortic aneurysm; familial thoracic 7,Pediatric
MYLK2,Cardiovascular,Cardiomyopathy; hypertrophic,Pediatric
MYOT,Cardiovascular,Myopathy; myofibrillar; 3,Pediatric
MYOZ2,Cardiovascular,Cardiomyopathy; familial hypertrophic; 16,Pediatric
MYPN,Cardiovascular,Cardiomyopathy; dilated; 1KK; Cardiomyopathy; familial hypertrophic; 22; Cardiomyopathy; familial restrictive; 4,Pediatric
MYRF,Cardiovascular,Encephalitis/encephalopathy; mild; with reversible myelin vacuolization,Pediatric
NAA10,Cardiovascular,N-terminal acetyltransferase deficiency (Ogden syndrome),Pediatric
NCAPG2,Cardiovascular,Kahn-Kahn-Katsanis syndrome,N/A
NDUFA1,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 12,N/A
NDUFA10,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 22; Leigh syndrome,N/A
NDUFA11,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 14,N/A
NDUFA12,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 23; Leigh syndrome,N/A
NDUFA2,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 13; Leigh syndrome,N/A
NDUFA9,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 26; Leigh syndrome,N/A
NDUFAF1,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 11,N/A
NDUFAF2,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 10; Leigh syndrome,N/A
NDUFAF3,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 18,N/A
NDUFAF4,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 15,N/A
NDUFAF5,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 16,N/A
NDUFAF6,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 17; Leigh syndrome,N/A
NDUFB11,Cardiovascular,Linear skin defects with multiple congenital anomalies 3,Pediatric
NDUFB3,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 25,N/A
NDUFB8,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 32,N/A
NDUFS1,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 5,N/A
NDUFS2,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 6,N/A
NDUFS3,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 8; Leigh syndrome,N/A
NDUFS4,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 1; Leigh syndrome,N/A
NDUFS6,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 9,N/A
NDUFS7,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 3; Leigh syndrome,N/A
NDUFS8,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 2; Leigh syndrome,N/A
NDUFV1,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 4,N/A
NDUFV2,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 7,N/A
NEK1,Cardiovascular,Short-rib thoracic dysplasia 6 with or without polydactyly,N/A
NEK8,Cardiovascular,Nephronophthisis 9; Renal-hepatic-pancreatic dysplasia 2,N/A
NEXN,Cardiovascular,Cardiomyopathy; familial hypertrophic; 20; Cardiomyopathy; dilated; 1CC,Pediatric
NF1,Cardiovascular,Neurofibromatosis type 1; Neurofibromatosis-Noonan syndrome; Watson syndrome,Pediatric
NFE2L2,Cardiovascular,Immunodeficiency; developmental delay; and hypohomocysteinemia (IMDDHH),Pediatric
NFU1,Cardiovascular,Multiple mitochondrial dysfunctions syndrome 1,N/A
NHLRC2,Cardiovascular,Fibrosis; neurodegeneration; and cerebral angiomatosis,N/A
NIPBL,Cardiovascular,Cornelia de Lange syndrome 1,N/A
NKX2-5,Cardiovascular,Atrial septal defect 7; with or without AV conduction defects; Conotruncal heart malformations; Hypothyroidism; congenital nongoitrous; 5,Pediatric
NKX2-6,Cardiovascular,Persistent truncus arteriosus; Conotruncal heart malformations,N/A
NME8,Cardiovascular,Ciliary dyskinesia; primary; 6,Pediatric
NNT,Cardiovascular,Glucocorticoid deficiency 4; with or without mineralocorticoid deficiency,Pediatric
NODAL,Cardiovascular,Heterotaxy; visceral; 5,N/A
NOTCH1,Cardiovascular,Aortic valve disease 1,Pediatric
NOTCH2,Cardiovascular,Alagille syndrome 2,Pediatric
NOTCH3,Cardiovascular,Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1 (CADASIL1); Myofibromatosis; infantile 2,Pediatric
NPPA,Cardiovascular,Atrial fibrillation; familial; 6; Atrial standstill 2,Adult
NR2F2,Cardiovascular,Congenital heart defects; multiple types; 4,N/A
NRAS,Cardiovascular,Autoimmune lymphoproliferative syndrome type IV; Noonan syndrome 6,Pediatric
NSD1,Cardiovascular,Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome,Pediatric
NSDHL,Cardiovascular,Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD syndrome); CK syndrome,N/A
NSMCE2,Cardiovascular,Seckel syndrome 10,Pediatric
NT5E,Cardiovascular,Calcification of joints and arteries,N/A
NUP155,Cardiovascular,Atrial fibrillation 15,Pediatric
NXF5,Cardiovascular,Familial heart block and focal segmental glomerulosclerosis,Pediatric
NXN,Cardiovascular,Robinow syndrome; autosomal recessive 2,N/A
OPA1,Cardiovascular,Glaucoma; normal tension; susceptibility to,Adult
PACS2,Cardiovascular,Epileptic encephalopathy; early infantile; 66,N/A
PALB2,Cardiovascular,Breast cancer; Pancreatic cancer; susceptibility to 3; Fanconi anemia; complementation group N,Pediatric (Fanconi anemia; complementation group N); Adult (Breast cancer; Pancreatic cancer; susceptibility to 3)
PAM16,Cardiovascular,Spondylometaphyseal dysplasia; Megarbane-Dagher-Melki type,N/A
PARS2,Cardiovascular,Epileptic encephalopathy; early infantile; 75,N/A
PCCA,Cardiovascular,Propionic acidemia,Pediatric
PCCB,Cardiovascular,Propionic acidemia,Pediatric
PCGF2,Cardiovascular,Turnpenny-Fry syndrome,N/A
PCSK9,Cardiovascular,Hypercholesterolemia; familial; 3,Pediatric
PDCD10,Cardiovascular,Cerebral cavernous malformations 3,Pediatric
PDE3A,Cardiovascular,Hypertension with brachydactyly,Pediatric
PDE4D,Cardiovascular,Acrodysostosis 2; with or without hormone resistance,Pediatric
PDSS1,Cardiovascular,Coenzyme Q10 deficiency 2,Pediatric
PEX7,Cardiovascular,Refsum disease,Pediatric
PFKM,Cardiovascular,Glycogen storage disease VII,Pediatric
PGM1,Cardiovascular,Congenital disorder of glycosylation; type It,Pediatric
PHEX,Cardiovascular,Hypophosphatemic rickets; X-linked dominant,Pediatric
PHYH,Cardiovascular,Refsum disease,Pediatric
PIGA,Cardiovascular,Multiple congenital anomalies-hypotonia-seizures syndrome 2,N/A
PIGL,Cardiovascular,CHIME syndrome,N/A
PIGN,Cardiovascular,Multiple congenital anomalies-hypotonia-seizures syndrome 1,N/A
PIGO,Cardiovascular,Hyperphosphatasia with mental retardation syndrome 2,N/A
PKD1,Cardiovascular,Polycystic kidney disease 1 with or without polycystic liver disease,Pediatric
PKD1L1,Cardiovascular,Heterotaxy; visceral; 8; autosomal,N/A
PKD2,Cardiovascular,Polycystic kidney disease 2 with or without polycystic liver disease,Pediatric
PKP2,Cardiovascular,Arrhythmogenic right ventricular dysplasia; familial 9,Pediatric
PLD1,Cardiovascular,Cardiac valvular defect; developmental,Pediatric
PLIN1,Cardiovascular,Lipodystrophy; familial partial; type 4,Pediatric
PLN,Cardiovascular,Cardiomyopathy; dilated; 1P; Cardiomyopathy; familial hypertrophic; 18,Pediatric
PLOD1,Cardiovascular,Ehlers-Danlos syndrome; kyphoscoliotic type; 1,Pediatric
PLOD3,Cardiovascular,Bone fragility with contractures; arterial rupture; and deafness,Pediatric
PMM2,Cardiovascular,Congenital disorder of glycosylation; type Ia,Pediatric
PNPLA2,Cardiovascular,Neutral lipid storage disease with myopathy,N/A
POMT1,Cardiovascular,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 1; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation); type B; 1; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 1 ,Pediatric
POMT2,Cardiovascular,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 2 ; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation); type B; 2; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C 2,Pediatric
POU1F1,Cardiovascular,Pituitary hormone deficiency; combined 1,Pediatric
PPA2,Cardiovascular,Sudden cardiac failure; alcohol induced,Pediatric
PPCS,Cardiovascular,Cardiomyopathy; dilated; 2C,Pediatric
PPP1CB,Cardiovascular,Noonan syndrome-like disorder with loose anagen hair 2,Pediatric
PQBP1,Cardiovascular,Renpenning syndrome 1,N/A
PRDM16,Cardiovascular,Cardiomyopathy; dilated; ILL; Left ventricular noncompaction 8,Pediatric
PRDM5,Cardiovascular,Brittle cornea syndrome 2,Pediatric
PRDM6,Cardiovascular,Patent ductus arteriosus 3,N/A
PRDX1,Cardiovascular,Methylmalonic aciduria and homocystinuria; cblC type; digenic,Pediatric
PRG4,Cardiovascular,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,Pediatric
PRKAG2,Cardiovascular,Cardiomyopathy; familial hypertrophic 6; Wolff-Parkinson-White syndrome,Pediatric
PRKAR1A,Cardiovascular,Pigmented nodular adrenocortical disease; primary; 1; Carney complex; type 1; Myxoma; intracardiac; Acrodysostosis 1; with or without hormone resistance,Pediatric
PRKD1,Cardiovascular,Congenital heart defects and ectodermal dysplasia,N/A
PRKG1,Cardiovascular,Aortic aneurysm; familial thoracic 8,Pediatric
PSEN1,Cardiovascular,Cardiomyopathy; dilated 1U,Pediatric
PSEN2,Cardiovascular,Cardiomyopathy; dilated; 1V; Peripartum/pregnancy-associated cardiomyopathy ,Pediatric
PSMA3,Cardiovascular,Proteasome-associated autoinflammatory syndrome 2,Pediatric
PSMB8,Cardiovascular,Proteasome-associated autoinflammatory syndrome 1,Pediatric
PSMD12,Cardiovascular,Stankiewicz-Isidor syndrome,N/A
PTPN11,Cardiovascular,Noonan syndrome 1; LEOPARD syndrome 1,Pediatric
PTPN14,Cardiovascular,Choanal atresia and lymphedema,N/A
PUF60,Cardiovascular,Verheij syndrome,N/A
RAB23,Cardiovascular,Carpenter syndrome 1,N/A
RAB3GAP2,Cardiovascular,Warburg micro syndrome 2; Martsolf syndrome ,Pediatric
RAD21,Cardiovascular,Cornelia de Lange syndrome 4; Mungan syndrome,N/A
RAD51C,Cardiovascular,Breast-ovarian cancer; familial; susceptibility to; Fanconi anemia goup O,Pediatric (Fanconi anemia goup O); Adult (Breast-ovarian cancer; familial; susceptibility to)
RAF1,Cardiovascular,Cardiomyopathy; dilated; 1NN; LEOPARD syndrome 2; Noonan syndrome 5,Pediatric
RARB,Cardiovascular,Microphthalmia; syndromic 12,N/A
RASA1,Cardiovascular,Capillary malformation-arteriovenous malformation 1; Parkes Weber syndrome; Spinal arteriovenous anomalies,Pediatric
RBCK1,Cardiovascular,Polyglucosan body myopathy 1,Pediatric
RBM10,Cardiovascular,TARP syndrome,N/A
RBM20,Cardiovascular,Cardiomyopathy; dilated; 1DD,Pediatric
RECQL4,Cardiovascular,Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome,Pediatric
RERE,Cardiovascular,Neurodevelopmental disorder with or without anomalies of the brain; eye; or heart (NEDBEH),N/A
RIT1,Cardiovascular,Noonan syndrome 8,Pediatric
RMND1,Cardiovascular,Combined oxidative phosphorylation deficiency 11,N/A
RNASEH2A,Cardiovascular,Aicardi-Goutieres syndrome 4,N/A
RNASEH2A,Cardiovascular,Aicardi-Goutieres syndrome 4,N/A
RNASEH2B,Cardiovascular,Aicardi-Goutieres syndrome 2,N/A
RNASEH2C,Cardiovascular,Aicardi-Goutieres syndrome 3,N/A
RNF213,Cardiovascular,Moyamoya disease 2,Adult
ROBO4,Cardiovascular,Aortic valve disease 3,Pediatric
ROR2,Cardiovascular,Robinow syndrome; autosomal recessive; Brachydactyly; type B1,N/A
RPL11,Cardiovascular,Diamond-Blackfan anemia 7,Pediatric
RPL15,Cardiovascular,Diamond-Blackfan anemia 12,Pediatric
RPL26,Cardiovascular,Diamond-Blackfan anemia 11,Pediatric
RPL27,Cardiovascular,Diamond-Blackfan anemia 16,Pediatric
RPL5,Cardiovascular,Diamond-Blackfan anemia 6,Pediatric
RPS19,Cardiovascular,Diamond-Blackfan anemia 1,Pediatric
RPS24,Cardiovascular,Diamond-Blackfan anemia 3,Pediatric
RPS29,Cardiovascular,Diamond-Blackfan anemia 13,Pediatric
RPS6KA3,Cardiovascular,Coffin-Lowry syndrome; Mental retardation; X-linked 19,Pediatric
RRAS2,Cardiovascular,Noonan syndrome 12,Pediatric
RSPO2,Cardiovascular,Tetraamelia syndrome 2; Humerofemoral hypoplasia with radiotibial ray deficiency,N/A
RYR1,Cardiovascular,Malignant hyperthermia; susceptibility 1; Central core disease; Minicore myopathy; Multicore myopathy; Minicore myopathy with external ophthalmoplegia; Centronuclear myopathy,Pediatric
RYR2,Cardiovascular,Ventricular tachycardia; catecholaminergic polymorphic; 1; Arrhythmogenic right ventricular dysplasia 2  ,Pediatric
SACS,Cardiovascular,Spastic ataxia; Charlevoix-Saguenay type,N/A
SALL1,Cardiovascular,Townes-Brocks syndrome 1,Pediatric
SALL4,Cardiovascular,Duane-radial ray/Okohiro syndrome; Acro-Renal-Ocular syndrome,Pediatric
SAMHD1,Cardiovascular,Aicardi-Goutieres syndrome 5,Pediatric
SCARB2,Cardiovascular,Epilepsy; progressive myoclonic 4; with or without renal failure,N/A
SCN1B,Cardiovascular,Atrial fibrillation; familial 13; Brugada syndrome 5,Pediatric
SCN2B,Cardiovascular,Atrial fibrillation; familial 14,Adult
SCN3B,Cardiovascular,Brugada syndrome 7; Atrial fibrillation; familial 16,Adult
SCN4A,Cardiovascular,Paramyotonia congenita; Hyperkalemic periodic paralysis; type 2; Hypokalemic periodic paralysis; type 2; Normokalemic potassium-sensitive periodic paralysis; Malignant hyperthermia; susceptibility to; Myasthenic syndrome; congenital; 16; Myotonia; potassium-aggravated,Pediatric
SCN4B,Cardiovascular,Long QT syndrome 10; Atrial fibrilliation; familial 17,Pediatric
SCN5A,Cardiovascular,Atrial fibrillation; familial 10; Long QT syndrome 3; Idiopathic ventricular fibrillation; Heart block; progressive; type IA; Heart block; nonprogressive; Sick sinus syndrome 1; autosomal recessive; Cardiomyopathy; dilated; 1E; Brugada syndrome 1; Ventricular fibrillation; familial 1,Pediatric
SCO1,Cardiovascular,Mitochondrial complex IV deficiency,N/A
SCO2,Cardiovascular,Myopia 6; Leigh syndrome; Cardioencephalomyopathy; fatal infantile; due to cytochrome c oxidase deficiency 1; Hypertrophic cardiomyopathy,N/A
SDHA,Cardiovascular,Paragangliomas 5; Gastrointestinal stromal tumors; Cardiomyopathy; dilated; 1GG; Leigh syndrome/Mitochondrial respiratory chain complex II deficiency,Adult (Paragangliomas 5; Gastrointestinal stromal tumors); Pediatric (Cardiomyopathy; dilated; 1GG; Leigh syndrome/Mitochondrial respiratory chain complex II deficiency)
SDHAF1,Cardiovascular,Mitochondrial complex II deficiency,Pediatric
SEMA3E,Cardiovascular,CHARGE syndrome,N/A
SETBP1,Cardiovascular,Mental retardation; autosomal dominant 29; Schinzel-Giedion midface retraction syndrome,N/A
SETD5,Cardiovascular,Mental retardation; autosomal dominant 23,N/A
SGCA,Cardiovascular,Muscular dystrophy; limb-girdle; autosomal recessive 3,Pediatric
SGCB,Cardiovascular,Muscular dystrophy; limb-girdle; autosomal recessive; 4,Pediatric
SGCD,Cardiovascular,Cardiomyopathy; dilated; 1L; Muscular dystrophy; limb-girdle autosomal recessive 6,Pediatric
SH3PXD2B,Cardiovascular,Frank-ter Haar syndrome,Pediatric
SHOC2,Cardiovascular,Noonan-like syndrome with loose anagen hair 1,Pediatric
SKI,Cardiovascular,Shprintzen-Goldberg syndrome,Pediatric
SLC12A3,Cardiovascular,Gitelman syndrome,Pediatric
SLC17A5,Cardiovascular,Infantile sialic acid storage disorder; Sialuria; Finnish type (Salla disease),N/A
SLC22A5,Cardiovascular,Carnitine deficiency; systemic primary,Pediatric
SLC25A20,Cardiovascular,Carnitine-acylcarnitine translocase deficiency,Pediatric
SLC25A26,Cardiovascular,Combined oxidative phosphorylation deficiency 28,N/A
SLC25A3,Cardiovascular,Micochondrial phosphate carrier deficiency,N/A
SLC25A4,Cardiovascular,Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type); Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal dominant; 2; Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type),Pediatric
SLC25A42,Cardiovascular,Metabolic crises; recurrent; with variable encephalomyopathic features and neurologic regression,N/A
SLC29A3,Cardiovascular,Histiocytosis-lymphadenopathy plus syndrome ,Pediatric
SLC2A10,Cardiovascular,Arterial tortuosity syndrome,Pediatric
SLC40A1,Cardiovascular,Hemochromatosis; type 4,Pediatric
SMAD3,Cardiovascular,Aneurysms-osteoarthritis syndrome; Loeys-Dietz syndrome; type 3,Pediatric
SMAD4,Cardiovascular,Hereditary hemorrhagic telangiectasia; type 1; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome; Polyposis; juvenile intestinal; Myhre syndrome,Pediatric
SMAD6,Cardiovascular,Aortic valve disease 2,Pediatric
SMAD9,Cardiovascular,Pulmonary hypertension; primary 2,Pediatric
SMARCA4,Cardiovascular,Rhabdoid tumor predisposition syndrome 2,Pediatric
SMARCAL1,Cardiovascular,Schimke immunoosseous dysplasia,Pediatric
SMARCB1,Cardiovascular,Schwannomatosis; Rhabdoid tumor predisposition syndrome 1,Pediatric
SMC1A,Cardiovascular,Cornelia de Lange syndrome 2,N/A
SMG9,Cardiovascular,Heart and brain malformation syndrome,N/A
SMPD1,Cardiovascular,Niemann-Pick disease; type A; Niemann-Pick disease; type B,N/A
SMPD4,Cardiovascular,Neurodevelopmental disorder with microcephaly; arthrogryposis; and structural brain anomalies,Pediatric
SNORD118,Cardiovascular,Leukoencephalopathy; brain calcifications; and cysts (Labrune syndrome),N/A
SNTA1,Cardiovascular,Long QT syndrome 12,Adult
SON,Cardiovascular,ZTTK syndrome,N/A
SOS1,Cardiovascular,Noonan syndrome 4,Pediatric
SOS2,Cardiovascular,Noonan syndrome 9,Pediatric
SOX18,Cardiovascular,Hypotrichosis-lymphedema-telangiectasia syndrome; Hypotrichosis-lymphedema-telangiectasia-renal defect  syndrome,N/A
SOX4,Cardiovascular,Coffin-Siris syndrome 10,N/A
SOX9,Cardiovascular,46; XY sex reversal 10; Campomelic dysplasia,Pediatric
SP110,Cardiovascular,Hepatic venoocclusive disease with immunodeficiency,Pediatric
SPECC1L,Cardiovascular,Facial clefting; oblique; 1; Opitz GBBB syndrome; type II; Hypertelorism; Teebi type,N/A
SPEG,Cardiovascular,Centronuclear myopathy 5,Pediatric
SPZ1,Cardiovascular,Ciliary dyskinesia; primary; 38,Pediatric
SRD5A3,Cardiovascular,Kahrizi syndrome; Congenital disorder of glycosylation; type Iq,Pediatric
STAT3,Cardiovascular,Hyper-IgE recurrent infection syndrome 1; autosomal dominant; Autoimmune disease; multisystem; infantile onset 1,Pediatric
STIM1,Cardiovascular,Stormorken syndrome; Immunodeficiency 10,Pediatric
STING1,Cardiovascular,STING-associated vasculopathy; infantile-onsent (SAVI),N/A
STK4,Cardiovascular,T-cell immunodeficiency syndrome; recurrent infections; autoimmunity; with or without cardiac malformations,Pediatric
STN1,Cardiovascular,Cerebroretinal microangiopathy with calcifications and cysts 2,Pediatric
STRA6,Cardiovascular,Microphthalmia; syndromic 9,N/A
STRADA,Cardiovascular,Polyhydramnios; megalencephaly; and symptomatic epilepsy,N/A
SUCLA2,Cardiovascular,Mitochondrial DNA depletion syndrome 5,Pediatric
SUMF1,Cardiovascular,Multiple sulfatase deficiency,N/A
SURF1,Cardiovascular,Charcot-Marie-Tooth disease type 4K; Leigh syndrome,N/A
SYNE1,Cardiovascular,Emery-Dreifuss muscular dystrophy 4; autosomal dominant,Pediatric
SYNE2,Cardiovascular,Emery-Dreifuss muscular dystrophy 5; autosomal dominant,Pediatric
TAB2,Cardiovascular,Congenital heart defects; multiple types; 2,Pediatric
TALDO1,Cardiovascular,Transaldolase deficiency,N/A
TANGO2,Cardiovascular,Metabolic encephalomyopathic crises; recurrent; with rhabdomyolysis; cardiac arrhythmias; and neurodegeneration (MECRCN),Pediatric
TAZ,Cardiovascular,Barth syndrome (3-Methylglutaconic aciduria; type II),Pediatric
TBX1,Cardiovascular,Conotruncal anomaly face syndrome; Tetralogy of Fallot,N/A
TBX2,Cardiovascular,Vertebral anomalies and variable endocrine and T-cell dysfunction,Pediatric
TBX20,Cardiovascular,Atrial septal defect 4,Pediatric
TBX3,Cardiovascular,Ulnar-Mammary syndrome,N/A
TBX4,Cardiovascular,Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension,Pediatric
TBX5,Cardiovascular,Holt-Oram syndrome,Pediatric
TCAP,Cardiovascular,Cardiomyopathy; dilated; 1N; Cardiomyopathy; familial hypertrophic 25; Muscular dystrophy; limb-girdle; autosomal recessive 7,Pediatric
TCTN3,Cardiovascular,Joubert syndrome 18; Orofaciodigital syndrome IV (Mohr-Majewski syndrome),N/A
TDGF1,Cardiovascular,Forebrain anomalies; Congenital cardiac malformations,N/A
TECRL,Cardiovascular,Ventricular tachycardia; catecholaminergic polymorphic; 3,Pediatric
TEK,Cardiovascular,Glaucoma 3; primary congenital; E; Venous malformations; multiple cutaneous and mucosal,Pediatric
TELO2,Cardiovascular,You-Hoover-Fong syndrome,N/A
TERT,Cardiovascular,Aplastic anemia; Dyskeratosis congenita; autosomal dominant; Dyskeratosis congenita; autosomal recessive; Pulmonary fibrosis and/or bone marrow failure; telomere-related 1,Pediatric
TFAP2B,Cardiovascular,Char syndrome; Patent ductus arteriosus 2,N/A
TFR2,Cardiovascular,Hemochromatosis; type 3,Pediatric
TGFB2,Cardiovascular,Loeys-Dietz syndrome; type 4,Pediatric
TGFB3,Cardiovascular,Arrhythmogenic right ventricular dysplasia 1; Loeys-Dietz syndrome 5 (Reinhoff syndrome),Pediatric
TGFBR1,Cardiovascular,Loeys-Dietz syndrome; type 1A; Loeys-Dietz syndrome; type 2A,Pediatric
TGFBR2,Cardiovascular,Loeys-Dietz syndrome; type 2,Pediatric
TKT,Cardiovascular,Short stature; developmental delay; and congenital heart defects,N/A
TLL1,Cardiovascular,Atrial septal defect 6,Pediatric
TMEM126A,Cardiovascular,Optic atrophy 7 with or without auditory neuropathy,N/A
TMEM126B,Cardiovascular,Mitochondrial complex I deficiency; nuclear type 29,Pediatric
TMEM260,Cardiovascular,Structural heart defects and renal anomalies syndrome (SHDRA),N/A
TMEM43,Cardiovascular,Arrhythmogenic right ventricular dysplasia 5; Emery-Dreifuss muscular dystrophy 7; autosomal dominant,Pediatric
TMEM70,Cardiovascular,Mitochondrial complex V (ATP synthase) deficiency; nuclear type 2,N/A
TMEM94,Cardiovascular,Intellectual developmental disorder with cardiac defects and dysmorphic facies,N/A
TMPO,Cardiovascular,Cardiomyopathy; dilated; 1T,Pediatric
TNNC1,Cardiovascular,Cardiomyopathy; familial hypertrophic 13; Cardiomyopathy; dilated; 1Z,Pediatric
TNNI3,Cardiovascular,Cardiomyopathy; familial hypertrophic 7; Cardiomyopathy; dilated 1FF; Cardiomyopathy; dilated; 2A; Cardiomyopathy; familial restrictive 1,Pediatric
TNNI3K,Cardiovascular,Cardiac conduction disease with or without dilated cardiomyopathy,Pediatric
TNNT2,Cardiovascular,Cardiomyopathy; familial restrictive; 3; Cardiomyopathy; dilated; 1D; Left ventricular noncompaction 6; Cardiomyopathy; familial hypertrophic; 2 ,Pediatric
TNXB,Cardiovascular,Vesicoureteral reflux 8; Ehlers-Danlos syndrome; classic-like,Pediatric
TOP3A,Cardiovascular,Microcephaly; growth restriction; and increased sister chromatid exchange 2; Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive 5,Pediatric (Microcephaly; growth restriction; and increased sister chromatid exchange 2); Adult (Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive 5)
TOR1AIP1,Cardiovascular,Muscular dystrophy; autosomal recessive; with rigid spine and distal joint contractures,Pediatric
TOR1AIP2,Cardiovascular,Muscular dystrophy; limb-girdle; type 2Y,N/A
TPI1,Cardiovascular,Triosephosphate isomerase deficiency,Pediatric
TPM1,Cardiovascular,Cardiomyopathy; dilated; 1Y; Cardiomyopathy; familial hypertrophic; 3,Pediatric
TPM2,Cardiovascular,Nemaline myopathy 4; CAP myopathy 2; Arthrogryposis; distal; type 1A; Arthrogryposis; distal; type 2B,N/A
TRAP1,Cardiovascular,Congenital abnormalities of the kidney and urinary tract; VACTERL association,Pediatric
TRDN,Cardiovascular,Ventricular tachycardia; catecholaminergic polymorphic; 5; with or without muscle weakness,Pediatric
TREX1,Cardiovascular,Aicardi-Goutieres syndrome 1,Pediatric
TRIM32,Cardiovascular,Muscular dystrophy; limb-girdle; ; autosomal recessive; 8; Bardet-Biedl syndrome 11,N/A
TRIM37,Cardiovascular,Mulibrey nanism,Pediatric
TRMT10C,Cardiovascular,Combined oxidative phosphorylation deficiency 30,N/A
TRNI,Cardiovascular,Deafness; mitochondrial; Hypertension; hypercholesterolemia; and hypomagnesemia  (Maternal),Pediatric
TRNK,Cardiovascular,Parkinson disease; mitochondrial; Myoclonic epilepsy with ragged red fibers; Diabetes-deafness syndrome; Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes,N/A
TRPM4,Cardiovascular,Progressive familial heart block; type IB,Pediatric
TRRAP,Cardiovascular,Developmental delay with or without dysmorphic facies and autism; Schizophrenia,N/A
TSC1,Cardiovascular,Tuberous sclerosis; Lymphangioleiomyomatosis,Pediatric
TSC2,Cardiovascular,Tuberous sclerosis 2; Lymphangioleiomyomatosis ,Pediatric
TSFM,Cardiovascular,Combined oxidative phosphorylation deficiency 3,N/A
TTC25,Cardiovascular,Ciliary dyskinesia; primary; 35,Pediatric
TTC8,Cardiovascular,Bardet-Biedl syndrome 8; Retinitis pigmentosa 51,N/A
TTN,Cardiovascular,Cardiomyopathy; familial hypertrophic 9; Cardiomyopathy; dilated; 1G,Pediatric
TWNK,Cardiovascular,Mitochondrial DNA depletion syndrome 7 (hepatocerebral type); Perrault syndrome 5,Pediatric
TXNL4A,Cardiovascular,Burn-McKeown syndrome,Pediatric
UBR1,Cardiovascular,Johanson-Blizzard syndrome,Pediatric
USP18,Cardiovascular,Pseudo-TORCH syndrome 2,N/A
USP9X,Cardiovascular,Mental retardation; X-linked 99; Mental retardation; X-linked 99; syndromic; female restricted,N/A
VCL,Cardiovascular,Cardiomyopathy; familial hypertrophic 15; Cardiomyopathy; dilated; 1W,Adult
VHL,Cardiovascular,Von Hippel Lindau; Erythrocytosis; familial; 2 (Chuvash polycythemia); Pheochromocytoma,Pediatric
VPS33A,Cardiovascular,Mucopolysaccharidosis-plus syndrome,N/A
WDPCP,Cardiovascular,Bardet-Biedl syndrome 15; Congenital heart defects; hamartomas of tongue; and polysyndactyly; Meckel-Gruber syndrome type 6; modifier of,N/A
WDR19,Cardiovascular,Short-rib thoracic dysplasia 5 with or without polydactyly; Cranioectodermal dysplasia 4; Nephronophthisis 13; Retinitis pigmentosa; Senior-Loken syndrome 8,N/A
WDR60,Cardiovascular,Short-rib thoracic dysplasia 8 with or without polydactyly,N/A
WNT4,Cardiovascular,Mullerian aplasia and hyperandrogenism; 46;XX sex reversal with dysgenesis of kidneys; adrenals; and lungs (SERKAL syndrome),N/A
WNT5A,Cardiovascular,Robinow syndrome; autosomal dominant 1,N/A
WRN,Cardiovascular,Werner syndrome,Pediatric
WT1,Cardiovascular,Denys-Drash syndrome; Wilms tumor; type 1; Frasier syndrome,Pediatric
XK,Cardiovascular,McLeod syndrome,Pediatric
XYLT2,Cardiovascular,Spondyloocular syndrome,N/A
YARS2,Cardiovascular,Myopathy; lactic acidosis; and sideroblastic anemia 2,Pediatric
YY1AP1,Cardiovascular,Grange syndrome,Pediatric
ZFPM2,Cardiovascular,46;XY sex reversal 9,Pediatric
ZIC3,Cardiovascular,Congenital heart defects; nonsyndromic; 1; X-linked; Heterotaxy; visceral; 1; X-linked; VACTERL association; X-linked; with or without hydrocephalus,N/A
ZMYND10,Cardiovascular,Ciliary dyskinesia; primary; 22,Pediatric
ZNF148,Cardiovascular,Global developmental delay; absent or hypoplastic corpus callosum; and dysmorphic facies (GDACCF),N/A
ZNF462,Cardiovascular,Weiss-Kruszka syndrome,N/A
AAAS,Endocrine,Achalasia-addisonianism-alacrimia syndrome,Pediatric
AARS2,Endocrine,Leukoencephalopathy; progressive; with ovarian failure,Pediatric
ABCC8,Endocrine,Diabetes mellitus; transient neonatal; 2; Diabetes; permanent neonatal; Hyperinsulinemic hypoglycemia; familial; 1; Hypoglycemia; leucine-induced,Pediatric
ABCD1,Endocrine,Adrenoleukodystrophy,Pediatric
ACP5,Endocrine,Spondyloenchondrodysplasia with immune dysregulation,Pediatric
ADCY3,Endocrine,Obesity; susceptibility to; 19,N/A
AFF2,Endocrine,Premature ovarian failure,Pediatric
AGPAT2,Endocrine,Lipodystrophy; congenital generalized; type 1,Pediatric
AIP,Endocrine,Pituitary adenoma 1; multiple types,Pediatric
AIRE,Endocrine,Autoimmune polyendocrinopathy syndrome ; type I; with or without reversible metaphyseal dysplasia,Pediatric
AKR1C2,Endocrine,46;XY sex reversal 8,Pediatric
AKT2,Endocrine,Hypoinsulinemic hypoglycemia with hemihypertrophy,Pediatric
ALB,Endocrine,Dysalbuminemic hyperthyroxinemia; Analbuminemia,Pediatric
ALG6,Endocrine,Congenital disorder of glycosylation; type Ic,Pediatric
ALMS1,Endocrine,Alstrom syndrome,Pediatric
ALPL,Endocrine,Hypophosphatasia; infantile; Odontohypophosphatasia,Pediatric
AMACR,Endocrine,Bile acid synthesis defect; congenital; 4; Alpha-methylacyl-CoA racemase deficiency,Pediatric
AMH,Endocrine,Persistent Mullerian duct syndrome; type I,Pediatric
AMHR2,Endocrine,Persistent Mullerian duct syndrome; type II,Pediatric
ANAPC1,Endocrine,Rothmund-Thomson syndrome; type 1,Pediatric
ANOS1,Endocrine,Kallmann syndrome 1,Pediatric
AP2S1,Endocrine,Hypocalciuric hypercalcemia; familial; type III,Pediatric
APPL1,Endocrine,Maturity-onset diabetes of the young; type 14,N/A
AQP2,Endocrine,Diabetes insipidus; nephrogenic; autosomal,Pediatric
AR,Endocrine,Androgen insensitivity; Androgen insensitivity; partial,Pediatric
ARL6,Endocrine,Retinitis pigmentosa 55; Bardet Biedl syndrome 3,N/A
ARMC5,Endocrine,ACTH-independent macronodular adrenal hyperplasia 2,Adult
ARMC9,Endocrine,Joubert syndrome 30,Pediatric
ARNT2,Endocrine,Webb-Datani syndrome,Pediatric
ASXL2,Endocrine,Shashi-Pena syndrome,N/A
AVP,Endocrine,Diabetes insipidus; neurohypophyseal,Pediatric
AVPR2,Endocrine,Diabetes insipidus; nephrogenic; X-linked; Nephrogenic syndrome of inappropriate antidiuresis,Pediatric
BBIP1,Endocrine,Bardet-Biedl syndrome 18,N/A
BBS1,Endocrine,Bardet-Biedl syndrome 1,N/A
BBS10,Endocrine,Bardet-Biedl syndrome 10,N/A
BBS12,Endocrine,Bardet-Biedl syndrome 12,N/A
BBS2,Endocrine,Bardet-Biedl syndrome 2; Retinitis pigmentosa 74,N/A
BBS4,Endocrine,Bardet-Biedl syndrome 4,N/A
BBS5,Endocrine,Bardet-Biedl syndrome 5,N/A
BBS7,Endocrine,Bardet-Biedl syndrome 7,N/A
BBS9,Endocrine,Bardet-Biedl syndrome 9,N/A
BLK,Endocrine,Maturity-onset diabetes of the young; type 11,N/A
BLM,Endocrine,Bloom syndrome,Pediatric
BMP15,Endocrine,Premature ovarian failure 4; Ovarian dysgenesis 2,Pediatric
BMP4,Endocrine,Microphthalmia; syndromic 6; Orofacial cleft 11,N/A
BSCL2,Endocrine,Lipodystrophy; congenital generalized; type 2; Encephalopathy; progressive; with or without lipodystrophy,Pediatric
CACNA1D,Endocrine,Primary aldosteronism; seizures; and neurologic abnormalities; Sinoatrial node dysfunction and deafness,Pediatric
CACNA1H,Endocrine,Hyperaldosteronism; familial; type IV,Pediatric
CACNA1S,Endocrine,Malignant hyperthermia susceptibility 5; Thyrotoxic period paralysis; susceptibility 1; Hypokalemic periodic paralysis; type 1,Pediatric
CASR,Endocrine,Hyperparathyroidism; neonatal; Hypocalcemia; autosomal dominant 1; Hypocalciuric hypercalcemia; type I; Hyperparathyroidism; neonatal severe primary; Hypoparathyroidism; familial isolated; Hyperparathyroidism; familial primary,Pediatric
CAV1,Endocrine,Pulmonary hypertension; primary 3; Lipodystrophy; familial partial; type 7; Lipodystrophy; congenital generalized; type 3,Pediatric
CAVIN1,Endocrine,Lipodystrophy; congenital generalized; type 4,N/A
CBX2,Endocrine,46;XY sex reversal 5,N/A
CCBE1,Endocrine,Hennekam lymphangiectasia-lymphedema syndrome,Pediatric
CDC73,Endocrine,Hyperparathyroidism 1; Hyperparathyroidism-jaw tumor syndrome; Carcinoma; parathyroid,Pediatric
CDKN1B,Endocrine,Multiple endocrine neoplasia; type IV,Pediatric
CDKN1C,Endocrine,IMAGE syndrome; Beckwith-Wiedemann syndrome,Pediatric
CDON,Endocrine,Holoprosencephaly 11,N/A
CDT1,Endocrine,Meier-Gorlin syndrome 4,N/A
CEL,Endocrine,Maturity-onset diabetes of the young; type 8; with exocrine dysfunction,Pediatric
CELA2A,Endocrine,Abdominal obesity-metabolic syndrome 4,Pediatric
CEP19,Endocrine,Morbid obesity and spermatogenic failure,N/A
CEP57,Endocrine,Mosaic variegated aneuploidy syndrome 2,Pediatric
CFTR,Endocrine,Cystic fibrosis,Pediatric
CHD7,Endocrine,CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia,Pediatric
CIDEC,Endocrine,Lipodystrophy; familial partial; type 5,Pediatric
CILK1,Endocrine,Epilepsy; juvenile myoclonic; susceptibility to; 10; Endocrine-cerebroosteodysplasia,N/A
CISD2,Endocrine,Wolfram syndrome 2,Pediatric
CLCN2,Endocrine,Hyperaldosteronism; familial; type II,Pediatric
CLCN5,Endocrine,Dent disease 1; Hypophosphatemic rickets; X-linked recessive; Nephrolithiasis; type I; Proteinuria; low molecular weight; with hypercalciuric nephrocalcinosis,Pediatric
CLPB,Endocrine,3-methylglutaconic aciduria with cataracts; neurologic involvement; and neutropenia (MEGCANN),Pediatric
CLPP,Endocrine,Perrault syndrome 3,Pediatric
CNBP,Endocrine,Myotonic dystrophy 2,Pediatric
CNOT1,Endocrine,Holoprosencephaly 12; with or without pancreatic agenesis,Pediatric
COX14,Endocrine,Mitochondrial complex IV deficiency,N/A
CP,Endocrine,Aceruloplasminemia; Hypoceruloplasminemia,Pediatric
CTDP1,Endocrine,Congenital cataracts; facial dysmorphism; and neuropathy,Pediatric
CTNS,Endocrine,Cystinosis,Pediatric
CUL4B,Endocrine,Mental retardation; X-linked; syndromic 15 (Cabezas type),N/A
CYB5A,Endocrine,46; XY disorder of sex development; Methemoglobinemia and ambiguous genitalia,Pediatric
CYP11A1,Endocrine,Adrenal insufficiency; congenital; with 46;XY sex reversal; partial or complete,Pediatric
CYP11B1,Endocrine,Adrenal hyperplasia; congenital; due to 11-beta-hydroxylase deficiency; Hyperaldosteronism; familial; type I,Pediatric
CYP11B2,Endocrine,Corticosterone methyloxidase type I deficiency; Corticosterone methyloxidase type II deficiency;  Glucocorticoid-remediable aldosteronism,Pediatric
CYP17A1,Endocrine,Adrenal hyperplasia; congenital; due to 17-alpha-hydroxylase deficiency,Pediatric
CYP19A1,Endocrine,Aromatase deficiency,Pediatric
CYP21A2,Endocrine,Adrenal hyperplasia; congenital; due to 21-hydroxylase deficiency; Hyperandrogenism; nonclassic type; due to 21-hydroxylase deficiency,Pediatric
CYP24A1,Endocrine,Hypercalcemia; infantile 1,Pediatric
CYP27B1,Endocrine,Vitamin D-dependent rickets; type 1A,Pediatric
CYP2R1,Endocrine,Vitamin D hydroxylation deficient rickets; type 1B,Pediatric
DCAF17,Endocrine,Woodhouse-Sakati syndrome,Pediatric
DHCR7,Endocrine,Smith-Lemli-Opitz syndrome,Pediatric
DHH,Endocrine,46;XY partial gonadal dysgenesis; with minifascicular neuropathy; 46;XY sex reversal 7,Pediatric
DIAPH2,Endocrine,Premature ovarian failure 2A,Pediatric
DKC1,Endocrine,Dyskeratosis congenita; X-linked; Hoyeraal-Hreidarsson syndrome,Pediatric
DLL1,Endocrine,Holoprosencephaly,N/A
DMP1,Endocrine,Hypophosphatemic rickets; autosomal recessive 1,Pediatric
DMPK,Endocrine,Myotonic dystrophy 1,Pediatric
DMXL2,Endocrine,Polyendocrine-polyneuropathy syndrome,Pediatric
DNAJC3,Endocrine,Ataxia; combined cerebellar and peripheral; with hearing loss and diabetes mellitus,N/A
DUOX2,Endocrine,Thyroid dyshormonogenesis 6,Pediatric
DUOXA2,Endocrine,Thyroid dyshormonogenesis 5,Pediatric
DUSP6,Endocrine,Hypogonadotropic hypogonadism 19; with or without anosmia,Pediatric
DYRK1B,Endocrine,Abdominal obesity-metabolic syndrome 3,Adult
EIF2AK3,Endocrine,Epiphyseal dysplasia; multiple; with early-onset diabetes mellitus (Wolcott-Rallison syndrome),Pediatric
EIF2B1,Endocrine,Leukoencephalopathy with vanishing white matter; Ovarioleukodystrophy,Pediatric
EIF2B2,Endocrine,Leukoencephalopathy with vanishing white matter; Ovarioleukodystrophy,Pediatric
EIF2B3,Endocrine,Leukoencephalopathy with vanishing white matter; Ovarioleukodystrophy,Pediatric
EIF2B4,Endocrine,Leukoencephalopathy with vanishing white matter; Ovarioleukodystrophy,Pediatric
EIF2B5,Endocrine,Leukoencephalopathy with vanishing white matter; Ovarioleukodystrophy,Pediatric
EIF2S3,Endocrine,MEHMO syndrome,Pediatric
ERCC2,Endocrine,Trichothiodystrophy 1; photosensitive; Xeroderma pigmentosum; group D,Pediatric
ERCC3,Endocrine,Xeroderma pigmentosum; complementation group B; Trichothiodystrophy 2; photosensitive,Pediatric
ERCC4,Endocrine,Fanconi anemia; complementation group Q; Xeroderma pigmentosum; group F,Pediatric
ERCC6,Endocrine,Premature ovarian failure 11; Xeroderma Pigmentosum-Cockayne Syndrome; De Sanctis-Cacchione syndrome,Pediatric
ESR1,Endocrine,Estrogen resistance,N/A
ESR2,Endocrine,Ovarian dysgenesis 8,Pediatric
FAM111A,Endocrine,Kenny-Caffey syndrome; type 2,Pediatric
FANCM,Endocrine,Fanconi anemia type M; Premature ovarian failure 15,Pediatric
FEZF1,Endocrine,Hypogonadotropic hypogonadism 22 with or without anosmia,Pediatric
FGF10,Endocrine,Lacrimoauriculodentodigital syndrome,Pediatric
FGF17,Endocrine,Hypogonadotropic hypogonadism 20; with or without anosmia,Pediatric
FGF8,Endocrine,Hypogonadotropic hypogonadism 6; with or without anosmia,Pediatric
FGFR1,Endocrine,Hypogonadotropic hypogonadism 2 with or without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome,Pediatric
FIGLA,Endocrine,Premature ovarian failure 6,Pediatric
FLRT3,Endocrine,Hypogonadotropic hypogonadism 21; with or without anosmia,Pediatric
FMR1,Endocrine,Premature ovarian failure 1,Pediatric
FOXE1,Endocrine,Thyroid cancer; nonmedullary 4; Hypothyroidism; thyroidal; with spiky hair and cleft palate (Bamforth-Lazarus syndrome); Congenital hypothyroidism,Pediatric/Adult
FOXH1,Endocrine,Holoprosencephaly; Congenital heart malformations,N/A
FOXI1,Endocrine,Deafness; autosomal recessive 4; with enlarged vestibular aqueduct,Pediatric
FOXL2,Endocrine,Blepharophimosis; epicanthus inversus; and ptosis; Premature ovarian failure 3,Pediatric
FOXP3,Endocrine,Immunodysregulation; polyendocrinopathy; and enteropathy; X-linked (IPEX),Pediatric
FSHB,Endocrine,Hypogonadotropic hypogonadism 24 without anosmia,Pediatric
FSHR,Endocrine,Ovarian hyperstimulation syndrome; Ovarian dysgenesis 1,Pediatric
FXN,Endocrine,Friedreich ataxia 1,Pediatric
G6PC3,Endocrine,Neutropenia; severe congenital; 4; autosomal recessive; Dursun syndrome,Pediatric
GALT,Endocrine,Galactosemia,Pediatric
GAS1,Endocrine,Holoprosencephaly 4,N/A
GATA3,Endocrine,Hypoparathyroidism; sensorineural deafness; and renal dysplasia,Pediatric
GATA6,Endocrine,Heart defects; congenital; and other congenital anomalies,Pediatric
GCK,Endocrine,Diabetes mellitus; permanent neonatal; Hyperinsulinemic hypoglycemia; familial 3,Pediatric
GCM2,Endocrine,Hypoparathyroidism; familial isolated; Hyperparathyroidism 4,Pediatric
GDF9,Endocrine,Premature ovarian failure 14,Pediatric
GH1,Endocrine,Isolated growth hormone deficiency; isolated; type IA; Isolated growth hormone deficiency; type 1B; Isolated growth hormone deficiency; type II; Kowarski syndrome,Pediatric
GHR,Endocrine,Growth hormone insensitivity syndrome (Laron syndrome),Pediatric
GHRHR,Endocrine,Isolated growth hormone deficiency; type IV,Pediatric
GLI2,Endocrine,Culler-Jones syndrome,Pediatric
GLI3,Endocrine,Acrocallosal syndrome; Pallister-Hall syndrome; Grieg cephalopolysndactyly syndrome; Polydactyly; postaxial; type A1; Polydactyly; preaxial; type IV; Polydactyly; postaxial; types A1 and B,N/A
GLIS3,Endocrine,Diabetes mellitus; neonatal; with congenital hypothyroidism,Pediatric
GLUD1,Endocrine,Hyperinsulinemic hypoglycemia; familial 6; Hyperammonemia-hyperinsulinism,Pediatric
GNA11,Endocrine,Hypocalcemia 2; autosomal dominant; Hypocalciuric hypercalcemia; autosomal dominant,Pediatric
GNAS,Endocrine,Pseudohypoparathyroidism; type IA; Pseudohypoparathyroidism; type IB; Pseudohypoparathyroidism; type IC; Progressive osseous heteroplasia; McCune-Albright syndrome,Pediatric
GNRH1,Endocrine,Hypogonadotropic hypogonadism 12 with or without anosmia,Pediatric
GNRHR,Endocrine,Hypogonadotropic hypogonadism 7 with or without anosmia; Hypogonadotropic hypogonadism 23 with or without anosmia,Pediatric
GPR101,Endocrine,Pituitary adenoma; growth hormone secreting; 2,Pediatric
H19,Endocrine,Wilms tumor 2; Beckwith-Wiedemann syndrome,Pediatric
H6PD,Endocrine,Cortisone reductase deficiency,N/A
HADH,Endocrine,3-hydroxyacyl-CoA dehydrogenase deficiency; Hyperinsulinemic hypoglycemia; familial; 4,Pediatric
HAMP,Endocrine,Hemochromatosis; type 2B,Pediatric
HARS2,Endocrine,Perrault syndrome 2,Pediatric
HESX1,Endocrine,Pituitary hormone deficiency; combined; Septooptic dysplasia,Pediatric
HFE,Endocrine,Hemochromatosis,Pediatric
HFM1,Endocrine,Premature ovarian failure 9,Pediatric
HJV,Endocrine,Hemochromatosis; type 2A,Pediatric
HMBS,Endocrine,Hydroxymethylbilane synthase deficiency; Porphyria; acute intermittent,Pediatric
HNF1A,Endocrine,Renal cell carcinoma; nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young; type III,Pediatric
HNF1B,Endocrine,Renal cell carcinoma; nonpapillary chromophobe,Adult
HNF4A,Endocrine,Congenital hyperinsulinism; diazoxide-responsive; Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young; Maturity onset diabetes of the young; 1,Pediatric
HS6ST1,Endocrine,Hypogonadotropic hypogonadism 15; with or without anosmia,Pediatric
HSD11B1,Endocrine,Cortisone reductase deficiency 1,N/A
HSD11B2,Endocrine,Cortisol 11-beta-ketoreductase deficiency,Pediatric
HSD17B3,Endocrine,17-Beta hydroxysteroid dehydrogenase III deficiency,Pediatric
HSD17B4,Endocrine,Perrault syndrome 1,Pediatric
HSD3B2,Endocrine,Adrenal hyperplasia; congenital; due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency,Pediatric
HTR1A,Endocrine,Periodic fever; menstrual cycle dependent,Pediatric
HYOU1,Endocrine,Immunodeficiency 59 and hypoglycemia,Pediatric
IARS2,Endocrine,Cataracts; growth hormone deficiency; sensory neuropathy; sensorineural hearing loss; and skeletal dysplasia (CAGSSS),Pediatric
IER3IP1,Endocrine,Microcephaly; epilepsy; and diabetes syndrome,N/A
IFT172,Endocrine,Retinitis pigmentosa 71; Short rib thoracic dysplasia 10 with or without polydactyly,N/A
IFT27,Endocrine,Bardet Biedl syndrome 19,N/A
IFT74,Endocrine,Bardet Biedl syndrome 20,N/A
IGF1,Endocrine,Insulin-like growth factor I deficiency,Pediatric
IGF1R,Endocrine,Insulin-like growth factor I; resistance to,Pediatric
IGF2,Endocrine,Growth restriction; severe; with distinctive facies,Pediatric
IGFALS,Endocrine,Insulin-like growth factor-binding protein; acid-labile subunit; deficiency of,Pediatric
IGSF1,Endocrine,Central hypothyroidism and testicular enlargement,Pediatric
IL17RD,Endocrine,Hypogonadotropic hypogonadism 18; with or without anosmia,Pediatric
INPP5E,Endocrine,Joubert syndrome 1; Mental retardation; truncal obesity; retinal dystrophy; and micropenis (MORM syndrome),N/A
INS,Endocrine,Diabetes mellitus; permanent neonatal,Pediatric
INSR,Endocrine,Hyperinsulinemic hypoglycemia; familial; 5; Rabson-Mendenhall syndrome; Donohoe syndrome,Pediatric
IRS4,Endocrine,Hypothyroidism; congenital; nongoitrous; 9,Pediatric
ITCH,Endocrine,Autoimmune disease; syndromic multisystem,Pediatric
IYD,Endocrine,Thyroid dyshormonogenesis 4,Pediatric
KAT6B,Endocrine,Ohdo syndrome; SBBYS variant; Genitopatellar syndrome,Pediatric
KCNJ11,Endocrine,Hyperinsulinemic hypoglycemia; familial; 2; Diabetes mellitus; transient neonatal; 3; Diabetes; permanent neonatal; Diabetes; permanent neonatal; with Neurologic features,Pediatric
KCNJ18,Endocrine,Thyrotoxic periodic paralysis; susceptibility to,Pediatric
KCNJ5,Endocrine,Long QT syndrome 13; Hyperaldosteronism; familial; type III,Pediatric
KCNJ6,Endocrine,Keppen-Lubinsky syndrome,N/A
KCNQ1OT1,Endocrine,Beckwith-Wiedemann syndrome,Pediatric
KIAA0556,Endocrine,Joubert syndrome 26,Pediatric
KIDINS220,Endocrine,Spastic paraplegia; intellectual disability; nystagmus; and obesity (SINO),N/A
KISS1,Endocrine,Hypogonadotropic hypogonadism 13 with or without anosmia,Pediatric
KISS1R,Endocrine,Hypogonadotropic hypogonadism 8 with or without anosmia,Pediatric
KLF11,Endocrine,Maturity-onset diabetes of the young; type VII,N/A
KMT2D,Endocrine,Kabuki syndrome 1,Pediatric
LARS2,Endocrine,Perrault syndrome 4,Pediatric
LAS1L,Endocrine,Wilson-Turner X-linked mental retardation syndrome,N/A
LEP,Endocrine,Leptin deficiency or dysfunction,Pediatric
LEPR,Endocrine,Leptin receptor deficiency,Pediatric
LHB,Endocrine,Hypogonadotropic hypogonadism 23 with or without anosmia,Pediatric
LHCGR,Endocrine,Leydig cell hypoplasia type I; Leydig cell hypoplasia type II; Luteinizing hormone resistance; female; Precocious puberty; male,Pediatric
LHX3,Endocrine,Pituitary hormone deficiency; combined; 3,Pediatric
LHX4,Endocrine,Pituitary hormone deficiency; combined; 4,Pediatric
LIPE,Endocrine,Lipodystrophy; familial partial; type 6,Pediatric
LMF1,Endocrine,Combined lipase deficiency,Pediatric
LMNA,Endocrine,Cardiomyopathy; dilated; 1A; Heart-hand syndrome; Slovenian type; Emery-Dreiffus muscular dystrophy 2; autosomal dominant; Emery-Dreiffus muscular dystrophy 3; autosomal recessive; Muscular dystrophy; congenital; LMNA-related; Muscular dystrophy; limb-girdle; type 1B; Cardiomyopathy; dilated; with hypergonadotropic hypogonadism (Malouf syndrome); Lipodystrophy; familial partial; 2 (Dunnigan type),Pediatric
LRBA,Endocrine,Common variable immunodeficiency 8; with autoimmunity,Pediatric
LZTFL1,Endocrine,Bardet-Biedl syndrome 17,N/A
MAFA,Endocrine,Insulinomatosis and diabetes mellitus syndrome,Pediatric
MAGEL2,Endocrine,Schaaf-Yang syndrome (Prader-Willi-like syndrome),Pediatric
MAP3K1,Endocrine,46;XY sex reversal 6,Pediatric
MAPK8IP1,Endocrine,Diabetes mellitus,N/A
MARS1,Endocrine,Interstitial lung and liver disease,Pediatric
MC2R,Endocrine,Glucocorticoid deficiency 1,Pediatric
MC3R,Endocrine,Obesity; severe; susceptibility to; 9,N/A
MC4R,Endocrine,Obesity; autosomal dominant,N/A
MCM4,Endocrine,Immunodeficiency 54,Pediatric
MCM8,Endocrine,Premature ovarian failure 10,Pediatric
MCM9,Endocrine,Ovarian dysgenesis 4,Pediatric
MEGF8,Endocrine,Carpenter syndrome 2,N/A
MEN1,Endocrine,Multiple endocrine neoplasia type I; Hyperparathyroidism; familial primary,Adult
MGME1,Endocrine,Mitochondrial DNA depletion syndrome 11,Pediatric
MKKS,Endocrine,McKusick-Kaufman syndrome; Bardet-Biedl syndrome 6,N/A
MKRN3,Endocrine,Central precocious puberty,N/A
MKS1,Endocrine,Joubert syndrome 28; Meckel syndrome 1; Bardet-Biedl syndrome 13,N/A
MRAP,Endocrine,Glucocorticoid deficiency 2,Pediatric
MRAP2,Endocrine,Obesity; susceptibility to; 18,N/A
MRPS22,Endocrine,Combined oxidative phosphorylation deficiency 5; Ovarian dysgenesis 7,N/A
MRPS7,Endocrine,Combined oxidative phosphorylation deficiency 34,Pediatric
MSH5,Endocrine,Premature ovarian failure 13,Pediatric
MT-TE,Endocrine,Diabetes-deafness syndrome; Mitochondrial myopathy; infantile; transient; Mitochondrial myopathy with diabetes,N/A
NEUROD1,Endocrine,Maturity onset diabetes of the young 6,N/A
NEUROG3,Endocrine,Diarrhea 4; malabsorptive; congenital,Pediatric
NFKB2,Endocrine,Immunodeficiency; common variable; 10,Pediatric
NHP2,Endocrine,Dyskeratosis congenita; autosomal recessive 2,Pediatric
NIN,Endocrine,Seckel syndrome 7,N/A
NKX2-1,Endocrine,Choreoathetosis; hypothyroidism; and neonatal respiratory distress; Thyroid cancer; nonmedullary 1,Pediatric/Adult
NKX2-5,Endocrine,Atrial septal defect 7; with or without AV conduction defects; Conotruncal heart malformations; Hypothyroidism; congenital nongoitrous; 5,Pediatric
NNT,Endocrine,Glucocorticoid deficiency 4; with or without mineralocorticoid deficiency,Pediatric
NOBOX,Endocrine,Premature ovarian failure 5,Pediatric
NOP10,Endocrine,Dyskeratosis congenita; autosomal recessive 1,Pediatric
NOTCH2,Endocrine,Alagille syndrome 2,Pediatric
NR0B1,Endocrine,Adrenal hypoplasia; congenital; 46;XY sex reversal 2 ,Pediatric
NR3C1,Endocrine,Glucocorticoid resistance,Pediatric
NR5A1,Endocrine,Adrenocortical insufficiency; 46;XX sex reversal 4; 46; XY sex reversal 3; Premature ovarian failure 7,Pediatric
NSMCE2,Endocrine,Seckel syndrome 10,Pediatric
NSMF,Endocrine,Hypogonadotropic hypogonadism 9 with or without anosmia,Pediatric
NTRK2,Endocrine,Obesity; hyperphagia; and developmental delay,N/A
NUP107,Endocrine,Nephrotic syndrome; type 11; Ovarian dysgenesis 6; Galloway-Mowat syndrome 7,N/A
OBSL1,Endocrine,Three M syndrome 2,N/A
OTX2,Endocrine,Pituitary hormone deficiency; combined 6; Microphthalmia; syndromic 5; Retinal dystrophy; early-onset; and pituitary dysfunction,Pediatric
PAPSS2,Endocrine,Brachyolmia 4 with mild epiphyseal and metaphyseal changes,N/A
PAX4,Endocrine,Diabetes mellitus,N/A
PAX8,Endocrine,Hypothyroidism; congenital; nongoitrous 2,Pediatric
PCBD1,Endocrine,Hyperphenylalaninemia; BH4-deficient; D,Pediatric
PCSK1,Endocrine,Proprotein convertase 1/3 deficiency,N/A
PDE11A,Endocrine,Pigmented nodular adrenocortical disease; primary; 2,Pediatric
PDE4D,Endocrine,Acrodysostosis 2; with or without hormone resistance,Pediatric
PDE8B,Endocrine,Pigmented nodular adrenocortical disease; primary; 3,Pediatric
PDSS1,Endocrine,Coenzyme Q10 deficiency 2,Pediatric
PDX1,Endocrine,Pancreatic agenesis 1; Neonatal diabetes mellitus,Pediatric
PGM1,Endocrine,Congenital disorder of glycosylation; type It,Pediatric
PHF6,Endocrine,Borjeson-Forssman-Lehmann syndrome,N/A
PHGDH,Endocrine,Phosphoglycerate dehydrogenase deficiency,Pediatric
PIK3C2A,Endocrine,Oculoskeletodental syndrome,Pediatric
PIK3CA,Endocrine,Cowden syndrome 5,Adult
PIK3R1,Endocrine,Agammaglobulinemia 7; autosomal recessive; Immunodeficiency 36,Pediatric
PKHD1,Endocrine,Polycystic kidney disease 4 with or without polycystic liver disease,Pediatric
PLAGL1,Endocrine,Diabetes mellitus; transient neonatal,Pediatric
PLIN1,Endocrine,Lipodystrophy; familial partial; type 4,Pediatric
PNPLA2,Endocrine,Neutral lipid storage disease with myopathy,N/A
PNPLA6,Endocrine,Boucher-Neuhauser syndrome; Laurence-Moon syndrome; Oliver-McFarlane syndrome,Pediatric
POC1A,Endocrine,Short stature; onychodysplasia; facial dysmorphism; and hypotrichosis (SOFT syndrome),N/A
POF1B,Endocrine,Premature ovarian failure 2B,Pediatric
POLA1,Endocrine,Pigmentary disorder; reticulate; with systemic manifestations; X-linked; Van Esch-O'Driscoll syndrome,Pediatric
POLD1,Endocrine,Colorectal cancer; susceptibility to; 10,Pediatric
POLE,Endocrine,Colorectal cancer; susceptibility to; 12; Facial dysmorphism; immunodeficiency; livedo; and short stature syndrome (FILS syndrome); Intrauterine growth retardation; metaphyseal dysplasia; adrenal hypoplasia congenita; genital anomalies; and immunodeficiency (IMAGEI),Pediatric
POLR3A,Endocrine,Leukodystrophy; hypomyelinating; 7; with or without oligodontia and/or hypogonadotropic hypogonadism; Wiedemann-Rautenstrauch syndrome,N/A
POLR3B,Endocrine,Leukodystrophy; hypomyelinating; 8; with or without oligodontia and/or hypogonadotropic hypogonadism,N/A
POMC,Endocrine,Obesity; early onset; with adrenal insufficiency and red hair,Pediatric
POR,Endocrine,Antley-Bixler syndrome; Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency,Pediatric
POU1F1,Endocrine,Pituitary hormone deficiency; combined 1,Pediatric
PPARG,Endocrine,Lipodystrophy; familial; partial; type 3; Insulin resistance; severe; digenic,N/A
PPP1R15B,Endocrine,Microcephaly; short stature; and impaired glucose metabolism 2,Pediatric
PPP1R3A,Endocrine,Insulin resistance; severe; digenic,N/A
PRKACA,Endocrine,Primary pigmented nodular adrenocortical disease 4,Pediatric
PRKAR1A,Endocrine,Pigmented nodular adrenocortical disease; primary; 1; Carney complex; type 1; Myxoma; intracardiac; Acrodysostosis 1; with or without hormone resistance,Pediatric
PRLR,Endocrine,Hyperprolactinemia; Multiple fibroadenomas of the breast,Pediatric
PROK2,Endocrine,Hypogonadotropic hypogonadism 4 with or without anosmia,Pediatric
PROKR2,Endocrine,Hypogonadotropic hypogonadism 3 with or without anosmia,Pediatric
PROP1,Endocrine,Pituitary hormone deficiency; combined; 2,Pediatric
PSMA3,Endocrine,Proteasome-associated autoinflammatory syndrome 2,Pediatric
PSMB8,Endocrine,Proteasome-associated autoinflammatory syndrome 1,Pediatric
PSMC3IP,Endocrine,Ovarian dysgenesis 3,Pediatric
PSTPIP1,Endocrine,Pyogenic sterile arthritis; pyoderma gangrenosum; and acne,Pediatric
PTCH1,Endocrine,Basal cell nevus syndrome,Pediatric
PTH,Endocrine,Hypoparathyroidism; autosomal dominant; Hypoparathyroidism; autosomal recessive ,Pediatric
PTPRF,Endocrine,Breasts and/or nipples; aplasia or hypoplasia of; 2,N/A
PTRH2,Endocrine,Infantile-onset multisystem neurologic; endocrine; and pancreatic disease (IMNEPD),Pediatric
PURA,Endocrine,Mental retardation; autosomal dominant 31,N/A
PUS1,Endocrine,Myopathy; lactic acidosis; and sideroblastic anemia 1,Pediatric
RAB23,Endocrine,Carpenter syndrome 1,N/A
RAB3GAP1,Endocrine,Warburg micro syndrome 1,Pediatric
RAB3GAP2,Endocrine,Warburg micro syndrome 2; Martsolf syndrome ,Pediatric
RBM28,Endocrine,Alopecia; neurologic defects; and endocrinopathy syndrome,Pediatric
RECQL4,Endocrine,Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome,Pediatric
RET,Endocrine,Central hypoventilation syndrome; congenital; Multiple endocrine neoplasia; type IIA; Multiple endocrine neoplasia; type IIB; Medullary thyroid carcinoma; familial; Pheochromocytoma; Hirschsprung disease; susceptibility to 1,Pediatric
RFWD3,Endocrine,Fanconi anemia; complementation group W,Pediatric
RFX6,Endocrine,Pancreatic hypoplasia; intestinal atresia; and gallbladder aplasia or hypoplasia; with or without tracheoesophageal fistula; Martinez-Frias syndrome; Mitchell-Riley syndrome,Pediatric
RNF216,Endocrine,Cerebellar ataxia and hypogonadotropic hypogonadism (Gordon Holmes syndrome),Pediatric
RNPC3,Endocrine,Isolated growth hormone deficiency; type V,Pediatric
RSPO1,Endocrine,Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and 46;XX sex reversal,Adult
RTEL1,Endocrine,Pulmonary fibrosis and/or bone marrow failure; telomere-related 3; Dyskeratosis congenita; autosomal dominant 4; Dyskeratosis congenita; autosomal recessive 5,Pediatric
SALL1,Endocrine,Townes-Brocks syndrome 1,Pediatric
SALL4,Endocrine,Duane-radial ray/Okohiro syndrome; Acro-Renal-Ocular syndrome,Pediatric
SAMD9,Endocrine,Mirage syndrome; Tumoral calcinosis; normophosphatemic,Pediatric
SARS2,Endocrine,Hyperuricemia; pulmonary hypertension; renal failure; and alkalosis,N/A
SCP2,Endocrine,Leukoencephalopathy with dystonia and motor neuropathy,N/A
SEC23B,Endocrine,Cowden syndrome 7; Anemia; dyserythropoietic congenital; type II ,Pediatric (Anemia; dyserythropoietic congenital; type II); Adult (Cowden syndrome 7)
SECISBP2,Endocrine,Selenoprotein deficiency; Thyroid hormone metabolism; abnormal,N/A
SEMA3A,Endocrine,Hypogonadotropic hypogonadism 16 with or without anosmia,Pediatric
SERPINA6,Endocrine,Corticosteroid-binding globulin deficiency,N/A
SERPINA7,Endocrine,Thyroxine-binding globulin deficiency; Thyroxine-binding globulin excess,N/A
SGPL1,Endocrine,Nephrotic syndrome 14,Pediatric
SHH,Endocrine,Holoprosencephaly 3; Microphthalmia with coloboma 5 ,N/A
SHOC2,Endocrine,Noonan-like syndrome with loose anagen hair 1,Pediatric
SIK3,Endocrine,Spondyloepimetaphyseal dysplasia; Krakow type,Pediatric
SIL1,Endocrine,Marinesco-Sjogren syndrome,N/A
SIX3,Endocrine,Holoprosencephaly 2,N/A
SLC16A1,Endocrine,Hyperinsulinemic hypoglycemia; familial; 7; Erythrocyte lactate transporter defect; Monocarboxylate transporter 1 deficiency,Pediatric (Erythrocyte lactate transporter defect; Monocarboxylate transporter 1 deficiency ); Adult (Hyperinsulinemic hypoglycemia; familial; 7)
SLC16A2,Endocrine,Allan-Herndon-Dudley syndrome,Pediatric
SLC19A2,Endocrine,Thiamine-responsive megaloblastic anemia syndrome,Pediatric
SLC25A4,Endocrine,Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type); Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal dominant; 2; Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type),Pediatric
SLC26A4,Endocrine,Pendred syndrome; Deafness; autosomal recessive 4; with enlarged vestibular aqueduct,Pediatric
SLC29A3,Endocrine,Histiocytosis-lymphadenopathy plus syndrome ,Pediatric
SLC2A2,Endocrine,Fanconi-Bickel syndrome; Glycogen storage disease XI; Neonatal diabetes mellitus,Pediatric
SLC40A1,Endocrine,Hemochromatosis; type 4,Pediatric
SLC5A5,Endocrine,Thyroid dyshormonogenesis 1,Pediatric
SLC6A2,Endocrine,Orthostatic intolerance,N/A
SMCHD1,Endocrine,Bosma arhinia microphthalmia syndrome,Pediatric
SMPD1,Endocrine,Niemann-Pick disease; type A; Niemann-Pick disease; type B,N/A
SOHLH1,Endocrine,Ovarian dysgenesis 5,Pediatric
SOX2,Endocrine,Microphthalmia; syndromic 3,Pediatric
SOX3,Endocrine,Panhypopituitarism; X-linked,Pediatric
SPRY4,Endocrine,Hypogonadotropic hypogonadism 17; with or without anosmia,Pediatric
SRD5A2,Endocrine,Steroid 5-alpha-reductase 2 deficiency,Pediatric
SRD5A3,Endocrine,Kahrizi syndrome; Congenital disorder of glycosylation; type Iq,Pediatric
SRY,Endocrine,46;XY disorder of sex development; 46; XX disorder of sex development,Pediatric
STAG3,Endocrine,Premature ovarian failure 8,Pediatric
STAR,Endocrine,Lipoid adrenal hyperplasia,Pediatric
STAT5B,Endocrine,Growth hormone insensitivity with immunodeficiency,Pediatric
STEAP3,Endocrine,Hypochromic microcytic anemia with iron overload 2,Pediatric
STRADA,Endocrine,Polyhydramnios; megalencephaly; and symptomatic epilepsy,N/A
STX16,Endocrine,Pseudohypoparathyroidism; type IB,Pediatric
SYCE1,Endocrine,Premature ovarian failure 12,Pediatric
TAC3,Endocrine,Hypogonadotropic hypogonadism,Pediatric
TACR3,Endocrine,Hypogonadotropic hypogonadism,Pediatric
TAF13,Endocrine,Mental retardation; autosomal recessive 60,N/A
TANGO2,Endocrine,Metabolic encephalomyopathic crises; recurrent; with rhabdomyolysis; cardiac arrhythmias; and neurodegeneration (MECRCN),Pediatric
TBC1D4,Endocrine,Diabetes mellitus; noninsulin-dependent 5,N/A
TBCE,Endocrine,Kenny-Caffey syndrome; type 1; Hypoparathyroidism-retardation-dysmorphism syndrome,Pediatric
TBL1X,Endocrine,Hypothyroidism; congenital; nongoitrous; 8,Pediatric
TBX19,Endocrine,Adrenocorticotropic hormone deficiency,Pediatric
TBX2,Endocrine,Vertebral anomalies and variable endocrine and T-cell dysfunction,Pediatric
TBX3,Endocrine,Ulnar-Mammary syndrome,N/A
TDGF1,Endocrine,Forebrain anomalies; Congenital cardiac malformations,N/A
TERC,Endocrine,Dyskeratosis congenita; autosomal dominant 1; Aplastic anemia; Pulmonary fibrosis and/or bone marrow failure; telomere-related 2,Pediatric
TERT,Endocrine,Aplastic anemia; Dyskeratosis congenita; autosomal dominant; Dyskeratosis congenita; autosomal recessive; Pulmonary fibrosis and/or bone marrow failure; telomere-related 1,Pediatric
TEX15,Endocrine,Spermatogenic failure 25,N/A
TFR2,Endocrine,Hemochromatosis; type 3,Pediatric
TG,Endocrine,Thyroid dyshormonogenesis 3,Pediatric
TGIF1,Endocrine,Holoprosencephaly 4,N/A
THRA,Endocrine,Hypothyroidism; congenital; nongoitrous; 6,Pediatric
THRB,Endocrine,Thyroid hormone resistance; general; Thyroid hormone resistance; selective pituitary ,Pediatric
TMEM165,Endocrine,Congenital disorder of glycosylation; type IIk,N/A
TMEM67,Endocrine,Nephronophthisis 11; Meckel syndrome 3; Joubert syndrome 6; COACH syndrome; RHYNS syndrome,N/A
TNFRSF11A,Endocrine,Familial expansile osteolysis; Paget disease of bone 2; early-onset; Osteopetrosis; autosomal recessive 7,Pediatric (Polyostotic osteolytic dysplasia; hereditary expansile/Osteopetrosis; autosomal recessive 7); Adult (Paget disease of bone)
TNFRSF11B,Endocrine,Paget disease of bone 5; juvenile,Pediatric
TOE1,Endocrine,Pontocerebellar hypoplasia type 7,N/A
TONSL,Endocrine,Spondyloepimetaphyseal dysplasia; sponastrime type,N/A
TPO,Endocrine,Thyroid dyshormonogenesis 2A,Pediatric
TRAF3IP1,Endocrine,Senior-Loken syndrome 9,N/A
TRAPPC9,Endocrine,Mental retardation; autosomal recessive 13,N/A
TRHR,Endocrine,Hypothyroidism; congenital; nongoitrous; 7,Pediatric
TRIM32,Endocrine,Muscular dystrophy; limb-girdle; ; autosomal recessive; 8; Bardet-Biedl syndrome 11,N/A
TRIM37,Endocrine,Mulibrey nanism,Pediatric
TRMT10A,Endocrine,Microcephaly; short stature; and impaired glucose metabolism 1,Pediatric
TRNI,Endocrine,Deafness; mitochondrial; Hypertension; hypercholesterolemia; and hypomagnesemia  (Maternal),Pediatric
TRRAP,Endocrine,Developmental delay with or without dysmorphic facies and autism; Schizophrenia,N/A
TSHB,Endocrine,Hypothyroidism; congenital; nongoitrous; 4,Pediatric
TSHR,Endocrine,Hyperthyroidism; familial; gestational; Hyperthyroidism; nonautoimmune; Hypothyroidism; congenital; nongoitrous; 1,Pediatric
TTC8,Endocrine,Bardet-Biedl syndrome 8; Retinitis pigmentosa 51,N/A
TTR,Endocrine,Amyloidosis; hereditary; transthyretin-related; Dystransthyretinemic hyperthyroxinemia,Pediatric
TUB,Endocrine,Retinal dystrophy and obesity,N/A
TWNK,Endocrine,Mitochondrial DNA depletion syndrome 7 (hepatocerebral type); Perrault syndrome 5,Pediatric
TXNRD2,Endocrine,Glucocorticoid deficiency 5,Pediatric
UBR1,Endocrine,Johanson-Blizzard syndrome,Pediatric
VDR,Endocrine,Vitamin D-dependent rickets; type 2A,Pediatric
WDPCP,Endocrine,Bardet-Biedl syndrome 15; Congenital heart defects; hamartomas of tongue; and polysyndactyly; Meckel-Gruber syndrome type 6; modifier of,N/A
WDR11,Endocrine,Hypogonadotropic hypogonadism 14 with or without anosmia,Pediatric
WDR4,Endocrine,Galloway-Mowat syndrome 6,Pediatric
WFS1,Endocrine,Wolfram syndrome 1,Pediatric
WNT3,Endocrine,Tetraamelia syndrome 1,N/A
WNT4,Endocrine,Mullerian aplasia and hyperandrogenism; 46;XX sex reversal with dysgenesis of kidneys; adrenals; and lungs (SERKAL syndrome),N/A
WRN,Endocrine,Werner syndrome,Pediatric
WT1,Endocrine,Denys-Drash syndrome; Wilms tumor; type 1; Frasier syndrome,Pediatric
XRCC4,Endocrine,Short stature; microcephaly; and endocrine dysfunction,Pediatric
ZFP57,Endocrine,Diabetes mellitus; transient neonatal; 1,Pediatric
ZIC2,Endocrine,Holoprosencephaly 5,N/A
ABCA3,Pulmonary,Surfactant metabolism dysfunction; pulmonary; 3; Interstitial lung disease,Pediatric
ACVRL1,Pulmonary,Telangiectasia; hereditary hemorrhagic; type 2,Pediatric
AFF4,Pulmonary,Cognitive impairment; coarse facies; Heart defects; Obesity; Pulmonary involvement; Short stature; and skeletal dysplasia (CHOPS syndrome),N/A
AKT1,Pulmonary,Cowden syndrome 6; Proteus syndrome ,Pediatric
ALG9,Pulmonary,Congenital disorder of glycosylation; type Il,Pediatric
AP3B1,Pulmonary,Hermansky-Pudlak syndrome 2,Pediatric
ARMC4,Pulmonary,Ciliary dyskinesia; primary; 23,Pediatric
ASAH1,Pulmonary,Farber lipogranulomatosis; Spinal muscular atrophy with progressive myoclonic epilepsy,N/A
BLM,Pulmonary,Bloom syndrome,Pediatric
BMPR2,Pulmonary,Pulmonary hypertension; primary 1; Pulmonary venoocclusive disease 1,Pediatric
CARMIL2,Pulmonary,Immunodeficiency 58,Pediatric
CAV1,Pulmonary,Pulmonary hypertension; primary 3; Lipodystrophy; familial partial; type 7; Lipodystrophy; congenital generalized; type 3,Pediatric
CC2D2A,Pulmonary,Joubert syndrome 9; Meckel syndrome 6; COACH syndrome,N/A
CCDC103,Pulmonary,Ciliary dyskinesia; primary; 17,Pediatric
CCDC114,Pulmonary,Ciliary dyskinesia; primary; 20,Pediatric
CCDC151,Pulmonary,Ciliary dyskinesia; primary; 30,Pediatric
CCDC39,Pulmonary,Ciliary dyskinesia; primary; 14,Pediatric
CCDC40,Pulmonary,Ciliary dyskinesia; primary; 15,Pediatric
CCDC65,Pulmonary,Ciliary dyskinesia; primary; 27,Pediatric
CCNO,Pulmonary,Ciliary dyskinesia; primary 29,Pediatric
CEP164,Pulmonary,Nephronophthisis 15,N/A
CEP290,Pulmonary,Leber congenital amaurosis 10; Meckel syndrome 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14,N/A
CEP41,Pulmonary,Joubert syndrome 15,N/A
CEP57,Pulmonary,Mosaic variegated aneuploidy syndrome 2,Pediatric
CFAP298,Pulmonary,Ciliary dyskinesia; primary 26,Pediatric
CFAP53,Pulmonary,Heterotaxy; visceral; 6; autosomal recessive,Pediatric
CFTR,Pulmonary,Cystic fibrosis,Pediatric
CHUK,Pulmonary,Cocoon syndrome,N/A
CSF2RA,Pulmonary,Surfactant metabolism dysfunction; pulmonary; 4,Pediatric
CSF2RB,Pulmonary,Surfactant metabolism dysfunction; pulmonary; 5,Pediatric
DCTN1,Pulmonary,Neuropathy; distal hereditary motor; type VIIB; Perry syndrome,N/A
DDRGK1,Pulmonary,Spondyloepimetaphyseal dysplasia; Shohat type,Pediatric
DKC1,Pulmonary,Dyskeratosis congenita; X-linked; Hoyeraal-Hreidarsson syndrome,Pediatric
DNAAF1,Pulmonary,Ciliary dyskinesia; primary; 13,Pediatric
DNAAF2,Pulmonary,Ciliary dyskinesia; primary; 10,Pediatric
DNAAF4,Pulmonary,Ciliary dyskinesia; primary 25,Pediatric
DNAAF5,Pulmonary,Ciliary dyskinesia; primary; 18,Pediatric
DNAH1,Pulmonary,Ciliary dyskinesia; primary; 37,Pediatric
DNAH11,Pulmonary,Ciliary dyskinesia; primary; 7,Pediatric
DNAH5,Pulmonary,Ciliary dyskinesia; primary; 3,Pediatric
DNAH9,Pulmonary,Ciliary dyskinesia; primary; 40,Pediatric
DNAI1,Pulmonary,Ciliary dyskinesia; primary; 1,Pediatric
DNAI2,Pulmonary,Ciliary dyskinesia; primary; 9,Pediatric
DNAJB13,Pulmonary,Ciliary dyskinesia; primary; 34,Pediatric
DNAL1,Pulmonary,Ciliary dyskinesia; primary; 16,Pediatric
DRC1,Pulmonary,Ciliary dyskinesia; primary; 21,Pediatric
ECM1,Pulmonary,Lipoid proteinosis,N/A
EDN3,Pulmonary,Waardenburg syndrome; type 4B; Central hypoventilation syndrome; congenital; Hirschsprung disease; susceptibility to; 4,Pediatric
EFEMP2,Pulmonary,Cutis laxa; autosomal recessive type IB,Pediatric
EIF2AK4,Pulmonary,Pulmonary venoocclusive disease 2,Pediatric
ELN,Pulmonary,Cutis laxa; autosomal dominant 1; Supravalvular aortic stenosis,Pediatric
ERF,Pulmonary,Chitayat syndrome,Pediatric
FAM111B,Pulmonary,Hereditary Fibrosing Poikiloderma with Tendon Contracture; Myopathy; and Pulmonary Fibrosis,N/A
FARSB,Pulmonary,Rajab interstitial lung disease with brain calcifications,Pediatric
FBLN5,Pulmonary,Neuropathy; hereditary; with or witout age-related macular degeneration; Macular degeneration; age-related; 3; Cutis laxa; autosomal dominant 2; Cutis laxa; autosomal recessive; type IA,N/A
FBN1,Pulmonary,Marfan syndrome; MASS syndrome; Shprintzen-Goldberg syndrome; Marfanoid-progeroid-lipodystrophy syndrome; Ectopia lentis 1; isolated; autosomal dominant,Pediatric
FLCN,Pulmonary,Birt-Hogg-Dube syndrome; Pneumothorax; primary spontaneous ,Adult
FLNA,Pulmonary,Cardiac valvular dysplasia; X-linked; Heterotopia; periventricular; Ehlers-Danlos variant;  Intestinal pseudoobstruction; neuronal; X-linked/Congenital short bowel syndrome,Pediatric
FOXF1,Pulmonary,Alveolar capillary dysplasia with misalignment of pulmonary veins,N/A
GAA,Pulmonary,Glycogen storage disease II,Pediatric
GALNS,Pulmonary,Mucopolysaccharidosis IVA (Morquio syndrome A),Pediatric
GAS8,Pulmonary,Ciliary dyskinesia; primary; 33,Pediatric
GATA2,Pulmonary,Immunodeficiency 21; Emberger syndrome; Myelodysplastic syndrome; Acute myeloid leukemia; familial; Chronic neutropenia associated with monocytopenia; evolving to myelodysplasia and acute myeloid leukemia,Pediatric
GDF1,Pulmonary,Congenital heart defects; multiple types; 6,N/A
GDF2,Pulmonary,Hereditary hemorrhagic telangiectasia; type 5,Pediatric
HBB,Pulmonary,Beta-thalassemia; Heinz body anemias; Erythrocytosis; familial 6; Sickle cell disease; Thalassemia-beta; dominant inclusion body; Other Thalassemias/Hemoglobinopathies,Pediatric
HPS1,Pulmonary,Hermansky-Pudlak syndrome 1,Pediatric
HPS3,Pulmonary,Hermansky-Pudlak syndrome 3,Pediatric
HPS4,Pulmonary,Hermansky-Pudlak syndrome 4,Pediatric
HPS5,Pulmonary,Hermansky-Pudlak syndrome 5,Pediatric
HPS6,Pulmonary,Hermansky-Pudlak syndrome 6,Pediatric
HYDIN,Pulmonary,Ciliary dyskinesia; primary; 5,Pediatric
HYLS1,Pulmonary,Hydrolethalus syndrome,N/A
IDUA,Pulmonary,Mucopolysaccharidosis type I,Pediatric
IFIH1,Pulmonary,Aicardi-Goutieres syndrome 7; Singleton-Merten syndrome 1,Pediatric
INPPL1,Pulmonary,Opsismodysplasia,Pediatric
INTU,Pulmonary,Orofaciodigital syndrome XVII; Short-rib throacic dysplasia 20 with polydactyly,N/A
ITCH,Pulmonary,Autoimmune disease; syndromic multisystem,Pediatric
ITGA3,Pulmonary,Interstitial lung disease with nephrotic syndrome and epidermolysis bullosa,N/A
KAT6A,Pulmonary,Mental retardation; autosomal dominant 32,N/A
KCNK3,Pulmonary,Pulmonary hypertension; primary; 4,Pediatric
LEFTY2,Pulmonary,Left-right axis malformations,N/A
LHX4,Pulmonary,Pituitary hormone deficiency; combined; 4,Pediatric
LRRC56,Pulmonary,Ciliary dyskinesia; primary 39,Pediatric
LRRC6,Pulmonary,Ciliary dyskinesia; primary 19,Pediatric
LTBP4,Pulmonary,Cutis laxa with severe pulmonary; gastrointestinal; and urinary abnormalities,N/A
MARS1,Pulmonary,Interstitial lung and liver disease,Pediatric
MIR140,Pulmonary,Spondyloepiphyseal dysplasia; Nishimura type,N/A
MYRF,Pulmonary,Encephalitis/encephalopathy; mild; with reversible myelin vacuolization,Pediatric
NEK8,Pulmonary,Nephronophthisis 9; Renal-hepatic-pancreatic dysplasia 2,N/A
NFIX,Pulmonary,Marshall-Smith syndrome; Sotos syndrome 2,N/A
NHLRC2,Pulmonary,Fibrosis; neurodegeneration; and cerebral angiomatosis,N/A
NHP2,Pulmonary,Dyskeratosis congenita; autosomal recessive 2,Pediatric
NKX2-1,Pulmonary,Choreoathetosis; hypothyroidism; and neonatal respiratory distress; Thyroid cancer; nonmedullary 1,Pediatric/Adult
NME8,Pulmonary,Ciliary dyskinesia; primary; 6,Pediatric
NOD2,Pulmonary,Blau syndrome; Sarcoidosis; early-onset,Pediatric
NODAL,Pulmonary,Heterotaxy; visceral; 5,N/A
NOP10,Pulmonary,Dyskeratosis congenita; autosomal recessive 1,Pediatric
NSDHL,Pulmonary,Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD syndrome); CK syndrome,N/A
NSMCE3,Pulmonary,Lung disease; immunodeficiency; and chromosome breakage syndrome (LICS),Pediatric
OFD1,Pulmonary,Orofaciodigital syndrome 1; Simpson-Golabi-Behmel syndrome type 2; Joubert syndrome 10; Retinitis pigmentosa 23,N/A
P4HTM,Pulmonary,Hypotonia; hyperventilation; impaired intellectual development; dysautonomia; epilepsy; and eye abnormalities,Pediatric
PARN,Pulmonary,Pulmonary fibrosis and/or bone marrow failure; telomere-related 4; Dyskeratosis congenita; autosomal recessive 6,Pediatric
PHGDH,Pulmonary,Phosphoglycerate dehydrogenase deficiency,Pediatric
PIH1D3,Pulmonary,Ciliary dyskinesia; primary; 36,Pediatric
PLA2G7,Pulmonary,Platelet-activating factor acetylhydrolase deficiency,N/A
PLG,Pulmonary,Plasminogen deficiency; type I,Pediatric
POLR3A,Pulmonary,Leukodystrophy; hypomyelinating; 7; with or without oligodontia and/or hypogonadotropic hypogonadism; Wiedemann-Rautenstrauch syndrome,N/A
RARB,Pulmonary,Microphthalmia; syndromic 12,N/A
RSPH1,Pulmonary,Ciliary dyskinesia; primary; 24,Pediatric
RSPH4A,Pulmonary,Ciliary dyskinesia; primary; 11,Pediatric
RSPH9,Pulmonary,Ciliary dyskinesia; primary; 12,Pediatric
RSPO2,Pulmonary,Tetraamelia syndrome 2; Humerofemoral hypoplasia with radiotibial ray deficiency,N/A
RTEL1,Pulmonary,Pulmonary fibrosis and/or bone marrow failure; telomere-related 3; Dyskeratosis congenita; autosomal dominant 4; Dyskeratosis congenita; autosomal recessive 5,Pediatric
SCNN1A,Pulmonary,Pseudohypoaldosteronism; type I; Liddle syndrome 3; Bronchiectasis with or without elevated sweat chloride 2,Pediatric
SCNN1B,Pulmonary,Pseudohypoaldosteronism; type I; Liddle syndrome 1; Bronchiectasis with or without elevated sweat chloride 1,Pediatric
SCNN1G,Pulmonary,Pseudohypoaldosteronism; type I; Liddle syndrome 2; Bronchiectasis with or without elevated sweat chloride 3,Pediatric
SERPINA1,Pulmonary,Alpha-1-Antitrypsin deficiency,Pediatric
SFTPA2,Pulmonary,Pulmonary fibrosis; idiopathic,Pediatric
SFTPB,Pulmonary,Surfactant metabolism dysfunction; pulmonary 1,Pediatric
SFTPC,Pulmonary,Surfactant metabolism dysfunction; pulmonary; 2,Pediatric
SLC34A2,Pulmonary,Pulmonary alveolar microlithiasis,Pediatric
SLC7A7,Pulmonary,Lysinuric protein intolerance,Pediatric
SMAD9,Pulmonary,Pulmonary hypertension; primary 2,Pediatric
SMPD1,Pulmonary,Niemann-Pick disease; type A; Niemann-Pick disease; type B,N/A
SPZ1,Pulmonary,Ciliary dyskinesia; primary; 38,Pediatric
STING1,Pulmonary,STING-associated vasculopathy; infantile-onsent (SAVI),N/A
STRA6,Pulmonary,Microphthalmia; syndromic 9,N/A
TAP1,Pulmonary,Bare lymphocyte syndrome; type I,Pediatric
TAP2,Pulmonary,Bare lymphocyte syndrome; type I,Pediatric
TBX4,Pulmonary,Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension,Pediatric
TERC,Pulmonary,Dyskeratosis congenita; autosomal dominant 1; Aplastic anemia; Pulmonary fibrosis and/or bone marrow failure; telomere-related 2,Pediatric
TERT,Pulmonary,Aplastic anemia; Dyskeratosis congenita; autosomal dominant; Dyskeratosis congenita; autosomal recessive; Pulmonary fibrosis and/or bone marrow failure; telomere-related 1,Pediatric
TINF2,Pulmonary,Dyskeratosis congenita; autosomal dominant 3; Revesz syndrome,Pediatric
TOR1AIP1,Pulmonary,Muscular dystrophy; autosomal recessive; with rigid spine and distal joint contractures,Pediatric
TRAIP,Pulmonary,Seckel syndrome 9,N/A
TREX1,Pulmonary,Aicardi-Goutieres syndrome 1,Pediatric
TRIP11,Pulmonary,Achondrogenesis; type IA; Odontochondrodysplasia,N/A
TSC1,Pulmonary,Tuberous sclerosis; Lymphangioleiomyomatosis,Pediatric
TSC2,Pulmonary,Tuberous sclerosis 2; Lymphangioleiomyomatosis ,Pediatric
WDR19,Pulmonary,Short-rib thoracic dysplasia 5 with or without polydactyly; Cranioectodermal dysplasia 4; Nephronophthisis 13; Retinitis pigmentosa; Senior-Loken syndrome 8,N/A
WDR60,Pulmonary,Short-rib thoracic dysplasia 8 with or without polydactyly,N/A
WNT4,Pulmonary,Mullerian aplasia and hyperandrogenism; 46;XX sex reversal with dysgenesis of kidneys; adrenals; and lungs (SERKAL syndrome),N/A
WRAP53,Pulmonary,Dyskeratosis congenita; autosomal recessive 3,Pediatric
WT1,Pulmonary,Denys-Drash syndrome; Wilms tumor; type 1; Frasier syndrome,Pediatric
ZFPM2,Pulmonary,46;XY sex reversal 9,Pediatric
ZIC3,Pulmonary,Congenital heart defects; nonsyndromic; 1; X-linked; Heterotaxy; visceral; 1; X-linked; VACTERL association; X-linked; with or without hydrocephalus,N/A
ZNF423,Pulmonary,Joubert syndrome 19; Nephronophthisis 14,N/A
AARS2,Musculoskeletal,Leukoencephalopathy; progressive; with ovarian failure,Pediatric
ABCC9,Musculoskeletal,Cardiomyopathy; dilated; 10; Atrial fibrillation; familial 12; Cantu syndrome,Pediatric
ABHD12,Musculoskeletal,Polyneuropathy; hearing loss; ataxia; retinitis pigmentosa; and cataract,N/A
ABL1,Musculoskeletal,Congenital heart defects and skeletal malformations syndrome (CHDSKM),Adult
ACAD8,Musculoskeletal,Isobutyryl-CoA dehydrogenase deficiency,Pediatric
ACAD9,Musculoskeletal,Mitochondrial complex I deficiency; nuclear type 20,Pediatric
ACADM,Musculoskeletal,Acyl-CoA dehydrogenase; medium chain; deficiency of,Pediatric
ACADS,Musculoskeletal,Acyl-CoA dehydrogenase; short-chain; deficiency of,Pediatric
ACADVL,Musculoskeletal,Acyl-CoA dehydrogenase; very long chain; deficiency of,Pediatric
ACAN,Musculoskeletal,Spondyloepimetaphyseal dysplasia; aggrecan type; Spondyloepiphyseal dysplasia; Kimberley type; Osteochondritis dissecans; short stature; and early-onset osteoarthritis ,N/A
ACER3,Musculoskeletal,Leukodystrophy; progressive; early childhood-onset (PLDECO),N/A
ACP5,Musculoskeletal,Spondyloenchondrodysplasia with immune dysregulation,Pediatric
ACTA1,Musculoskeletal,Myopathy; congenital; with fiber-type disproportion 1; Nemaline myopathy 3; Myopathy; nemaline; with stiffness and hypertonia; Myopathy; scapuloperoneal,N/A
ACTA2,Musculoskeletal,Moyamoya disease 5; Multisystemic smooth muscle dysfunction syndrome; Aortic aneurysm; familial thoracic 6,Pediatric
ACTB,Musculoskeletal,Baraitser-Winter syndrome 1,Pediatric
ACTG1,Musculoskeletal,Deafness; autosomal dominant 20; Baraitser-Winter syndrome 2,Pediatric
ACTL6B,Musculoskeletal,Intellectual developmental disorder with severe speech and ambulation defects; Epileptic encephalopathy; early infantile; 76,N/A
ACTN3,Musculoskeletal,ACTN3 deficiency,N/A
ACVR1,Musculoskeletal,Fibrodysplasia ossificans progressiva,N/A
ACVR2B,Musculoskeletal,Heterotaxy; visceral; 4; autosomal,N/A
ADAMTS10,Musculoskeletal,Weill-Marchesani syndrome 1,Pediatric
ADAMTS17,Musculoskeletal,Weill-Marchesan syndrome 4,Pediatric
ADAMTS2,Musculoskeletal,Ehlers-Danlos syndrome; dermatosparaxis type,Pediatric
ADAMTSL2,Musculoskeletal,Geleophysic dysplasia 1,Pediatric
ADCY6,Musculoskeletal,Lethal congenital contracture syndrome 8,N/A
ADGRG6,Musculoskeletal,Lethal congenital contracture syndrome 9,N/A
ADNP,Musculoskeletal,Helsmoortel-van der Aa syndrome (Mental retardation; autosomal dominant 28),N/A
AEBP1,Musculoskeletal,Ehlers-Danlos syndrome; classic-like; 2,Pediatric
AFF4,Musculoskeletal,Cognitive impairment; coarse facies; Heart defects; Obesity; Pulmonary involvement; Short stature; and skeletal dysplasia (CHOPS syndrome),N/A
AGA,Musculoskeletal,Aspartylglucosaminuria,N/A
AGK,Musculoskeletal,Sengers syndrome,Pediatric
AGL,Musculoskeletal,Glycogen storage disease III,Pediatric
AGPAT2,Musculoskeletal,Lipodystrophy; congenital generalized; type 1,Pediatric
AGPS,Musculoskeletal,Rhizomelic chondrodysplasia punctata; type 3,N/A
AGRN,Musculoskeletal,Myasthenic syndrome; congenital 8,Pediatric
AIFM1,Musculoskeletal,Deafness; X-linked 5,Pediatric
AKT1,Musculoskeletal,Cowden syndrome 6; Proteus syndrome ,Pediatric
AKT2,Musculoskeletal,Hypoinsulinemic hypoglycemia with hemihypertrophy,Pediatric
ALB,Musculoskeletal,Dysalbuminemic hyperthyroxinemia; Analbuminemia,Pediatric
ALDH18A1,Musculoskeletal,Cutis laxa; autosomal dominant 3; Spastic paraplegia 9A; autosomal dominant; Cutis laxa; autosomal recessive; type IIIA; Spastic paraplegia 9B; autosomal recessive,N/A
ALDOA,Musculoskeletal,Glycogen storage disease XII,Pediatric
ALG12,Musculoskeletal,Congenital disorder of glycosylation; type Ig,Pediatric
ALG14,Musculoskeletal,Myasthenic syndrome; congenital 15,Pediatric
ALG2,Musculoskeletal,Congenital disorder of glycosylation; type Ii; Myasthenic syndrome; congenital 14,Pediatric
ALG9,Musculoskeletal,Congenital disorder of glycosylation; type Il,Pediatric
ALKBH8,Musculoskeletal,Intellectual developmental disorder; autosomal recessive 71,N/A
ALPL,Musculoskeletal,Hypophosphatasia; infantile; Odontohypophosphatasia,Pediatric
ALX1,Musculoskeletal,Frontonasal dysplasia 3,N/A
ALX3,Musculoskeletal,Frontonasal dysplasia 1,N/A
ALX4,Musculoskeletal,Parietal foramina 2; Frontonasal dysplasia 2,N/A
AMER1,Musculoskeletal,Osteopathia striata with cranial sclerosis,N/A
AMMECR1,Musculoskeletal,Midface hypoplasia; hearing impairment; elliptocytosis; and nephrocalcinosis,Pediatric
AMPD1,Musculoskeletal,Myoadenylate deaminase deficiency,N/A
ANAPC1,Musculoskeletal,Rothmund-Thomson syndrome; type 1,Pediatric
ANKH,Musculoskeletal,Craniometaphyseal dysplasia; Chondrocalcinosis 2 ,N/A
ANKRD11,Musculoskeletal,KBG syndrome,N/A
ANO5,Musculoskeletal,Gnathodiaphyseal dysplasia,Pediatric
ANOS1,Musculoskeletal,Kallmann syndrome 1,Pediatric
ANTXR1,Musculoskeletal,Hemangioma; capillary infantile; susceptibility to; Growth retardation; alopecia; pseudoanodontia; and optic atrophy (GAPO syndrome),N/A
ANTXR2,Musculoskeletal,Hyalinosis; infantile systemic; Fibromatosis; juveline hyaline,Pediatric
AP1S2,Musculoskeletal,Mental retardation; X-linked syndromic; Fried type (Pettigrew syndrome),N/A
AP4B1,Musculoskeletal,Spastic paraplegia 47; autosomal recessive,N/A
APC,Musculoskeletal,Familial adenomatous polyposis; Gardner syndrome; Desmoid disease; hereditary,Pediatric
APRT,Musculoskeletal,Adenine phosphoribosyltransferase deficiency,Pediatric
ARCN1,Musculoskeletal,Rhizomelic short stature with microcephaly; micrognathia; and developmental delay (SRMMD),N/A
ARHGAP31,Musculoskeletal,Adams-Oliver syndrome 1,N/A
ARID1A,Musculoskeletal,Mental retardation; autosomal dominant 14; Coffin-Siris syndrome 2,N/A
ARID1B,Musculoskeletal,Coffin-Siris syndrome 1,N/A
ARID2,Musculoskeletal,Coffin-Siris syndrome 6,N/A
ARL6,Musculoskeletal,Retinitis pigmentosa 55; Bardet Biedl syndrome 3,N/A
ARMC9,Musculoskeletal,Joubert syndrome 30,Pediatric
ARSB,Musculoskeletal,Mucopolysaccharidosis type VI (Maroteaux-Lamy),Pediatric
ARSL,Musculoskeletal,Chondrodysplasia punctata 1; X-linked recessive ,N/A
ARX,Musculoskeletal,Partington X-linked mental retardation syndrome; Epileptic encephalopathy; early infantile; 1; Lissencephaly; X-linked 2; Hydranencephaly with abnormal genitalia; Mental retardation; X-linked 29/32/33/38/43/54/76/87; Proud syndrome; Corpus callosum; agenesis of; with abnormal genitalia,N/A
ASAH1,Musculoskeletal,Farber lipogranulomatosis; Spinal muscular atrophy with progressive myoclonic epilepsy,N/A
ASCC1,Musculoskeletal,Barrett esophagus/Esophageal adenocarcinoma,Adult
ASH1L,Musculoskeletal,Mental retardation; autosomal dominant; 50,N/A
ASXL1,Musculoskeletal,Bohring-Opitz syndrome,N/A
ASXL3,Musculoskeletal,Bainbridge-Ropers syndrome,N/A
ATAD3A,Musculoskeletal,Harel-Yoon syndrome,N/A
ATN1,Musculoskeletal,Congenital hypotonia; epilepsy; developmental delay; and digital anomalies; Dentatorubro-pallidoluysian atrophy,N/A
ATP2A1,Musculoskeletal,Brody myopathy,Pediatric
ATP5F1A,Musculoskeletal,Combined oxidative phosphorylation deficiency 22; Mitochondrial complex V (ATP synthase) deficiency; nuclear type 4,N/A
ATP6AP2,Musculoskeletal,Mental retardation; X-linked; syndromic; Hedera type; Parkinsonism with spasticity; X-linked,N/A
ATP6V0A2,Musculoskeletal,Cutis laxa; autosomal recessive; type IIA; Wrinkly skin syndrome,N/A
ATP6V1A,Musculoskeletal,Cutis laxa; autosomal recessive; type IID,Pediatric
ATP6V1B2,Musculoskeletal,Deafness; congenital; with onychodystrophy; autosomal dominant; Zimmermann-Laband syndrome 2,Pediatric
ATP6V1E1,Musculoskeletal,Cutis laxa; autosomal recessive; type IIC,Pediatric
ATP7A,Musculoskeletal,Menkes disease,Pediatric
ATPAF2,Musculoskeletal,Mitochondrial complex V (ATP synthase) deficiency; nuclear type 1,N/A
ATR,Musculoskeletal,Cutaneous telangiectasia and cancer syndrome; familial; Seckel syndrome 1,Pediatric
ATRX,Musculoskeletal,Alpha-thalassemia/mental retardation syndrome; Mental retardation-hypotonic facies syndrome; X-linked,N/A
AUTS2,Musculoskeletal,Mental retardation; autosomal dominant 26,N/A
AXIN1,Musculoskeletal,Caudal duplication anomaly,N/A
B3GALNT2,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 11,N/A
B3GALT6,Musculoskeletal,Ehlers-Danlos syndrome; spondylodysplastic type; 2; Spondyloepimetaphyseal dysplasia with joint laxity; type 1; with or without fractures,N/A
B3GAT3,Musculoskeletal,Multiple joint dislocations; short stature; craniofacial dysmorphism; and congenital heart defects,N/A
B3GLCT,Musculoskeletal,Peters-plus syndrome,Pediatric
B4GALT1,Musculoskeletal,Congenital disorder of glycosylation; type IId,Pediatric
B4GALT7,Musculoskeletal,Ehlers-Danlos syndrome; spondylodysplastic type; 1,N/A
B4GAT1,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 13,N/A
B9D1,Musculoskeletal,Joubert syndrome 27; Meckel syndrome 9,N/A
B9D2,Musculoskeletal,Meckel syndrome 10,N/A
BAG3,Musculoskeletal,Cardiomyopathy; dilated; 1HH; Myopathy; myofibrillar 6,Adult
BANF1,Musculoskeletal,Nestor-Guillermo progeria syndrome,N/A
BBIP1,Musculoskeletal,Bardet-Biedl syndrome 18,N/A
BBS1,Musculoskeletal,Bardet-Biedl syndrome 1,N/A
BBS10,Musculoskeletal,Bardet-Biedl syndrome 10,N/A
BBS12,Musculoskeletal,Bardet-Biedl syndrome 12,N/A
BBS2,Musculoskeletal,Bardet-Biedl syndrome 2; Retinitis pigmentosa 74,N/A
BBS4,Musculoskeletal,Bardet-Biedl syndrome 4,N/A
BBS5,Musculoskeletal,Bardet-Biedl syndrome 5,N/A
BBS7,Musculoskeletal,Bardet-Biedl syndrome 7,N/A
BBS9,Musculoskeletal,Bardet-Biedl syndrome 9,N/A
BCL11B,Musculoskeletal,Immunodeficiency 49; Intellectual developmental disorder with speech delay; dysmorphic facies; and T-cell abnormalities,Pediatric
BCOR,Musculoskeletal,Microphthalmia; syndromic 2; Oculofaciocardiodental syndrome,N/A
BCORL1,Musculoskeletal,Shukla-Vernon syndrome,N/A
BGN,Musculoskeletal,Meester-Loeys syndrome,Pediatric
BHLHA9,Musculoskeletal,Camptopolysyndactyly; complex; Syndactyly; mesoaxial synostotic; with phalangeal reduction,N/A
BICD2,Musculoskeletal,Spinal muscular atrophy; lower extremity-predominant; 2A; childhood onset; autosomal dominant; Spinal muscular atrophy; lower extremity-predominant; 2B; prenatal onset; autosomal dominant,N/A
BIN1,Musculoskeletal,Myopathy; centronuclear; 2,N/A
BLM,Musculoskeletal,Bloom syndrome,Pediatric
BMP1,Musculoskeletal,Osteogenesis imperfecta; type XIII,N/A
BMP2,Musculoskeletal,Short stature; facial dysmorphism; and skeletal anomalies with or without cardiac anomalies,Pediatric
BMP4,Musculoskeletal,Microphthalmia; syndromic 6; Orofacial cleft 11,N/A
BMPER,Musculoskeletal,Diaphanospondylodysostosis,N/A
BMPR1B,Musculoskeletal,Acromesomelic dysplasia; Demirhan type; Brachydactyly; type A1; D; Brachydactyly A2; Brachydactyly C/Symphalangism-like phenotype,N/A
BPTF,Musculoskeletal,Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies (NEDDFL),N/A
BRAF,Musculoskeletal,Noonan syndrome; Cardiofaciocutaneous syndrome 1; LEOPARD syndrome 3,Pediatric
BRCA1,Musculoskeletal,Breast-ovarian cancer; familial; susceptibility to; 1; Pancreatic cancer; susceptibility to; 4; Fanconi anemia; complementation group S,Pediatric (Fanconi anemia; complementation group S); (Adult (Breast-ovarian cancer; familial; susceptibility to; 1; Pancreatic cancer; susceptibility to; 4)
BRF1,Musculoskeletal,Cerebellofaciodental syndrome,N/A
BRIP1,Musculoskeletal,Breast cancer; Fanconi anemia; complementation group J,Pediatric (Fanconi anemia; complementation group J); Adult (Breast  cancer)
BRPF1,Musculoskeletal,Intellectual disability disorder with dysmorphic facies and ptosis (IDDDFP),N/A
BRWD3,Musculoskeletal,Mental retardation; X-linked 93,N/A
BUB1B,Musculoskeletal,Mosaic variegated aneuploidy syndrome; Premature chromatid separation trait,Pediatric
BVES,Musculoskeletal,Muscular dystrophy; limb-girdle; autosomal recessive; 25,Pediatric
C12ORF4,Musculoskeletal,Mental retardation; autosomal recessive 66,N/A
C15ORF41,Musculoskeletal,Congenital dyserythropoietic anemia type Ib,Pediatric
C1QBP,Musculoskeletal,Combined oxidative phosphorylation deficiency 33,Pediatric
C1R,Musculoskeletal,Ehlers-Danlos syndrome; periodontal type 1,Pediatric
C1S,Musculoskeletal,Ehlers-Danlos syndrome; periodontal type 2; Complement component C1s deficiency,Pediatric
C2CD3,Musculoskeletal,Orofaciodigital syndrome XIV,N/A
C5,Musculoskeletal, Eculizumab; poor response to; Complement component 5 deficiency,Pediatric
C8ORF37,Musculoskeletal,Bardet-Biedl syndrome 21; Cone-rod dystrophy 16; Retinitis pigmentosa 64,N/A
CA2,Musculoskeletal,Osteopetrosis; autosomal recessive 3; with renal tubular acidosis,Pediatric
CACNA1C,Musculoskeletal,Brugada syndrome 3; Timothy syndrome,Pediatric
CACNA1G,Musculoskeletal,Spinocerebellar ataxia 42; Spinocerebellar ataxia 42; early-onset; severe; with neurodevelopmental deficits,N/A
CACNA1S,Musculoskeletal,Malignant hyperthermia susceptibility 5; Thyrotoxic period paralysis; susceptibility 1; Hypokalemic periodic paralysis; type 1,Pediatric
CAMK2G,Musculoskeletal,Intellectual developmental disorder 59,N/A
CANT1,Musculoskeletal,Desbuquois dysplasia 1; Epiphyseal dysplasia; multiple; 7,N/A
CAPN3,Musculoskeletal,Muscular dystrophy; limb-girdle; autosomal recessive; 1; Eosinophilic myositis,N/A
CASQ1,Musculoskeletal,Myopathy; vacuolar; with CASQ1 aggregates,N/A
CASR,Musculoskeletal,Hyperparathyroidism; neonatal; Hypocalcemia; autosomal dominant 1; Hypocalciuric hypercalcemia; type I; Hyperparathyroidism; neonatal severe primary; Hypoparathyroidism; familial isolated; Hyperparathyroidism; familial primary,Pediatric
CAV1,Musculoskeletal,Pulmonary hypertension; primary 3; Lipodystrophy; familial partial; type 7; Lipodystrophy; congenital generalized; type 3,Pediatric
CAV3,Musculoskeletal,Cardiomyopathy; familial hypertrophic; Long QT syndrome 9; Creatine phosphokinase; elevated serum,Pediatric
CAVIN1,Musculoskeletal,Lipodystrophy; congenital generalized; type 4,N/A
CBL,Musculoskeletal,Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia; Juvenile myelomonocytic leukemia; familial,Pediatric
CBS,Musculoskeletal,Homocystinuria due to cystathionine beta-synthase deficiency,Pediatric
CC2D2A,Musculoskeletal,Joubert syndrome 9; Meckel syndrome 6; COACH syndrome,N/A
CCDC151,Musculoskeletal,Ciliary dyskinesia; primary; 30,Pediatric
CCDC174,Musculoskeletal,Hypotonia; infantile; with psychomotor retardation,N/A
CCDC22,Musculoskeletal,Ritscher-Schinzel syndrome 2,N/A
CCDC47,Musculoskeletal,Trichohepatoneurodevelopmental syndrome,Pediatric
CCDC78,Musculoskeletal,Myopathy; centronuclear; 4,N/A
CCDC8,Musculoskeletal,Three M syndrome 3,N/A
CCN6,Musculoskeletal,Spondyloepiphyseal dysplasia tarda with progressive arthropathy; Arthropathy; progressive pseudorheumatoid; of childhood,N/A
CCND2,Musculoskeletal,Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome,N/A
CCNK,Musculoskeletal,Intellectual developmental disorder with hypertelorism and distinctive facies,N/A
CCNQ,Musculoskeletal,Toe syndactyly; telecanthus; and anogenital and renal malformations (STAR syndrome),N/A
CD96,Musculoskeletal,C syndrome (Opitz trigonocephaly syndrome),N/A
CDAN1,Musculoskeletal,Anemia; dyserythropoietic  congenital; type Ia,Pediatric
CDC42,Musculoskeletal,Takenouchi-Kosaki syndrome,N/A
CDC45,Musculoskeletal,Meier-Gorlin syndrome 7,N/A
CDC6,Musculoskeletal,Meier-Gorlin syndrome 5,N/A
CDH11,Musculoskeletal,Elsahy-Waters syndrome,N/A
CDH15,Musculoskeletal,Mental retardation; autosomal dominant 3,N/A
CDH3,Musculoskeletal,Hypotrichosis; congenital; with juvenile macular dystrophy; Ectodermal dysplasia; ectrodactyly; and macular dystrophy syndrome,N/A
CDK10,Musculoskeletal,Al Kaissi syndrome,N/A
CDK13,Musculoskeletal,Congenital heart defects; dysmorphic facial features; and intellectual developmental disorder,N/A
CDK5,Musculoskeletal,Lissencephaly 7 with cerebellar hypoplasia,N/A
CDKN1C,Musculoskeletal,IMAGE syndrome; Beckwith-Wiedemann syndrome,Pediatric
CDT1,Musculoskeletal,Meier-Gorlin syndrome 4,N/A
CENPE,Musculoskeletal,Microcephaly 13; primary; autosomal recessive,N/A
CENPJ,Musculoskeletal,Seckel syndrome 4; Microcephaly; primary autosomal recessive; 6,N/A
CEP120,Musculoskeletal,Joubert syndrome 31; Short-rib thoracic dysplasia 13 with or without polydactyly,N/A
CEP135,Musculoskeletal,Microcephaly 8; primary; autosomal recessive,N/A
CEP152,Musculoskeletal,Seckel syndrome 5; Microcephaly 9; primary; autosomal recessive,N/A
CEP290,Musculoskeletal,Leber congenital amaurosis 10; Meckel syndrome 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14,N/A
CEP57,Musculoskeletal,Mosaic variegated aneuploidy syndrome 2,Pediatric
CEP63,Musculoskeletal,Seckel syndrome 6,N/A
CFAP410,Musculoskeletal,Retinal dystrophy with or without macular staphyloma; Spondylometaphyseal dysplasia; axial,N/A
CFAP57,Musculoskeletal,van der Woude syndrome 2,N/A
CFL2,Musculoskeletal,Nemaline myopathy 7,N/A
CHAMP1,Musculoskeletal,Mental retardation; autosomal dominant 40,N/A
CHAT,Musculoskeletal,Myasthenic syndrome; congenital 6; presynaptic,Pediatric
CHCHD10,Musculoskeletal,Myopathy; isolated mitochondrial; autosomal dominant,Pediatric
CHD3,Musculoskeletal,Snijders Blok-Campeau syndrome,N/A
CHD4,Musculoskeletal,Sifrim-Hitz-Weiss syndrome,Pediatric
CHD7,Musculoskeletal,CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia,Pediatric
CHKB,Musculoskeletal,Muscular dystrophy; congenital; megaconial type,Pediatric
CHP1,Musculoskeletal,Spastic ataxia 9; autosomal recessive,N/A
CHRM3,Musculoskeletal,Eagle-Barrett syndrome,N/A
CHRNA1,Musculoskeletal,Myasthenic syndrome; congenital; 1A; slow-channel; Myasthenic syndrome; congenital; 1B; fast-channel,Pediatric
CHRNB1,Musculoskeletal,Myasthenic syndrome; congenital; 2A; slow-channel; Myasthenic syndrome; congenital; 2C; associated with acetylcholine receptor deficiency,Pediatric
CHRND,Musculoskeletal,Myasthenic syndrome; congenital; 3A; slow-channel; Myasthenic syndrome; congenital; 3B; fast-channel; Myasthenic syndrome; congenital; 3C; associated with acetylcholine receptor deficiency,Pediatric
CHRNE,Musculoskeletal,Myasthenic syndrome; congenital; associated with acetylcholine receptor deficiency;  Myasthenic syndrome; congenital; 4B; fast-channel; Myasthenic syndrome; congenital; 4C; associated with acetylcholine receptor deficiency,Pediatric
CHRNG,Musculoskeletal,Multiple pterygium syndrome (Escobar syndrome),N/A
CHST11,Musculoskeletal,Osteochondrodysplasia; brachydactyly; and overlapping malformed digits,N/A
CHST14,Musculoskeletal,Ehlers-Danlos syndrome; musculocontractural type 1,Pediatric
CHST3,Musculoskeletal,Spondyloepiphyseal dysplasia with congenital joint dislocations,N/A
CHSY1,Musculoskeletal,Temtamy preaxial brachydactyly syndrome,Pediatric
CHUK,Musculoskeletal,Cocoon syndrome,N/A
CILK1,Musculoskeletal,Epilepsy; juvenile myoclonic; susceptibility to; 10; Endocrine-cerebroosteodysplasia,N/A
CIT,Musculoskeletal,Microcephaly 17; primary; autosomal recessive,N/A
CKAP2L,Musculoskeletal,Filippi syndrome,N/A
CLCF1,Musculoskeletal,Crisponi/Cold-induced sweating syndrome 2,Pediatric
CLCN1,Musculoskeletal,Myotonia congenita; autosomal dominant; Myotonia congenita; autosomal recessive; Myotonia levior,Pediatric
CLCN7,Musculoskeletal,Osteopetrosis; autosomal dominant 2; Osteopetrosis; autosomal recessive 4,Pediatric
CLIC2,Musculoskeletal,Mental retardation; X-linked; syndromic 32,Adult
CNBP,Musculoskeletal,Myotonic dystrophy 2,Pediatric
CNOT2,Musculoskeletal,Intellectual developmental disorder with nasal speech; dysmorphic facies; and variable skeletal anomalies,N/A
CNTN1,Musculoskeletal,Myopathy; congenital; Compton-North,N/A
CNTNAP1,Musculoskeletal,Lethal congenital contracture syndrome 7; Neuropathy; congenital hypomyelinating; 3,N/A
CNTNAP2,Musculoskeletal,Cortical dysplasia-focal epilepsy syndrome; Pitt-Hopkins like syndrome 1,N/A
COA3,Musculoskeletal,Mitochondrial complex IV deficiency,N/A
COG1,Musculoskeletal,Congenital disorder of glycosylation; type IIg,Pediatric
COG4,Musculoskeletal,Congenital disorder of glycosylation; type IIj,Pediatric
COG7,Musculoskeletal,Congenital disorder of glycosylation; type IIe,Pediatric
COL10A1,Musculoskeletal,Metaphyseal chondrodysplasia; Schmid type,N/A
COL11A1,Musculoskeletal,Stickler syndrome; type II; Fibrochondrogenesis; Marshall syndrome,Pediatric
COL11A2,Musculoskeletal,Deafness; autosomal dominant 13; Otospondylomegaepiphyseal dysplasia; autosomal dominant (Stickler syndrome; type III/Weissenbacher-Zweymuller syndrome); Fibrochondrogenesis 2; Otospondylomegaepiphyseal dysplasia; autosomal recessive; Deafness; autosomal recessive 53,Pediatric
COL12A1,Musculoskeletal,Bethlem myopathy 2; Ullrich congenital muscular dystrophy 2,N/A
COL13A1,Musculoskeletal,Myasthenic syndrome; congenital; 19,Pediatric
COL18A1,Musculoskeletal,Knobloch syndrome 1,N/A
COL1A1,Musculoskeletal,Ehlers-Danlos syndrome; classic type; 1,Pediatric
COL1A2,Musculoskeletal,Ehlers-Danlos syndrome; cardiac valvular form,Pediatric
COL25A1,Musculoskeletal,Fibrosis of extraocular muscles; congenital 5,N/A
COL27A1,Musculoskeletal,Steel syndrome,Pediatric
COL2A1,Musculoskeletal,Stickler syndrome; type I; Rhegmatogenous retinal detachment; autosomal dominant; Czech dysplasia; Otospondylomegaepiphyseal dysplasia; Epiphyseal dysplasia; multiple; with myopia and deafness; Avascular necrosis of femoral head; primary 1,Pediatric
COL3A1,Musculoskeletal,Ehlers-Danlos syndrome; vascular type; Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome,Pediatric
COL4A1,Musculoskeletal,Angiopathy; hereditary; with nephropathy; aneurysms; and muscle cramps; Brain small vessel disease 1 with or without ocular anomalies; Anterior segment dysgenesis with cerebral involvement; Porencephaly 1; Retinal artery tortuosity; Schizencephaly,Adult
COL5A1,Musculoskeletal,Ehlers-Danlos syndrome; classic type; 1,Pediatric
COL5A2,Musculoskeletal,Ehlers-Danlos syndrome; classic type; 2,Pediatric
COL6A1,Musculoskeletal,Ullrich congenital muscular dystrophy 1; Bethlem myopathy 1,N/A
COL6A2,Musculoskeletal,Ullrich congenital muscular dystrophy 1 ; Myosclerosis; congenital; Bethlem myopathy 1; Epilepsy; progressive myoclonic; autosomal recessive,N/A
COL6A3,Musculoskeletal,Ullrich congenital muscular dystrophy 1; Bethlem myopathy 1; Dystonia 27,N/A
COL9A1,Musculoskeletal,Stickler syndrome; type IV,Pediatric
COL9A2,Musculoskeletal,Stickler syndrome; Type V,Pediatric
COL9A3,Musculoskeletal,Epiphyseal dysplasia; multiple; 3,N/A
COLEC10,Musculoskeletal,3MC syndrome 3,N/A
COLEC11,Musculoskeletal,3MC syndrome 2,Pediatric
COLQ,Musculoskeletal,Myasthenic syndrome; congenital; 5,Pediatric
COMP,Musculoskeletal,Epiphyseal dysplasia; multiple; 1; Pseudoachondroplasia,N/A
COQ2,Musculoskeletal,Coenzyme Q10 deficiency 1,Pediatric
COQ6,Musculoskeletal,Coenzyme Q10 deficiency; primary 6,Pediatric
COQ7,Musculoskeletal,Coenzyme Q10 deficiency; primary 8,Pediatric
COQ9,Musculoskeletal,Coenzyme Q10 deficiency 5,Pediatric
COX10,Musculoskeletal,Mitochondrial complex IV deficiency; Leigh syndrome,N/A
COX14,Musculoskeletal,Mitochondrial complex IV deficiency,N/A
COX15,Musculoskeletal,Leigh syndrome; Cardioencephalomyopathy; fatal infantile; due to cytochrome c oxidase deficiency 2,N/A
COX20,Musculoskeletal,Mitochondrial complex IV deficiency,N/A
COX4I2,Musculoskeletal,Exocrine pancreatic insufficiency; dyserythropoietic anemia; and calvarial hyperostosis,Pediatric
COX6A1,Musculoskeletal,Charcot-Marie-Tooth disease; recessive intermediate D,N/A
COX6B1,Musculoskeletal,Mitochondrial complex IV deficiency,N/A
COX7B,Musculoskeletal,Linear skin defects with multiple congenital anomalies 2,N/A
COX8A,Musculoskeletal,Mitochondrial complex IV deficiency,N/A
CPLANE1,Musculoskeletal,Joubert syndrome 17; Orofaciodigital syndrome VI,N/A
CPT1A,Musculoskeletal,Carnitine palmitoyltransferase deficiency I,Pediatric
CPT2,Musculoskeletal,Carnitine palmitoyltransferase II deficiency,Pediatric
CREB3L1,Musculoskeletal,Osteogenesis imperfecta; type XVI,N/A
CREBBP,Musculoskeletal,Rubinstein-Taybi syndrome; Menke-Hennekam syndrome 1,Pediatric
CRIPT,Musculoskeletal,Short stature with microcephaly and distinctive facies,N/A
CRLF1,Musculoskeletal,Crisponi/Cold-induced sweating syndrome; type 1,Pediatric
CRPPA,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital; with brain and eye anomalies); type A; 7; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 7,N/A
CRTAP,Musculoskeletal,Osteogenesis imperfecta; type VII,N/A
CRYAB,Musculoskeletal,Myopathy; myofibrillar; 2; Cardiomyopathy; dilated; 1II ,Pediatric
CSF1R,Musculoskeletal,Leukoencephalopathy; diffuse hereditary; with spheroids; Brain abnormalities; neurodegeneration; and dysosteosclerosis,N/A
CSNK2A1,Musculoskeletal,Okur-Chung neurodevelopmental syndrome,Pediatric
CSPP1,Musculoskeletal,Jeune asphyxiating thoracic dystrophy; Joubert syndrome 21,N/A
CSRP3,Musculoskeletal,Cardiomyopathy; familial hypertrophic 12; Cardiomyopathy; dilated; 1M,Pediatric
CTC1,Musculoskeletal,Cerebroretinal microangiopathy with calcifications and cysts 1,N/A
CTDP1,Musculoskeletal,Congenital cataracts; facial dysmorphism; and neuropathy,Pediatric
CTNS,Musculoskeletal,Cystinosis,Pediatric
CTSA,Musculoskeletal,Galactosialidosis,Pediatric
CTSK,Musculoskeletal,Pycnodysostosis,N/A
CTU2,Musculoskeletal,Microcephaly; facial dysmorphism; renal agenesis; and ambiguous genitalia syndrome,N/A
CUL4B,Musculoskeletal,Mental retardation; X-linked; syndromic 15 (Cabezas type),N/A
CUL7,Musculoskeletal,Three M syndrome 1; Yakut short stature syndrome,N/A
CWC27,Musculoskeletal,Retinitis pigmentosa with or without skeletal anomalies (RPSKA),N/A
CYTB,Musculoskeletal,Myoglobinuria; recurrent; Leber hereditary optic neuropathy; Cardiomyopathy; infantile histiocytoid,N/A
DAG1,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 9; Muscular dystrophy-dystroglycanopathy; type C; 9,N/A
DCC,Musculoskeletal,Mirror movements 1; Gaze palsy; familial horizontal; with progressive scoliosis 2,N/A
DCHS1,Musculoskeletal,Mitral valve prolapse 2; Van Maldegrem syndrome 1,Pediatric
DCPS,Musculoskeletal,Al-Raqad syndrome,N/A
DDR2,Musculoskeletal,Warburg-Cinotti syndrome,Pediatric
DDRGK1,Musculoskeletal,Spondyloepimetaphyseal dysplasia; Shohat type,Pediatric
DDX11,Musculoskeletal,Warsaw breakage syndrome,N/A
DDX3X,Musculoskeletal,Mental retardation; X-linked 102,N/A
DDX58,Musculoskeletal,Singleton-Merten syndrome 2,Pediatric
DDX59,Musculoskeletal,Orofaciodigital syndrome V,N/A
DES,Musculoskeletal,Myopathy; myofibrillar 1; Cardiomyopathy; dilated; 1I; Muscular dystrophy; limb-girdle; type 2R,Pediatric
DGUOK,Musculoskeletal,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type),Pediatric
DHCR24,Musculoskeletal,Desmosterolosis,N/A
DHCR7,Musculoskeletal,Smith-Lemli-Opitz syndrome,Pediatric
DHODH,Musculoskeletal,Postaxial acrofacial dysostosis (Miller syndrome),N/A
DHPS,Musculoskeletal,Neurodevelopmental disorder with seizures and speech and walking impairment,N/A
DHTKD1,Musculoskeletal,Charcot-Marie-Tooth disease; axonal; type 2Q; 2-aminoadipic and 2-oxoadipic aciduria,N/A
DHX30,Musculoskeletal,Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL),N/A
DIAPH1,Musculoskeletal,Deafness; autosomal dominant 1,Pediatric
DIS3L2,Musculoskeletal,Perlman syndrome,Pediatric
DLG3,Musculoskeletal,Mental retardation; X-linked 90,N/A
DLL3,Musculoskeletal,Spondylocostal dysostosis 1; autosomal recessive,N/A
DLL4,Musculoskeletal,Adams-Oliver syndrome 6,N/A
DLX3,Musculoskeletal,Trichodontoosseous syndrome; Amelogenesis imperfecta; type IV,N/A
DLX5,Musculoskeletal,Split-hand/foot malformation 1 with sensorineural hearing loss,Pediatric
DMD,Musculoskeletal,Duchenne muscular dystrophy; Becker muscular dystrophy; Cardiomyopathy; dilated; 3B,Pediatric
DMGDH,Musculoskeletal,Dimethylglycine dehydrogenase deficiency,N/A
DMPK,Musculoskeletal,Myotonic dystrophy 1,Pediatric
DNA2,Musculoskeletal,Progressive external ophthalmoplegia with mitochondrial deletions; autosomal dominant; 6; Seckel syndrome 8,N/A
DNAJB6,Musculoskeletal,Muscular dystrophy; limb-girdle; type 1E,N/A
DNAJC21,Musculoskeletal,Bone marrow failure syndrome 3,Pediatric
DNM2,Musculoskeletal,Charcot-Marie-Tooth disease; dominant intermediate B; Charcot-Marie-Tooth disease; axonal; type 2M; Myopathy; centronuclear; 1; Lethal congenital contracture syndrome 5,N/A
DNMT3A,Musculoskeletal,Tatton-Brown-Rahman syndrome,N/A
DOCK3,Musculoskeletal,Neurodevelopmental disorder with impaired intellectual development; hypotonia; and ataxia,N/A
DOCK6,Musculoskeletal,Adams-Oliver syndrome 2,N/A
DOK7,Musculoskeletal,Myasthenic syndrome; congenital; 10,Pediatric
DOLK,Musculoskeletal,Congenital disorder of glycosylation; type Im,Pediatric
DONSON,Musculoskeletal,Microcephaly; short stature; and limb abnormalities (MISSLA); Microcephaly-Micromelia syndrome,N/A
DPAGT1,Musculoskeletal,Myasthenic syndrome; congenital; 13; Congenital disorder of glycosylation; type Ij,Pediatric
DPF2,Musculoskeletal,Coffin-Siris syndrome 7,N/A
DPH1,Musculoskeletal,Developmental delay with short stature; dysmorphic features; and sparse hair,N/A
DPM2,Musculoskeletal,Congenital disorder of glycosylation; type Iu,Pediatric
DPM3,Musculoskeletal,Muscular dystrophy-dystroglycanopathy; type C; 15 (Congenital disorder of glycosylation; type Io),Pediatric
DPP6,Musculoskeletal,Ventricular fibrillation; paroxysmal familial; 2,Pediatric
DRD2,Musculoskeletal,Myoclonic dystonia,N/A
DSE,Musculoskeletal,Ehlers-Danlos syndrome; musculocontractural type 2,Pediatric
DUSP6,Musculoskeletal,Hypogonadotropic hypogonadism 19; with or without anosmia,Pediatric
DUX4,Musculoskeletal,Facioscapulohumeral muscular dystrophy; type 2,N/A
DVL1,Musculoskeletal,Robinow syndrome; autosomal dominant 2,N/A
DYM,Musculoskeletal,Dyggve-Melchior-Clausen disease; Smith-McCort dysplasia 1,N/A
DYNC1H1,Musculoskeletal,Charcot-Marie-Tooth disease; axonal; type 2O; Mental retardation; autosomal dominant 13; Spinal muscular atrophy; lower extremity-predominant 1; autosomal dominant,N/A
DYNC2H1,Musculoskeletal,Short-rib thoracic dysplasia 3 with or without polydactyly,N/A
DYNC2LI1,Musculoskeletal,Short-rib throacic dysplasia 15 with polydactyly,N/A
DYSF,Musculoskeletal,Miyoshi muscular dystrophy 1; Muscular dystrophy; limb-girdle; autosomal recessive; 2; Myopathy; distal; with anterior tibial onset,Pediatric
EBP,Musculoskeletal,Chondrodysplasia punctata 2; X-linked dominant; Male EBP disorder with neurologic defects (MEND),N/A
ECE1,Musculoskeletal,Hirschsprung disease; cardiac defects; and autonomic dysfunction,N/A
ECEL1,Musculoskeletal,Arthrogryposis; distal; type 5D,N/A
EED,Musculoskeletal,Cohen-Gibson syndrome,N/A
EFEMP2,Musculoskeletal,Cutis laxa; autosomal recessive type IB,Pediatric
EFL1,Musculoskeletal,Shwachman-Diamond syndrome 2,Pediatric
EFNB1,Musculoskeletal,Craniofrontonasal dysplasia,N/A
EFTUD2,Musculoskeletal,Mandibulofacial dysostosis; Guion-Almeida type; Esophageal atresia; syndromic,Pediatric
EHMT1,Musculoskeletal,Kleefstra syndrome 1,N/A
EIF2AK3,Musculoskeletal,Epiphyseal dysplasia; multiple; with early-onset diabetes mellitus (Wolcott-Rallison syndrome),Pediatric
EIF2S3,Musculoskeletal,MEHMO syndrome,Pediatric
EIF4A3,Musculoskeletal,Richieri-Costa-Pereira Syndrome,N/A
ELMO2,Musculoskeletal,Vascular malformation; primary intraosseus,Pediatric
ELN,Musculoskeletal,Cutis laxa; autosomal dominant 1; Supravalvular aortic stenosis,Pediatric
EMD,Musculoskeletal,Emery-Dreifuss muscular dystrophy 1; X-linked,Pediatric
EMG1,Musculoskeletal,Bowen-Conradi syndrome,N/A
ENO3,Musculoskeletal,Glycogen storage disease XIII,N/A
ENPP1,Musculoskeletal,Hypophosphatemic rickets; autosomal recessive 2; Arterial calcification; generalized; of infancy; 1,Pediatric
EOGT,Musculoskeletal,Adams-Oliver syndrome 4,N/A
EP300,Musculoskeletal,Rubinstein-Taybi syndrome 2; Menke-Hennekam syndrome 2,Pediatric
EPCAM,Musculoskeletal,Colorectal cancer; hereditary nonpolyposis; type 8; Diarrhea 5; with tufting enteropathy; congenital,Pediatric
EPG5,Musculoskeletal,Vici syndrome,Pediatric
ERBB3,Musculoskeletal,Erythroleukemia; familial; susceptibility to (AD),N/A
ERCC1,Musculoskeletal,Cerebrooculofacioskeletal syndrome 4,N/A
ERCC2,Musculoskeletal,Trichothiodystrophy 1; photosensitive; Xeroderma pigmentosum; group D,Pediatric
ERCC3,Musculoskeletal,Xeroderma pigmentosum; complementation group B; Trichothiodystrophy 2; photosensitive,Pediatric
ERCC4,Musculoskeletal,Fanconi anemia; complementation group Q; Xeroderma pigmentosum; group F,Pediatric
ERCC5,Musculoskeletal,Xeroderma pigmentosum; complementation group G; Xeroderma pigmentosum; complementation group G/Cockayne syndrome,Pediatric
ERCC6,Musculoskeletal,Premature ovarian failure 11; Xeroderma Pigmentosum-Cockayne Syndrome; De Sanctis-Cacchione syndrome,Pediatric
ERCC8,Musculoskeletal,UV-sensitive syndrome 2; Cockayne syndrome A,N/A
ERF,Musculoskeletal,Chitayat syndrome,Pediatric
ERGIC1,Musculoskeletal,Arthrogryposis multiplex congenita; neurogenic type,N/A
ESCO2,Musculoskeletal,SC phocomelia syndrome; Roberts syndrome,N/A
ETFA,Musculoskeletal,Multiple acyl-CoA dehydrogenase deficiency; Glutaric aciduria II,Pediatric
ETFB,Musculoskeletal,Multiple acyl-CoA dehydrogenase deficiency; Glutaric aciduria II,Pediatric
ETFDH,Musculoskeletal,Multiple acyl-CoA dehydrogenase deficiency; Glutaric aciduria II,Pediatric
EVC,Musculoskeletal,Ellis-van Creveld syndrome; Weyers acrofacial dysostosis,N/A
EVC2,Musculoskeletal,Ellis-van Creveld syndrome; Weyers acrodental dysostosis,N/A
EXOC6B,Musculoskeletal,Spondyloepimetaphyseal dysplasia with joint laxity 3,N/A
EXOSC2,Musculoskeletal,Short stature; hearing loss; retinitis pigmentosa; and distinctive facies (SHRF),Pediatric
EXT1,Musculoskeletal,Exostoses; multiple; type 1,Pediatric
EXT2,Musculoskeletal,Exostoses; multiple; type 2,Pediatric
EXTL3,Musculoskeletal,Immunoskeletal dysplasia with neurodevelopmental abnormalities (ISDNA),Pediatric
EZH2,Musculoskeletal,Weaver syndrome,N/A
FAH,Musculoskeletal,Tyrosinemia; type I,Pediatric
FAM111A,Musculoskeletal,Kenny-Caffey syndrome; type 2,Pediatric
FAM111B,Musculoskeletal,Hereditary Fibrosing Poikiloderma with Tendon Contracture; Myopathy; and Pulmonary Fibrosis,N/A
FAM20C,Musculoskeletal,Hypophosphatemia; hyperphosphaturia; dental anomalies; intracerebral calcifications and osteosclerosis (Raine syndrome),Pediatric
FAM92A,Musculoskeletal,Polydactyly; postaxial; type A9,N/A
FANCA,Musculoskeletal,Fanconi anemia; complementation group A,Pediatric
FANCB,Musculoskeletal,Fanconi anemia;complementation group B,Pediatric
FANCC,Musculoskeletal,Fanconi anemia; complementation group C,Pediatric
FANCD2,Musculoskeletal,Fanconi anemia; complementation group D2,Pediatric
FANCE,Musculoskeletal,Fanconi anemia; complementation group E,Pediatric
FANCF,Musculoskeletal,Fanconia anemia; complementation group F,Pediatric
FANCG,Musculoskeletal,Fanconi anemia type G,Pediatric
FANCI,Musculoskeletal,Fanconi anemia; complementation group I,Pediatric
FANCL,Musculoskeletal,Fanconi anemia; complementation group L,Pediatric
FANCM,Musculoskeletal,Fanconi anemia type M; Premature ovarian failure 15,Pediatric
FARS2,Musculoskeletal,Combined oxidative phosphorylation deficiency 14; Spastic paraplegia 77; autosomal recessive,N/A
FARSB,Musculoskeletal,Rajab interstitial lung disease with brain calcifications,Pediatric
FAT4,Musculoskeletal,Hennekam lymphangiectasia-lymphedema syndrome 2,Pediatric
FBLN1,Musculoskeletal,Synpolydactyly 2,N/A
FBN1,Musculoskeletal,Marfan syndrome; MASS syndrome; Shprintzen-Goldberg syndrome; Marfanoid-progeroid-lipodystrophy syndrome; Ectopia lentis 1; isolated; autosomal dominant,Pediatric
FBN2,Musculoskeletal,Congenital contractural arachnodactyly (Beals syndrome),Pediatric
FBXL3,Musculoskeletal,Intellectual developmental disorder with short stature; facial anomalies; and speech defects,N/A
FBXO11,Musculoskeletal,Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,N/A
FDFT1,Musculoskeletal,Squalene synthase deficiency,N/A
FDX2,Musculoskeletal,Mitochondrial myopathy; episodic; with or without optic atrophy and reversible leukoencephalopathy,Pediatric
FGA,Musculoskeletal,Afibrinogenemia; congenital; Dysfibrinogenemia; congenital; Hypodysfibrinogenemia; congenital; Familial visceral amyloidosis,Pediatric
FGD1,Musculoskeletal,Aarskog-Scott syndrome; Mental retardation; X-linked syndromic 16,N/A
FGF10,Musculoskeletal,Lacrimoauriculodentodigital syndrome,Pediatric
FGF16,Musculoskeletal,Metacarpal 4-5 fusion,N/A
FGF17,Musculoskeletal,Hypogonadotropic hypogonadism 20; with or without anosmia,Pediatric
FGF23,Musculoskeletal,Hypophosphatemic rickets; autosomal dominant; Tumoral calcinosis; hyperphosphatemic; familial; 2,Pediatric
FGF8,Musculoskeletal,Hypogonadotropic hypogonadism 6; with or without anosmia,Pediatric
FGF9,Musculoskeletal,Multiple synostoses syndrome 3,N/A
FGFR1,Musculoskeletal,Hypogonadotropic hypogonadism 2 with or without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome,Pediatric
FGFR2,Musculoskeletal,Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Sraniofacial-skeletal-dermatological dysplasia; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome,Pediatric
FGFR3,Musculoskeletal,Camptodactyly; tall stature; and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Lacrimoauriculodentodigital syndrome; Muenke syndrome,Pediatric
FHL1,Musculoskeletal,Reducing bod myopathy; X-linked 1A; with infantile or early childhood onset; Reducing bod myopathy; X-linked 1B; with late childhood or adult onset; Emery-Dreifuss muscular dystrophy 6; X-linked; Myopathy; X-linked; with postural muscle atrophy; Uruguay faciocardiomusculoskeletal syndrome,Pediatric
FIBP,Musculoskeletal,Thauvin-Robinet-Faivre syndrome,Pediatric
FIG4,Musculoskeletal,Amyotrophic lateral sclerosis 11; Charcot-Marie Tooth disease; autosomal recessive; type 4J; Polymicrogyria; bilateral temporooccipital; Yunis-Varon syndrome,N/A
FITM2,Musculoskeletal,Siddiqi syndrome,Pediatric
FKBP10,Musculoskeletal,Osteogenesis imperfecta; type XI; Bruck syndrome 1,N/A
FKBP14,Musculoskeletal,Ehlers-Danlos syndrome; kyphoscoliotic type; 2,Pediatric
FKRP,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 5; Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation); type B; 5; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 5,Pediatric
FKTN,Musculoskeletal,Cardiomyopathy; dilated; 1X; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 4; Muscular dystrophy-dystroglycanopathy (congenital without mental retardation); type B; 4; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 4,Pediatric
FLNA,Musculoskeletal,Cardiac valvular dysplasia; X-linked; Heterotopia; periventricular; Ehlers-Danlos variant;  Intestinal pseudoobstruction; neuronal; X-linked/Congenital short bowel syndrome,Pediatric
FLNB,Musculoskeletal,Larsen syndrome; Spondylocarpotarsal synostosis syndrome; Boomerang dysplasia; Atelosteogenesis; type I; Atelosteogenesis; type III,Pediatric
FLNC,Musculoskeletal,Cardiomyopathy; familial hypertrophic 26; Cardiomyopthy; familial restrictive 5; Myopathy; distal; 4; Myopathy; myofibrillar; 5,Adult
FLRT3,Musculoskeletal,Hypogonadotropic hypogonadism 21; with or without anosmia,Pediatric
FLVCR2,Musculoskeletal,Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome,N/A
FN1,Musculoskeletal,Glomerulopathy with fibronectin deposits 2; Spondylometaphyseal dysplasia; corner fracture type,N/A
FOXC1,Musculoskeletal,Peters anomaly; Axenfeld-Rieger syndrome; type 3; Anterior segment dysgenesis 3,Adult
FOXC2,Musculoskeletal,Lymphedema-distichiasis syndrome,N/A
FOXE1,Musculoskeletal,Thyroid cancer; nonmedullary 4; Hypothyroidism; thyroidal; with spiky hair and cleft palate (Bamforth-Lazarus syndrome); Congenital hypothyroidism,Pediatric/Adult
FOXF1,Musculoskeletal,Alveolar capillary dysplasia with misalignment of pulmonary veins,N/A
FOXP2,Musculoskeletal,Speech-language disorder 1,N/A
FOXRED1,Musculoskeletal,Mitochondrial complex I deficiency; nuclear type 19; Leigh syndrome,N/A
FRAS1,Musculoskeletal,Fraser syndrome 1,N/A
FREM1,Musculoskeletal,Bifid nose with or without anorectal and renal anomalies; Trigonocephaly 2; Manitoba oculotrichoanal syndrome; Congenital diaphragmatic hernia; autosomal recessive,N/A
FREM2,Musculoskeletal,Fraser syndrome 2; Cryptophthalmos; unilateral or bilateral; isolated,N/A
FSHMD1A,Musculoskeletal,Facioscapulohumeral muscular dystrophy 1A,Pediatric
FTO,Musculoskeletal,Growth retardation; developmental delay; and facial dysmorphism,N/A
FUCA1,Musculoskeletal,Fucosidosis,N/A
FUT8,Musculoskeletal,Congenital disorder of glycosylation with defective fucosylation 1,N/A
FUZ,Musculoskeletal,Neural tube defects; susceptibility to,N/A
FXN,Musculoskeletal,Friedreich ataxia 1,Pediatric
FZD2,Musculoskeletal,Omodysplasia 2,N/A
G6PC,Musculoskeletal,Glycogen storage disease Ia,Pediatric
GAA,Musculoskeletal,Glycogen storage disease II,Pediatric
GABBR2,Musculoskeletal,Epileptic encephalopathy; early infantile; 59; Neurodevelopmental disorder with poor language and loss of hand skills (AD),N/A
GALNS,Musculoskeletal,Mucopolysaccharidosis IVA (Morquio syndrome A),Pediatric
GALNT3,Musculoskeletal,Tumoral calcinosis; hyperphosphatemic; familial; 1,Pediatric
GAN,Musculoskeletal,Giant axonal neuropathy 1; autosomal recessive,N/A
GATA6,Musculoskeletal,Heart defects; congenital; and other congenital anomalies,Pediatric
GBA,Musculoskeletal,Gaucher disease,Pediatric
GBE1,Musculoskeletal,Glycogen storage disease IV,Pediatric
GDF3,Musculoskeletal,Microphthalmia; isolated 7; Microphthalmia; isolated; with coloboma 6; Klippel-Feil syndrome 3; autosomal dominant; Coloboma; ocular,N/A
GDF5,Musculoskeletal,Acromesomelic dysplasia; Hunter-Thompson type; Fibular hypoplasia and complex brachydactyly; Multiple synostoses syndrome 2; Chondrodysplasia; Grebe type; Symphalangism; proximal 1B; Brachydactyly; type A1; Brachydactyly; type A1; C; Brachydactyly; type A2; Brachydactyly; type C,N/A
GDF6,Musculoskeletal,Microphthalmia; isolated 4; Microphthalmia; isolated; with coloboma 6; Multiple synostoses syndrome 4; Coloboma; ocular; Klippel-Feil syndrome 1; autosomal dominant; Leber congenital amaurosis 17,N/A
GFER,Musculoskeletal,Myopathy; mitochondrial progressive; with congenital cataract; hearing loss; and developmental delay ,N/A
GFM1,Musculoskeletal,Combined oxidative phosphorylation deficiency 1,N/A
GFM2,Musculoskeletal,Combined oxidative phosphorylation deficiency 39,N/A
GFPT1,Musculoskeletal,Myasthenic syndrome; congenital 12,Pediatric
GGCX,Musculoskeletal,Vitamin K-dependent clotting factors; combined deficiency of; 1; Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency,Pediatric
GHSR,Musculoskeletal,Short stature,N/A
GJA1,Musculoskeletal,Oculodentodigital dysplasia,Pediatric
GLB1,Musculoskeletal,Mucopolysaccharidosis type IVB (Morquio syndrome B); GM1-gangliosidosis; type I; GM1-gangliosidosis; type II; GM1-gangliosidosis; type III,N/A
GLDN,Musculoskeletal,Lethal congenital contracture syndrome 11,N/A
GLE1,Musculoskeletal,Congenital arthrogryposis with anterior horn cell disease; Lethal congenital contracture syndrome 1,N/A
GLI1,Musculoskeletal,Polydactyly; postaxial; type A8; Polydactyly; preaxial I,N/A
GLI2,Musculoskeletal,Culler-Jones syndrome,Pediatric
GLI3,Musculoskeletal,Acrocallosal syndrome; Pallister-Hall syndrome; Grieg cephalopolysndactyly syndrome; Polydactyly; postaxial; type A1; Polydactyly; preaxial; type IV; Polydactyly; postaxial; types A1 and B,N/A
GLIS3,Musculoskeletal,Diabetes mellitus; neonatal; with congenital hypothyroidism,Pediatric
GMNN,Musculoskeletal,Meier-Gorlin syndrome 6,N/A
GMPPB,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 14; Limb-girdle muscular dystrophy-dystroglycanopathy; type B; 14; Limb-girdle muscular dystrophy-dystroglycanopathy; type C; 14,Pediatric
GNAI3,Musculoskeletal,Auriculocondylar syndrome 1,N/A
GNAS,Musculoskeletal,Pseudohypoparathyroidism; type IA; Pseudohypoparathyroidism; type IB; Pseudohypoparathyroidism; type IC; Progressive osseous heteroplasia; McCune-Albright syndrome,Pediatric
GNE,Musculoskeletal,Sialuria; French type ; Nonaka myopathy; Inclusion body myopathy; autosomal recessive,N/A
GNPAT,Musculoskeletal,Rhizomelic chondrodysplasia punctata; rhizomelic; type 2,N/A
GNPTAB,Musculoskeletal,Mucolipidosis III alpha/beta (Pseudo-Hurler polydstrophy); Mucolipidosis II alpha/beta (I-cell disease),N/A
GNPTG,Musculoskeletal,Mucolipidosis III gamma,N/A
GNS,Musculoskeletal,Mucopolysaccharidosis IIID (Sanfilippo syndrome D),N/A
GORAB,Musculoskeletal,Geroderma osteodysplasticum,N/A
GOSR2,Musculoskeletal,Epilepsy; progessive myoclonic 6,N/A
GPAA1,Musculoskeletal,Glycosylphosphatidylinositol biosynthesis defect 15,N/A
GPC3,Musculoskeletal,Simpson-Golabi-Behmel syndrome; type 1,Pediatric
GPC6,Musculoskeletal,Omodysplasia 1,N/A
GPHN,Musculoskeletal,Hyperekplexia; autosomal dominant; Molybdenum cofactor deficiency; type C,N/A
GPX4,Musculoskeletal,Sedaghatian-type spondylometaphyseal dysplasia,N/A
GRHL2,Musculoskeletal,Cornealy dystrophy; posterior polymorphous; 4; Ectodermal dysplasia/short stature syndrome,Pediatric
GRHL3,Musculoskeletal,van der Woude syndrome 2,N/A
GRIA3,Musculoskeletal,Mental retardation; X-linked 94,N/A
GRIP1,Musculoskeletal,Fraser syndrome 3,N/A
GSC,Musculoskeletal,Short Stature; Auditory-Canal Atresia; Mandibular Hypoplasia; and Skeletal Abnormalities (SAMS),Pediatric
GTF2E2,Musculoskeletal,Trichothiodystrophy 6; nonphotosensitive,N/A
GTF2H5,Musculoskeletal,Trichothiodystrophy 3; photosensitive,N/A
GTPBP2,Musculoskeletal,Jaberi-Elahi syndrome,N/A
GUSB,Musculoskeletal,Mucopolysaccharidosis type VII,N/A
GYG1,Musculoskeletal,Glycogen storage disease XV,Pediatric
GYS1,Musculoskeletal,Glycogen storage disease; type 0; muscle,Pediatric
GZF1,Musculoskeletal,Joint laxity; short stature; and myopia (JLSM),N/A
H1-4,Musculoskeletal,Rahman syndrome,N/A
H19,Musculoskeletal,Wilms tumor 2; Beckwith-Wiedemann syndrome,Pediatric
HAAO,Musculoskeletal,Vertebral; cardiac; renal; and limb defects syndrome 1,N/A
HADHA,Musculoskeletal,Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency; Trifunctional protein deficiency,Pediatric
HADHB,Musculoskeletal,Trifunctional protein deficiency,Pediatric
HBB,Musculoskeletal,Beta-thalassemia; Heinz body anemias; Erythrocytosis; familial 6; Sickle cell disease; Thalassemia-beta; dominant inclusion body; Other Thalassemias/Hemoglobinopathies,Pediatric
HCCS,Musculoskeletal,Linear skin defects with multiple congenital anomalies 1 (MIDAS syndrome),Pediatric
HDAC4,Musculoskeletal,Brachydacytly-mental retardation syndrome,N/A
HDAC6,Musculoskeletal,Chondrodysplasia with platyspondyly; distinctive brachydactyly; hydrocephaly; and microphthalmia,N/A
HDAC8,Musculoskeletal,Cornelia de Lange syndrome 5,N/A
HEPHL1,Musculoskeletal,Abnormal hair; joint laxity; and developmental delay,N/A
HERC1,Musculoskeletal,Macrocephaly; dysmorphic facies; and psychomotor retardation,N/A
HES7,Musculoskeletal,Spondylocostal dysostosis 4; autosomal recessive,N/A
HGD,Musculoskeletal,Alkaptonuria,Pediatric
HINT1,Musculoskeletal,Neuromyotonia and axonal neuropathy; autosomal recessive,N/A
HIVEP2,Musculoskeletal,Mental retardation; autosomal dominant 43,N/A
HK1,Musculoskeletal,Hemolytic anemia; nonspherocytic; due to hexokinase deficiency,Pediatric
HMGB3,Musculoskeletal,Microphthalmia; syndromic 13,N/A
HMOX1,Musculoskeletal,Heme oxygenase 1 deficiency,N/A
HNRNPA1,Musculoskeletal,Amyotrophic lateral sclerosis 20; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3,N/A
HNRNPA2B1,Musculoskeletal,Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2,N/A
HNRNPDL,Musculoskeletal,Muscular dystrophy; limb-girdle; autosomal dominant 3,N/A
HNRNPH2,Musculoskeletal,Mental retardation; X-linked; syndromic; Bain type,N/A
HNRNPK,Musculoskeletal,Au-Kline syndrome,N/A
HOXA11,Musculoskeletal,Radioulnar synostosis with amegakaryocytic thrombocytopenia 1,Pediatric
HOXA13,Musculoskeletal,Hand-foot-genital syndrome; Guttmacher syndrome; Hand-foot-uterus syndrome,N/A
HOXA2,Musculoskeletal,Microtia; hearing impairment; and cleft palate,Pediatric
HOXD10,Musculoskeletal,Vertical talus; congenital,N/A
HOXD13,Musculoskeletal,Brachydactyly-syndactyly syndrome; Brachydactyly; type D; Brachydactyly; type E1; Syndactyly; type V; Synopolydactyly; type I; Synopolydactyly; type II; Synopolydactyly with clefting; autosomal recessive,N/A
HPGD,Musculoskeletal,Hypertrophic osteoarthropathy; primary; autosomal recessive 1; Cranioosteoarthropathy; Digital clubbing; isolated congenital ,Pediatric
HPRT1,Musculoskeletal,Kelley-Seegmiller syndrome; Lesch-Nyhan syndrome,Pediatric
HRAS,Musculoskeletal,Costello syndrome; Congenital myopathy with excess of muscle spindles,Pediatric
HS6ST1,Musculoskeletal,Hypogonadotropic hypogonadism 15; with or without anosmia,Pediatric
HSD17B4,Musculoskeletal,Perrault syndrome 1,Pediatric
HSPA9,Musculoskeletal,Anemia; sideroblastic 4,Pediatric
HSPG2,Musculoskeletal,Schwartz-Jampel syndrome; type 1,Pediatric
HUWE1,Musculoskeletal,Mental retardation; X-linked syndromic; Turner type; Xp11.22 microduplication syndrome,N/A
HYAL1,Musculoskeletal,Mucopolysaccharidosis type IX,N/A
HYLS1,Musculoskeletal,Hydrolethalus syndrome,N/A
IARS1,Musculoskeletal,Growth retardation; intellectual developmental disorder; hypotonia; and hepatopathy,Pediatric
IARS2,Musculoskeletal,Cataracts; growth hormone deficiency; sensory neuropathy; sensorineural hearing loss; and skeletal dysplasia (CAGSSS),Pediatric
IBA57,Musculoskeletal,Multiple mitochondrial dysfunctions syndrome 3; Spastic paraplegia 74; autosomal recessive,N/A
IDUA,Musculoskeletal,Mucopolysaccharidosis type I,Pediatric
IFIH1,Musculoskeletal,Aicardi-Goutieres syndrome 7; Singleton-Merten syndrome 1,Pediatric
IFITM5,Musculoskeletal,Osteogenesis imperfecta; type V,N/A
IFT122,Musculoskeletal,Cranioectodermal dysplasia 1; Sensenbrenner syndrome,N/A
IFT140,Musculoskeletal,Short-rib thoracic dysplasia 9 with or without polydactyly,N/A
IFT172,Musculoskeletal,Retinitis pigmentosa 71; Short rib thoracic dysplasia 10 with or without polydactyly,N/A
IFT27,Musculoskeletal,Bardet Biedl syndrome 19,N/A
IFT43,Musculoskeletal,Cranioectodermal dysplasia 3; Retinitis pigmentosa 81; Short-rib thoracic dysplasia 18 with polydactyly,N/A
IFT52,Musculoskeletal,Short-rib thoracic dysplasia 16 with or without polydactyly,N/A
IFT57,Musculoskeletal,Orofaciodigital syndrome XVIII,N/A
IFT74,Musculoskeletal,Bardet Biedl syndrome 20,N/A
IFT80,Musculoskeletal,Short-rib thoracic dysplasia 2 with or without polydactyly,N/A
IFT81,Musculoskeletal,Short-rib thoracic dysplasia 19 with or without polydactyly,N/A
IGBP1,Musculoskeletal,Corpus callosum; agenesis of; with mental retardation; ocular coloboma and micrognathia,N/A
IGF2,Musculoskeletal,Growth restriction; severe; with distinctive facies,Pediatric
IHH,Musculoskeletal,Acrocapitofemoral dysplasia; Brachydactyly; type A1 ,N/A
IL17RD,Musculoskeletal,Hypogonadotropic hypogonadism 18; with or without anosmia,Pediatric
IL6ST,Musculoskeletal,Hyper-IgE recurrent infection syndrome 4; autosomal recessive,Pediatric
IMPAD1,Musculoskeletal,Chondrodysplasia with joint dislocations; GPAPP type,N/A
INPP5K,Musculoskeletal,Muscular dystrophy; congenital; with cataracts and intellectual disability (MDCCAID),N/A
INPPL1,Musculoskeletal,Opsismodysplasia,Pediatric
INSR,Musculoskeletal,Hyperinsulinemic hypoglycemia; familial; 5; Rabson-Mendenhall syndrome; Donohoe syndrome,Pediatric
INTU,Musculoskeletal,Orofaciodigital syndrome XVII; Short-rib throacic dysplasia 20 with polydactyly,N/A
IQCE,Musculoskeletal,Postaxial polydactyly; tye A7,N/A
IRF6,Musculoskeletal,Popliteal pterygium syndrome; van der Woude syndrome 1; Orofacial cleft 6,N/A
ISCA1,Musculoskeletal,Multiple mitochondrial dysfunctions syndrome 5,N/A
ISCA2,Musculoskeletal,Multiple mitochondrial dysfunctions syndrome 4,N/A
ISCU,Musculoskeletal,Myopathy with lactic acidosis; hereditary,Pediatric
ITGA7,Musculoskeletal,Muscular dystrophy; congenital; due to integrin alpha-7 deficiency,N/A
JAG1,Musculoskeletal,Alagille syndrome; Deafness; congenital heart defects; and posterior embryotoxon,Pediatric
KANK2,Musculoskeletal,Nephrotic syndrome 16; Palmoplantar keratoderma and woolly hair,N/A
KANSL1,Musculoskeletal,Koolen-de Vries syndrome,N/A
KAT6B,Musculoskeletal,Ohdo syndrome; SBBYS variant; Genitopatellar syndrome,Pediatric
KBTBD13,Musculoskeletal,Nemaline myopathy 6,N/A
KCNH1,Musculoskeletal,Temple-Baraitser syndrome; Zimmermann-Laband syndrome 1,N/A
KCNJ2,Musculoskeletal,Atrial fibrillation; familial 9; Short QT syndrome 3; Andersen syndrome; Long QT syndrome 7,Pediatric
KCNK4,Musculoskeletal,Facial dysmorphism; hypertrichosis; epilepsy; intellectual disability/developmental delay; and gingival overgrowth syndrome,N/A
KCNK9,Musculoskeletal,Birk-Barel mental retardation dysmorphism syndrome,N/A
KCNQ1OT1,Musculoskeletal,Beckwith-Wiedemann syndrome,Pediatric
KDM1A,Musculoskeletal,Cleft palate; psychomotor retardation; and distinctive facial features,N/A
KDM5B,Musculoskeletal,Mental retardation; autosomal recessive 65,N/A
KDM5C,Musculoskeletal,Mental retardation; X-linked; syndromic; Claes-Jensen type,N/A
KDM6A,Musculoskeletal,Kabuki syndrome 2,N/A
KDM6B,Musculoskeletal,Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities,N/A
KIAA0586,Musculoskeletal,Joubert syndrome 23; Short rib thoracic dysplasia 14 with polydactyly,N/A
KIAA0753,Musculoskeletal,Orofaciodigital syndrome XV,N/A
KIAA0825,Musculoskeletal,Polydactyly; postaxial; type A10,N/A
KIF21A,Musculoskeletal,Fibrosis of extraocular muscles; congenital 1,N/A
KIF22,Musculoskeletal,Spondyloepimetaphyseal dysplasia with joint laxity; type 2,N/A
KIF5C,Musculoskeletal,Cortical dysplasia; complex; with other brain malformations 2,N/A
KIF7,Musculoskeletal,Hydrolethalus syndrome 2; Acrocallosal syndrome; Joubert syndrome 12; Al-Gazali-Bakalinova syndrome,N/A
KIRREL3,Musculoskeletal,Mental retardation; autosomal dominant 4,N/A
KL,Musculoskeletal,Tumoral calcinosis; hyperphosphatemic; familial; 3,Pediatric
KLC2,Musculoskeletal,Spastic paraplegia; optic atrophy; and neuropathy,N/A
KLHL40,Musculoskeletal,Nemaline myopathy 8,N/A
KLHL41,Musculoskeletal,Nemaline myopathy 9,N/A
KLHL7,Musculoskeletal,Crisponi/Cold-induced sweating syndrome 3,Pediatric
KMT2A,Musculoskeletal,Wiedemann-Steiner syndrome,N/A
KMT2C,Musculoskeletal,Kleefstra syndrome 2,N/A
KMT2D,Musculoskeletal,Kabuki syndrome 1,Pediatric
KMT2E,Musculoskeletal,O'Donnell-Luria-Rodan syndrome,N/A
KMT5B,Musculoskeletal,Mental retardation; autosomal dominant; 51,N/A
KRAS,Musculoskeletal,Noonan syndrome; Cardiofaciocutaneous syndrome,Pediatric
KY,Musculoskeletal,Myopathy; myofibrillar; 7,N/A
KYNU,Musculoskeletal,Hydroxykynureninuria; Vertebral; cardiac; renal; and limb defects syndrome 2,N/A
L1CAM,Musculoskeletal,Hydrocephalus due to congenital stenosis of aqueduct of Sylvius; Mental retardation; aphasia; shuffling gait; and adducted thumbs (MASA) syndrome; CRASH syndrome; Corpus callosum; partial agenesis of; Spastic paraplegia-1,N/A
LAGE3,Musculoskeletal,Galloway-Mowat syndrome 2; X-linked,N/A
LAMA2,Musculoskeletal,Schizophrenia; Muscular dystrophy; congenital merosin-deficient; 1A; Muscular dystrophy; limb-girdle; autosomal recessive 23,N/A
LAMB2,Musculoskeletal,Pierson syndrome; Nephrotic syndrome; type 5; with or without ocular abnormalities,N/A
LAMP2,Musculoskeletal,Danon disease,Pediatric
LAMTOR2,Musculoskeletal,Immunodeficiency due to defect in MAPBP-interacting protein,Pediatric
LARGE1,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 6; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation); type B; 6 ,N/A
LARP7,Musculoskeletal,Alazami syndrome,N/A
LAS1L,Musculoskeletal,Wilson-Turner X-linked mental retardation syndrome,N/A
LBR,Musculoskeletal,Reynolds syndrome; Pelger-Huet anomaly; Pelger-Huet anomaly with mild skeletal anomalies; Greenberg skeletal dysplasia,N/A
LDB3,Musculoskeletal,Cardiomyopathy; dilated 1C; with or without ventricular noncompaction; Myopathy; myofibrillar 4,Pediatric
LDHA,Musculoskeletal,Glycogen storage disease XI,Pediatric
LEMD3,Musculoskeletal,Buschke-Ollendorff syndrome; Osteopoikilosis ,N/A
LFNG,Musculoskeletal,Spondylocostal dysostosis 3; autosomal recessive,N/A
LGI4,Musculoskeletal,Arthrogryposis multiplex congenita; neurogenic; with myelin defect,N/A
LHX3,Musculoskeletal,Pituitary hormone deficiency; combined; 3,Pediatric
LHX4,Musculoskeletal,Pituitary hormone deficiency; combined; 4,Pediatric
LIFR,Musculoskeletal,Stuve-Wiedemann syndrome,N/A
LIG4,Musculoskeletal,LIG4 syndrome; Severe combined immunodeficiency with sensitivity to ionizing radiation,Pediatric
LIMS2,Musculoskeletal,Muscular dystrophy; autosomal recessive; with cardiomyopathy and triangular tongue,Adult
LMBR1,Musculoskeletal,Acheiropody; Syndactyly; type IV; Laurin-Sandrow syndrome; Triphalangeal thumb; type I; Polydactyly; preaxial type II; Triphalangeal thumb-polysyndactyly syndrome; Tibial aplasia/hypoplasia; Hypoplastic or aplastic tibia with polydactyly,N/A
LMNA,Musculoskeletal,Cardiomyopathy; dilated; 1A; Heart-hand syndrome; Slovenian type; Emery-Dreiffus muscular dystrophy 2; autosomal dominant; Emery-Dreiffus muscular dystrophy 3; autosomal recessive; Muscular dystrophy; congenital; LMNA-related; Muscular dystrophy; limb-girdle; type 1B; Cardiomyopathy; dilated; with hypergonadotropic hypogonadism (Malouf syndrome); Lipodystrophy; familial partial; 2 (Dunnigan type),Pediatric
LMNB2,Musculoskeletal,Liopdystrophy; partial; acquired; Epilepsy; progressive myoclonic; 9,N/A
LMOD3,Musculoskeletal,Nemaline myopathy 10,N/A
LMX1B,Musculoskeletal,Nail-patella syndrome,Pediatric
LONP1,Musculoskeletal,Cerebral; Ocular; Dental; Auricular; and Skeletal anomalies (CODAS) syndrome,N/A
LOX,Musculoskeletal,Aortic aneurysm; familial thoracic 10,Pediatric
LPIN1,Musculoskeletal,Myoglobinuria; acute; recurrent; autosomal recessive,Pediatric
LRP12,Musculoskeletal,Oculopharyngodistal myopathy 1,N/A
LRP2,Musculoskeletal,Donnai-Barrow syndrome; Faciooculoacousticorenal syndrome,Pediatric
LRP4,Musculoskeletal,Cenani-Lenz syndactyly syndrome; Myasthenic syndrome; congenital 17; Sclerosteosis 2,N/A
LRP5,Musculoskeletal,van Buchem disease; type 2; Osteopetrosis; autosomal dominant 1; Osteosclerosis; Polycystic liver disease 4 with or without kidney cysts; Hyperostosis; endosteal; Exudative vitreoretinopathy 4; Osteoporosis-pseudoglioma syndrome,N/A
LRPPRC,Musculoskeletal,Leigh syndrome; French-Canadian type,N/A
LTBP2,Musculoskeletal,Glaucoma 3; primary congenital; D; Microspherophakia and/or megalocornea; with ectopia lentis and with or without secondary glaucoma; Weill-Marchesani syndrome 3,Pediatric
LTBP3,Musculoskeletal,Geleophysic dysplasia 3; Dental anomalies and short stature,N/A
LTBP4,Musculoskeletal,Cutis laxa with severe pulmonary; gastrointestinal; and urinary abnormalities,N/A
LYRM7,Musculoskeletal,Mitochondrial complex III deficiency; nuclear type 8,N/A
LZTFL1,Musculoskeletal,Bardet-Biedl syndrome 17,N/A
LZTR1,Musculoskeletal,Schwannomatosis 2; Noonan syndrome 10; Noonan syndrome 2,Pediatric (Noonan syndrome 10; Noonan syndrome 2); Adult (Schwannomatosis 2)
MAB21L2,Musculoskeletal,Microphthalmia/coloboma and skeletal dysplasia syndrome,N/A
MAFB,Musculoskeletal,Duane retraction syndrome-3 (DURS3) with or without deafness,Pediatric
MAGEL2,Musculoskeletal,Schaaf-Yang syndrome (Prader-Willi-like syndrome),Pediatric
MAN2B1,Musculoskeletal,Mannosidosis; alpha B; lysosomal,Pediatric
MANBA,Musculoskeletal,Mannosidosis; beta A; lysosomal,N/A
MAP2K1,Musculoskeletal,Cardiofaciocutaneous syndrome 3,Pediatric
MAP2K2,Musculoskeletal,Cardiofaciocutaneous syndrome 4,Pediatric
MAP3K20,Musculoskeletal,Split-foot malformation with mesoaxial polydactyly; Myopathy; centronuclear 6; with fiber-type disproportion,N/A
MAP3K7,Musculoskeletal,Cardiospondylocarpofacial syndrome,Pediatric
MAPK8IP3,Musculoskeletal,Neurodevelopmental disorder with or without variable brain abnormalities,N/A
MASP1,Musculoskeletal,3MC syndrome 1,Pediatric
MATN3,Musculoskeletal,Spondyloepimetaphyseal dysplasia; matrilin-3 related; Epiphyseal dysplasia; multiple; 5,N/A
MATR3,Musculoskeletal,Amyotrophic lateral sclerosis 21,N/A
MBTPS1,Musculoskeletal,Spondyloepiphyseal dysplasia; Kondo-Fu type,N/A
MBTPS2,Musculoskeletal,Keratosis follicularis spinulosa decalvans; X-linked; IFAP syndrome with or without BRESHECK syndrome; Palmoplantar keratoderma; mutilating; with periorificial keratotic plaques; X-linked; Osteogenesis imperfecta; type XIX,N/A
MCM3AP,Musculoskeletal,Peripheral neuropathy; autosomal recessive; with or without impaired intellectual development,N/A
MCM4,Musculoskeletal,Immunodeficiency 54,Pediatric
MCM5,Musculoskeletal,Meier-Gorlin syndrome 8,N/A
MECOM,Musculoskeletal,Radioulnar synostosis with amegakaryocytic thrombocytopenia 2,Pediatric
MED12,Musculoskeletal,Lujan-Fryns syndrome; Opitz-Kaveggia syndrome; Mental retardation; X-linked; with Marfanoid habitus; FG syndrome; Ohdo syndrome; X-linked,N/A
MEFV,Musculoskeletal,Familial Mediterranean fever,Pediatric
MEGF10,Musculoskeletal,Myopathy; areflexia; respiratory distress; and dysphagia; early-onset,N/A
MEGF8,Musculoskeletal,Carpenter syndrome 2,N/A
MEIS2,Musculoskeletal,Cleft palate; cardiac defects; and mental retardation (CPCMR),N/A
MEOX1,Musculoskeletal,Klippel-Feil syndrome 2,N/A
MESD,Musculoskeletal,Osteogenesis imperfecta; type XX,N/A
MESP2,Musculoskeletal,Spondylocostal dysostosis 2; autosomal recessive,N/A
MET,Musculoskeletal,Renal cell carcinoma; papillary; Deafness; autosomal recessive 97,Pediatric (Deafness; autosomal recessive 97); Adult (Renal cell carcinoma; papillary)
METTL23,Musculoskeletal,Mental retardation; autosomal recessive 44,N/A
MGAT2,Musculoskeletal,Congenital disorder of glycosylation; type IIa,Pediatric
MGME1,Musculoskeletal,Mitochondrial DNA depletion syndrome 11,Pediatric
MGP,Musculoskeletal,Keutel syndrome,N/A
MICU1,Musculoskeletal,Myopathy with extrapyramidal signs,N/A
MIR140,Musculoskeletal,Spondyloepiphyseal dysplasia; Nishimura type,N/A
MIR17HG,Musculoskeletal,Feingold syndrome 2,N/A
MITF,Musculoskeletal,Waardenburg syndrome; type 2A; Tietz albinism-deafness syndrome; Coloboma; osteopetrosis; microphthalmia; macrocephaly; albinism; and deafness (COMMAD); Melanoma; cutaneous malignant; susceptibility to; 8; Renal cell carcinoma with or without malignant melanoma,Pediatric (Waardenburg syndrome; type 2A; Tietz albinism-deafness syndrome; Coloboma; osteopetrosis; microphthalmia; macrocephaly; albinism; and deafness (COMMAD)); Adult (Melanoma; cutaneous malignant; susceptibility to; 8; Renal cell carcinoma with or without malignant melanoma)
MKKS,Musculoskeletal,McKusick-Kaufman syndrome; Bardet-Biedl syndrome 6,N/A
MKS1,Musculoskeletal,Joubert syndrome 28; Meckel syndrome 1; Bardet-Biedl syndrome 13,N/A
MMP13,Musculoskeletal,Metaphyseal anadysplasia 1; Metaphyseal dysplasia; Spahr type; Spondyloepimetaphyseal dysplasia; Missouri type,N/A
MMP14,Musculoskeletal,Winchester syndrome,N/A
MMP2,Musculoskeletal,Torg-Winchester syndrome; Multicentric osteolysis; nodulosis; and arthropathy,N/A
MMP9,Musculoskeletal,Metaphyseal anadysplasia 2,N/A
MNX1,Musculoskeletal,Currarino syndrome,Pediatric
MOCOS,Musculoskeletal,Xanthinuria; type II,Pediatric
MOGS,Musculoskeletal,Congenital disorder of glycosylation; type IIb,Pediatric
MPDU1,Musculoskeletal,Congenital disorder of glycosylation; type If,Pediatric
MPV17,Musculoskeletal,Mitochondrial DNA depletion syndrome 6 (hepatocerebral type),Pediatric
MRAS,Musculoskeletal,Noonan syndrome 11,Pediatric
MRPL3,Musculoskeletal,Combined oxidative phosphorylation deficiency 9,N/A
MRPL44,Musculoskeletal,Combined oxidative phosphorylation deficiency 16,Pediatric
MRPS22,Musculoskeletal,Combined oxidative phosphorylation deficiency 5; Ovarian dysgenesis 7,N/A
MSMO1,Musculoskeletal,Microcephaly; congenital cataract; and psoriasiform dermatitis,Pediatric
MSTN,Musculoskeletal,Muscle hypertrophy,N/A
MSTO1,Musculoskeletal,Myopathy; mitochondrial; and ataxia,N/A
MSX2,Musculoskeletal,Craniosynostosis 2; Parietal foramina with cleidocranial dysplasia; Parietal foramina 1,N/A
MT-ATP6,Musculoskeletal,Myopathy; lactic acidosis; and sideroblastic anemia 3,N/A
MT-CO1,Musculoskeletal,Deafness; mitochondrial,Pediatric
MT-CO3,Musculoskeletal,Myoglobinuria; recurrent,N/A
MT-ND1,Musculoskeletal,Deafness; mitochondrial,Pediatric
MT-ND2,Musculoskeletal,Leber hereditary optic neuropathy; Mitochondrial complex I deficiency,N/A
MT-ND4,Musculoskeletal,Leber hereditary optic neuropathy; Leber optic atrophy and dystonia; Mitochondrial complex I deficiency,N/A
MT-ND5,Musculoskeletal,Myoclonic epilepsy with ragged red fibers; Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes; Leber hereditary optic neuropathy; Mitochondrial complex I deficiency,N/A
MT-ND6,Musculoskeletal,Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes; Oncocytoma; Leber hereditary optic neuropathy; Leber optic atrophy and dystonia; Mitochondrial complex I deficiency,N/A
MT-TC,Musculoskeletal,Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes,N/A
MT-TE,Musculoskeletal,Diabetes-deafness syndrome; Mitochondrial myopathy; infantile; transient; Mitochondrial myopathy with diabetes,N/A
MT-TF,Musculoskeletal,Myoclonic epilepsy with ragged red fibers; Nephropathy; tubulointerstitial; Encephalopathy; mitochondrial; Epilepsy; mitochondrial; Myopathy; mitochondrial; Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes,N/A
MT-TL1,Musculoskeletal,Brain pseudoatrophy; reversible; valproate-induced; susceptibility to,Pediatric
MT-TS1,Musculoskeletal,Deafness,Pediatric
MTAP,Musculoskeletal,Diaphyseal medullary stenosis with malignant fibrous histiocytoma,Pediatric
MTM1,Musculoskeletal,Myopathy; centronuclear; X-linked,Pediatric
MTOR,Musculoskeletal,Smith-Kingsmore syndrome,N/A
MUSK,Musculoskeletal,Myasthenic syndrome; congenital; 9; associated with acetylcholine receptor deficiency,Pediatric
MYBPC1,Musculoskeletal,Arthrogryposis; distal; type 1B; Myopathy; congenital; with tremor; Lethal congenital contractural syndrome 4,N/A
MYCN,Musculoskeletal,Feingold syndrome 1,N/A
MYF5,Musculoskeletal,Ophthalmoplegia; external; with rib and vertebral anomalies,N/A
MYF6,Musculoskeletal,Myopathy; centronuclear; 3,N/A
MYH14,Musculoskeletal,Deafness; autosomal dominant 4; Deafness; autosomal dominant 4B; Peripheral neuropathy; myopathy; hoarseness; and hearing loss,N/A
MYH2,Musculoskeletal,Myopathy; proximal; and ophthalmoplegia,N/A
MYH3,Musculoskeletal,Arthrogryposis; distal; type 2A; Arthyrgryposis; distal; type 2B3; Contractures; pterygia; and variable skeletal fusions syndrome 1A; Contractures; pterygia; and variable skeletal fusions syndrome 1B,N/A
MYH7,Musculoskeletal,Cardiomyopathy; dilated; 1S; Cardiomyopathy; familial hypertrophic 1; Myopathy; distal; Myopathy; myosin storage; autosomal recessive,Pediatric
MYH8,Musculoskeletal,Carney complex variant; Arthrogryposis; distal; type 7 (Trismus-pseudocamptodactyly syndrome),N/A
MYL1,Musculoskeletal,Myopathy; congenital; with fast-twitch (type II) fiber atrophy,N/A
MYL2,Musculoskeletal,Cardiomyopathy; familial hypertrophic; 10,Pediatric
MYMK,Musculoskeletal,Carey-Fineman-Ziter syndrome,N/A
MYO18B,Musculoskeletal,Klippel-Feil syndrome 4; autosomal recessive; with myopathy and facial dysmorphism,N/A
MYO9A,Musculoskeletal,Myasthenic syndrome; congenital; 24; presynaptic,Pediatric
MYOT,Musculoskeletal,Myopathy; myofibrillar; 3,Pediatric
NAA10,Musculoskeletal,N-terminal acetyltransferase deficiency (Ogden syndrome),Pediatric
NAA15,Musculoskeletal,Mental retardation; autosomal dominant; 50,N/A
NAGLU,Musculoskeletal,Mucopolysaccharidosis type IIIB (Sanfilippo syndrome B),N/A
NALCN,Musculoskeletal,Congenital contractures of the limbs and face; hypotonia; and developmental delay; Hypotonia; infantile; with psychomotor retardation and characteristic facies 1,N/A
NANS,Musculoskeletal,Spondyloepimetaphyseal dysplasiam Genevieve type,N/A
NARS2,Musculoskeletal,Deafness; autosomal recessive 94,Pediatric
NBAS,Musculoskeletal,Infantile liver failure syndrome 2; Short stature; optic nerve atrophy; and Pelger-Huet anomaly (SOPH syndrome),N/A
NBN,Musculoskeletal,Breast cancer; susceptibility to; Nijmegen breakage syndrome,Pediatric (Nijmegen breakage syndrome); Adult (Breast cancer; susceptibility to)
NCAPG2,Musculoskeletal,Kahn-Kahn-Katsanis syndrome,N/A
NDRG1,Musculoskeletal,Charcot-Marie-Tooth disease; type 4D,N/A
NEB,Musculoskeletal,Nemaline myopathy 2; autosomal recessive,N/A
NECTIN1,Musculoskeletal,Cleft lip/palate-ectodermal dysplasia syndrome,N/A
NECTIN4,Musculoskeletal,Ectodermal dysplasia-syndactyly syndrome 1,N/A
NEDD4L,Musculoskeletal,Periventricular nodular heterotopia 7,N/A
NEK1,Musculoskeletal,Short-rib thoracic dysplasia 6 with or without polydactyly,N/A
NEK8,Musculoskeletal,Nephronophthisis 9; Renal-hepatic-pancreatic dysplasia 2,N/A
NEK9,Musculoskeletal,Arthrogryposis; Perthes disease; and upward gaze palsy; Lethal congenital contracture syndrome 10,N/A
NEU1,Musculoskeletal,Sialidosis; type I; Sialidosis; type II,N/A
NF1,Musculoskeletal,Neurofibromatosis type 1; Neurofibromatosis-Noonan syndrome; Watson syndrome,Pediatric
NFIX,Musculoskeletal,Marshall-Smith syndrome; Sotos syndrome 2,N/A
NFU1,Musculoskeletal,Multiple mitochondrial dysfunctions syndrome 1,N/A
NGLY1,Musculoskeletal,Congenital disorder of deglycosylation,Pediatric
NHEJ1,Musculoskeletal,Severe combined immunodeficiency with microcephaly; growth retardation; and sensitivity to ionizing radiation,Pediatric
NIN,Musculoskeletal,Seckel syndrome 7,N/A
NIPBL,Musculoskeletal,Cornelia de Lange syndrome 1,N/A
NKX3-2,Musculoskeletal,Spondylo-megaepiphyseal-metaphyseal dysplasia,N/A
NLRP1,Musculoskeletal,Palmoplantar carcinoma; multiple self-healing; Autoinflammation with arthritis and dyskeratosis,Pediatric
NOD2,Musculoskeletal,Blau syndrome; Sarcoidosis; early-onset,Pediatric
NOG,Musculoskeletal,Brachydactyly; type B2; Tarsal-carpal coalition syndrome; Multiple synostosis syndrome 1; Symphalangism; proximal; 1A; Stapes ankylosis with broad thumb and toes (Teunissen-Cremers syndrome),Pediatric
NOTCH1,Musculoskeletal,Aortic valve disease 1,Pediatric
NOTCH2,Musculoskeletal,Alagille syndrome 2,Pediatric
NOTCH3,Musculoskeletal,Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1 (CADASIL1); Myofibromatosis; infantile 2,Pediatric
NPHP3,Musculoskeletal,Nephronophthisis 3; Meckel syndrome 7; Renal-hepatic-pancreatic dysplasia 1,N/A
NPR2,Musculoskeletal,Epiphyseal chondrodysplasia; Miura type; Short stature with nonspecific skeletal abnormalities; Acromesomelic dysplasia; Maroteaux type,N/A
NRAS,Musculoskeletal,Autoimmune lymphoproliferative syndrome type IV; Noonan syndrome 6,Pediatric
NSD1,Musculoskeletal,Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome,Pediatric
NSDHL,Musculoskeletal,Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD syndrome); CK syndrome,N/A
NSMCE2,Musculoskeletal,Seckel syndrome 10,Pediatric
NT5E,Musculoskeletal,Calcification of joints and arteries,N/A
NUBPL,Musculoskeletal,Mitochondrial complex I deficiency; nuclear type 21,N/A
NUP107,Musculoskeletal,Nephrotic syndrome; type 11; Ovarian dysgenesis 6; Galloway-Mowat syndrome 7,N/A
NUP37,Musculoskeletal,Microcephaly 24; primary; autosomal recessive,N/A
NUP85,Musculoskeletal,Nephrotic syndrome; type 17,N/A
NUP88,Musculoskeletal,Fetal akinesia deformation sequence 4,N/A
NUTM2B-AS1,Musculoskeletal,Oculopharyngeal myopathy with leukoencephalopathy 1,N/A
NXN,Musculoskeletal,Robinow syndrome; autosomal recessive 2,N/A
OAT,Musculoskeletal,Gyrate atrophy of choroid and retina,Pediatric
OBSL1,Musculoskeletal,Three M syndrome 2,N/A
OCRL,Musculoskeletal,Dent disease 2; Lowe syndrome,Pediatric
OFD1,Musculoskeletal,Orofaciodigital syndrome 1; Simpson-Golabi-Behmel syndrome type 2; Joubert syndrome 10; Retinitis pigmentosa 23,N/A
OGT,Musculoskeletal,Mental retardation; X-linked 106,N/A
OPA1,Musculoskeletal,Glaucoma; normal tension; susceptibility to,Adult
ORAI1,Musculoskeletal,Immunodeficiency 9,Pediatric
ORC1,Musculoskeletal,Meier-Gorlin syndrome 1,N/A
ORC4,Musculoskeletal,Meier-Gorlin syndrome 2,N/A
ORC6,Musculoskeletal,Meier-Gorlin syndrome 3,N/A
OSGEP,Musculoskeletal,Galloway-Mowat syndrome 3,N/A
OSTM1,Musculoskeletal,Osteopetrosis; autosomal recessive 5,N/A
OTUD6B,Musculoskeletal,Intellectual developmental disorder with dysmorphic facies; seizures; and distal limb anomalies (IDDFSDA),N/A
P3H1,Musculoskeletal,Osteogenesis imperfecta; type VIII,N/A
P4HB,Musculoskeletal,Cole Carpenter syndrome 1,N/A
PABPN1,Musculoskeletal,Oculopharyngeal muscular dystrophy,N/A
PACS1,Musculoskeletal,Schuss-Hoeijmakers syndrome (Mental retardation; autosomal dominant 17),N/A
PACS2,Musculoskeletal,Epileptic encephalopathy; early infantile; 66,N/A
PALB2,Musculoskeletal,Breast cancer; Pancreatic cancer; susceptibility to 3; Fanconi anemia; complementation group N,Pediatric (Fanconi anemia; complementation group N); Adult (Breast cancer; Pancreatic cancer; susceptibility to 3)
PAM16,Musculoskeletal,Spondylometaphyseal dysplasia; Megarbane-Dagher-Melki type,N/A
PAPSS2,Musculoskeletal,Brachyolmia 4 with mild epiphyseal and metaphyseal changes,N/A
PAX1,Musculoskeletal,Otofaciocervical syndrome 2,Pediatric
PAX3,Musculoskeletal,Waardenburg syndrome; type 1; Waardenburg syndrome; type 3; Craniofacial-deafness-hand syndrome,Pediatric
PAX7,Musculoskeletal,Myopathy; congenital progressive; with scoliosis,N/A
PCGF2,Musculoskeletal,Turnpenny-Fry syndrome,N/A
PCNT,Musculoskeletal,Microcephalic osteodysplastic primordial dwarfism; type II,N/A
PCYT1A,Musculoskeletal,Spondylometaphyseal dysplasia with cone-rod dystrophy,N/A
PDE3A,Musculoskeletal,Hypertension with brachydactyly,Pediatric
PDE4D,Musculoskeletal,Acrodysostosis 2; with or without hormone resistance,Pediatric
PDE6D,Musculoskeletal,Joubert syndrome 22,N/A
PDGFRA,Musculoskeletal,Gastrointestinal stromal tumor; GIST-plus syndrome,Adult
PDGFRB,Musculoskeletal,Basal ganglia calcification; idiopathic; 4; Kosaki overgrowth syndrome; Myofibromatosis; infantile 1; Premature aging syndrome; Penttinen type,Pediatric
PDSS1,Musculoskeletal,Coenzyme Q10 deficiency 2,Pediatric
PEPD,Musculoskeletal,Prolidase deficiency,Pediatric
PET100,Musculoskeletal,Mitochondrial complex IV deficiency,N/A
PEX1,Musculoskeletal,Heimler syndrome 1,Pediatric
PEX10,Musculoskeletal,Peroxisome biogenesis disorder 6A (Zellweger syndrome); Peroxisome biogenesis disorder 6B,N/A
PEX11B,Musculoskeletal,Peroxisome biogenesis factor disorder 14B,N/A
PEX12,Musculoskeletal,Peroxisome biogenesis disorder 3A; Peroxisome biogenesis factor disorder 3B,N/A
PEX13,Musculoskeletal,Peroxisome biogenesis disorder 11A (Zellweger syndrome); Peroxisome biogenesis disorder 11B,N/A
PEX14,Musculoskeletal,Peroxisome biogenesis factor disorder 14; Zellweger syndrome,N/A
PEX16,Musculoskeletal,Peroxisome biogenesis factor disorder 8A (Zellweger syndrome); Peroxisome biogenesis disorder 8B,N/A
PEX19,Musculoskeletal,Peroxisome biogenesis disorder; 19; Zellweger syndrome,N/A
PEX2,Musculoskeletal,Peroxisome biogenesis disorder 5A; Peroxisome biogenesis disorder 5B,N/A
PEX26,Musculoskeletal,Peroxisome biogenesis disorder 7A; Peroxisome biogenesis disorder 7B; Adrenoleukodystrophy; neonatal; Refsum disease; infantile,N/A
PEX3,Musculoskeletal,Peroxisome biogenesis factor disorder 3; Peroxisome biogenesis disorder 10A (Zellweger); Peroxisome biogenesis disorder 10B,N/A
PEX5,Musculoskeletal,Peroxisome biogenesis disorder 2A (Zellweger syndrome); Peroxisome biogenesis disorder 2B; Rhizomelic chondrodysplasia punctata; type 5,N/A
PEX6,Musculoskeletal,Heimler syndrome 2 (Peroxisome biogenesis disorder 4C),Pediatric
PEX7,Musculoskeletal,Refsum disease,Pediatric
PFKM,Musculoskeletal,Glycogen storage disease VII,Pediatric
PGAM2,Musculoskeletal,Glycogen storage disease X,Pediatric
PGAP2,Musculoskeletal,Hyperphosphatasia with mental retardation syndrome 3,N/A
PGAP3,Musculoskeletal,Hyperphosphatasia with mental retardation syndrome 4,N/A
PGK1,Musculoskeletal,Phosphoglycerate kinase 1 deficiency,Pediatric
PGM1,Musculoskeletal,Congenital disorder of glycosylation; type It,Pediatric
PGM3,Musculoskeletal,Immunodeficiency 23,Pediatric
PHEX,Musculoskeletal,Hypophosphatemic rickets; X-linked dominant,Pediatric
PHF6,Musculoskeletal,Borjeson-Forssman-Lehmann syndrome,N/A
PHF8,Musculoskeletal,Mental retardation syndrome; X-linked; Siderius type,N/A
PHGDH,Musculoskeletal,Phosphoglycerate dehydrogenase deficiency,Pediatric
PHIP,Musculoskeletal,Developmental delay; intellectual disability; obesity; and dysmorphic features,N/A
PHKA1,Musculoskeletal,Glycogen storage disease; type IXd,Pediatric
PHKA2,Musculoskeletal,Glycogen storage disease; type IXa1/Glycogen storage disease; type IXa2 (Phosphorylase kinase deficiency),Pediatric
PHKB,Musculoskeletal,Glycogen storage disease IXb,Pediatric
PHKG2,Musculoskeletal,Glycogen storage disease IXc,Pediatric
PHOX2A,Musculoskeletal,Fibrosis of extraocular muscles; congenital; 2,N/A
PHYH,Musculoskeletal,Refsum disease,Pediatric
PI4KA,Musculoskeletal,Perisylvian polymicrogyria; cerebellar hypoplasia; and arthrogryposis,N/A
PIEZO2,Musculoskeletal,Arthrogryposis; distal; type 3; Arthrogryposis; distal; type 5; Marden-Walker syndrome; Arthrogryposis; distal; with impaired proprioception and touch,N/A
PIGB,Musculoskeletal,Epileptic encephalopathy; early infantile; 80,N/A
PIGH,Musculoskeletal,Glycosylphosphatidylinositol biosynthesis defect 17,N/A
PIGO,Musculoskeletal,Hyperphosphatasia with mental retardation syndrome 2,N/A
PIGQ,Musculoskeletal,Epileptic encephalopathy; early infantile; 77,N/A
PIGT,Musculoskeletal,Multiple congenital anomalies-hypotonia-seizures syndrome 3,N/A
PIGU,Musculoskeletal,Glycosylphosphatidylinositol biosynthesis defect 21,N/A
PIGV,Musculoskeletal,Hyperphosphatasia with mental retardation syndrome 1,N/A
PIGY,Musculoskeletal,Hyperphosphatasia with mental retardation syndrome 6,N/A
PIK3C2A,Musculoskeletal,Oculoskeletodental syndrome,Pediatric
PIK3R1,Musculoskeletal,Agammaglobulinemia 7; autosomal recessive; Immunodeficiency 36,Pediatric
PIK3R2,Musculoskeletal,Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1,N/A
PIP5K1C,Musculoskeletal,Lethal congenital contractural syndrome 3,N/A
PITX1,Musculoskeletal,Clubfoot; congenital; with or without deficiency of long bones and/or mirror-image polydactyly; Liebenberg syndrome,N/A
PLAA,Musculoskeletal,Neurodevelopmental disorder with progressive microcephaly; spasticity; and brain anomalies (NDMSBA),N/A
PLEC,Musculoskeletal,Muscular dystrophy; limb-girdle; type 2Q; Epidermolysis bullosa simplex with pyloric atresia; Epidermolysis bullosa simplex with muscular dystrophy; Epidermolysis bullosa simplex; Ogna type; Epidermolysis bullosa simplex with nail dystrophy,N/A
PLEKHG5,Musculoskeletal,Charcot-Marie-Tooth disease; recessive intermediate C; Spinal muscular atrophy; distal; autosomal recessive; 4,N/A
PLEKHM1,Musculoskeletal,Osteopetrosis; autosomal dominant 3; Osteopetrosis; autosomal recessive 6,N/A
PLK4,Musculoskeletal,Microcephaly and chorioretinopathy; autosomal recessive 2,N/A
PLOD1,Musculoskeletal,Ehlers-Danlos syndrome; kyphoscoliotic type; 1,Pediatric
PLOD2,Musculoskeletal,Bruck syndrome 2,N/A
PLOD3,Musculoskeletal,Bone fragility with contractures; arterial rupture; and deafness,Pediatric
PLP1,Musculoskeletal,Spastic paraplegia-2; Pelizaeus-Merzbacher disease,N/A
PLS3,Musculoskeletal,Osteoporosis and osteoporotic fractures,N/A
PMM2,Musculoskeletal,Congenital disorder of glycosylation; type Ia,Pediatric
PNPLA2,Musculoskeletal,Neutral lipid storage disease with myopathy,N/A
PNPLA6,Musculoskeletal,Boucher-Neuhauser syndrome; Laurence-Moon syndrome; Oliver-McFarlane syndrome,Pediatric
PNPLA8,Musculoskeletal,Mitochondrial myopathy with lactic acidosis,N/A
POC1A,Musculoskeletal,Short stature; onychodysplasia; facial dysmorphism; and hypotrichosis (SOFT syndrome),N/A
POGLUT1,Musculoskeletal,Dowling-Degos disease 4; Muscular dystrophy; limb-girdle; autosomal recessive 21,N/A
POGZ,Musculoskeletal,Mental retardation; autosomal dominant 37 (White-Sutton syndrome),N/A
POLA1,Musculoskeletal,Pigmentary disorder; reticulate; with systemic manifestations; X-linked; Van Esch-O'Driscoll syndrome,Pediatric
POLD1,Musculoskeletal,Colorectal cancer; susceptibility to; 10,Pediatric
POLE,Musculoskeletal,Colorectal cancer; susceptibility to; 12; Facial dysmorphism; immunodeficiency; livedo; and short stature syndrome (FILS syndrome); Intrauterine growth retardation; metaphyseal dysplasia; adrenal hypoplasia congenita; genital anomalies; and immunodeficiency (IMAGEI),Pediatric
POLG,Musculoskeletal,Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal dominant 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive 1; Mitochondrial DNA depletion syndrome 4B; Sensory ataxia; dysarthria; and ophthalmoparesis; Mitochondrial DNA depletion syndrome 4A (Alpers type); Alpers syndrome;  POLG-related ataxia neuropathy spectrum disorders,N/A
POLG2,Musculoskeletal,Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal dominant 4; Mitochondrial DNA depletion syndrome 16,N/A
POLR1A,Musculoskeletal,Acrofacial dysostosis; Cincinnati type,N/A
POLR3A,Musculoskeletal,Leukodystrophy; hypomyelinating; 7; with or without oligodontia and/or hypogonadotropic hypogonadism; Wiedemann-Rautenstrauch syndrome,N/A
POMGNT1,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 3; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation); type B; 3; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 3; Retinitis pigmentosa 76,N/A
POMGNT2,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 8; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 8,N/A
POMK,Musculoskeletal,Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies; type A; 12; Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies; type C; 12; Muscle-eye brain disease; Walker-Warburg syndrome,N/A
POMP,Musculoskeletal,Proteasome-associated autoinflammatory syndrome 2,Pediatric
POMT1,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 1; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation); type B; 1; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C; 1 ,Pediatric
POMT2,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 2 ; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation); type B; 2; Muscular dystrophy-dystroglycanopathy (limb-girdle); type C 2,Pediatric
POP1,Musculoskeletal,Anauxetic dysplasia 2,N/A
POR,Musculoskeletal,Antley-Bixler syndrome; Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency,Pediatric
PORCN,Musculoskeletal,Focal dermal hypoplasia,N/A
POU3F3,Musculoskeletal,Snijders Block-Fisher syndrome,N/A
PPA2,Musculoskeletal,Sudden cardiac failure; alcohol induced,Pediatric
PPIB,Musculoskeletal,Osteogenesis imperfecta; type IX,N/A
PPM1D,Musculoskeletal,Intellectual developmental disorder with gastrointestinal difficulties and high pain threhold (Jansen-De Vries syndrome),N/A
PPOX,Musculoskeletal,Porphyria variegata,Pediatric
PPP1CB,Musculoskeletal,Noonan syndrome-like disorder with loose anagen hair 2,Pediatric
PPP1R15B,Musculoskeletal,Microcephaly; short stature; and impaired glucose metabolism 2,Pediatric
PPP2CA,Musculoskeletal,Neurodevelopmental disorder and language delay with or without structural brain abnormalities,N/A
PPP2R1A,Musculoskeletal,Mental retardation; autosomal dominant 36,N/A
PPP2R3C,Musculoskeletal,Spermatogenic failure 36; Gonadal dysgenesis; dysmorphic facies; retinal dystrophy; and myopathy,N/A
PPP2R5D,Musculoskeletal,Mental retardation; autosomal dominant 35,N/A
PPP3CA,Musculoskeletal,Epileptic encephalopathy; infantile or early childhood; 1; Arthrogryposis; cleft palate; craniosynostosis; and impaired intellectual development,N/A
PQBP1,Musculoskeletal,Renpenning syndrome 1,N/A
PRDM5,Musculoskeletal,Brittle cornea syndrome 2,Pediatric
PRG4,Musculoskeletal,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,Pediatric
PRKAG2,Musculoskeletal,Cardiomyopathy; familial hypertrophic 6; Wolff-Parkinson-White syndrome,Pediatric
PRKAG3,Musculoskeletal,Increased glyogen content in skeletal muscle,N/A
PRKAR1A,Musculoskeletal,Pigmented nodular adrenocortical disease; primary; 1; Carney complex; type 1; Myxoma; intracardiac; Acrodysostosis 1; with or without hormone resistance,Pediatric
PRMT7,Musculoskeletal,Short stature; brachydactyly; intellectual developmental disability; and seizures (SBIDDS),N/A
PSAP,Musculoskeletal,Krabbe disease; atypical; Combined saposin deficiency; Gaucher disease; atypical; due to saposin C deficiency; Metachromatic leukodystrophy due to saposin-b deficiency,N/A
PSAT1,Musculoskeletal,Phosphoserine aminotransferase deficiency,Pediatric
PSMA3,Musculoskeletal,Proteasome-associated autoinflammatory syndrome 2,Pediatric
PSMB4,Musculoskeletal,Proteasome-associated autoinflammatory syndrome 3,Pediatric
PSMB8,Musculoskeletal,Proteasome-associated autoinflammatory syndrome 1,Pediatric
PSMB9,Musculoskeletal,Proteasome-associated autoinflammatory syndrome 3,Pediatric
PSMD12,Musculoskeletal,Stankiewicz-Isidor syndrome,N/A
PSTPIP1,Musculoskeletal,Pyogenic sterile arthritis; pyoderma gangrenosum; and acne,Pediatric
PTCH1,Musculoskeletal,Basal cell nevus syndrome,Pediatric
PTCH2,Musculoskeletal,Basal cell nevus syndrome,Pediatric
PTDSS1,Musculoskeletal,Lenz-Majewski hyperostotic dwarfism,N/A
PTH1R,Musculoskeletal,Eiken syndrome; Chondrodysplasia; Blomstrand type; Metaphyseal chondrodysplasia; Murk Jansen type; Failure of tooth eruption; primary ,N/A
PTHLH,Musculoskeletal,Brachydactyly; type E2,N/A
PTPN11,Musculoskeletal,Noonan syndrome 1; LEOPARD syndrome 1,Pediatric
PTRH2,Musculoskeletal,Infantile-onset multisystem neurologic; endocrine; and pancreatic disease (IMNEPD),Pediatric
PUF60,Musculoskeletal,Verheij syndrome,N/A
PUM1,Musculoskeletal,Spinocerebellar ataxia 47,N/A
PUS1,Musculoskeletal,Myopathy; lactic acidosis; and sideroblastic anemia 1,Pediatric
PUS7,Musculoskeletal,Intellectual developmental disorder with abnormal behavior; microcephaly; and short stature,N/A
PYCR1,Musculoskeletal,Cutis laxa; autosomal recessive; type IIB; Cutis laxa; autosomal recessive type IIIB,N/A
PYCR2,Musculoskeletal,Leukodystrophy; hypomyelinating 10,N/A
PYGM,Musculoskeletal,Glycogen storage disease V,Pediatric
PYROXD1,Musculoskeletal,Myopathy; myofibrillar 8,N/A
QRICH1,Musculoskeletal,Ververi-Brady syndrome,N/A
RAB11B,Musculoskeletal,Neurodevelopmental disorder with ataxic gait; absent speech; and decreased cortical white matter,N/A
RAB18,Musculoskeletal,Warburg micro syndrome 3,N/A
RAB23,Musculoskeletal,Carpenter syndrome 1,N/A
RAB33B,Musculoskeletal,Dyggve-Melchior-Clausen syndrome; Smith-McCort dysplasia 2,N/A
RAB3GAP1,Musculoskeletal,Warburg micro syndrome 1,Pediatric
RAB3GAP2,Musculoskeletal,Warburg micro syndrome 2; Martsolf syndrome ,Pediatric
RAC3,Musculoskeletal,Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies,N/A
RAD50,Musculoskeletal,Breast cancer; susceptibility to,Adult
RAD51,Musculoskeletal,Mirror movements 2; Fanconi anemia; complementation group R,N/A
RAD51C,Musculoskeletal,Breast-ovarian cancer; familial; susceptibility to; Fanconi anemia goup O,Pediatric (Fanconi anemia goup O); Adult (Breast-ovarian cancer; familial; susceptibility to)
RAF1,Musculoskeletal,Cardiomyopathy; dilated; 1NN; LEOPARD syndrome 2; Noonan syndrome 5,Pediatric
RAI1,Musculoskeletal,Smith-Magenis syndrome,N/A
RAPSN,Musculoskeletal,Myasthenic syndrome; congenital 11; associated with acetylcholine receptor deficiency,Pediatric
RARB,Musculoskeletal,Microphthalmia; syndromic 12,N/A
RASA1,Musculoskeletal,Capillary malformation-arteriovenous malformation 1; Parkes Weber syndrome; Spinal arteriovenous anomalies,Pediatric
RBBP8,Musculoskeletal,Seckel syndrome 2; Jawad syndrome,N/A
RBCK1,Musculoskeletal,Polyglucosan body myopathy 1,Pediatric
RBM10,Musculoskeletal,TARP syndrome,N/A
RBM28,Musculoskeletal,Alopecia; neurologic defects; and endocrinopathy syndrome,Pediatric
RBPJ,Musculoskeletal,Adams-Oliver syndrome 3,N/A
RDH11,Musculoskeletal,Microphthalmia; isolated; with coloboma 10; Retinal dystrophy; juvenile cataracts; and short stature syndrome,N/A
RECQL4,Musculoskeletal,Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome,Pediatric
RFWD3,Musculoskeletal,Fanconi anemia; complementation group W,Pediatric
RIN2,Musculoskeletal,Macrocephaly; alopecia; cutis laxa; and scoliosis,N/A
RINT1,Musculoskeletal,Infantile liver failure syndrome 3,N/A
RIPK4,Musculoskeletal,Popliteal pterygium syndrome; lethal type; Bartsocas-Papas syndrome; CHAND syndrome,N/A
RIPPLY2,Musculoskeletal,Spondylocostal dysostosis; autosomal recessive 6,N/A
RIT1,Musculoskeletal,Noonan syndrome 8,Pediatric
RMND1,Musculoskeletal,Combined oxidative phosphorylation deficiency 11,N/A
RMRP,Musculoskeletal,Anauxetic dysplasia 1; Cartilage-hair hypoplasia; Metaphyseal dysplasia without hypotrichosis,Pediatric
RNASEH1,Musculoskeletal,Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive; 2,N/A
RNF113A,Musculoskeletal,Trichothiodystrophy 5; nonphotosensitive,Pediatric
RNF125,Musculoskeletal,Tenorio syndrome,N/A
RNF135,Musculoskeletal,Macrocephaly; macrosomia; facial dysmorphism syndrome,N/A
RNF168,Musculoskeletal,RIDDLE syndrome,Pediatric
RNU4ATAC,Musculoskeletal,Roifman syndrome,Pediatric
ROBO3,Musculoskeletal,Gaze palsy; familial horizontal; with progressive scoliosis 1,N/A
ROR2,Musculoskeletal,Robinow syndrome; autosomal recessive; Brachydactyly; type B1,N/A
RPGRIP1L,Musculoskeletal,Meckel syndrome 5; Joubert syndrome 7; COACH syndrome,N/A
RPL10,Musculoskeletal,Mental retardation; X-linked; syndromic; 35,N/A
RPL11,Musculoskeletal,Diamond-Blackfan anemia 7,Pediatric
RPL15,Musculoskeletal,Diamond-Blackfan anemia 12,Pediatric
RPL26,Musculoskeletal,Diamond-Blackfan anemia 11,Pediatric
RPL5,Musculoskeletal,Diamond-Blackfan anemia 6,Pediatric
RPS17,Musculoskeletal,Diamond-Blackfan anemia 4,Pediatric
RPS19,Musculoskeletal,Diamond-Blackfan anemia 1,Pediatric
RPS23,Musculoskeletal,Brachycephaly; trichomegaly; and developmental delay,N/A
RPS26,Musculoskeletal,Diamond-Blackfan anemia 10,Pediatric
RPS28,Musculoskeletal,Diamond-Blackfan anemia 15 with mandibulofacial dysostosis,Pediatric
RRAS2,Musculoskeletal,Noonan syndrome 12,Pediatric
RRM2B,Musculoskeletal,Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal dominant; 5; Mitochondrial DNA depletion syndrome 8A; Mitochondrial DNA depletion syndrome 8B,N/A
RSPO2,Musculoskeletal,Tetraamelia syndrome 2; Humerofemoral hypoplasia with radiotibial ray deficiency,N/A
RSPRY1,Musculoskeletal,Spondyloepimetaphyseal dysplasia; Faden-Alkuraya type,N/A
RTTN,Musculoskeletal,Microcephaly; short stature; and polymicrogyria with or without seizures,N/A
RUNX2,Musculoskeletal,Cleidocranial dysplasia; Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly,N/A
RUSC2,Musculoskeletal,Mental retardation; autosomal recessive; 61,N/A
RXYLT1,Musculoskeletal,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies); type A; 10,N/A
RYR1,Musculoskeletal,Malignant hyperthermia; susceptibility 1; Central core disease; Minicore myopathy; Multicore myopathy; Minicore myopathy with external ophthalmoplegia; Centronuclear myopathy,Pediatric
SACS,Musculoskeletal,Spastic ataxia; Charlevoix-Saguenay type,N/A
SALL1,Musculoskeletal,Townes-Brocks syndrome 1,Pediatric
SALL4,Musculoskeletal,Duane-radial ray/Okohiro syndrome; Acro-Renal-Ocular syndrome,Pediatric
SAMD9,Musculoskeletal,Mirage syndrome; Tumoral calcinosis; normophosphatemic,Pediatric
SAR1B,Musculoskeletal,Chylomicron retention disease (Anderson disease),Pediatric
SARS1,Musculoskeletal,Neurodevelopmental disorder with microcephaly; ataxia; and seizures,N/A
SATB2,Musculoskeletal,Glass syndrome,N/A
SBDS,Musculoskeletal,Shwachman-Diamond syndrome; Aplastic anemia,Pediatric
SC5D,Musculoskeletal,Lathosterolosis,N/A
SCARF2,Musculoskeletal,Van den Ende-Gupta syndrome,N/A
SCN4A,Musculoskeletal,Paramyotonia congenita; Hyperkalemic periodic paralysis; type 2; Hypokalemic periodic paralysis; type 2; Normokalemic potassium-sensitive periodic paralysis; Malignant hyperthermia; susceptibility to; Myasthenic syndrome; congenital; 16; Myotonia; potassium-aggravated,Pediatric
SCO1,Musculoskeletal,Mitochondrial complex IV deficiency,N/A
SCO2,Musculoskeletal,Myopia 6; Leigh syndrome; Cardioencephalomyopathy; fatal infantile; due to cytochrome c oxidase deficiency 1; Hypertrophic cardiomyopathy,N/A
SDCCAG8,Musculoskeletal,Bardet-Biedl syndrome 16; Senior-Loken syndrome 7,N/A
SDHA,Musculoskeletal,Paragangliomas 5; Gastrointestinal stromal tumors; Cardiomyopathy; dilated; 1GG; Leigh syndrome/Mitochondrial respiratory chain complex II deficiency,Adult (Paragangliomas 5; Gastrointestinal stromal tumors); Pediatric (Cardiomyopathy; dilated; 1GG; Leigh syndrome/Mitochondrial respiratory chain complex II deficiency)
SDHAF1,Musculoskeletal,Mitochondrial complex II deficiency,Pediatric
SEC23A,Musculoskeletal,Craniolenticulosutural dysplasia,N/A
SEC24D,Musculoskeletal,Cole-Carpenter syndrome 2,N/A
SECISBP2,Musculoskeletal,Selenoprotein deficiency; Thyroid hormone metabolism; abnormal,N/A
SELENON,Musculoskeletal,Muscular dystrophy; rigid spine; 1; Myopathy; congenital; with fiber-type disproportion,N/A
SEMA3E,Musculoskeletal,CHARGE syndrome,N/A
SERPINF1,Musculoskeletal,Osteogenesis imperfecta; type VI,N/A
SERPINH1,Musculoskeletal,Osteogenesis imperfecta; type X,N/A
SET,Musculoskeletal,Mental retardation; autosomal dominant; 58,N/A
SETBP1,Musculoskeletal,Mental retardation; autosomal dominant 29; Schinzel-Giedion midface retraction syndrome,N/A
SETD2,Musculoskeletal,Luscan-Lumish syndrome,N/A
SETD5,Musculoskeletal,Mental retardation; autosomal dominant 23,N/A
SF3B4,Musculoskeletal,Acrofacial dysostosis 1; Nager type,N/A
SFRP4,Musculoskeletal,Pyle disease,N/A
SGCA,Musculoskeletal,Muscular dystrophy; limb-girdle; autosomal recessive 3,Pediatric
SGCB,Musculoskeletal,Muscular dystrophy; limb-girdle; autosomal recessive; 4,Pediatric
SGCD,Musculoskeletal,Cardiomyopathy; dilated; 1L; Muscular dystrophy; limb-girdle autosomal recessive 6,Pediatric
SGCE,Musculoskeletal,Dystonia 11; myoclonic,N/A
SGCG,Musculoskeletal,Muscular dystrophy; limb-girdle; limb-girdle; autosomal recessive; 5,N/A
SGMS2,Musculoskeletal,Calvarial doughnut lesions with bone fragility and spondylometaphyseal dysplasia,N/A
SH3BP2,Musculoskeletal,Cherubism,N/A
SH3PXD2B,Musculoskeletal,Frank-ter Haar syndrome,Pediatric
SHOC2,Musculoskeletal,Noonan-like syndrome with loose anagen hair 1,Pediatric
SHOX,Musculoskeletal,Langer mesomelic dysplasia; Leri-Weill dyschondrosteosis; Short stature; idiopathic familial,N/A
SHROOM4,Musculoskeletal,Stocco dos Santos X-linked mental retardation syndrome,N/A
SIK3,Musculoskeletal,Spondyloepimetaphyseal dysplasia; Krakow type,Pediatric
SIL1,Musculoskeletal,Marinesco-Sjogren syndrome,N/A
SIN3A,Musculoskeletal,Witteveen-Kolk syndrome,N/A
SKI,Musculoskeletal,Shprintzen-Goldberg syndrome,Pediatric
SKIV2L,Musculoskeletal,Trichohepatoenteric syndrome 2,Pediatric
SLC10A7,Musculoskeletal,Short stature; amelogenesis imperfecta; and skeletal dysplasia with scoliosis,N/A
SLC12A6,Musculoskeletal,Agenesis of the corpus callosum with peripheral neuropathy (Andermann syndrome),N/A
SLC16A1,Musculoskeletal,Hyperinsulinemic hypoglycemia; familial; 7; Erythrocyte lactate transporter defect; Monocarboxylate transporter 1 deficiency,Pediatric (Erythrocyte lactate transporter defect; Monocarboxylate transporter 1 deficiency ); Adult (Hyperinsulinemic hypoglycemia; familial; 7)
SLC16A2,Musculoskeletal,Allan-Herndon-Dudley syndrome,Pediatric
SLC18A3,Musculoskeletal,Myasthenic syndrome; congenital; 21; presynaptic,Pediatric
SLC22A5,Musculoskeletal,Carnitine deficiency; systemic primary,Pediatric
SLC25A20,Musculoskeletal,Carnitine-acylcarnitine translocase deficiency,Pediatric
SLC25A24,Musculoskeletal,Fontaine progeroid syndrome,N/A
SLC25A3,Musculoskeletal,Micochondrial phosphate carrier deficiency,N/A
SLC25A32,Musculoskeletal,Exercise intolerance; riboflavin-responsive,Pediatric
SLC25A4,Musculoskeletal,Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type); Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal dominant; 2; Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type),Pediatric
SLC25A42,Musculoskeletal,Metabolic crises; recurrent; with variable encephalomyopathic features and neurologic regression,N/A
SLC26A2,Musculoskeletal,Achondrogenesis; type IB; Atelosteogenesis II; De la Chapelle dysplasia; Diastrophic dysplasia; Epiphyseal dysplasia; multiple; 4,N/A
SLC29A3,Musculoskeletal,Histiocytosis-lymphadenopathy plus syndrome ,Pediatric
SLC2A10,Musculoskeletal,Arterial tortuosity syndrome,Pediatric
SLC35A3,Musculoskeletal,Arthrogryposis; mental retardation; and seizures,N/A
SLC35D1,Musculoskeletal,Schneckenbecken dysplasia,N/A
SLC39A13,Musculoskeletal,Ehlers-Danlos syndrome; spondylodysplastic type; 3,N/A
SLC39A14,Musculoskeletal,Hyperostosis cranialis interna; Hypermanganesemia with dystonia 2,Pediatric
SLC39A8,Musculoskeletal,Congenital disorder of glycosylation; type IIn,Pediatric
SLC52A2,Musculoskeletal,Brown-Vialetto-Van Laere syndrome 2,Pediatric
SLC52A3,Musculoskeletal,Brown-Vialetto-Van Laere syndrome 1; Fazio-Londe disease,Pediatric
SLC6A8,Musculoskeletal,Creatine deficiency syndrome 1,Pediatric
SLC7A7,Musculoskeletal,Lysinuric protein intolerance,Pediatric
SLC9A7,Musculoskeletal,Intellectual developmental disorder; X-linked 108,N/A
SLCO2A1,Musculoskeletal,Hypertrophic osteoarthropathy; primary; autosomal recessive 2; Primary hypertrophic osteoarthropathy,N/A
SLX4,Musculoskeletal,Fanconi anemia; complementation group P,Pediatric
SMAD3,Musculoskeletal,Aneurysms-osteoarthritis syndrome; Loeys-Dietz syndrome; type 3,Pediatric
SMARCA2,Musculoskeletal,Nicolaides-Baraitser syndrome,N/A
SMARCA4,Musculoskeletal,Rhabdoid tumor predisposition syndrome 2,Pediatric
SMARCAL1,Musculoskeletal,Schimke immunoosseous dysplasia,Pediatric
SMARCB1,Musculoskeletal,Schwannomatosis; Rhabdoid tumor predisposition syndrome 1,Pediatric
SMARCC2,Musculoskeletal,Coffin-Siris syndrome 8,N/A
SMARCD2,Musculoskeletal,Specific granule defiency 2,Pediatric
SMARCE1,Musculoskeletal,Meningioma; familial; susceptibility to,Pediatric
SMC1A,Musculoskeletal,Cornelia de Lange syndrome 2,N/A
SMC3,Musculoskeletal,Cornelia de Lange syndrome 3,N/A
SMCHD1,Musculoskeletal,Bosma arhinia microphthalmia syndrome,Pediatric
SMN1,Musculoskeletal,Spinal muscular atrophy; type I; Spinal muscular atrophy; type II; Spinal muscular atrophy; type III; Spinal muscular atrophy; type IV,N/A
SMN2,Musculoskeletal,Spinal muscular atrophy; modifier of,N/A
SMOC1,Musculoskeletal,Microphthalmia with limb anomalies,N/A
SMPD4,Musculoskeletal,Neurodevelopmental disorder with microcephaly; arthrogryposis; and structural brain anomalies,Pediatric
SMS,Musculoskeletal,Mental retardation; X-linked; Snyder-Robinson type,N/A
SNAP25,Musculoskeletal,Myasthenic syndrome; congenital 18; with intellectual disability and ataxia,N/A
SNIP1,Musculoskeletal,Psychomotor retardation; epilepsy; and craniofacial dysmorphism,N/A
SNRPB,Musculoskeletal,Cerebrocostomandibular syndrome,N/A
SNX10,Musculoskeletal,Osteopetrosis; autosomal recessive 8,Pediatric
SON,Musculoskeletal,ZTTK syndrome,N/A
SOS1,Musculoskeletal,Noonan syndrome 4,Pediatric
SOS2,Musculoskeletal,Noonan syndrome 9,Pediatric
SOST,Musculoskeletal,Craniodiaphyseal dysplasia; autosomal dominant; Sclerosteosis 1; van Buchem disease ,Pediatric
SOX11,Musculoskeletal,Coffin-Siris syndrome 9 (Mental retardation; autosomal dominant 27),N/A
SOX2,Musculoskeletal,Microphthalmia; syndromic 3,Pediatric
SOX3,Musculoskeletal,Panhypopituitarism; X-linked,Pediatric
SOX4,Musculoskeletal,Coffin-Siris syndrome 10,N/A
SOX5,Musculoskeletal,Lamb-Shaffer syndrome,N/A
SOX9,Musculoskeletal,46; XY sex reversal 10; Campomelic dysplasia,Pediatric
SP7,Musculoskeletal,Osteogenesis imperfecta; type XII,N/A
SPARC,Musculoskeletal,Keratoconus; Osteogenesis imperfecta; type XVII,N/A
SPART,Musculoskeletal,Spastic paraplegia 20; autosomal recessive (Troyer syndrome),N/A
SPEG,Musculoskeletal,Centronuclear myopathy 5,Pediatric
SPINT2,Musculoskeletal,Diarrhea 3; secretory sodium; congenital; with or without other congenital anomalies,Pediatric
SPRED1,Musculoskeletal,Legius syndrome,N/A
SPRY4,Musculoskeletal,Hypogonadotropic hypogonadism 17; with or without anosmia,Pediatric
SPTBN4,Musculoskeletal,Spherocytosis; type 3; Pyropoikilocytosis; hereditary; Ellipsocytosis 2,N/A
SQSTM1,Musculoskeletal,Paget disease of bone 3,Pediatric
SRC,Musculoskeletal,Thrombocytopenia; autosomal dominant; 6,Pediatric
SRCAP,Musculoskeletal,Floating-Harbor syndrome,N/A
SSR4,Musculoskeletal,Congenital disorder of glycosylation; type Iy,N/A
STAC3,Musculoskeletal,Myopathy; congenital; Baily-Bloch,Pediatric
STAG2,Musculoskeletal,Mullegama-Klein-Martinez syndrome (Neurodevelopmental disorder; X-linked; with craniofacial abnormalities),N/A
STAT3,Musculoskeletal,Hyper-IgE recurrent infection syndrome 1; autosomal dominant; Autoimmune disease; multisystem; infantile onset 1,Pediatric
STAT5B,Musculoskeletal,Growth hormone insensitivity with immunodeficiency,Pediatric
STIM1,Musculoskeletal,Stormorken syndrome; Immunodeficiency 10,Pediatric
STRA6,Musculoskeletal,Microphthalmia; syndromic 9,N/A
SUCLA2,Musculoskeletal,Mitochondrial DNA depletion syndrome 5,Pediatric
SUCLG1,Musculoskeletal,Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria),N/A
SUFU,Musculoskeletal,Medulloblastoma; Basal cell nevus syndrome,Pediatric
SUMF1,Musculoskeletal,Multiple sulfatase deficiency,N/A
SURF1,Musculoskeletal,Charcot-Marie-Tooth disease type 4K; Leigh syndrome,N/A
SVBP,Musculoskeletal,Neurodevelopmental disorder with ataxia; hypotonia; and microcephaly,N/A
SYNE1,Musculoskeletal,Emery-Dreifuss muscular dystrophy 4; autosomal dominant,Pediatric
SYNE2,Musculoskeletal,Emery-Dreifuss muscular dystrophy 5; autosomal dominant,Pediatric
SYT1,Musculoskeletal,Baker-Gordon syndrome,N/A
SYT2,Musculoskeletal,Myasthenic syndrome; congenital 7; presynaptic,N/A
TACO1,Musculoskeletal,Mitochondrial complex IV deficiency,N/A
TAF1,Musculoskeletal,Dystonia 3; torsion; X-linked; Mental retardation; X-linked; syndromic 33,N/A
TAF6,Musculoskeletal,Alazami-Yuan syndrome,N/A
TANGO2,Musculoskeletal,Metabolic encephalomyopathic crises; recurrent; with rhabdomyolysis; cardiac arrhythmias; and neurodegeneration (MECRCN),Pediatric
TARS1,Musculoskeletal,Trichothiodystrophy 7; nonphotosensitive,Pediatric
TARS2,Musculoskeletal,Combined oxidative phosphorylation deficiency 21,N/A
TAZ,Musculoskeletal,Barth syndrome (3-Methylglutaconic aciduria; type II),Pediatric
TBC1D20,Musculoskeletal,Warburg micro syndrome 4,N/A
TBC1D24,Musculoskeletal,Deafness; onychodystrophy; osteodystrophy; mental retardation; and seizures (DOORS) syndrome; Deafness; autosomal recessive 86,Pediatric
TBC1D7,Musculoskeletal,Macrocephaly/megalencephaly syndrome; autosomal recessive,N/A
TBCE,Musculoskeletal,Kenny-Caffey syndrome; type 1; Hypoparathyroidism-retardation-dysmorphism syndrome,Pediatric
TBL1XR1,Musculoskeletal,Mental retardation; autosomal dominant 41; Pierpont syndrome,N/A
TBX15,Musculoskeletal,Cousin syndrome,N/A
TBX2,Musculoskeletal,Vertebral anomalies and variable endocrine and T-cell dysfunction,Pediatric
TBX3,Musculoskeletal,Ulnar-Mammary syndrome,N/A
TBX4,Musculoskeletal,Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension,Pediatric
TBX5,Musculoskeletal,Holt-Oram syndrome,Pediatric
TBX6,Musculoskeletal,Spondylocostal dysostosis 5,N/A
TBXAS1,Musculoskeletal,Ghosal hematodiaphyseal syndrome,Pediatric
TBXT,Musculoskeletal,Chordoma,Pediatric
TCAP,Musculoskeletal,Cardiomyopathy; dilated; 1N; Cardiomyopathy; familial hypertrophic 25; Muscular dystrophy; limb-girdle; autosomal recessive 7,Pediatric
TCF12,Musculoskeletal,Craniosynostosis 3,N/A
TCF20,Musculoskeletal,Developmental delay with variable intellectual impairment and behavioral abnormalities,N/A
TCF4,Musculoskeletal,Corneal dystrophy; Fuchs endothelial; 3; Pitt-Hopkins syndrome,N/A
TCIRG1,Musculoskeletal,Osteopetrosis; autosomal recessive 1,Pediatric
TCTEX1D2,Musculoskeletal,Short-rib thoracic dysplasia 17 with or without polydactyly,N/A
TCTN1,Musculoskeletal,Joubert syndrome 13,N/A
TCTN2,Musculoskeletal,Joubert syndrome 24; Meckel syndrome 8,N/A
TCTN3,Musculoskeletal,Joubert syndrome 18; Orofaciodigital syndrome IV (Mohr-Majewski syndrome),N/A
TELO2,Musculoskeletal,You-Hoover-Fong syndrome,N/A
TENT5A,Musculoskeletal,Osteogenesis imperfecta; type XVIII,N/A
TERT,Musculoskeletal,Aplastic anemia; Dyskeratosis congenita; autosomal dominant; Dyskeratosis congenita; autosomal recessive; Pulmonary fibrosis and/or bone marrow failure; telomere-related 1,Pediatric
TFAM,Musculoskeletal,Mitochondrial DNA depletion syndrome 15 (hepatocerebral type),N/A
TFAP2A,Musculoskeletal,Branchiooculofacial sydrome,Pediatric
TFAP2B,Musculoskeletal,Char syndrome; Patent ductus arteriosus 2,N/A
TFG,Musculoskeletal,Neuropathy; hereditary motor and sensory; Okinawa type; Spastic paraplegia 57,N/A
TGDS,Musculoskeletal,Catel-Manzke syndrome,N/A
TGFB1,Musculoskeletal,Camurati-Engelmann disease; Inflammatory bowel disease; immunodeficiency; and encephalopathy,Pediatric
TGFB2,Musculoskeletal,Loeys-Dietz syndrome; type 4,Pediatric
TGFB3,Musculoskeletal,Arrhythmogenic right ventricular dysplasia 1; Loeys-Dietz syndrome 5 (Reinhoff syndrome),Pediatric
TGFBR1,Musculoskeletal,Loeys-Dietz syndrome; type 1A; Loeys-Dietz syndrome; type 2A,Pediatric
TGFBR2,Musculoskeletal,Loeys-Dietz syndrome; type 2,Pediatric
THOC2,Musculoskeletal,Mental retardation; X-linked 12,N/A
TIA1,Musculoskeletal,Welander distal myopathy,N/A
TIMM8A,Musculoskeletal,Opticoacoustic nerve atrophy with dementia; Jensen syndrome; Mohr-Tranebjaerg syndrome ,Pediatric
TINF2,Musculoskeletal,Dyskeratosis congenita; autosomal dominant 3; Revesz syndrome,Pediatric
TK2,Musculoskeletal,Mitochondrial DNA depletion syndrome 2; Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive 3,N/A
TKT,Musculoskeletal,Short stature; developmental delay; and congenital heart defects,N/A
TLK2,Musculoskeletal,Mental retardation; autosomal dominant 57,N/A
TMCO1,Musculoskeletal,Craniofacial dysmorphism; skeletal anomalies; and mental retardation syndrome,Pediatric
TMEM107,Musculoskeletal,Joubert syndrome 29; Meckel syndrome 13; Orofaciodigital syndrome XVI,N/A
TMEM126B,Musculoskeletal,Mitochondrial complex I deficiency; nuclear type 29,Pediatric
TMEM138,Musculoskeletal,Joubert syndrome 16,N/A
TMEM165,Musculoskeletal,Congenital disorder of glycosylation; type IIk,N/A
TMEM216,Musculoskeletal,Joubert syndrome 2; Meckel syndrome 2,N/A
TMEM231,Musculoskeletal,Joubert syndrome 20; Meckel syndrome 11,N/A
TMEM237,Musculoskeletal,Joubert syndrome 14,N/A
TMEM38B,Musculoskeletal,Osteogenesis imperfecta; type XIV,N/A
TMEM43,Musculoskeletal,Arrhythmogenic right ventricular dysplasia 5; Emery-Dreifuss muscular dystrophy 7; autosomal dominant,Pediatric
TMEM67,Musculoskeletal,Nephronophthisis 11; Meckel syndrome 3; Joubert syndrome 6; COACH syndrome; RHYNS syndrome,N/A
TMEM70,Musculoskeletal,Mitochondrial complex V (ATP synthase) deficiency; nuclear type 2,N/A
TMEM94,Musculoskeletal,Intellectual developmental disorder with cardiac defects and dysmorphic facies,N/A
TMTC3,Musculoskeletal,Lissencephaly 8,N/A
TNFRSF11A,Musculoskeletal,Familial expansile osteolysis; Paget disease of bone 2; early-onset; Osteopetrosis; autosomal recessive 7,Pediatric (Polyostotic osteolytic dysplasia; hereditary expansile/Osteopetrosis; autosomal recessive 7); Adult (Paget disease of bone)
TNFRSF11B,Musculoskeletal,Paget disease of bone 5; juvenile,Pediatric
TNFSF11,Musculoskeletal,Osteopetrosis; autosomal recessive 2,Pediatric
TNNI2,Musculoskeletal,Arthrogryposis; distal; type 2B1,N/A
TNNT1,Musculoskeletal,Nemaline myopathy 5,N/A
TNNT3,Musculoskeletal,Arthyrgryposis; distal; type 2B2,N/A
TNPO3,Musculoskeletal,Muscular dystrophy; limb-girdle; autosomal dominant 2,N/A
TNXB,Musculoskeletal,Vesicoureteral reflux 8; Ehlers-Danlos syndrome; classic-like,Pediatric
TONSL,Musculoskeletal,Spondyloepimetaphyseal dysplasia; sponastrime type,N/A
TOP3A,Musculoskeletal,Microcephaly; growth restriction; and increased sister chromatid exchange 2; Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive 5,Pediatric (Microcephaly; growth restriction; and increased sister chromatid exchange 2); Adult (Progressive external ophthalmoplegia with mitochondrial DNA deletions; autosomal recessive 5)
TOR1AIP1,Musculoskeletal,Muscular dystrophy; autosomal recessive; with rigid spine and distal joint contractures,Pediatric
TOR1AIP2,Musculoskeletal,Muscular dystrophy; limb-girdle; type 2Y,N/A
TP53RK,Musculoskeletal,Galloway-Mowat syndrome 4,N/A
TP63,Musculoskeletal,Split-hand/foot malformation 4; Ectrodactyly; ectodermal dysplasia; and cleft lip/palate syndrome 3; Limb-mammary syndrome; Rapp-Hodgkin syndrome; ADULT syndrome; Ankyloblepharon-ectodermal defects-cleft lip/palate; Orofacial cleft 8,N/A
TPM2,Musculoskeletal,Nemaline myopathy 4; CAP myopathy 2; Arthrogryposis; distal; type 1A; Arthrogryposis; distal; type 2B,N/A
TPM3,Musculoskeletal,Nemaline myopathy 1; autosomal dominant; CAP myopathy; Myopathy; congenital; with fiber-type disproportion,N/A
TPP1,Musculoskeletal,Ceroid lipofuscinosis; neuronal; 2; Spinocerebellar ataxia; autosomal recessive 7,N/A
TPSAB1,Musculoskeletal,Irritable bowel syndrome; cutaneous complaints; connective tissue abnormalities; and dysautonomia,N/A
TRAF3IP1,Musculoskeletal,Senior-Loken syndrome 9,N/A
TRAIP,Musculoskeletal,Seckel syndrome 9,N/A
TRAP1,Musculoskeletal,Congenital abnormalities of the kidney and urinary tract; VACTERL association,Pediatric
TRAPPC11,Musculoskeletal,Muscular dystrophy; limb-girdle; autosomal recessive; 18,N/A
TRAPPC2,Musculoskeletal,Spondyloepiphyseal dysplasia tarda; X-linked,N/A
TRAPPC2L,Musculoskeletal,Encephalopathy; progressive; early-onset; with episodic rhabdomyolysis,N/A
TREM2,Musculoskeletal,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 (Nasu-Hakola disease); Early-onset dementia without bone cysts,N/A
TRIM32,Musculoskeletal,Muscular dystrophy; limb-girdle; ; autosomal recessive; 8; Bardet-Biedl syndrome 11,N/A
TRIM37,Musculoskeletal,Mulibrey nanism,Pediatric
TRIO,Musculoskeletal,Mental retardation; autosomal dominant 44,N/A
TRIP11,Musculoskeletal,Achondrogenesis; type IA; Odontochondrodysplasia,N/A
TRIP12,Musculoskeletal,Mental retardation; autosomal dominant 49,N/A
TRIP13,Musculoskeletal,Mosaic variegated aneuploidy syndrome 3,Pediatric
TRIP4,Musculoskeletal,Spinal muscular atrophy with congenital bone fractures 1; Muscular dystrophy; congenital; Davignon-Chauveau type,N/A
TRMT1,Musculoskeletal,Intellectual developmental disorder; autosomal recessive 68,N/A
TRMT10A,Musculoskeletal,Microcephaly; short stature; and impaired glucose metabolism 1,Pediatric
TRNH,Musculoskeletal,Deafness; nonsyndromic; sensorineural,Pediatric
TRNI,Musculoskeletal,Deafness; mitochondrial; Hypertension; hypercholesterolemia; and hypomagnesemia  (Maternal),Pediatric
TRNK,Musculoskeletal,Parkinson disease; mitochondrial; Myoclonic epilepsy with ragged red fibers; Diabetes-deafness syndrome; Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes,N/A
TRNP,Musculoskeletal,Myoclonic epilepsy with ragged red fibers,N/A
TRNQ,Musculoskeletal,Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes,N/A
TRNS2,Musculoskeletal,Myoclonic epilepsy with ragged red fibers; Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes; Retinitis pigmentosa-deafness syndrome,N/A
TRNT,Musculoskeletal,Mitochondrial myopathy; lethal,N/A
TRPS1,Musculoskeletal,Trichorhinophalangeal syndrome; type I; Trichorhinophalangeal syndrome; type III,N/A
TRPV4,Musculoskeletal,Avascular necrosis of femoral head; primary 2,N/A
TRRAP,Musculoskeletal,Developmental delay with or without dysmorphic facies and autism; Schizophrenia,N/A
TSFM,Musculoskeletal,Combined oxidative phosphorylation deficiency 3,N/A
TSR2,Musculoskeletal,Diamond-Blackfan anemia 14 with mandibulofacial dysostosis,Pediatric
TTC19,Musculoskeletal,Mitochondrial complex III deficiency; nuclear type 2,N/A
TTC21B,Musculoskeletal,Nephronophthisis 12; Short-rib thoracic dysplasia 4 with or without polydactyly,N/A
TTC37,Musculoskeletal,Trichohepatoenteric syndrome 1,Pediatric
TTC8,Musculoskeletal,Bardet-Biedl syndrome 8; Retinitis pigmentosa 51,N/A
TTI2,Musculoskeletal,Mental retardation; autosomal recessive 39,N/A
TTN,Musculoskeletal,Cardiomyopathy; familial hypertrophic 9; Cardiomyopathy; dilated; 1G,Pediatric
TTR,Musculoskeletal,Amyloidosis; hereditary; transthyretin-related; Dystransthyretinemic hyperthyroxinemia,Pediatric
TUBB3,Musculoskeletal,Cortical dysplasia; complex; with other brain malformations 1; Fibrosis of extraocular muscles; congenital; 3A,N/A
TWIST1,Musculoskeletal,Saethre-Chotzen syndrome; Robinow-Sorauf syndrome; Craniosynostosis 1; Sweeney-Cox syndrome,N/A
TWIST2,Musculoskeletal,Ablepharon-macrostomia syndrome; Barber-Say syndrome; Focal facial dermal dysplasia 3; Setleis type,N/A
TWNK,Musculoskeletal,Mitochondrial DNA depletion syndrome 7 (hepatocerebral type); Perrault syndrome 5,Pediatric
TYMP,Musculoskeletal,Mitochondrial DNA depletion syndrome 1 (MNGIE type),N/A
TYROBP,Musculoskeletal,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 (Nasu-Hakola disease),N/A
UBA1,Musculoskeletal,Spinal muscular atrophy; X-linked 2; infantile,N/A
UBE2A,Musculoskeletal,Mental retardation; X-linked; syndromic; Nascimento-type,N/A
UBE2T,Musculoskeletal,Fanconi anemia; complementation group T,Pediatric
UFC1,Musculoskeletal,Neurodevelopmental disorder with spasticity and poor growth,N/A
UFSP2,Musculoskeletal,Hip dysplasia; Beukes type; Spondyloepimetaphyseal dysplasia; Di Rocco type,N/A
UNC80,Musculoskeletal,Hypotonia; infantile; with psychomotor retardation and characteristic facies 2,N/A
UPF3B,Musculoskeletal,Mental retardation; X-linked; syndromic 14,N/A
USP18,Musculoskeletal,Pseudo-TORCH syndrome 2,N/A
USP9X,Musculoskeletal,Mental retardation; X-linked 99; Mental retardation; X-linked 99; syndromic; female restricted,N/A
VAMP1,Musculoskeletal,Myasthenic syndrome; congenital; 25; presynaptic,Pediatric
VANGL1,Musculoskeletal,Caudal regression syndrome; Neural tube defects,N/A
VANGL2,Musculoskeletal,Neural tube defects ,N/A
VDR,Musculoskeletal,Vitamin D-dependent rickets; type 2A,Pediatric
VIPAS39,Musculoskeletal,Arthrogryposis; renal dysfunction; and cholestasis 2,N/A
VMA21,Musculoskeletal,Myopathy; X-linked; with excessive autophagy,N/A
VPS13A,Musculoskeletal,Choreoacanthocytosis,N/A
VPS13B,Musculoskeletal,Cohen syndrome,Pediatric
VPS33A,Musculoskeletal,Mucopolysaccharidosis-plus syndrome,N/A
WDPCP,Musculoskeletal,Bardet-Biedl syndrome 15; Congenital heart defects; hamartomas of tongue; and polysyndactyly; Meckel-Gruber syndrome type 6; modifier of,N/A
WDR19,Musculoskeletal,Short-rib thoracic dysplasia 5 with or without polydactyly; Cranioectodermal dysplasia 4; Nephronophthisis 13; Retinitis pigmentosa; Senior-Loken syndrome 8,N/A
WDR26,Musculoskeletal,Skraban-Deardorff syndrome,N/A
WDR34,Musculoskeletal,Short -rib thoracic dysplasia 11 with or without polydactyly,N/A
WDR35,Musculoskeletal,Cranioectodermal dysplasia 2; Short -rib thoracic dysplasia 7 with or without polydactyly,N/A
WDR60,Musculoskeletal,Short-rib thoracic dysplasia 8 with or without polydactyly,N/A
WIPI2,Musculoskeletal,Intellectual developmental disorder with short stature and variable skeletal anomalies,N/A
WNT1,Musculoskeletal,Osteoprosis; autosomal dominant; Osteogenesis imperfecta; type XV,N/A
WNT10B,Musculoskeletal,Tooth agenesis; selective; 8; Split-hand/foot malformation 6,N/A
WNT3,Musculoskeletal,Tetraamelia syndrome 1,N/A
WNT4,Musculoskeletal,Mullerian aplasia and hyperandrogenism; 46;XX sex reversal with dysgenesis of kidneys; adrenals; and lungs (SERKAL syndrome),N/A
WNT5A,Musculoskeletal,Robinow syndrome; autosomal dominant 1,N/A
WNT7A,Musculoskeletal,Ulna and fibula; absence of; with severe limb deficiency (Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome); Fuhrmann syndrome,N/A
WRN,Musculoskeletal,Werner syndrome,Pediatric
XDH,Musculoskeletal,Xanthinuria; type I,Pediatric
XK,Musculoskeletal,McLeod syndrome,Pediatric
XRCC2,Musculoskeletal,Fanconi anemia; complementation group U,N/A
XRCC4,Musculoskeletal,Short stature; microcephaly; and endocrine dysfunction,Pediatric
XYLT1,Musculoskeletal,Desbuquois dysplasia 2,N/A
XYLT2,Musculoskeletal,Spondyloocular syndrome,N/A
YARS2,Musculoskeletal,Myopathy; lactic acidosis; and sideroblastic anemia 2,Pediatric
YWHAG,Musculoskeletal,Epileptic encephalopathy; early infantile; 56,N/A
YWHAZ,Musculoskeletal,Popov-Chang syndrome,N/A
YY1,Musculoskeletal,Gabriele-de Vries syndrome (GADEVS),N/A
YY1AP1,Musculoskeletal,Grange syndrome,Pediatric
ZBTB16,Musculoskeletal,Skeletal defects; genital hypoplasia; and mental retardation,N/A
ZBTB20,Musculoskeletal,Primrose syndrome,N/A
ZBTB24,Musculoskeletal,Immunodeficiency-Centromeric Instability-Facial Anomalies 2,Pediatric
ZBTB42,Musculoskeletal,Lethal congenital contracture syndrome 6,N/A
ZC4H2,Musculoskeletal,Wieacker-Wolff syndrome,N/A
ZDHHC15,Musculoskeletal,Mental retardation; X-linked 91,N/A
ZDHHC9,Musculoskeletal,Mental retardation; X-linked syndromic; Raymond type,N/A
ZEB2,Musculoskeletal,Mowat-Wilson syndrome,N/A
ZFPM2,Musculoskeletal,46;XY sex reversal 9,Pediatric
ZIC3,Musculoskeletal,Congenital heart defects; nonsyndromic; 1; X-linked; Heterotaxy; visceral; 1; X-linked; VACTERL association; X-linked; with or without hydrocephalus,N/A
ZMPSTE24,Musculoskeletal,Mandibuloacral dysplasia with type B lipodystrophy; Restrictive dermopathy; lethal,N/A
ZNF141,Musculoskeletal,Postaxial polydactyly type A; autosomal recessive,N/A
ZNF148,Musculoskeletal,Global developmental delay; absent or hypoplastic corpus callosum; and dysmorphic facies (GDACCF),N/A
ZNF462,Musculoskeletal,Weiss-Kruszka syndrome,N/A
ZNF469,Musculoskeletal,Brittle cornea syndrome 1,Pediatric
ZNF592,Musculoskeletal,Spinocerebellar ataxia; autosomal recessive 5,N/A
ZNF687,Musculoskeletal,Paget disease of bone 6,Adult
ZNF81,Musculoskeletal,Mental retardation; X-linked 45,N/A
ZSWIM6,Musculoskeletal,Acromelic frontonasal dysostosis; Neurodevelopmental disorder with movement abnormalities; abnormal gait; and autistic features,N/A
A4GALT,Hematologic,Blood group; P system,Pediatric
ABCB6,Hematologic,Pseudohyperkalemia; familial; 2; due to red cell leak; Blood group; Langereis system,Pediatric
ABCB7,Hematologic,Anemia; sideroblastic; and spinocerebellar ataxia,N/A
ABCC6,Hematologic,Pseudoxanthoma elasticum,Pediatric
ABCG2,Hematologic,Blood group; junior system,Pediatric
ABCG5,Hematologic,Sitosterolemia,Pediatric
ABCG8,Hematologic,Sitosterolemia,Pediatric
ABO,Hematologic,Blood group; ABO system,Pediatric
ACAD8,Hematologic,Isobutyryl-CoA dehydrogenase deficiency,Pediatric
ACD,Hematologic,Dyskeratosis congenita; autosomal dominant 6; Dyskeratosis congenita; autosomal recessive 7,Pediatric
ACHE,Hematologic,Blood group; Yt system,Pediatric
ACKR1,Hematologic,Blood group; Duffy system,Pediatric
ACTN1,Hematologic,Bleeding disorder; platelet-type; 15,N/A
ACVRL1,Hematologic,Telangiectasia; hereditary hemorrhagic; type 2,Pediatric
ADAMTS13,Hematologic,Thrombotic thrombocytopenic purpura; familial (Schulman-Upshaw syndrome),Pediatric
ADAR,Hematologic,Dyschromatosis symmetrica hereditaria; Aicardi-Goutieres syndrome 6,N/A
AIRE,Hematologic,Autoimmune polyendocrinopathy syndrome ; type I; with or without reversible metaphyseal dysplasia,Pediatric
AK1,Hematologic,Adenylate kinase deficiency; hemolytic anemia due to,Pediatric
AKT1,Hematologic,Cowden syndrome 6; Proteus syndrome ,Pediatric
ALAS2,Hematologic,Anemia; sideroblastic 1; Protoporphyria; erythropoietic; X-linked,Pediatric
ALDOA,Hematologic,Glycogen storage disease XII,Pediatric
ALG1,Hematologic,Congenital disorder of glycosylation; type Ik,Pediatric
ALG11,Hematologic,Congenital disorder of glycosylation; type Ip,Pediatric
ALG12,Hematologic,Congenital disorder of glycosylation; type Ig,Pediatric
ALG2,Hematologic,Congenital disorder of glycosylation; type Ii; Myasthenic syndrome; congenital 14,Pediatric
ALG3,Hematologic,Congenital disorder of glycosylation; type Id,Pediatric
ALG6,Hematologic,Congenital disorder of glycosylation; type Ic,Pediatric
ALG8,Hematologic,Congenital disorder of glycosylation; type Ih,Pediatric
ALG9,Hematologic,Congenital disorder of glycosylation; type Il,Pediatric
AMMECR1,Hematologic,Midface hypoplasia; hearing impairment; elliptocytosis; and nephrocalcinosis,Pediatric
AMN,Hematologic,Megaloblastic anemia 1; Norwegian type,Pediatric
ANK1,Hematologic,Spherocytosis; hereditary 1,Pediatric
ANKRD26,Hematologic,Thrombocytopenia 2,Pediatric
ANO6,Hematologic,Scott syndrome,Pediatric
AP3B1,Hematologic,Hermansky-Pudlak syndrome 2,Pediatric
APOB,Hematologic,Hypercholesterolemia; familial; 2; Hypobetalipoproteinemia; familial 1,Pediatric
APOE,Hematologic,Hyperlipoproteinemia; type III; Lipoprotein glomerulopathy; Sea-blue histiocyte disease,Pediatric
AQP1,Hematologic,Blood group; Colton,Pediatric
AQP3,Hematologic,Blood group; GIL,Pediatric
ARPC1B,Hematologic,Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease (PLTEID),Pediatric
ART4,Hematologic,Blood group; Dombrock,Pediatric
ATP11C,Hematologic,Hemolytic anemia; congenital; X-linked,N/A
ATRX,Hematologic,Alpha-thalassemia/mental retardation syndrome; Mental retardation-hypotonic facies syndrome; X-linked,N/A
B3GALNT1,Hematologic,Blood group; P system,Pediatric
B4GALT1,Hematologic,Congenital disorder of glycosylation; type IId,Pediatric
BCAM,Hematologic,Blood group; Lutheran system; Blood group; Auberger system; Lutheran; null,Pediatric
BLOC1S3,Hematologic,Hermansky-Pudlak syndrome 8,Pediatric
BLOC1S6,Hematologic,Hermansky-Pudlak syndrome 9,Pediatric
BPGM,Hematologic,Erythrocytosis; familial; 8,Pediatric
BRAF,Hematologic,Noonan syndrome; Cardiofaciocutaneous syndrome 1; LEOPARD syndrome 3,Pediatric
BRCA1,Hematologic,Breast-ovarian cancer; familial; susceptibility to; 1; Pancreatic cancer; susceptibility to; 4; Fanconi anemia; complementation group S,Pediatric (Fanconi anemia; complementation group S); (Adult (Breast-ovarian cancer; familial; susceptibility to; 1; Pancreatic cancer; susceptibility to; 4)
BRCA2,Hematologic,Breast-ovarian cancer; familial; susceptibility to; Pancreatic cancer; susceptibility to; 2; Glioma susceptibility 3; Fanconi anemia; complementation group D1; Wilms tumor; Medulloblastoma,Pediatric (Fanconi anemia; complementation group D1); Adult (Breast-ovarian cancer; familial; susceptibility to; Pancreatic cancer; susceptibility to; 2; Glioma susceptibility 3; Wilms tumor; Medulloblastoma)
BRIP1,Hematologic,Breast cancer; Fanconi anemia; complementation group J,Pediatric (Fanconi anemia; complementation group J); Adult (Breast  cancer)
BSG,Hematologic,Blood group; OK,Pediatric
C15ORF41,Hematologic,Congenital dyserythropoietic anemia type Ib,Pediatric
C3,Hematologic,Complement component 3 deficiency; autosomal recessive; Hemolytic uremic syndrome; atypical; susceptibility to; 5,Pediatric
C4A,Hematologic,Blood group; Chido/Rodgers system,Pediatric
CAD,Hematologic,Epileptic encephalopathy; early infantile; 50 (Congenital disorder of glycosylation; type Iz),Pediatric
CASP10,Hematologic,Autoimmune lymphoproliferative syndrome; type IIA,Pediatric
CBLIF,Hematologic,Intrinsic factor deficiency,Pediatric
CBS,Hematologic,Homocystinuria due to cystathionine beta-synthase deficiency,Pediatric
CCDC115,Hematologic,Congenital disorder of glycosylation; type IIo,Pediatric
CD151,Hematologic,Raph blood group,Pediatric
CD27,Hematologic,Lymphoproliferative syndrome 2,Pediatric
CD36,Hematologic,Platelet glycoprotein IV deficiency,Pediatric
CD40LG,Hematologic,Immunodeficiency; with hyper-IgM; type 1,Pediatric
CD44,Hematologic,Blood group; Indian,Pediatric
CD46,Hematologic,Hemolytic uremic syndrome; atypical; susceptibility to; 2,Pediatric
CD55,Hematologic,Complement hyperactivation; angiopathic thrombosis; and protein-losing enteropathy; Blood group; Cromer system,Pediatric
CD59,Hematologic,Hemolytic anemia; CD59-mediated; with or without immune-mediated polyneuropathy,Pediatric
CDAN1,Hematologic,Anemia; dyserythropoietic  congenital; type Ia,Pediatric
CDC42,Hematologic,Takenouchi-Kosaki syndrome,N/A
CFB,Hematologic,Hemolytic uremic syndrome; atypical; Complement factor B deficiency,Pediatric
CFH,Hematologic,Hemolytic uremic syndrome; atypical; Complement factor H deficiency,Pediatric
CFHR1,Hematologic,Hemolytic-uremic syndrome; atypical; susceptibility to,Pediatric
CFHR3,Hematologic,Hemolytic-uremic syndrome; atypical; susceptibility to,Pediatric
CFHR4,Hematologic,Hemolytic-uremic syndrome; atypical; susceptibility to,Pediatric
CFI,Hematologic,Hemolytic uremic syndrome; atypical; Complement factor I deficiency,Pediatric
CHST14,Hematologic,Ehlers-Danlos syndrome; musculocontractural type 1,Pediatric
CISD2,Hematologic,Wolfram syndrome 2,Pediatric
CLCN7,Hematologic,Osteopetrosis; autosomal dominant 2; Osteopetrosis; autosomal recessive 4,Pediatric
CLPB,Hematologic,3-methylglutaconic aciduria with cataracts; neurologic involvement; and neutropenia (MEGCANN),Pediatric
COG2,Hematologic,Congenital disorder of glycosylation; type IIq,Pediatric
COG4,Hematologic,Congenital disorder of glycosylation; type IIj,Pediatric
COG5,Hematologic,Congenital disorder of glycosylation; type IIi,Pediatric
COG6,Hematologic,Congenital disorder of glycosylation; type IIl,Pediatric
COG7,Hematologic,Congenital disorder of glycosylation; type IIe,Pediatric
COG8,Hematologic,Congenital disorder of glycosylation; type IIh,Pediatric
COX10,Hematologic,Mitochondrial complex IV deficiency; Leigh syndrome,N/A
COX4I2,Hematologic,Exocrine pancreatic insufficiency; dyserythropoietic anemia; and calvarial hyperostosis,Pediatric
CPOX,Hematologic,Coproporphyria; Harderoporphyria,Pediatric
CR1,Hematologic,Blood group; Knops system,Pediatric
CSF3R,Hematologic,Neutropenia; severe congenital; 7; autosomal recessive,Pediatric
CTC1,Hematologic,Cerebroretinal microangiopathy with calcifications and cysts 1,N/A
CTLA4,Hematologic,Autoimmune lymphoproliferative syndrome; type V,Pediatric
CTSA,Hematologic,Galactosialidosis,Pediatric
CUBN,Hematologic,Megaloblastic anemia 1; Finnish type,Pediatric
CXCR4,Hematologic,Warts; hypogammaglobulinemia; infections; and myelokathexis (WHIM) syndrome,Pediatric
CYB5A,Hematologic,46; XY disorder of sex development; Methemoglobinemia and ambiguous genitalia,Pediatric
CYB5R3,Hematologic,Methemoglobinemia due to methemoglobin reductase deficiency,Pediatric
CYCS,Hematologic,Thrombocytopenia 4,N/A
DHFR,Hematologic,Megaloblastic anemia due to dihydrofolate reductase deficiency,Pediatric
DKC1,Hematologic,Dyskeratosis congenita; X-linked; Hoyeraal-Hreidarsson syndrome,Pediatric
DNAJC19,Hematologic,3-methylglutaconic aciduria; type V,Pediatric
DNAJC21,Hematologic,Bone marrow failure syndrome 3,Pediatric
DNM2,Hematologic,Charcot-Marie-Tooth disease; dominant intermediate B; Charcot-Marie-Tooth disease; axonal; type 2M; Myopathy; centronuclear; 1; Lethal congenital contracture syndrome 5,N/A
DPAGT1,Hematologic,Myasthenic syndrome; congenital; 13; Congenital disorder of glycosylation; type Ij,Pediatric
DSE,Hematologic,Ehlers-Danlos syndrome; musculocontractural type 2,Pediatric
DTNBP1,Hematologic,Hermansky-Pudlak syndrome 7,Pediatric
EFL1,Hematologic,Shwachman-Diamond syndrome 2,Pediatric
EGLN1,Hematologic,Erythrocytosis; familial; 3,Pediatric
EIF2AK3,Hematologic,Epiphyseal dysplasia; multiple; with early-onset diabetes mellitus (Wolcott-Rallison syndrome),Pediatric
ENG,Hematologic,Hereditary hemorrhagic telangiectasia; type 1; Juvenile polyposis syndrome,Pediatric
EPAS1,Hematologic,Erthyrocytosis; familial 4,Pediatric
EPB41,Hematologic,Ellipsocytosis 1,Pediatric
EPB42,Hematologic,Spherocytosis; type 5,Pediatric
EPHB2,Hematologic,Bleeding disorder; platelet-type; 22,Pediatric
EPO,Hematologic,Erythrocytosis; familial; 5; Diamond-Blackfan anemia-like,Pediatric
EPOR,Hematologic,Erythrocytosis; familial; 1,Pediatric
ERBB3,Hematologic,Erythroleukemia; familial; susceptibility to (AD),N/A
ERCC4,Hematologic,Fanconi anemia; complementation group Q; Xeroderma pigmentosum; group F,Pediatric
ERCC6L2,Hematologic,Bone marrow failure syndrome 2,Pediatric
ERMAP,Hematologic,Blood group; Scianna system; Blood group; Radin,Pediatric
ETV6,Hematologic,Thrombocytopenia 5,Pediatric
F10,Hematologic,Factor X deficiency,Pediatric
F11,Hematologic,Factor XI deficiency,Pediatric
F12,Hematologic,Angioedema; hereditary; type III,Pediatric
F13A1,Hematologic,Factor XIIIA deficiency,Pediatric
F13B,Hematologic,Factor XIIIB deficiency,Pediatric
F2,Hematologic,Prothrombin deficiency; congenital; Thrombophilia due to thrombin defect ,Pediatric
F5,Hematologic,Thrombophilia due to activated protein C resistance; Factor V deficiency,Pediatric
F7,Hematologic,Factor VII deficiency,Pediatric
F8,Hematologic,Hemophilia A,Pediatric
F9,Hematologic,Hemophilia B; Thrombophilia; X-linked; due to factor IX defect; Warfarin sensitivity,Pediatric
FANCA,Hematologic,Fanconi anemia; complementation group A,Pediatric
FANCB,Hematologic,Fanconi anemia;complementation group B,Pediatric
FANCC,Hematologic,Fanconi anemia; complementation group C,Pediatric
FANCD2,Hematologic,Fanconi anemia; complementation group D2,Pediatric
FANCE,Hematologic,Fanconi anemia; complementation group E,Pediatric
FANCF,Hematologic,Fanconia anemia; complementation group F,Pediatric
FANCG,Hematologic,Fanconi anemia type G,Pediatric
FANCI,Hematologic,Fanconi anemia; complementation group I,Pediatric
FANCL,Hematologic,Fanconi anemia; complementation group L,Pediatric
FANCM,Hematologic,Fanconi anemia type M; Premature ovarian failure 15,Pediatric
FAS,Hematologic,Autoimmune lymphoproliferative syndrome; type IA,Pediatric
FASLG,Hematologic,Autoimmune lymphoproliferative syndrome; type IB,Pediatric
FECH,Hematologic,Protoporphyria; erythropoietic 1,Pediatric
FERMT3,Hematologic,Leukocyte adhesion deficiency; type III,Pediatric
FGA,Hematologic,Afibrinogenemia; congenital; Dysfibrinogenemia; congenital; Hypodysfibrinogenemia; congenital; Familial visceral amyloidosis,Pediatric
FGB,Hematologic,Afibrinogenemia; congenital; Dysfibrinogenemia; congenital; Hypodysfibrinogenemia; congenital,Pediatric
FGG,Hematologic,Afibrinogenemia; congenital; Dysfibrinogenemia; congenital; Hypodysfibrinogenemia; congenital; Hypodysfibrinogenemia,Pediatric
FLI1,Hematologic,Thrombocytopenia; Paris-Trousseau type; Bleeding disorder; platelet type 21,Pediatric
FLNA,Hematologic,Cardiac valvular dysplasia; X-linked; Heterotopia; periventricular; Ehlers-Danlos variant;  Intestinal pseudoobstruction; neuronal; X-linked/Congenital short bowel syndrome,Pediatric
FOXP3,Hematologic,Immunodysregulation; polyendocrinopathy; and enteropathy; X-linked (IPEX),Pediatric
FTH1,Hematologic,Hemochromatosis; type 5,Pediatric
FTL,Hematologic,L-ferritin deficiency; Neurodegeneration with brain iron accumulation 3; Hyperferritinemia with or without cataract,N/A
FUT1,Hematologic,Bombay phenotype; Para-Bombay phenotype; H-deficient blood group; Reunion variant,Pediatric
FUT3,Hematologic,Blood group; Lewis,Pediatric
FYB1,Hematologic,Thrombocytopenia 3,Pediatric
G6PC,Hematologic,Glycogen storage disease Ia,Pediatric
G6PC3,Hematologic,Neutropenia; severe congenital; 4; autosomal recessive; Dursun syndrome,Pediatric
G6PD,Hematologic,Glucose-6-phosphate dehydrogenase deficiency,Pediatric
GALT,Hematologic,Galactosemia,Pediatric
GATA1,Hematologic,Thrombocytopenia with beta-thalessemia; X-linked; Anemia; X-linked; with or without thrombocytopenia and platelet abnormalities; Dyserythropoietic anemia with thrombocytopenia,Pediatric
GATA2,Hematologic,Immunodeficiency 21; Emberger syndrome; Myelodysplastic syndrome; Acute myeloid leukemia; familial; Chronic neutropenia associated with monocytopenia; evolving to myelodysplasia and acute myeloid leukemia,Pediatric
GBA,Hematologic,Gaucher disease,Pediatric
GCLC,Hematologic,Gamma-glutamylcysteine synthetase deficiency,Pediatric
GCNT2,Hematologic,Blood group; Ii; Adult i phenotype without cataract; Cataract 13 with adult i phenotype,Pediatric
GDF2,Hematologic,Hereditary hemorrhagic telangiectasia; type 5,Pediatric
GFI1B,Hematologic,Bleeding disorder; platelet-type; 17,Pediatric
GGCX,Hematologic,Vitamin K-dependent clotting factors; combined deficiency of; 1; Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency,Pediatric
GLRX5,Hematologic,Anemia; sideroblastic 3; pyridoxine-refractory,Pediatric
GP1BA,Hematologic,Bernard-Soulier syndrome; type A2; Bernard-Soulier syndrome; type A1; Pseudo-von Willebrand disease,Pediatric
GP1BB,Hematologic,Bernard-Soulier syndrome; Giant platelet disorder; isolated,Pediatric
GP6,Hematologic,Bleeding disorder; platelet-type; 11,Pediatric
GP9,Hematologic,Bernard-Soulier syndrome; type C,Pediatric
GPI,Hematologic,Hemolytic anemia; nonspherocytic due to glucose phosphate isomerase deficiency,Pediatric
GSS,Hematologic,Glutathione synthetase deficiency,Pediatric
GTF2E2,Hematologic,Trichothiodystrophy 6; nonphotosensitive,N/A
GYPA,Hematologic,Blood group; MN locus; Blood group; Erik,Pediatric
GYPB,Hematologic,Blood group; Ss,Pediatric
GYPC,Hematologic,Blood group; Gerbich; Blood group; Webb; Blood group; Duch,Pediatric
HAMP,Hematologic,Hemochromatosis; type 2B,Pediatric
HBA1,Hematologic,Heinz body anemias; Erythrocytosis; familial; 7; Alpha-thalassemia (Hemoglobin Bart syndrome); Alpha-thalassemia (Hemoglobin H disease),Pediatric
HBA2,Hematologic,Heinz body anemias; Erythrocytosis; familial; 7; Alpha-thalassemia (Hemoglobin Bart syndrome); Alpha-thalassemia (Hemoglobin H disease),Pediatric
HBB,Hematologic,Beta-thalassemia; Heinz body anemias; Erythrocytosis; familial 6; Sickle cell disease; Thalassemia-beta; dominant inclusion body; Other Thalassemias/Hemoglobinopathies,Pediatric
HBG1,Hematologic,Hereditary persistence of fetal hemoglobin,N/A
HBG2,Hematologic,Cyanosis; transient neonatal,Pediatric
HFE,Hematologic,Hemochromatosis,Pediatric
HJV,Hematologic,Hemochromatosis; type 2A,Pediatric
HK1,Hematologic,Hemolytic anemia; nonspherocytic; due to hexokinase deficiency,Pediatric
HMBS,Hematologic,Hydroxymethylbilane synthase deficiency; Porphyria; acute intermittent,Pediatric
HMOX1,Hematologic,Heme oxygenase 1 deficiency,N/A
HOXA11,Hematologic,Radioulnar synostosis with amegakaryocytic thrombocytopenia 1,Pediatric
HP,Hematologic,Anhaptoglobinemia; Hypohaptoglobinemia,Pediatric
HPRT1,Hematologic,Kelley-Seegmiller syndrome; Lesch-Nyhan syndrome,Pediatric
HPS1,Hematologic,Hermansky-Pudlak syndrome 1,Pediatric
HPS3,Hematologic,Hermansky-Pudlak syndrome 3,Pediatric
HPS4,Hematologic,Hermansky-Pudlak syndrome 4,Pediatric
HPS5,Hematologic,Hermansky-Pudlak syndrome 5,Pediatric
HPS6,Hematologic,Hermansky-Pudlak syndrome 6,Pediatric
HRG,Hematologic,Thrombophilia due to histidine-rich glycoprotein deficiency,Adult
HSPA9,Hematologic,Anemia; sideroblastic 4,Pediatric
ICAM4,Hematologic,Blood group; Landsteiner-Wiener,Pediatric
ITGA2B,Hematologic,Bleeding disorder; platelet-type; 16; autosomal dominant; Glanzmann thrombasthenia,AD/AR
ITGB3,Hematologic,Bleeding disorder; platelet-type; 16; autosomal dominant; Glanzmann thrombasthenia; Thrombocytopenia; neonatal alloimmune,Pediatric
JAK2,Hematologic,Thrombocythemia 3,Adult
KCNN4,Hematologic,Dehydrated hereditary stomatocytosis 2,Pediatric
KEL,Hematologic,Blood group; Kell system,Pediatric
KLF1,Hematologic,Anemia; dyserythropoietic congenital; type IV; Blood group; Lutheran inhibitor,Pediatric
KLKB1,Hematologic,Prekallikrein deficiency,N/A
KNG1,Hematologic,High molecular weight kininogen deficiency,N/A
KRAS,Hematologic,Noonan syndrome; Cardiofaciocutaneous syndrome,Pediatric
LARS1,Hematologic,Infantile liver failure syndrome 1,N/A
LBR,Hematologic,Reynolds syndrome; Pelger-Huet anomaly; Pelger-Huet anomaly with mild skeletal anomalies; Greenberg skeletal dysplasia,N/A
LCAT,Hematologic,Lecithin:cholesterol acyltransferase deficiency (Norum disease); Fish-eye disease,Pediatric
LIG4,Hematologic,LIG4 syndrome; Severe combined immunodeficiency with sensitivity to ionizing radiation,Pediatric
LMAN1,Hematologic,Combined factor V and VIII deficiency,Pediatric
LMBRD1,Hematologic,Methylmalonic aciduria and homocystinuria; cblF type,Pediatric
LMNA,Hematologic,Cardiomyopathy; dilated; 1A; Heart-hand syndrome; Slovenian type; Emery-Dreiffus muscular dystrophy 2; autosomal dominant; Emery-Dreiffus muscular dystrophy 3; autosomal recessive; Muscular dystrophy; congenital; LMNA-related; Muscular dystrophy; limb-girdle; type 1B; Cardiomyopathy; dilated; with hypergonadotropic hypogonadism (Malouf syndrome); Lipodystrophy; familial partial; 2 (Dunnigan type),Pediatric
LPIN2,Hematologic,Majeed syndrome,Pediatric
LPL,Hematologic,Hyperlipidemia; familial combined; 3; Lipoprotein lipase deficiency,Pediatric
LRBA,Hematologic,Common variable immunodeficiency 8; with autoimmunity,Pediatric
LYST,Hematologic,Chediak-Higashi syndrome,Pediatric
LZTR1,Hematologic,Schwannomatosis 2; Noonan syndrome 10; Noonan syndrome 2,Pediatric (Noonan syndrome 10; Noonan syndrome 2); Adult (Schwannomatosis 2)
MAD2L2,Hematologic,Fanconi anemia; complementation group V,Pediatric
MAP2K1,Hematologic,Cardiofaciocutaneous syndrome 3,Pediatric
MARS1,Hematologic,Interstitial lung and liver disease,Pediatric
MASTL,Hematologic,Thrombocytopenia 2,Pediatric
MCFD2,Hematologic,Factor V & Factor VIII; combined deficiency of,Pediatric
MECOM,Hematologic,Radioulnar synostosis with amegakaryocytic thrombocytopenia 2,Pediatric
MGAT2,Hematologic,Congenital disorder of glycosylation; type IIa,Pediatric
MMAA,Hematologic,Methylmalonic acidemia; cblA type,Pediatric
MMAB,Hematologic,Methylmalonic acidemia; cblB type,Pediatric
MMACHC,Hematologic,Methylmalonic aciduria and homocystinuria; cblC type,Pediatric
MMADHC,Hematologic,Methylmalonic aciduria and homocystinuria; cblD type,Pediatric
MMUT,Hematologic,Methylmalonic acidemia due to methylmalonyl-CoA mutase deficiency,Pediatric
MOGS,Hematologic,Congenital disorder of glycosylation; type IIb,Pediatric
MPDU1,Hematologic,Congenital disorder of glycosylation; type If,Pediatric
MPI,Hematologic,Congenital disorder of glycosylation; type Ib ,Pediatric
MPIG6B,Hematologic,Thrombocytopenia; anemia; and myelofibrosis,Pediatric
MPL,Hematologic,Thrombocythemia 2; Amegakaryocytic thrombocytopenia,Pediatric
MT-ATP6,Hematologic,Myopathy; lactic acidosis; and sideroblastic anemia 3,N/A
MT-CO1,Hematologic,Deafness; mitochondrial,Pediatric
MTHFD1,Hematologic,Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia (CIMAH),Pediatric
MTHFR,Hematologic,Homocystinuria due to MTHFR deficiency,Pediatric
MTM1,Hematologic,Myopathy; centronuclear; X-linked,Pediatric
MTR,Hematologic,Homocystinuria-megaloblastic anemia; cblG complementation type,Pediatric
MTRR,Hematologic,Homocystinuria-megaloblastic anemia; cobalamin E complementation type,Pediatric
MTTP,Hematologic,Abetalipoproteinemia,Pediatric
MYH9,Hematologic,Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss,Pediatric
NAXD,Hematologic,Encephalopathy; progressive; early-onset; with brain edema and/or leukoencephalopathy; 2,Pediatric
NBAS,Hematologic,Infantile liver failure syndrome 2; Short stature; optic nerve atrophy; and Pelger-Huet anomaly (SOPH syndrome),N/A
NBEAL2,Hematologic,Gray platelet syndrome,Pediatric
NBN,Hematologic,Breast cancer; susceptibility to; Nijmegen breakage syndrome,Pediatric (Nijmegen breakage syndrome); Adult (Breast cancer; susceptibility to)
NGLY1,Hematologic,Congenital disorder of deglycosylation,Pediatric
NHLRC2,Hematologic,Fibrosis; neurodegeneration; and cerebral angiomatosis,N/A
NHP2,Hematologic,Dyskeratosis congenita; autosomal recessive 2,Pediatric
NIPBL,Hematologic,Cornelia de Lange syndrome 1,N/A
NLRP1,Hematologic,Palmoplantar carcinoma; multiple self-healing; Autoinflammation with arthritis and dyskeratosis,Pediatric
NOP10,Hematologic,Dyskeratosis congenita; autosomal recessive 1,Pediatric
NPHP1,Hematologic,Joubert syndrome 4; Nephronophthisis 1; Senior-Loken syndrome 1,N/A
NPHP3,Hematologic,Nephronophthisis 3; Meckel syndrome 7; Renal-hepatic-pancreatic dysplasia 1,N/A
NT5C3A,Hematologic,Uridine 5-prime monophosphate hydrolase deficiency; hemolytic anemia due to,Pediatric
OSTM1,Hematologic,Osteopetrosis; autosomal recessive 5,N/A
P2RY12,Hematologic,Bleeding disorder; platelet-type; 8,Pediatric
PACS2,Hematologic,Epileptic encephalopathy; early infantile; 66,N/A
PALB2,Hematologic,Breast cancer; Pancreatic cancer; susceptibility to 3; Fanconi anemia; complementation group N,Pediatric (Fanconi anemia; complementation group N); Adult (Breast cancer; Pancreatic cancer; susceptibility to 3)
PANK2,Hematologic,Hypoprebetalipoproteinemia; acanthocytosis; retinitis pigmentosa; and pallidal degeneration; Neurodegeneration with brain iron accumulation 1  ,N/A
PARN,Hematologic,Pulmonary fibrosis and/or bone marrow failure; telomere-related 4; Dyskeratosis congenita; autosomal recessive 6,Pediatric
PCCA,Hematologic,Propionic acidemia,Pediatric
PCCB,Hematologic,Propionic acidemia,Pediatric
PDSS1,Hematologic,Coenzyme Q10 deficiency 2,Pediatric
PFKM,Hematologic,Glycogen storage disease VII,Pediatric
PGK1,Hematologic,Phosphoglycerate kinase 1 deficiency,Pediatric
PIEZO1,Hematologic,Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema,Pediatric
PIGM,Hematologic,Glycosylphosphatidylinositol deficiency,Pediatric
PKLR,Hematologic,Pyruvate kinase deficiency of red cells,Pediatric
PLA2G4A,Hematologic,Gastrointestinal ulceration; recurrent; with dysfunctional platelets,Pediatric
PLAU,Hematologic,Quebec platelet disorder,Pediatric
PLG,Hematologic,Plasminogen deficiency; type I,Pediatric
PMM2,Hematologic,Congenital disorder of glycosylation; type Ia,Pediatric
PRDX1,Hematologic,Methylmalonic aciduria and homocystinuria; cblC type; digenic,Pediatric
PRF1,Hematologic,Hemophagocytic lymphohistiocytosis; familial; 2; Lymphoma; non-Hodgkin; Aplastic anemia; adult-onset ,Pediatric
PRKACG,Hematologic,Bleeding disorder; platelet-type; 19,Pediatric
PROC,Hematologic,Thrombophilia; hereditary; due to protein C deficiency,Pediatric
PROS1,Hematologic,Thrombophilia; hereditary; due to protein S deficiency,Pediatric
PRPS1,Hematologic,Arts syndrome; Deafness; X-linked 1; Phosphoribosylpyrophosphate synthetase I superactivity ,Pediatric
PSMA3,Hematologic,Proteasome-associated autoinflammatory syndrome 2,Pediatric
PSMB4,Hematologic,Proteasome-associated autoinflammatory syndrome 3,Pediatric
PSMB8,Hematologic,Proteasome-associated autoinflammatory syndrome 1,Pediatric
PSMB9,Hematologic,Proteasome-associated autoinflammatory syndrome 3,Pediatric
PTPN11,Hematologic,Noonan syndrome 1; LEOPARD syndrome 1,Pediatric
PUS1,Hematologic,Myopathy; lactic acidosis; and sideroblastic anemia 1,Pediatric
RAB27A,Hematologic,Griscelli syndrome; type 2; Elejalde syndrome,Pediatric
RAF1,Hematologic,Cardiomyopathy; dilated; 1NN; LEOPARD syndrome 2; Noonan syndrome 5,Pediatric
RASGRP2,Hematologic,Bleeding disorder; platelet-type; 18,Pediatric
RFT1,Hematologic,Congenital disorder of glycosylation; type In,Pediatric
RFWD3,Hematologic,Fanconi anemia; complementation group W,Pediatric
RHAG,Hematologic,Overhydrated hereditary stomatocytosis; Anemia; hemolytic; Rh-null; regulator type; Anemia; hemolytic;Rh-Mod type; RHAG blood group,Pediatric
RHCE,Hematologic,Rhesus blood group,Pediatric
RMRP,Hematologic,Anauxetic dysplasia 1; Cartilage-hair hypoplasia; Metaphyseal dysplasia without hypotrichosis,Pediatric
RNASEH2A,Hematologic,Aicardi-Goutieres syndrome 4,N/A
RNASEH2B,Hematologic,Aicardi-Goutieres syndrome 2,N/A
RNASEH2C,Hematologic,Aicardi-Goutieres syndrome 3,N/A
RPL11,Hematologic,Diamond-Blackfan anemia 7,Pediatric
RPL15,Hematologic,Diamond-Blackfan anemia 12,Pediatric
RPL18,Hematologic,Diamond-Blackfan anemia 18,Pediatric
RPL26,Hematologic,Diamond-Blackfan anemia 11,Pediatric
RPL27,Hematologic,Diamond-Blackfan anemia 16,Pediatric
RPL35,Hematologic,Diamond-Blackfan anemia 19,Pediatric
RPL35A,Hematologic,Diamond-Blackfan anemia 5,Pediatric
RPL5,Hematologic,Diamond-Blackfan anemia 6,Pediatric
RPS10,Hematologic,Diamond-Blackfan anemia 9,Pediatric
RPS15A,Hematologic,Diamond-Blackfan anemia 20,Pediatric
RPS17,Hematologic,Diamond-Blackfan anemia 4,Pediatric
RPS19,Hematologic,Diamond-Blackfan anemia 1,Pediatric
RPS24,Hematologic,Diamond-Blackfan anemia 3,Pediatric
RPS26,Hematologic,Diamond-Blackfan anemia 10,Pediatric
RPS27,Hematologic,Diamond-Blackfan anemia 17,Pediatric
RPS28,Hematologic,Diamond-Blackfan anemia 15 with mandibulofacial dysostosis,Pediatric
RPS29,Hematologic,Diamond-Blackfan anemia 13,Pediatric
RPS7,Hematologic,Diamond-Blackfan anemia 8,Pediatric
RTEL1,Hematologic,Pulmonary fibrosis and/or bone marrow failure; telomere-related 3; Dyskeratosis congenita; autosomal dominant 4; Dyskeratosis congenita; autosomal recessive 5,Pediatric
RUNX1,Hematologic,Platelet disorder; familial; with associated myeloid malignancy,Pediatric
SAMD9,Hematologic,Mirage syndrome; Tumoral calcinosis; normophosphatemic,Pediatric
SAMD9L,Hematologic,Ataxia-pancytopenia syndrome,Pediatric
SAMHD1,Hematologic,Aicardi-Goutieres syndrome 5,Pediatric
SBDS,Hematologic,Shwachman-Diamond syndrome; Aplastic anemia,Pediatric
SEC23B,Hematologic,Cowden syndrome 7; Anemia; dyserythropoietic congenital; type II ,Pediatric (Anemia; dyserythropoietic congenital; type II); Adult (Cowden syndrome 7)
SEMA7A,Hematologic,Blood group; John Milton Hagen,Pediatric
SERPINC1,Hematologic,Antithrombin III deficiency,Pediatric
SERPIND1,Hematologic,Heparin cofactor II deficiency,N/A
SERPINE1,Hematologic,Plasminogen activator inhibitor-1 deficiency,Pediatric
SERPINF2,Hematologic,Alpha-2-plasmin inhibitor deficiency,Pediatric
SFXN4,Hematologic,Combined oxidative phosphorylation deficiency 18,N/A
SH2D1A,Hematologic,Lymphoproliferative syndrome; X-linked; 1,Pediatric
SHOC2,Hematologic,Noonan-like syndrome with loose anagen hair 1,Pediatric
SKIV2L,Hematologic,Trichohepatoenteric syndrome 2,Pediatric
SLC11A2,Hematologic,Anemia; hypochromic microcytic; with iron overload,Pediatric
SLC14A1,Hematologic,Blood group; Kidd,Pediatric
SLC19A2,Hematologic,Thiamine-responsive megaloblastic anemia syndrome,Pediatric
SLC25A13,Hematologic,Citrin deficiency,Pediatric
SLC25A38,Hematologic,Anemia; sideroblastic 2; pyridoxine-refractory,Pediatric
SLC2A1,Hematologic,GLUT1 deficiency syndrome 1; GLUT1 deficiency syndrome 2; Dystonia 9; Epilepsy; idiopathic generalized; susceptibility to; 12; Stomatin-deficient cryohydrocytosis with neurologic defects,Pediatric
SLC30A10,Hematologic,Hypermanganesemia with dystonia; polycythemia; and cirrhosis,Pediatric
SLC35A1,Hematologic,Congenital disorder of glycosylation; type IIf,Pediatric
SLC35A2,Hematologic,Congenital disorder of glycosylation; type IIm,Pediatric
SLC40A1,Hematologic,Hemochromatosis; type 4,Pediatric
SLC46A1,Hematologic,Folate malabsorption; hereditary,Pediatric
SLC4A1,Hematologic,Spherocytosis; type 4; Ovalcytosis; Southeast Asian; Cryohydrocytosis; Renal tubular acidosis; distal; with hemolytic anemia; Renal tubular acidosis; distal; autosomal dominant; Renal tubular acidosis; distal; autosomal recessive; Blood group; Wright; Blood group; Waldner; Blood group; Diego; Blood group; Froese; Blood group; Swann,Pediatric
SLC4A11,Hematologic,Cryohydrocytosis,Pediatric
SLC7A7,Hematologic,Lysinuric protein intolerance,Pediatric
SLFN14,Hematologic,Bleeding disorder; platelet-type; 20,Pediatric
SLX4,Hematologic,Fanconi anemia; complementation group P,Pediatric
SMAD4,Hematologic,Hereditary hemorrhagic telangiectasia; type 1; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome; Polyposis; juvenile intestinal; Myhre syndrome,Pediatric
SMARCD2,Hematologic,Specific granule defiency 2,Pediatric
SMIM1,Hematologic,Blood group; Vel system,Pediatric
SNX10,Hematologic,Osteopetrosis; autosomal recessive 8,Pediatric
SON,Hematologic,ZTTK syndrome,N/A
SOS1,Hematologic,Noonan syndrome 4,Pediatric
SOS2,Hematologic,Noonan syndrome 9,Pediatric
SPATA5,Hematologic,Epilepsy; hearing loss; and mental retardation syndrome (EHLMRS),Pediatric
SPINT2,Hematologic,Diarrhea 3; secretory sodium; congenital; with or without other congenital anomalies,Pediatric
SPTA1,Hematologic,Spherocytosis; type 3; Pyropoikilocytosis ; hereditary; Ellipsocytosis 2,Pediatric
SPTB,Hematologic,Spherocytosis; type 2; Ellipsocytosis 3,Pediatric
SPTBN4,Hematologic,Spherocytosis; type 3; Pyropoikilocytosis; hereditary; Ellipsocytosis 2,N/A
SRC,Hematologic,Thrombocytopenia; autosomal dominant; 6,Pediatric
SRD5A3,Hematologic,Kahrizi syndrome; Congenital disorder of glycosylation; type Iq,Pediatric
SRP72,Hematologic,Bone marrow failure syndrome 1,Pediatric
STEAP3,Hematologic,Hypochromic microcytic anemia with iron overload 2,Pediatric
STIM1,Hematologic,Stormorken syndrome; Immunodeficiency 10,Pediatric
STING1,Hematologic,STING-associated vasculopathy; infantile-onsent (SAVI),N/A
STN1,Hematologic,Cerebroretinal microangiopathy with calcifications and cysts 2,Pediatric
STT3B,Hematologic,Congenital disorder of glycosylation; type Ix,N/A
TALDO1,Hematologic,Transaldolase deficiency,N/A
TBXA2R,Hematologic,Bleeding disorder; platelet-type 13; susceptibility to,Pediatric
TBXAS1,Hematologic,Ghosal hematodiaphyseal syndrome,Pediatric
TCIRG1,Hematologic,Osteopetrosis; autosomal recessive 1,Pediatric
TCN2,Hematologic,Transcobalamin II deficiency,Pediatric
TERC,Hematologic,Dyskeratosis congenita; autosomal dominant 1; Aplastic anemia; Pulmonary fibrosis and/or bone marrow failure; telomere-related 2,Pediatric
TERT,Hematologic,Aplastic anemia; Dyskeratosis congenita; autosomal dominant; Dyskeratosis congenita; autosomal recessive; Pulmonary fibrosis and/or bone marrow failure; telomere-related 1,Pediatric
TF,Hematologic,Atransferrinemia,Pediatric
TFR2,Hematologic,Hemochromatosis; type 3,Pediatric
TFRC,Hematologic,Immunodeficiency 46,Pediatric
TGFB1,Hematologic,Camurati-Engelmann disease; Inflammatory bowel disease; immunodeficiency; and encephalopathy,Pediatric
THBD,Hematologic,Thrombophilia due to thrombomodulin defect; Hemolytic uremic syndrome; atypical; susceptibility to; 6,Pediatric (Hemolytic uremic syndrome; atypical; susceptibility to; 6); Adult (Thrombophilia due to thrombomodulin defect)
THPO,Hematologic,Thrombocythemia 1,Pediatric
TINF2,Hematologic,Dyskeratosis congenita; autosomal dominant 3; Revesz syndrome,Pediatric
TMEM165,Hematologic,Congenital disorder of glycosylation; type IIk,N/A
TMEM199,Hematologic,Congenital disorder of glycosylation; type IIp,Pediatric
TMPRSS6,Hematologic,Iron-refractory iron deficiency anemia,Pediatric
TNFSF11,Hematologic,Osteopetrosis; autosomal recessive 2,Pediatric
TONSL,Hematologic,Spondyloepimetaphyseal dysplasia; sponastrime type,N/A
TP53,Hematologic,Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma; intracranial; Osteogenic sarcoma; Breast cancer; familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer; Bone marrow failure syndrome 5,Pediatric
TPI1,Hematologic,Triosephosphate isomerase deficiency,Pediatric
TREX1,Hematologic,Aicardi-Goutieres syndrome 1,Pediatric
TRNT1,Hematologic,Sideroblastic anemia with B-cell immunodeficiency; periodic fevers; and developmental delay,Pediatric
TSR2,Hematologic,Diamond-Blackfan anemia 14 with mandibulofacial dysostosis,Pediatric
TTC37,Hematologic,Trichohepatoenteric syndrome 1,Pediatric
TUBB1,Hematologic,Macrothrombocytopenia; autosomal dominant; TUBB1-related,N/A
UBE2T,Hematologic,Fanconi anemia; complementation group T,Pediatric
UBR1,Hematologic,Johanson-Blizzard syndrome,Pediatric
UMPS,Hematologic,Orotic aciduria,Pediatric
UNC13D,Hematologic,Hemophagocytic lymphohistiocytosis; familial 3,Pediatric
UROD,Hematologic,Porphyria; hepatoerythropoietic; Porphyria cutanea tarda ,Pediatric
UROS,Hematologic,Porphyria; congenital erythropoietic,Pediatric
USP18,Hematologic,Pseudo-TORCH syndrome 2,N/A
VHL,Hematologic,Von Hippel Lindau; Erythrocytosis; familial; 2 (Chuvash polycythemia); Pheochromocytoma,Pediatric
VKORC1,Hematologic,Vitamin K-dependent clotting factors; combined deficiency of; 2; Drug metabolism; VKORC1-related,Pediatric
VPS13A,Hematologic,Choreoacanthocytosis,N/A
VWF,Hematologic,von Willebrand disease; type 1; von Willebrand disease; type 2A; von Willebrand disease; type 3,Pediatric
WAS,Hematologic,Wiskott-Aldrich syndrome; Thrombocytopenia 1; Neutropenia; severe congenital; X-linked,Pediatric
WIPF1,Hematologic,Wiskott-Aldrich syndrome 2,Pediatric
WRAP53,Hematologic,Dyskeratosis congenita; autosomal recessive 3,Pediatric
XG,Hematologic,XG blood group,Pediatric
XIAP,Hematologic,Lymphoproliferative syndrome; X-linked; 2,Pediatric
XK,Hematologic,McLeod syndrome,Pediatric
YARS2,Hematologic,Myopathy; lactic acidosis; and sideroblastic anemia 2,Pediatric
